Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003785	s-cea	ug/l (ug/l)	22077	83311	0.00%
3003785	p-cea	ug/l (ug/l)	12422	50740	2.99%
3003785	s-cea	— (—)	10273	26282	100.00%	Distribution not available
3003785	p-cea	— (—)	5563	13033	100.00%	Distribution not available
3003785	s-cea	ug/l______ (ug/l)	1163	3766	0.00%
3003785	s-karsinoembryonaalinenantigeeni	ug/l______ (ug/l)	448	1053	0.00%
3003785	s-cea	µg/l (ug/l)	386	635	0.00%
3003785	s-ceakym	ug/l______ (ug/l)	118	141	0.00%
3003785	s-karsinoembryonaalinenantigeeni	ug/l (ug/l)	55	68	0.00%
3003785	s-cea	µg/L (ug/l)	36	51	0.00%
3003785	p-cea	UG/L (ug/l)	14	19	0.00%
3003785	s-cea	UG/L (ug/l)	7	7	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Unspecified jaundice

738

1689

6.06

323.01

5.5

4.2

41.88

21.77

ug/l

0.77

680

1401

Other diseases of intestine

1736

6743

3.04

322.70

5.1

4.4

16.00

35.03

ug/l

2.05

1405

5578

Pneumonia, organism unspecified

7233

30773

1.70

322.70

4.1

4.3

20.84

26.89

ug/l

0.88

6047

24443

Persons encountering health services in other circumstances, wide

8893

29386

1.63

320.88

4.3

4.2

19.30

28.23

ug/l

1.45

7163

23692

Other and unspecified iron deficiency

3326

16904

2.18

318.55

4.2

4.1

12.61

23.78

ug/l

2.35

2757

13762

Explicit Sepsis

4180

20773

2.00

318.02

4.4

4.3

22.43

28.04

ug/l

0.68

3586

17047

Malaise and fatigue

4539

19748

1.94

317.96

3.7

4.2

29.40

26.49

ug/l

0.20

3709

15981

Examination and observation for other reasons

4692

14442

1.95

315.51

4.0

4.6

16.15

35.03

ug/l

3.31

3784

11609

Malignant neoplasm of urinary organs, including Hilmo

889

2298

4.46

314.76

3.3

1.5

15.34

15.01

ug/l

0.01

709

1754

Secondary and unspecified malignant neoplasm of lymph nodes

703

1539

5.41

310.12

2.9

1.5

13.63

2.72

ug/l

2.87

543

1141

Secondary uncertain malignant neoplasm

1757

2689

8.66

307.65

4.0

1.5

76.53

13.35

ug/l

3.35

1493

2033

Other symptoms and signs involving the digestive system and abdomen

1861

6766

3.22

307.65

3.5

4.1

29.01

18.95

ug/l

0.25

1515

5398

Acute pancreatitis

1981

8148

2.80

307.65

4.3

8.86

30.35

ug/l

3.39

1647

6663

Other bacterial diseases

9309

29880

2.26

307.65

4.8

4.1

35.43

22.79

ug/l

1.50

7829

23752

Malignant neoplasm of breast, HER-negative

1888

4388

4.92

307.65

3.6

1.5

13.93

2.70

ug/l

4.86

1438

3274

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7718

32096

1.68

307.65

4.2

4.3

22.09

26.08

ug/l

0.48

6428

25439

Renal tubulo-interstitial diseases

7402

31919

1.81

307.65

4.4

4.2

16.19

28.49

ug/l

4.13

6220

25435

Malignant neoplasm of digestive organs, including Hilmo

15204

7527

40.90

307.65

7.8

1.5

39.36

6.54

ug/l

9.05

13812

5668

Other diseases of intestines

8801

24663

2.13

307.65

4.5

4.1

16.34

32.40

ug/l

4.84

7067

19602

Serous carcinoma of ovary, including Hilmo

599

635

16.89

307.65

1.9

1.4

4.05

2.68

ug/l

1.03

431

480

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

2063

3162

8.77

307.65

5.2

1.5

24.02

11.78

ug/l

0.68

1758

2376

L02BG Aromatase inhibitors

4222

14429

3.70

307.65

4.5

3.9

17.51

21.13

ug/l

0.51

3352

11588

Malignant neoplasm of breast, including Hilmo

5957

6187

8.01

307.65

4.0

1.5

15.93

2.67

ug/l

9.85

4535

4491

Artificial opening status

1102

2197

8.80

307.65

9.7

4.3

12.87

21.66

ug/l

1.04

970

1837

Benign neoplasm of colon, rectum, anus and anal canal

8059

28572

2.79

307.65

4.8

4.1

14.77

29.99

ug/l

2.89

6778

23350

Malignant neoplasm of other and unspecified female genital organs

371

335

27.61

307.65

1.7

1.5

4.59

2.59

ug/l

0.47

221

253

Malignant neoplasm of prostate, including Hilmo

1766

3409

3.33

307.65

4.3

1.5

22.37

11.13

ug/l

0.62

1451

2579

Adenocarcinoma and ductal carcinoma of pancreas

967

687

38.53

307.65

7.9

1.4

90.85

2.73

ug/l

2.13

931

516

Benign neoplasm: Rectum

2197

9032

2.97

307.65

5.2

4.3

10.58

25.88

ug/l

3.76

1868

7488

Malignant neoplasm of pancreas, including Hilmo

2269

1759

29.62

307.65

5.9

1.4

59.27

18.97

ug/l

1.20

2128

1322

Anaemias

1849

1453

9.25

307.65

4.6

1.9

29.85

13.73

ug/l

0.79

1473

959

Malignant neoplasm of skin, including Hilmo

3676

8571

3.13

307.65

4.0

1.5

16.29

6.10

ug/l

1.11

2945

6396

Tramadol

6328

20526

1.97

307.65

4.0

21.54

19.66

ug/l

0.18

5223

16031

Adenocarcinoma and papilloma adenocarcinoma of rectum

3524

1973

89.34

307.65

10.6

1.4

34.82

17.21

ug/l

0.53

3231

1489

Malignant neoplasm of bronchus and lung, including Hilmo

2873

4022

7.79

307.65

3.5

1.5

60.28

9.82

ug/l

4.51

2616

3049

Personal history of malignant neoplasm

1606

3526

7.13

307.65

2.8

4.2

3.44

25.19

ug/l

3.02

1090

2838

Follow-up examination after treatment for malignant neoplasms

1616

4757

4.56

307.65

6.6

4.4

12.17

24.48

ug/l

1.53

1388

3914

Fentanyl

1379

4249

4.04

307.65

5.9

3.9

29.39

14.96

ug/l

1.75

1226

3441

Other bacterial diseases, including avohilmo

9407

29254

2.18

307.65

4.8

4.1

32.06

22.96

ug/l

0.99

7843

23084

Colitis, primary sclerosing

448

362

61.38

307.65

9.4

4.5

2.54

18.79

ug/l

0.77

362

295

Abnormal findings on diagnostic imaging of lung

5396

24464

2.37

307.65

3.7

4.4

21.85

28.28

ug/l

0.72

4633

20096

Colon adenocarcinoma

4436

2631

72.96

307.65

9.6

1.4

35.48

13.59

ug/l

1.24

4120

1987

Other medical care

9385

18934

5.79

307.65

5.6

4.0

60.28

16.81

ug/l

11.01

8307

15173

Fever of other and unknown origin

5711

21947

2.49

307.65

5.4

4.2

27.76

26.39

ug/l

0.12

4705

17596

Any gastric operation

6809

6566

5.78

307.65

4.7

1.7

29.40

20.08

ug/l

0.73

5449

4674

L02BA Anti-estrogens

2369

7422

4.22

307.65

5.3

3.8

17.03

25.46

ug/l

0.72

1837

5897

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

3673

2067

89.53

307.65

10.7

1.4

34.11

16.48

ug/l

0.57

3369

1566

Malignant neoplasm of colon, including Hilmo

6548

4105

56.04

307.65

9.0

1.4

36.02

9.74

ug/l

2.95

5996

3091

Colorectal cancer

9219

5218

68.19

307.65

9.8

1.5

36.48

8.18

ug/l

4.23

8490

3959

Colorectal adenocarcinoma

7869

4463

79.59

307.65

10.0

1.4

35.46

9.13

ug/l

3.09

7266

3380

Family history of malignant neoplasm

1339

3958

4.17

307.65

5.6

4.2

6.78

31.84

ug/l

1.82

1016

3110

Gastrointestinal diseases

3631

8777

2.17

307.65

4.3

3.9

20.10

43.63

ug/l

2.35

2881

6748

Pneumonias (Asthma/COPD co-morbidities)

7816

31846

1.68

307.65

4.2

4.3

20.61

26.25

ug/l

0.83

6493

25233

First line medication for Crohn's disease

9434

26099

2.08

307.65

5.1

3.7

32.21

22.21

ug/l

1.08

7764

20517

Septicaemia

4101

19342

2.13

307.65

4.4

4.1

21.19

24.75

ug/l

0.41

3523

15808

Hernia of abdominal wall, postoperative

2179

3119

8.58

307.65

6.3

1.7

11.04

26.60

ug/l

1.88

1883

2288

Malignant neoplasm of small intestine, including Hilmo

550

553

17.50

307.65

5.0

1.4

10.24

2.73

ug/l

1.92

461

415

Solid cancers, including Hilmo

12872

10964

8.71

307.65

5.5

1.6

31.95

5.39

ug/l

7.78

10435

7978

Malignant neoplasm of stomach, including Hilmo

1234

1127

19.43

307.65

5.9

1.4

26.14

27.37

ug/l

0.02

1110

853

Complications of surgical and medical care, not elsewhere classified

8984

32978

1.95

307.65

4.8

4.1

17.52

27.71

ug/l

1.57

7374

26374

Other anaemias

4594

21746

2.21

307.65

4.0

4.2

29.88

27.91

ug/l

0.10

3868

18017

Medicines for HER+ breast cancer

5172

15977

3.83

307.65

4.2

3.9

16.69

23.84

ug/l

1.15

3992

12780

Benign neoplasm: Colon

6607

27766

2.60

307.65

4.7

4.2

15.46

29.13

ug/l

1.92

5587

22807

Ulcerative colitis (strict) with PSC

274

174

124.96

307.65

10.7

4.8

2.53

10.08

ug/l

1.88

221

141

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9795

31205

2.32

307.65

4.4

4.2

25.17

25.92

ug/l

0.05

8052

24879

Malignant neoplasm, without specification of site

457

604

10.63

307.65

2.8

1.4

95.56

2.88

ug/l

1.86

386

443

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3139

7727

3.00

307.65

3.9

1.5

19.07

6.44

ug/l

1.24

2537

5813

Lung cancer and mesothelioma

2953

8267

3.89

307.65

3.4

4.6

56.84

26.33

ug/l

2.55

2674

6826

Malignant neoplasm of digestive organs

13989

7168

42.70

307.65

8.3

1.5

39.62

6.72

ug/l

8.32

12810

5419

Liquid cancers

2343

6150

4.08

307.65

3.0

1.5

11.03

7.34

ug/l

0.34

1779

4653

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8818

29246

1.68

307.65

4.4

4.2

22.57

28.31

ug/l

0.53

7013

23578

Malignant neoplasm of colon

5486

3372

61.46

307.65

9.4

1.4

36.73

11.22

ug/l

2.12

5075

2545

Other functional intestinal disorders

3960

18866

2.06

307.65

4.0

4.1

15.15

32.51

ug/l

4.72

3197

15296

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

1291

970

30.23

307.65

5.5

1.4

27.44

2.73

ug/l

3.42

1167

731

Malignant neoplasm of anus and anal canal, including Hilmo

301

208

37.00

307.65

5.6

1.5

62.65

2.78

ug/l

0.79

252

155

Malignant neoplasm

12619

10929

8.58

307.65

5.6

1.6

30.38

5.40

ug/l

7.26

10232

7953

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

5667

5274

19.27

307.65

8.1

1.5

78.50

8.11

ug/l

9.92

5154

3986

Malignant neoplasm, without specification of site, including Hilmo

727

925

11.36

307.65

3.5

1.4

90.47

2.73

ug/l

3.16

605

698

Adenocarcinoma of pancreas

722

536

32.55

307.65

7.1

1.4

117.42

2.72

ug/l

2.02

692

402

Pleural effusion

2009

7478

3.33

307.65

3.7

4.3

16.22

20.80

ug/l

0.69

1690

6233

Diseases of the digestive system

4348

23059

2.05

307.65

4.5

4.1

19.10

26.66

ug/l

1.04

3659

18930

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

764

1220

8.22

307.65

3.1

1.4

5.40

2.71

ug/l

1.31

561

920

Malignant neoplasm of small intestine

409

399

18.20

307.65

4.8

1.4

8.02

2.69

ug/l

1.08

333

299

Malignant neoplasm, including Hilmo

12650

10995

8.44

307.65

5.5

1.6

32.18

5.39

ug/l

7.72

10234

7983

Malignant neoplasm of oesophagus

582

474

25.67

307.65

4.8

1.4

38.88

2.79

ug/l

2.14

530

346

Diverticular disease of intestine

6627

21984

2.03

307.65

3.5

4.2

13.67

34.12

ug/l

6.57

5397

17924

malignant neoplasm of male genital organs

1786

3467

3.38

307.65

4.1

1.5

19.04

10.97

ug/l

0.43

1463

2625

Malignant neoplasm of respiratory system and intrathoracic organs

2760

3974

7.40

307.65

3.3

1.5

60.10

9.94

ug/l

4.20

2483

3005

Other and unspecified anaemias

4548

21602

2.21

307.65

4.0

4.2

30.13

27.78

ug/l

0.12

3829

17896

Iron deficiency anaemia

4224

21601

2.12

307.65

4.2

4.1

15.44

23.66

ug/l

1.57

3518

17601

Malignant neoplasm of prostate

1733

3373

3.32

307.65

4.1

1.5

19.51

11.20

ug/l

0.43

1420

2555

Cholangitis (primary sclerosing, PSC), with reimbursement 202

530

560

31.03

307.65

9.0

4.5

2.93

14.92

ug/l

0.92

430

458

Solid cancers

12802

10857

8.87

307.65

5.7

1.6

31.47

5.42

ug/l

7.81

10429

7919

Adenocarcinoma and papillary adenocarcinoma of stomach

597

466

23.85

307.65

6.6

1.4

26.44

2.77

ug/l

3.64

562

353

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

609

537

26.30

307.65

2.0

1.5

6.29

2.66

ug/l

1.09

369

406

Malignant neoplasm of rectosigmoid junction, including Hilmo

843

517

59.17

307.65

10.1

1.4

22.69

2.79

ug/l

2.90

747

382

Malignant neoplasm of pancreas

1840

1391

30.60

307.65

6.1

1.4

64.78

2.78

ug/l

3.30

1735

1047

Disorders of gallbladder, biliary tract and pancreas

10050

30058

2.29

307.65

4.4

4.2

20.59

28.23

ug/l

1.25

8301

24011

Colon adenocarcinoma, helper endpoint

4436

5861

30.80

307.65

9.6

3.5

35.48

25.74

ug/l

0.76

4120

4788

Secondary malignant neoplasm of respiratory and digestive organs

384

314

26.37

307.65

6.0

1.4

139.13

2.73

ug/l

2.90

360

232

Neoplasms

6254

4956

7.38

307.65

4.9

1.7

34.59

2.62

ug/l

5.35

4891

3520

Non-small cell lung cancer

1434

2153

8.77

307.65

3.7

1.4

82.19

15.92

ug/l

2.49

1320

1630

Other septicaemia, including avohilmo

3793

18180

2.16

307.65

4.5

4.1

19.41

23.80

ug/l

0.62

3284

14884

malignant neoplasm of female genital organs

1888

3461

6.92

307.65

2.5

1.5

7.23

2.72

ug/l

2.85

1365

2608

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

5380

4091

32.29

307.65

8.7

1.5

89.09

9.69

ug/l

9.59

4918

3085

Other diseases of biliary tract

1807

3659

8.33

307.65

6.2

4.1

22.05

27.21

ug/l

0.35

1621

2982

Oxycodone

7104

16261

5.00

307.65

6.0

4.1

50.02

19.89

ug/l

5.98

6336

13066

GASTRO-related operations

6809

6566

5.78

307.65

4.7

1.7

29.40

20.08

ug/l

0.73

5449

4674

Laparoscopic right hemicolectomy

1951

2618

52.25

307.65

8.4

3.9

7.07

22.70

ug/l

2.82

1772

2139

Primary Sclerosing Cholangitis, IBD and UDCA required

668

566

44.45

307.65

8.7

4.5

2.83

28.57

ug/l

1.09

546

450

Other septicaemia

3703

17860

2.16

307.65

4.4

4.1

19.76

23.78

ug/l

0.54

3204

14620

Nutritional anaemias

4914

24884

2.07

307.65

4.3

4.1

20.58

25.10

ug/l

0.34

4107

20324

Intestinal stricture

4293

15438

3.45

307.65

6.5

4.0

14.32

26.39

ug/l

2.79

3649

12712

Malignant neoplasm, wide definition

12694

11032

8.44

307.65

5.5

1.6

32.08

5.38

ug/l

7.72

10266

8009

Constipation

7923

31480

1.82

307.65

4.3

4.2

18.37

28.56

ug/l

1.38

6437

25411

Malignant neoplasm of bronchus and lung

2483

3559

7.55

307.65

3.4

1.4

65.47

10.73

ug/l

4.14

2266

2706

Malignant neoplasm of other and unspecified parts of biliary tract

411

271

44.28

307.65

7.4

1.4

36.95

2.71

ug/l

1.91

386

201

Cholangitis (primary sclerosing, PSC)

1322

2324

10.04

307.65

7.0

4.2

9.31

23.94

ug/l

1.63

1136

1897

Basal cell carcinoma

3054

7585

2.99

307.65

3.8

1.5

17.71

6.51

ug/l

1.02

2479

5709

Explicit Sepsis, including avohilmo

4276

21108

2.00

307.65

4.4

4.3

22.04

27.87

ug/l

0.74

3670

17309

Abdominal and pelvic pain

7790

21163

1.96

307.65

4.2

4.3

23.36

27.51

ug/l

0.43

6289

17035

Aplastic and other anaemias

4882

22839

2.18

307.65

4.0

4.2

29.94

27.36

ug/l

0.14

4112

18889

Bacterial infection, other or unspecified

6481

23116

2.73

307.65

5.2

4.1

42.09

23.52

ug/l

2.01

5542

18779

Malignant neoplasm of ovary

862

924

15.99

307.65

2.0

1.5

5.99

2.65

ug/l

2.36

623

691

Nausea and vomiting

2624

10492

2.73

307.65

5.0

4.2

22.39

23.24

ug/l

0.06

2180

8527

Hepatocellular carcinoma, including Hilmo

674

515

28.75

307.65

4.2

1.4

4.33

2.84

ug/l

1.31

584

384

Other or unspecified ileus, impaction or obstruction

2697

8112

4.24

307.65

6.8

4.2

16.62

30.81

ug/l

2.14

2311

6758

General symptoms and signs

7883

24240

1.70

307.65

4.4

4.2

26.96

25.95

ug/l

0.07

6385

19286

Right hemicolectomy

1275

2461

10.01

307.65

7.9

4.0

16.74

21.35

ug/l

0.32

1152

2045

Colitis, primary sclerosing, strict definition

342

257

70.19

307.65

9.6

4.7

2.52

24.11

ug/l

0.72

279

213

Diseases of oesophagus, stomach and duodenum

8680

30704

1.76

307.65

3.7

4.4

15.23

28.54

ug/l

4.49

6957

24651

All pneumoniae

7830

31840

1.68

307.65

4.2

4.3

20.55

26.26

ug/l

0.84

6497

25229

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1668

1273

29.87

307.65

5.4

1.4

37.30

2.85

ug/l

3.30

1502

959

Ascites

1487

2942

8.31

307.65

4.5

4.3

57.06

25.92

ug/l

0.74

1234

2421

Any event in cancer register

12529

12190

7.39

307.65

5.5

1.7

29.58

9.77

ug/l

4.58

10161

8910

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

555

368

42.12

307.65

7.3

1.4

41.28

2.74

ug/l

1.80

521

275

Malignant neoplasm of breast

5905

6144

8.08

307.65

4.1

1.5

16.04

2.67

ug/l

9.88

4504

4466

Laparoscopic left hemicolectomy

521

715

33.92

307.65

9.6

4.5

12.73

28.56

ug/l

0.64

477

594

Basal cell carcinoma, including Hilmo

3178

7788

3.01

307.65

3.8

1.5

17.65

6.41

ug/l

1.07

2582

5850

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

7527

30230

2.45

307.65

3.8

4.3

23.46

27.11

ug/l

0.39

6342

24478

Malignant neoplasm of breast, HER2-negative, including Hilmo

5955

6187

8.01

307.65

4.0

1.5

15.93

2.67

ug/l

9.85

4533

4491

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3258

7960

3.01

307.65

3.9

1.5

17.47

6.36

ug/l

1.10

2635

5973

Malignant neoplasm of ovary, including Hilmo

1200

1233

17.25

307.65

2.5

1.5

7.25

2.61

ug/l

4.35

871

931

Other diseases of pancreas

1605

3449

7.59

307.65

3.7

4.3

5.51

26.21

ug/l

4.05

1338

2808

Malignant neoplasm of rectum

3474

1987

78.51

307.65

10.4

1.4

38.63

17.14

ug/l

0.68

3191

1495

Non-Hodgkin lymphoma, all, including Hilmo

1118

2648

4.97

307.65

2.7

1.5

9.86

13.49

ug/l

0.13

822

1997

Non-small cell lung cancer, including Hilmo

2100

3087

8.49

307.65

3.8

1.4

64.43

12.03

ug/l

3.06

1913

2327

All kidney diseases

7933

31665

1.78

307.65

4.4

4.2

16.25

28.37

ug/l

3.77

6555

25128

Persons encountering health services for specific procedures and health care

10792

26122

2.70

307.65

4.8

4.0

40.64

15.62

ug/l

6.12

9080

20243

Symptoms and signs involving the digestive system and abdomen

8106

21164

2.04

307.65

4.3

30.61

27.50

ug/l

0.21

6607

17036

Benign neoplasm of other and ill-defined parts of digestive system

2101

8685

2.92

307.65

3.5

4.3

5.51

24.95

ug/l

6.79

1668

7105

Chronic pancreatitis

1972

4858

5.75

307.65

6.0

4.6

15.87

27.23

ug/l

1.14

1795

4002

Hepatocellular carcinoma

498

382

27.34

307.65

3.9

1.4

3.76

2.77

ug/l

2.18

430

285

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

1200

904

29.34

307.65

4.8

1.4

33.86

2.79

ug/l

2.13

1065

675

Malignant neoplasm of breast, HER2-negative

5888

6137

8.06

307.65

4.1

1.5

16.08

2.67

ug/l

9.87

4488

4462

Liquid cancers, including Hilmo

3718

7144

5.47

307.65

4.2

1.5

18.44

6.73

ug/l

1.89

3007

5381

Complications of medical and surgical care

6564

34049

1.86

307.65

4.9

4.1

19.50

27.34

ug/l

0.75

5401

27361

Malignant neoplasm of liver and intrahepatic bile ducts

724

546

28.56

307.65

4.6

1.4

22.56

2.88

ug/l

1.41

633

409

Benign neoplasms

7558

21996

1.98

307.65

4.3

23.46

32.98

ug/l

0.82

6068

17592

IBD (strict) with PSC

339

216

121.68

307.65

10.4

4.6

2.48

28.59

ug/l

0.71

273

174

Colectomy operation

4566

7458

13.77

307.65

8.3

3.7

11.18

26.93

ug/l

4.18

4085

6089

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

3168

4412

7.66

307.65

3.4

1.5

53.74

9.18

ug/l

4.34

2846

3345

malignant neoplasm of female genital organs, including Hilmo

2235

3820

7.32

307.65

2.8

1.5

8.00

2.70

ug/l

4.52

1643

2865

Colorectal cancer, including Hilmo

10092

5735

60.78

307.65

9.3

1.5

36.86

7.66

ug/l

5.10

9214

4368

Malignant neoplasm

12665

10954

8.60

307.65

5.6

1.6

30.29

5.40

ug/l

7.26

10278

7971

Complications of procedures, not elsewhere classified

7369

32562

1.96

307.65

5.0

4.1

21.31

27.69

ug/l

0.59

6059

26072

Opioids

7309

20891

1.90

307.65

4.6

4.0

30.36

19.47

ug/l

1.20

5984

16214

Malignant neoplasm of breast, ER-positive, including Hilmo

4978

5636

8.94

307.65

4.3

1.5

16.94

2.69

ug/l

8.70

3862

4160

Bacterial infection, other or unspecified, including avohilmo

6924

24140

2.69

307.65

5.1

4.2

44.16

23.34

ug/l

2.18

5908

19542

Malignant neoplasm of breast, ER-negative, including Hilmo

2063

4583

5.02

307.65

3.5

1.5

13.54

2.75

ug/l

5.24

1575

3410

Malignant neoplasm of rectum, including Hilmo

4200

2449

70.04

307.65

9.9

1.4

35.03

14.37

ug/l

0.85

3827

1847

malignant neoplasm of male genital organs, including Hilmo

1823

3502

3.41

307.65

4.3

1.5

21.57

10.89

ug/l

0.60

1491

2653

Non-small cell lung cancer, adenocarcinoma

944

1253

11.05

307.65

4.3

1.4

103.27

2.76

ug/l

4.75

869

940

Malignant neoplasm of skin

3522

8263

3.15

307.65

3.9

1.5

17.19

6.23

ug/l

1.16

2826

6192

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

8299

28838

1.94

307.65

4.3

4.2

19.82

29.51

ug/l

1.39

6551

23095

Malignant neoplasm of stomach

1092

976

20.16

307.65

6.1

1.4

26.92

31.03

ug/l

0.05

988

744

Any death

8362

22255

3.19

307.65

5.3

4.2

75.26

5.51

ug/l

19.89

7443

17816

Malignant neoplasm of rectosigmoid junction

496

290

67.98

307.65

10.6

1.4

24.77

2.78

ug/l

2.93

448

219

Ductal carcinoma of pancreas

245

143

104.97

307.65

10.2

1.4

13.93

2.67

ug/l

2.12

239

112

Diseases of liver

3383

16701

2.27

307.65

3.8

4.4

14.11

28.52

ug/l

2.09

2777

13612

Paralytic ileus and intestinal obstruction

3525

11827

3.65

307.65

6.5

4.1

14.60

31.54

ug/l

3.42

3000

9771

Any reimbursement code in KELA

3464

6031

3.05

307.65

4.9

2.5

31.27

14.82

ug/l

0.82

2708

4326

Abnormal findings on diagnostic imaging of other body structures

1731

6473

3.26

307.65

3.7

4.3

30.54

30.05

ug/l

0.01

1395

5227

Benign neoplasm: Rectum, anus and anal canal

2364

10194

2.77

307.65

5.1

4.2

10.14

29.37

ug/l

4.58

2003

8452

Malignant neoplasm of breast, HER-positive

4960

5629

8.92

307.65

4.3

1.5

16.98

2.69

ug/l

8.68

3849

4157

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

360

291

25.65

307.65

4.5

1.4

134.23

2.71

ug/l

3.45

318

222

Malignant neoplasm of oesophagus, including Hilmo

772

632

24.73

307.65

5.1

1.4

36.80

2.79

ug/l

2.92

710

470

Influenza and pneumonia

7946

31304

1.64

306.65

4.2

4.3

20.24

26.63

ug/l

1.00

6592

24760

Other diseases of pleura

4287

21075

1.93

290.56

3.6

4.3

27.31

25.15

ug/l

0.12

3623

17534

Malignant neoplasm of mesothelium and soft tissue

456

724

8.32

290.46

2.7

1.4

5.61

2.73

ug/l

0.77

341

538

Carcinoma in situ of other and unspecified digestive organs

743

1917

6.07

289.81

4.2

4.4

11.77

22.27

ug/l

0.96

598

1595

Depression medications

1126

1514

3.90

288.77

4.0

2.0

17.04

13.27

ug/l

0.16

861

999

Other diseases of the digestive system

3116

16073

2.15

288.52

4.3

4.1

22.82

28.57

ug/l

0.47

2622

13332

Intestinal adhesions without obstruction

1068

3446

3.89

282.59

7.0

4.1

10.30

30.19

ug/l

2.75

904

2848

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

295

300

17.48

280.60

3.2

1.4

3.86

2.70

ug/l

1.10

208

224

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5220

31094

1.76

273.31

4.9

4.1

19.81

27.09

ug/l

0.55

4278

25114

Non-invasive ventilation

2251

8917

2.40

271.83

5.4

4.8

20.48

29.80

ug/l

0.35

1904

6984

Hypothyroidism, drug reimbursement

739

1161

4.78

270.40

4.1

1.7

6.87

16.00

ug/l

0.46

557

781

6966

25932

1.65

270.00

4.2

4.3

19.18

26.79

ug/l

1.38

5781

20636

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6966

25932

1.65

270.00

4.2

4.3

19.18

26.79

ug/l

1.38

5781

20636

Secondary malignant neoplasm of other and unspecified sites

299

325

15.41

269.69

5.7

1.5

80.92

2.67

ug/l

3.12

282

242

Benign neoplasm: Sigmoid colon

2077

9563

2.54

268.41

4.7

4.4

24.28

25.17

ug/l

0.02

1767

7928

GI-bleeding

3055

16028

2.10

268.40

4.3

4.1

21.84

28.87

ug/l

0.62

2575

13313

Cholelithiasis, broad definition with cholecystitis

6814

28996

1.65

267.82

3.9

4.2

22.14

28.50

ug/l

0.68

5551

23185

Metabolic disorders

7299

28317

1.62

266.37

3.9

4.4

31.29

24.94

ug/l

0.43

5946

22664

Venous thromboembolism

4848

28098

1.79

264.93

5.1

4.1

36.34

23.30

ug/l

1.19

4022

23046

Hypothyroidism (congenital or acquired)

987

1480

3.90

264.26

4.1

1.9

24.64

13.55

ug/l

0.35

750

975

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

755

1974

4.40

263.11

3.2

1.4

12.82

17.20

ug/l

0.12

602

1489

Pulmonary embolism

2898

15140

2.14

260.40

5.5

4.1

30.90

22.59

ug/l

0.96

2435

12519

Hypothyroidism and >3 levothyroxin purchases

978

1475

3.88

260.33

4.0

1.9

24.99

13.60

ug/l

0.36

737

971

Hypothyroidism, levothyroxine purchases

978

1475

3.88

260.33

4.0

1.9

24.99

13.60

ug/l

0.36

737

971

Pulmonary heart disease

2898

15149

2.13

259.95

5.5

4.1

30.90

22.56

ug/l

0.96

2435

12527

Acute pancreatitis (for exclusion)

1981

9052

2.50

255.67

4.3

4.4

8.86

28.25

ug/l

4.30

1647

7474

Malignant neoplasm of bladder, including Hilmo

835

2342

3.96

255.45

3.8

1.4

34.59

14.91

ug/l

0.51

708

1780

Certain infectious and parasitic diseases

6963

22275

1.63

255.17

4.4

4.1

27.76

25.78

ug/l

0.13

5616

17637

Malignant melanoma, including Hilmo

1097

3701

3.27

253.75

3.9

1.5

10.41

10.49

ug/l

0.00

863

2777

Non-small cell lung cancer, adenocarcinoma, helper endpoint

944

3090

4.16

252.39

4.3

4.2

103.27

20.35

ug/l

3.32

869

2573

DVT of lower extremities and pulmonary embolism

3860

22132

1.89

250.96

5.2

4.0

41.90

24.02

ug/l

1.40

3235

18247

Malignant neoplasm of urinary organs

727

1933

4.31

247.26

3.2

1.4

12.32

17.56

ug/l

0.14

574

1454

Cholelithiasis

6508

28698

1.63

245.59

3.9

4.1

21.86

27.98

ug/l

0.62

5281

22952

Benign neoplasm: Pancreas

527

1218

7.69

241.68

3.9

4.4

3.04

22.34

ug/l

2.16

434

1005

Pulmonary heart disease, diseases of pulmonary circulation

3052

16635

2.03

240.08

5.4

4.1

29.86

22.59

ug/l

0.86

2556

13760

Malignant melanoma

991

3270

3.35

238.60

3.8

1.5

7.85

11.47

ug/l

0.17

775

2460

Non-small cell lung cancer, squamous

447

841

6.37

235.01

2.7

1.3

39.98

2.87

ug/l

0.60

413

641

Malignant neoplasm of other and ill-defined digestive organs

195

141

33.19

233.47

3.6

1.4

199.08

2.89

ug/l

2.63

175

112

Diffuse large B-cell lymphoma, including Hilmo

464

922

6.28

232.34

2.2

1.4

6.74

2.67

ug/l

1.16

324

696

Diffuse large B-cell lymphoma, helper endpoint

464

922

6.28

232.34

2.2

1.4

6.74

2.67

ug/l

1.16

324

696

Diffuse large B-cell lymphoma

464

922

6.28

232.34

2.2

1.4

6.74

2.67

ug/l

1.16

324

696

Agranulocytosis

1216

4734

3.10

227.83

6.1

4.2

24.01

26.39

ug/l

0.13

1010

3810

Benign neoplasm: Colon, unspecified

2526

13373

2.13

220.95

4.3

14.93

26.35

ug/l

1.83

2127

11138

Neuroendocrine tumor and carcinoma of small intestine

234

241

16.53

219.62

3.4

1.4

5.65

2.65

ug/l

0.69

186

182

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4787

30025

1.69

219.22

4.9

4.1

20.03

25.88

ug/l

0.38

3918

24336

Other diseases of anus and rectum

2615

13829

2.05

218.90

4.3

4.1

14.95

31.44

ug/l

2.99

2102

11365

Codeine

5980

20808

1.61

214.07

3.7

4.0

19.35

19.53

ug/l

0.01

4822

16158

Fibrosis and cirrhosis of liver

946

3381

3.53

212.07

3.8

4.4

6.23

22.26

ug/l

4.02

815

2772

Drug-induced neutropenia

878

3018

3.74

212.02

6.2

4.3

25.62

21.40

ug/l

0.24

733

2442

Malignant neoplasm of kidney, except renal pelvis

647

1769

4.18

211.45

3.2

1.4

9.62

18.95

ug/l

0.25

510

1330

Total colectomy

545

1371

5.39

211.25

7.7

4.4

11.41

22.77

ug/l

0.84

436

1117

Total colectomy operation

545

1371

5.39

211.25

7.7

4.4

11.41

22.77

ug/l

0.84

436

1117

Benign neoplasm: Ascending colon

1558

7064

2.62

210.70

4.7

4.3

6.73

24.29

ug/l

6.35

1336

5828

Procreative management

2285

9489

2.12

210.41

5.6

4.2

11.27

22.31

ug/l

2.07

1710

7409

All chronic kidney diseases

4549

22538

1.71

210.41

4.1

4.3

16.33

29.56

ug/l

2.86

3852

18420

Implicit Sepsis

5959

28921

1.59

209.31

3.7

4.4

20.58

27.36

ug/l

0.60

4924

23390

Mucinous and mucinous cystic tumor of rectum

150

108.79

209.31

12.2

1.4

17.50

2.64

ug/l

2.47

139

Malignant melanoma of skin, including Hilmo

882

2974

3.26

204.21

3.9

1.5

11.13

12.32

ug/l

0.04

689

2238

Benign neoplasm: Caecum

1252

5279

2.90

201.97

4.7

4.3

4.88

23.58

ug/l

5.96

1079

4354

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

842

2766

3.34

200.49

3.7

1.4

15.29

12.97

ug/l

0.08

693

2113

Factors influencing health status and contact with health services

1898

4311

2.33

200.35

4.4

4.3

16.50

26.61

ug/l

0.83

1562

3431

Dyspnoea

6889

34033

1.52

199.30

3.6

4.4

25.15

26.13

ug/l

0.06

5645

27359

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1466

6626

2.56

196.34

3.6

4.6

10.03

24.92

ug/l

3.47

1302

5526

Other pleural conditions

1142

4668

2.92

193.71

3.5

4.3

23.99

19.91

ug/l

0.20

951

3884

Oral corticosteroids

7731

31644

1.49

192.69

3.7

4.4

25.82

26.07

ug/l

0.02

6321

25303

Malignant neoplasm of corpus uteri, including Hilmo

675

2030

3.81

192.05

3.3

1.4

9.33

2.69

ug/l

1.41

537

1520

Medical observation and evaluation for suspected diseases and conditions

4586

14538

1.68

190.50

3.8

4.6

23.26

34.89

ug/l

0.86

3690

11691

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2083

5022

2.17

189.01

4.4

4.8

19.96

27.02

ug/l

0.39

1667

3916

Implicit Sepsis, including avohilmo

6196

29974

1.54

188.73

3.7

4.3

20.73

27.26

ug/l

0.59

5101

24107

Inflammatory bowel disease treatment related agents

8112

31747

1.47

188.22

3.8

4.4

25.11

26.02

ug/l

0.07

6574

25353

Ventral hernia

2220

11825

2.08

187.69

6.1

4.2

23.04

29.28

ug/l

0.41

1905

9690

Gastrointestinal stromal tumor and sarcoma

203

215

16.44

187.43

3.4

1.4

4.04

2.65

ug/l

0.69

156

164

Hydronephrosis

1205

5105

2.75

187.06

6.6

4.2

24.66

28.07

ug/l

0.15

1021

4168

ILD medications: prednisolone, methylprednisolone, prednisone

7784

30346

1.48

186.86

3.8

4.4

25.10

25.95

ug/l

0.06

6345

24218

Bacterial Sepsis

4095

21179

1.70

186.78

3.8

4.4

31.02

27.87

ug/l

0.14

3461

17494

Bleeding

6454

31060

1.52

184.41

4.0

4.3

17.78

28.59

ug/l

2.70

5365

25238

Left hemicolectomy

407

947

7.25

183.42

9.0

4.2

12.11

27.34

ug/l

0.89

370

788

Other diseases of blood and blood-forming organs, wide

1965

10213

2.14

178.95

5.0

4.3

23.44

27.15

ug/l

0.25

1614

8326

Malignant melanoma of skin

736

2427

3.35

177.47

3.8

1.4

8.08

14.58

ug/l

0.24

574

1812

L01XE Protein kinase inhibitors

694

2336

4.02

177.28

9.2

4.2

27.25

20.33

ug/l

0.35

622

1919

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2988

10757

1.84

176.80

4.6

4.5

18.45

27.12

ug/l

0.81

2411

8240

Cirrhosis of liver, NAS

706

2389

3.88

176.72

3.5

4.4

5.36

24.43

ug/l

3.58

625

1973

Malignant neoplasm of other connective and soft tissue, including Hilmo

358

726

5.98

174.06

3.4

1.4

7.78

2.70

ug/l

1.16

271

536

Parasetamol

4517

14387

1.64

173.67

4.4

4.3

21.08

32.56

ug/l

1.43

3637

11287

Other disorders of fluid, electrolyte and acid-base balance

2862

15793

1.85

173.44

4.1

4.4

26.85

25.96

ug/l

0.03

2438

13078

Attention to artificial openings

506

1384

4.75

173.35

6.4

4.1

33.51

14.13

ug/l

0.74

425

1111

Malignant neoplasm of gallbladder, including Hilmo

157

132

27.03

172.35

6.8

1.4

13.71

2.57

ug/l

1.97

146

107

Noninfective enteritis and colitis

3395

20795

1.72

169.85

4.7

4.2

20.27

27.12

ug/l

0.69

2713

16736

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

6355

29737

1.50

168.73

3.7

4.4

21.51

27.05

ug/l

0.54

5218

23683

Malignant neoplasm of anus and anal canal

132

44.40

167.83

4.4

1.4

5.02

2.69

ug/l

3.11

106

Small cell lung cancer, including Hilmo

264

416

7.97

167.77

2.1

1.4

32.34

2.91

ug/l

2.54

242

316

Small cell lung cancer

264

416

7.97

167.77

2.1

1.4

32.34

2.91

ug/l

2.54

242

316

Squamous cell neoplasms and carcinomas of the skin

675

2199

3.41

166.55

3.8

1.4

14.31

15.39

ug/l

0.03

554

1671

Cholecystectomy

5585

32567

1.53

164.93

4.4

4.1

17.02

26.13

ug/l

1.39

4495

26325

Other diseases of liver

1592

7905

2.24

164.30

3.6

4.5

18.42

31.21

ug/l

0.64

1247

6405

Carcinoma in situ of colon

461

1273

5.52

163.87

4.3

4.5

6.32

22.95

ug/l

1.65

375

1061

Malignant neoplasm of corpus uteri

598

1859

3.67

161.38

3.3

1.4

10.07

2.68

ug/l

1.37

473

1400

Abnormalities of breathing

6043

23801

1.50

160.14

3.7

4.5

25.11

28.65

ug/l

0.25

4822

19036

Exclusions for E4_PCOS_CONSORTIUM

4775

19653

1.58

160.08

3.4

4.2

18.11

23.63

ug/l

0.71

3623

15450

Gastro-oesophageal reflux disease

5116

29252

1.54

159.78

3.4

4.5

15.56

28.75

ug/l

3.26

4059

23636

Any operation in hilmo

171

38.34

159.55

4.9

1.0

48.84

408.14

ug/l

0.41

143

Malignant neoplasm of endocrine gland, including Hilmo

514

1454

3.95

158.77

4.8

1.5

22.03

2.61

ug/l

1.27

395

1074

Acute tubulo-interstitial nephritis

4793

27169

1.56

157.11

4.3

4.1

14.45

28.24

ug/l

4.09

3987

21796

Implicit bacterial Sepsis, including avohilmo

3891

20871

1.65

156.27

3.7

4.3

29.78

28.02

ug/l

0.07

3289

17252

Malignant neoplasm of other and ill-defined sites, including Hilmo

206

272

10.62

156.21

4.2

1.4

87.52

2.71

ug/l

0.72

162

206

Hernia

6748

31926

1.46

155.00

4.3

4.2

17.72

27.50

ug/l

2.11

5553

25583

Condition for Implicit Sepsis (Organ dysfunction codes)

6179

30052

1.48

154.70

3.7

4.3

22.84

27.11

ug/l

0.33

5087

24108

Neuroendocrine tumor and carcinoma of pancreas

140

117

26.59

153.95

3.8

1.4

6.88

2.58

ug/l

1.52

114

Oesophageal varices

523

1606

4.31

152.86

4.0

4.4

5.46

22.12

ug/l

2.29

464

1333

Implicit bacterial Sepsis

3569

19549

1.67

150.34

3.7

4.3

31.57

27.56

ug/l

0.17

3025

16200

ILD medications

7756

30387

1.42

150.25

3.8

4.4

23.29

25.94

ug/l

0.23

6304

24234

Malignant neoplasm of head and neck, including Hilmo

584

1857

3.47

149.54

3.7

1.5

10.54

18.15

ug/l

0.21

500

1399

Erysipelas, including avohilmo

5286

26979

1.51

148.44

3.9

4.2

20.84

24.09

ug/l

0.23

4389

21629

Malignant neoplasm of retroperitoneum and peritoneum

145

134

20.71

148.04

2.6

1.4

2.89

2.66

ug/l

0.26

106

Pain, not elsewhere classified

2123

11926

1.90

146.73

4.2

18.52

22.78

ug/l

0.36

1689

9512

Asthma, unspecified (mode), excluding more controls

3648

16670

1.64

144.76

3.6

4.6

19.13

28.08

ug/l

0.71

2996

13088

Cardiovascular diseases (excluding rheumatic etc)

3339

11753

1.68

144.63

4.2

4.5

20.00

26.21

ug/l

0.49

2575

8813

Benign neoplasm: Transverse colon

1127

5230

2.53

143.86

5.0

4.4

7.55

22.89

ug/l

3.88

979

4327

Heart failure, not strict

5765

27295

1.49

143.75

3.7

4.6

16.31

29.90

ug/l

4.02

4860

22174

Benign neoplasm: Liver/bile ducts

349

841

5.67

143.34

2.7

4.5

2.70

24.56

ug/l

1.50

241

685

Malignant neoplasm of endocrine gland

444

1221

4.07

143.04

4.6

1.5

17.75

2.57

ug/l

0.89

338

917

In situ neoplasms

3336

21379

1.67

142.48

3.8

4.1

14.62

24.11

ug/l

1.93

2682

17452

Hypertension, essential

5180

20079

1.51

140.89

4.0

4.5

21.62

24.47

ug/l

0.23

4203

15902

Asthma, unspecified (mode)

3800

17920

1.60

136.61

3.6

4.5

19.08

27.29

ug/l

0.67

3133

14118

Pure hypercholesterolaemia

5774

26021

1.47

135.51

3.8

4.4

28.31

26.04

ug/l

0.13

4730

21147

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

7014

32469

1.41

135.29

4.3

4.2

23.75

26.53

ug/l

0.23

5759

26128

Disorders of lipoprotein metabolism and other lipidaemias

6150

26795

1.45

134.86

3.8

4.4

28.25

25.77

ug/l

0.16

5004

21697

Benign neoplasm: Liver

313

732

5.87

133.57

2.7

4.5

2.69

14.54

ug/l

1.31

213

594

Malignant neoplasm of thyroid gland, including Hilmo

441

1268

3.87

132.86

4.8

1.5

25.14

2.59

ug/l

1.23

333

943

Pain in throat and chest

5666

23719

1.46

131.15

3.7

4.5

15.86

28.69

ug/l

2.26

4473

19003

Gastroduodenal ulcer

2192

12873

1.83

130.91

4.0

4.4

20.70

27.66

ug/l

0.61

1844

10803

Malignant neoplasm of gallbladder

117

28.97

130.71

6.9

1.4

16.55

2.79

ug/l

1.79

111

Type 2 diabetes, wide definition

5897

26659

1.45

130.29

3.9

4.4

23.08

28.11

ug/l

0.54

4943

21474

Renal failure

3946

22661

1.57

129.86

3.7

4.3

22.23

28.09

ug/l

0.60

3374

18858

Symptoms and signs involving the urinary system

5701

30844

1.45

129.28

4.0

4.3

24.67

27.13

ug/l

0.15

4708

25080

Enlarged lymph nodes

1259

6233

2.21

129.03

3.6

4.4

17.27

24.93

ug/l

0.70

1008

5022

Oedema, not elsewhere classified

2578

15486

1.73

128.52

3.9

4.2

24.87

24.73

ug/l

0.01

2132

12658

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

194

296

8.50

127.99

2.3

1.4

15.47

2.77

ug/l

0.80

153

209

Other postsurgical states

653

2482

3.12

127.29

6.1

4.2

6.35

25.99

ug/l

2.61

594

2037

Care involving use of rehabilitation procedures

4061

24729

1.53

126.96

3.7

4.0

15.69

16.13

ug/l

0.04

3312

19344

COPD (mode)

2565

12252

1.75

126.74

3.1

4.7

43.85

26.80

ug/l

0.75

2307

10052

Mesothelioma, including Hilmo

162

208

11.13

126.12

2.3

1.4

2.24

2.85

ug/l

2.39

126

152

Clear cell adenocarcinoma of kidney

347

889

4.56

125.46

3.4

1.4

9.50

2.66

ug/l

0.74

265

670

Malignant neoplasm of bladder

439

1308

3.73

125.07

3.4

1.4

43.80

24.60

ug/l

0.24

375

985

Certain infectious and parasitic diseases, including avohilmo

4853

16771

1.50

124.04

4.4

4.2

32.10

27.79

ug/l

0.20

3934

13350

Appendectomy

4250

27877

1.51

123.05

4.1

4.3

13.43

25.90

ug/l

3.59

3277

22203

Hernia of abdominal wall

3470

23138

1.58

122.50

5.5

4.2

23.82

28.13

ug/l

0.36

2948

18853

Malignant neoplasm of thyroid gland

398

1136

3.90

121.30

4.7

1.5

19.75

2.56

ug/l

0.88

298

851

Use of hypnotics and sedatives

7418

31752

1.38

121.08

4.2

4.3

21.75

27.33

ug/l

0.82

6100

25409

Iron deficiency anaemia secondary to blood loss (chronic)

1417

7531

2.08

120.72

4.1

4.0

25.14

25.65

ug/l

0.02

1193

6173

Excluding asthma or asthma-COPD overlap

5216

18383

1.47

120.25

4.3

4.6

20.71

27.09

ug/l

0.73

4260

14465

Colorectal neuroendocrine tumor and carcinoma

160

213

10.18

119.88

4.8

1.5

10.34

2.78

ug/l

1.11

135

161

Pain (limb, back, neck, head abdominally)

4718

16361

1.49

118.26

4.2

4.6

19.02

29.55

ug/l

1.47

3797

13302

Benzodiazepine use

6969

35202

1.38

117.39

3.8

4.3

20.50

26.64

ug/l

0.97

5625

28260

Postprocedural disorders of digestive system, not elsewhere classified

395

1201

4.25

116.33

7.3

4.3

16.56

22.28

ug/l

0.26

342

997

COPD differential diagnosis

5177

18366

1.46

115.16

4.3

4.6

20.97

27.09

ug/l

0.68

4224

14462

ILD differential diagnosis

5176

18364

1.46

115.04

4.3

4.6

20.97

27.09

ug/l

0.68

4223

14460

Mesothelioma

136

159

12.87

114.79

2.2

1.4

2.12

2.80

ug/l

2.82

108

115

Acute renal failure

1925

11389

1.84

114.61

4.0

4.3

28.02

25.21

ug/l

0.13

1659

9521

Dental caries

1979

11031

1.81

114.57

4.9

4.6

21.05

30.80

ug/l

0.76

1660

8961

Benign neoplasm: Descending colon

754

3272

2.77

113.74

5.7

4.3

4.96

24.11

ug/l

4.93

646

2707

Malignant neoplasm of heart, mediastinum and pleura

155

212

9.95

113.63

2.2

1.4

3.99

2.80

ug/l

0.57

123

153

Other heart diseases

2683

10916

1.66

112.61

3.7

4.6

23.92

27.39

ug/l

0.17

2113

8344

Hypertensive diseases (excluding secondary)

2976

11071

1.62

111.79

3.9

4.5

21.47

27.12

ug/l

0.34

2379

8447

Caries of dentine

1770

9863

1.85

111.51

4.9

4.6

22.72

29.82

ug/l

0.44

1487

8033

Malignant neoplasm of head and neck

464

1549

3.29

109.53

3.4

1.5

9.66

21.24

ug/l

0.28

393

1166

Non-Hodgkin lymphoma, all

315

829

4.36

109.19

2.3

1.4

3.42

2.80

ug/l

0.94

244

628

Ovarian cyst

2326

8086

1.73

109.00

3.2

4.4

12.81

31.22

ug/l

2.22

1758

6396

Other pulmonary diagnosis

5135

18383

1.44

108.44

4.3

4.6

20.95

27.09

ug/l

0.68

4183

14465

Dysphagia

1865

11035

1.80

108.31

3.4

4.3

13.39

24.08

ug/l

1.79

1533

9052

Mucosal proctocolitis

895

4157

2.35

107.98

5.9

4.3

6.20

32.62

ug/l

2.42

698

3308

Misadventures to patients during surgical and medical care

1211

6368

2.10

106.41

4.9

4.1

17.70

25.58

ug/l

0.34

1008

5142

Inflammatory bowel disease

2081

12722

1.73

105.63

4.7

4.3

16.21

25.80

ug/l

0.83

1639

10215

Ulcerative colitis

1651

9500

1.85

105.29

5.0

4.3

13.02

27.59

ug/l

1.69

1302

7656

Insulin medication

4243

25052

1.46

102.07

4.1

4.4

20.23

26.97

ug/l

0.97

3689

20251

General examination and investigation of persons without complaint and reported diagnosis

4037

14509

1.49

102.03

3.9

4.6

20.11

34.91

ug/l

2.05

3269

11669

Hypertensive diseases

4965

20212

1.43

101.64

4.0

4.5

23.84

24.38

ug/l

0.04

4017

15971

Hypertension

4965

20210

1.43

101.60

4.0

4.5

23.85

24.38

ug/l

0.04

4017

15969

Symptoms and signs concerning food and fluid intake

908

4368

2.30

101.14

2.8

4.2

10.80

20.12

ug/l

1.10

750

3545

Gastric ulcer

1479

8448

1.90

99.25

4.0

4.4

21.39

29.72

ug/l

0.52

1238

7062

Other noninfective gastroenteritis and colitis

1759

10559

1.77

96.43

4.7

4.2

23.19

27.93

ug/l

0.28

1420

8541

Erysipelas

3962

24305

1.46

96.02

3.9

4.2

25.08

23.42

ug/l

0.08

3301

19729

Provisional assignment of new diseases of uncertain etiology

3648

25471

1.48

95.44

4.3

4.1

18.48

25.10

ug/l

0.40

2993

20505

Hypokalaemia

1068

5593

2.11

95.41

4.4

4.3

20.24

22.91

ug/l

0.14

918

4566

Codes for special purposes

3651

25504

1.48

95.22

4.3

4.1

18.47

25.08

ug/l

0.40

2996

20532

Pain in limb

5545

26263

1.38

95.02

3.8

4.5

15.60

29.97

ug/l

2.96

4401

21096

COPD/asthma related infections

6787

25932

1.35

94.77

4.2

4.3

18.73

26.79

ug/l

1.46

5480

20636

COPD/asthma/ILD related infections

6787

25932

1.35

94.77

4.2

4.3

18.73

26.79

ug/l

1.46

5480

20636

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

321

946

3.86

94.29

2.6

1.4

3.50

2.72

ug/l

1.60

260

716

Endometroid carcinoma of ovary, including Hilmo

124

167

11.47

94.09

3.4

1.5

4.63

2.60

ug/l

1.01

125

Multiple myeloma, including Hilmo

304

873

3.98

92.96

2.8

1.4

5.33

2.74

ug/l

2.06

239

663

Malignant neoplasm of other connective and soft tissue

196

409

5.73

92.17

3.4

1.5

9.45

2.70

ug/l

0.82

152

308

Diarrhoea and gastroenteritis of presumed infectious origin

4597

30109

1.40

91.86

4.2

17.54

25.66

ug/l

1.45

3692

24149

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6394

28999

1.34

91.11

3.9

4.4

25.65

26.59

ug/l

0.08

5330

23066

Fitting and adjustment of other devices

2627

15408

1.58

90.94

3.5

4.0

20.80

16.08

ug/l

0.37

2180

12471

Insulin, intermediate and long-acting

3888

26959

1.45

90.87

4.1

4.3

20.08

28.33

ug/l

1.25

3375

21943

Diabetes, insulin treatment (Kela reimbursement)

6887

31763

1.32

88.80

3.9

4.3

24.79

25.78

ug/l

0.09

5765

25319

Intestinal infectious diseases, including avohilmo, including avohilmo

7774

34017

1.30

88.47

4.1

4.2

17.24

27.88

ug/l

3.00

6231

27406

Cardiovascular diseases

2802

9816

1.55

88.21

4.2

4.5

19.46

28.48

ug/l

0.66

2134

7327

IBD patients in KELA-register

1403

8105

1.83

87.72

5.2

4.4

15.37

31.73

ug/l

1.15

1091

6437

Carcinoma in situ of rectum

222

576

6.30

87.43

3.9

4.5

12.78

36.22

ug/l

0.86

170

477

Diabetes, varying definitions

6610

29567

1.33

87.24

3.9

4.3

23.31

26.31

ug/l

0.31

5458

23378

Portal vein thrombosis

233

614

5.44

86.85

5.2

4.4

4.71

34.09

ug/l

1.48

196

516

Chronic gastritis

2156

14017

1.64

86.85

3.3

4.4

12.43

26.97

ug/l

2.75

1732

11667

Persons encountering health services for examination and investigation

4067

14542

1.44

86.78

4.1

4.6

26.03

34.88

ug/l

0.75

3302

11693

Prophylactic surgery

125

188

10.45

86.63

3.3

3.9

5.24

6.79

ug/l

0.21

146

Ulcerative colitis, NAS

951

4910

2.09

86.39

5.3

4.3

7.86

32.54

ug/l

2.50

753

3919

Covid-19 confirmed case

2743

18727

1.54

85.59

4.4

4.1

16.75

24.91

ug/l

0.40

2281

15336

Infections, IBD-co-morbidities

1209

4656

1.95

85.54

4.0

5.6

24.99

45.61

ug/l

1.00

999

3716

Diaphragmatic hernia

2809

19351

1.53

85.35

3.4

4.2

17.59

27.34

ug/l

0.86

2272

15867

5-aminosalicylic acid

1364

7884

1.83

85.33

5.2

4.5

14.37

27.28

ug/l

0.84

1068

6265

Diabetes mellitus

6618

29580

1.32

85.20

3.9

4.3

23.32

26.29

ug/l

0.31

5466

23383

Dipeptidyl peptidase 4 (DPP-4) inhibitors

4296

24849

1.42

84.48

3.7

4.4

20.20

25.88

ug/l

0.85

3662

20380

Other gastritis (incl. Duodenitis)

1710

10609

1.72

83.80

3.7

4.5

26.43

29.64

ug/l

0.14

1430

8809

Medullary carcinoma of thyroid gland, including Hilmo

75.59

83.00

9.6

1.8

77.94

2.28

ug/l

0.67

Diabetes medication

6813

31055

1.31

82.53

3.9

4.3

25.95

25.69

ug/l

0.02

5636

24614

Codeine or tramadol medication

7445

31862

1.30

82.47

3.8

4.3

18.15

26.33

ug/l

1.14

6028

25534

Inflammatory bowel disease, strict (require KELA)

1403

8270

1.79

81.68

5.2

4.4

15.37

29.32

ug/l

0.94

1091

6591

Hypo-osmolality and hyponatraemia

1484

8900

1.79

81.37

3.8

4.3

12.94

23.63

ug/l

2.85

1253

7378

Diseases of arteries, arterioles and capillaries (FINNGEN)

1678

7063

1.73

81.24

3.5

4.9

27.55

26.52

ug/l

0.04

1420

5686

Follow-up examination after treatment for conditions other than malignant neoplasms

2830

12881

1.51

80.83

3.5

4.6

24.94

34.54

ug/l

0.41

2231

10305

Functional dyspepsia

1923

12362

1.64

80.17

3.3

4.4

17.85

24.75

ug/l

0.68

1501

9979

Other soft tissue disorders, not elsewhere classified

6018

26414

1.33

79.01

3.8

4.5

15.55

29.86

ug/l

3.08

4788

21207

Intestinal infectious diseases

6183

35810

1.31

79.00

4.2

17.91

27.23

ug/l

2.12

4955

28757

Insulin, combination of fast acting with intermediate-acting or long-acting

4247

28689

1.39

78.33

4.1

4.3

20.22

28.02

ug/l

1.27

3691

23319

Primary_lymphoid and hematopoietic malignant neoplasms

1876

12118

1.66

78.23

3.0

4.3

8.65

27.35

ug/l

5.87

1408

10121

Mucinous and mucinous cystic tumor, including Hilmo

110

13.02

78.12

2.8

1.5

11.97

2.66

ug/l

1.50

Primary biliary cholangitis, wide definition

289

937

4.05

77.86

5.1

4.4

7.59

22.92

ug/l

0.91

235

755

Other disorders of urethra and urinary system

4868

25612

1.36

77.43

4.0

4.2

13.87

29.26

ug/l

4.69

3886

20656

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1008

5504

1.95

76.68

5.6

4.4

8.48

31.50

ug/l

2.58

782

4384

Other special examinations and investigations of persons without complaint or reported diagnosis

3958

14541

1.41

76.56

4.0

4.6

21.17

34.88

ug/l

1.53

3228

11692

Abnormal findings on examination of blood, without diagnosis

3393

22211

1.44

76.26

3.8

4.4

30.23

28.36

ug/l

0.07

2782

18402

Other inflammatory liver diseases

558

2496

2.55

76.25

4.6

4.4

6.75

21.50

ug/l

2.68

454

2021

Type 2 diabetes

6466

29322

1.31

76.12

3.8

4.4

24.50

26.39

ug/l

0.17

5342

23252

Crohn's disease (strict) with PSC

100.38

76.00

8.4

4.0

2.10

3.72

ug/l

1.00

Persons encountering health services for specific procedures, not carried out

573

2561

2.44

75.83

4.5

4.1

8.84

12.63

ug/l

0.36

471

1999

Other heart diseases, wide

5600

26119

1.33

74.87

3.8

4.5

19.84

29.28

ug/l

1.29

4440

20744

Other diseases of urinary system

6534

28858

1.30

73.88

4.0

4.3

13.07

30.32

ug/l

6.85

5245

23286

Autoimmune diseases excluding thyroid diseases

6744

28830

1.30

73.87

4.1

4.4

23.49

25.90

ug/l

0.18

5471

23144

Autoimmune diseases excluding thyroid diseases, strict definition

6555

28049

1.30

73.39

4.1

4.4

22.57

26.22

ug/l

0.29

5318

22542

Ulcerative colitis (strict definition, require KELA)

1023

5722

1.90

71.93

5.6

4.4

8.36

30.89

ug/l

2.65

796

4562

Haemorrhage from respiratory passages

2624

16282

1.49

70.37

3.6

4.6

17.31

29.22

ug/l

1.36

2182

13551

Noninfectious colitis NAS

969

5391

1.94

70.34

4.8

4.1

19.59

29.31

ug/l

0.58

785

4346

Benign neoplasm: Small intestine

419

1741

2.94

70.29

3.7

4.3

11.14

20.44

ug/l

0.73

345

1438

Endometroid carcinoma of ovary

110

12.36

69.60

2.8

1.5

4.00

2.60

ug/l

0.76

Intestinal malabsorption

402

1617

2.87

69.57

4.5

4.4

12.28

18.54

ug/l

0.36

351

1316

Disorders of mineral metabolism

706

3582

2.19

69.28

3.9

4.4

34.22

27.30

ug/l

0.29

593

2910

Transplanted organ and tissue status

691

3463

2.19

69.22

3.8

4.6

6.34

22.48

ug/l

3.15

576

2843

Speech therapy

1923

12816

1.59

69.07

3.6

4.3

14.40

25.37

ug/l

1.67

1608

10458

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

329

1177

3.01

68.31

3.3

1.5

22.89

2.71

ug/l

0.77

254

873

Non-follicular lymphoma

808

4341

2.08

67.96

2.5

4.3

9.71

19.32

ug/l

1.49

574

3614

Type 2 diabetes, definitions combined

6290

29021

1.29

67.29

3.9

4.4

26.08

26.54

ug/l

0.04

5188

23067

Need for other prophylactic measures

463

2016

2.61

67.09

5.1

4.4

13.66

21.09

ug/l

0.37

376

1649

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1080

6277

1.82

66.54

5.5

4.4

16.57

30.15

ug/l

0.67

842

5013

Asthma

4651

18242

1.35

66.50

3.6

4.6

17.89

27.22

ug/l

0.99

3793

14352

Benign neoplasm: Rectosigmoid junction

418

1779

2.83

66.23

5.0

4.2

9.37

19.85

ug/l

1.15

338

1472

Other complications of surgical and medical care, not elsewhere classified

725

3773

2.10

65.31

5.8

4.0

52.85

22.56

ug/l

0.31

590

3033

Infections of the skin and subcutaneous tissue

3631

26715

1.38

65.27

4.1

4.3

18.46

27.46

ug/l

1.47

2984

21435

Type 2 diabetes, strict (exclude DM1)

6319

29298

1.28

64.91

3.9

4.4

25.98

26.35

ug/l

0.03

5215

23312

Alcoholic liver disease

775

4158

2.05

64.44

3.2

4.8

13.26

28.96

ug/l

2.00

695

3465

Type 2 diabetes, definitions combined, including avohilmo

6272

28898

1.28

64.26

3.9

4.4

24.54

26.39

ug/l

0.17

5156

22966

Asthma, excluding more controls

4363

16962

1.35

64.13

3.7

4.7

18.45

28.04

ug/l

0.93

3554

13295

Abnormal weight loss

767

4135

2.05

63.25

2.6

4.3

9.89

19.77

ug/l

1.03

623

3394

Unspecified haematuria

3060

18234

1.42

63.23

4.0

4.4

21.67

30.46

ug/l

0.66

2526

15184

Atrial fibrillation and flutter

1959

8442

1.56

63.03

3.8

4.8

13.86

27.03

ug/l

1.57

1591

6737

Morphin

247

816

3.72

63.00

4.9

3.8

22.24

10.78

ug/l

0.78

213

677

Acute peritonitis

530

2513

2.38

62.85

5.1

4.2

41.64

15.79

ug/l

0.94

456

2087

Syncope and collapse

2994

18207

1.42

62.68

3.6

4.3

21.78

25.93

ug/l

0.25

2426

14865

Endocrine, nutritional and metabolic diseases

4393

16855

1.34

62.32

4.0

4.6

29.87

24.63

ug/l

0.26

3520

13243

Phlebitis and thrombophlebitis (not including DVT)

1639

10790

1.61

62.15

4.8

4.3

17.70

26.58

ug/l

0.91

1338

8748

Other (not insulin) diabetes medications

6496

30643

1.27

61.99

3.8

4.3

26.81

25.84

ug/l

0.08

5351

24403

Diseases of peritoneum

788

4306

2.01

61.90

4.6

4.1

38.01

22.06

ug/l

0.59

649

3505

Hepatic failure, not elsewhere classified

352

1421

2.93

61.45

3.5

4.3

9.52

21.57

ug/l

0.97

304

1169

Osteopathies and chondropathies

3920

27351

1.35

61.40

3.8

4.2

23.07

24.68

ug/l

0.08

3250

22134

Cardiac arrhythmias

3383

16037

1.39

60.82

3.8

4.6

16.97

28.04

ug/l

1.12

2650

12364

Symptoms and signs involving the circulatory and respiratory systems

5983

23807

1.28

60.81

3.8

4.5

17.09

28.64

ug/l

2.43

4742

19040

Weight loss

806

4468

1.98

60.56

2.7

4.2

10.94

21.79

ug/l

1.17

655

3648

Disorders of calcium metabolism

556

2726

2.29

60.50

3.4

4.3

40.45

22.70

ug/l

0.81

467

2213

Later onset COPD, excluding more controls

1702

8611

1.60

60.49

3.2

4.5

43.81

24.58

ug/l

0.64

1520

7152

Malignant neoplasm of oral cavity, including Hilmo

247

813

3.36

60.26

3.8

1.5

5.55

2.79

ug/l

1.63

221

614

Autoimmune diseases related-to ILD

5426

36002

1.29

60.20

3.9

4.3

27.17

25.35

ug/l

0.12

4311

28912

Mucinous and mucinous cystic tumor

13.40

59.89

2.2

1.5

13.96

2.59

ug/l

1.38

Crohn disease

792

4338

1.95

59.86

4.5

4.3

9.70

30.69

ug/l

1.70

617

3436

Chronic kidney disease

2393

16421

1.47

59.63

3.2

4.2

15.43

26.96

ug/l

1.77

2053

13712

Headache

3826

22449

1.35

59.14

3.4

4.2

26.00

25.22

ug/l

0.04

2962

17787

Papillary adenocarcinoma of thyroid gland

255

862

3.22

59.07

4.0

1.5

8.09

2.62

ug/l

0.59

180

648

Paralytic ileus

332

1323

2.90

58.72

5.7

4.1

13.67

28.50

ug/l

0.76

284

1108

Other diseases of stomach and duodenum

552

2730

2.27

58.67

4.5

10.65

20.94

ug/l

1.35

469

2243

Early onset COPD, excluding more controls

1384

8869

1.65

58.43

3.1

4.8

32.73

28.50

ug/l

0.13

1233

7216

Disorders of breast

3132

20494

1.39

58.36

3.7

4.0

13.55

21.71

ug/l

1.63

2401

15946

Vitamin B12 deficiency anaemia

821

4622

1.94

58.35

5.0

3.9

43.00

22.52

ug/l

0.30

707

3813

Benign neoplasm of ovary

1292

8215

1.69

58.29

3.3

4.0

14.33

18.41

ug/l

0.24

1004

6567

Biguanides

6383

31160

1.26

58.08

3.8

4.3

26.34

25.66

ug/l

0.05

5258

24913

Low back pain

4953

26322

1.30

57.53

3.6

4.6

25.29

27.08

ug/l

0.10

3934

21054

L04AD Calcineurin inhibitors

708

3809

2.01

57.44

3.7

4.5

12.61

24.02

ug/l

0.77

576

3073

Other ulcerative colitis

405

1771

2.54

57.31

6.4

4.3

6.15

21.23

ug/l

1.84

320

1425

Volume depletion

758

4209

1.96

56.11

4.5

4.2

14.24

22.02

ug/l

1.10

652

3478

Asthma (mode)

4507

18364

1.32

55.98

3.7

4.6

13.70

27.09

ug/l

2.57

3649

14460

Symptoms and signs involving cognition, perception, emotional state and behaviour

6266

33983

1.26

55.72

3.6

4.4

14.65

28.49

ug/l

4.37

5056

27311

Neuroendocrine tumor and carcinoma of lung

139

8.28

55.42

2.7

1.6

21.84

2.58

ug/l

0.52

108

Persons encountering health services in other circumstances

2480

17752

1.43

55.25

3.9

4.2

13.97

27.93

ug/l

3.15

2064

14311

Retention of urine

2478

14490

1.44

55.21

4.1

4.4

18.86

32.41

ug/l

1.68

2087

12139

Streptococcal septicaemia, including avohilmo

687

3729

2.01

54.73

3.9

4.1

23.40

17.98

ug/l

0.20

565

3061

Nonalcoholic fatty liver disease

706

3866

1.98

54.48

3.2

4.4

7.83

23.12

ug/l

2.16

548

3103

COPD

3387

20951

1.36

54.22

3.1

4.5

39.97

24.77

ug/l

0.90

3005

17282

Implicit viral Sepsis, including avohilmo

2141

15190

1.47

54.12

3.4

4.3

9.01

25.98

ug/l

5.80

1744

12471

Haemorrhoids and perianal venous thrombosis

2222

15758

1.45

54.02

3.7

4.2

18.84

32.77

ug/l

1.38

1807

12915

Asthma (only as main-diagnosis), excluding more controls

3991

16962

1.33

53.53

3.5

4.7

19.38

28.04

ug/l

0.72

3248

13295

Other embolism and thrombosis

947

5685

1.79

53.32

4.9

4.2

14.01

22.47

ug/l

1.20

807

4624

Renal cell carcinoma of kidney

190

576

3.68

53.27

2.8

1.4

13.63

2.82

ug/l

0.99

156

437

Alcohol use disorder, Swedish definition

3373

23349

1.35

53.18

3.5

4.5

22.83

28.60

ug/l

0.50

2932

18953

Anosmia

128

276

4.90

53.10

3.8

1.6

8.51

35.28

ug/l

0.38

110

209

Cerebrovascular diseases (FINNGEN)

1862

8966

1.51

52.75

3.8

4.7

24.87

30.37

ug/l

0.25

1570

7051

Periodontitis

6570

34355

1.24

52.58

4.2

4.3

18.81

27.35

ug/l

1.72

5374

27618

Streptococcal septicaemia

667

3637

2.00

52.40

3.9

4.1

23.96

18.32

ug/l

0.20

549

2984

Genitourinary diseases

3070

11390

1.38

52.36

4.4

4.8

24.22

43.96

ug/l

2.08

2471

9353

Sequelae with surgical and medical care as external cause

1481

9937

1.58

51.78

4.5

4.3

21.63

28.11

ug/l

0.32

1207

8160

Chronic hepatitis, not elsewhere classified

297

1199

2.88

51.47

4.7

4.2

3.07

20.32

ug/l

2.68

253

975

Chronic periodontitis, including avohilmo

6552

34372

1.24

51.37

4.2

4.3

18.85

27.32

ug/l

1.70

5359

27634

Ulcerative ileocolitis

293

1168

2.83

51.12

6.9

4.5

12.12

25.05

ug/l

0.58

226

945

Benign neoplasm: Duodenum

277

1106

3.12

50.99

3.6

4.5

13.60

24.03

ug/l

0.50

226

925

Paracetamol or NSAID medication

850

2394

1.85

50.82

4.3

26.15

38.44

ug/l

0.51

692

1908

Non-small cell lung cancer, squamous, helper endpoint

447

2159

2.33

50.73

2.7

4.0

39.98

28.73

ug/l

0.14

413

1828

Heart failure and antihypertensive medication

1661

7315

1.54

50.50

3.4

4.9

13.23

34.17

ug/l

3.96

1395

5931

Fall on same level

7045

31041

1.23

50.18

3.9

4.4

23.03

27.58

ug/l

0.39

5660

24770

Malignant neoplasm of bone and articular cartilage, including Hilmo

124

292

4.90

50.14

4.4

1.5

31.54

2.70

ug/l

0.85

216

Sequelae of external causes of morbidity and mortality

1801

12618

1.50

49.94

4.5

4.3

19.07

27.65

ug/l

0.56

1461

10348

Explicit bacterial Sepsis, including avohilmo

787

4565

1.85

49.93

4.0

4.3

24.49

24.73

ug/l

0.01

651

3750

Budesonide

920

5558

1.75

49.62

4.0

4.4

4.54

29.63

ug/l

3.14

708

4400

Viral Sepsis

1466

9878

1.56

49.56

3.4

4.3

7.42

30.04

ug/l

5.70

1202

8128

Asthma (only as main-diagnosis)

4175

18242

1.31

49.52

3.5

4.6

24.26

27.22

ug/l

0.17

3409

14352

Chronic apical periodontitis

7072

32877

1.23

49.51

4.2

20.53

27.57

ug/l

1.19

5733

26363

Other chronic obstructive pulmonary disease

3240

20336

1.35

49.47

3.1

4.5

39.62

25.03

ug/l

0.82

2884

16789

Other bacterial intestinal infections

1282

8409

1.61

49.43

3.9

4.2

19.82

32.63

ug/l

1.03

1063

6918

Other bacterial intestinal infections, including avohilmo

1596

10936

1.53

49.38

3.9

4.2

18.72

28.64

ug/l

0.95

1300

8957

Implicit viral Sepsis

1463

9862

1.56

49.35

3.4

4.3

7.43

30.10

ug/l

5.69

1199

8112

Pain in joint

3383

15844

1.34

49.26

3.4

4.6

20.70

29.32

ug/l

0.61

2653

12867

Insulin, fast-acting

2231

16209

1.43

49.03

4.1

4.3

16.89

28.37

ug/l

1.38

1920

13157

Heart failure,strict

3836

20952

1.32

48.77

3.3

4.6

14.11

28.46

ug/l

4.73

3231

17350

Diseases of the respiratory system

4088

15999

1.31

48.15

4.3

4.5

20.22

25.35

ug/l

0.52

3293

12658

Explicit bacterial Sepsis

767

4465

1.84

48.08

4.0

4.3

25.00

25.12

ug/l

0.00

635

3664

Other CVD (FINNGEN)

854

3863

1.80

47.90

3.6

4.9

19.46

30.96

ug/l

0.49

717

3169

Polyarthropathies

4316

21968

1.29

47.41

3.5

4.6

19.33

30.15

ug/l

1.64

3472

17706

Carcinoma in situ of breast, intraductal

690

3953

1.93

47.35

3.8

4.1

19.56

22.02

ug/l

0.10

547

3175

Benign neoplasm: Appendix

150

447

4.71

47.25

4.0

4.2

3.71

35.64

ug/l

1.14

124

378

Hyperlipidaemia, other/unspecified

2847

19436

1.37

47.03

3.7

4.4

31.75

26.37

ug/l

0.19

2328

16117

Other disorders of skin and subcutaneous tissue

4979

34082

1.26

46.89

3.6

4.3

15.82

27.87

ug/l

3.13

4042

27624

Malignant neoplasm of oral cavity

187

608

3.40

46.73

3.5

1.5

5.78

2.68

ug/l

1.35

166

458

Multiple myeloma

169

520

3.65

46.52

2.2

1.4

3.97

2.83

ug/l

0.54

133

383

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

169

520

3.65

46.52

2.2

1.4

3.97

2.83

ug/l

0.54

133

383

Marginal zone B-cell lymphoma, including Hilmo

116

278

4.92

46.25

3.1

1.5

4.41

2.70

ug/l

0.83

211

Lower back pain or/and sciatica

6829

35365

1.22

46.16

3.6

4.3

22.81

26.18

ug/l

0.27

5451

28434

Colorectal squamous cell carcinoma

65.40

46.11

3.2

1.5

2.09

2.99

ug/l

0.78

Cholecystitis

970

6065

1.70

46.09

4.1

4.2

18.80

26.69

ug/l

0.60

834

4950

Symptoms and signs involving the skin and subcutaneous tissue

4662

35580

1.27

45.66

3.7

4.3

12.34

27.41

ug/l

6.66

3758

28574

Dizziness and giddiness

5047

31919

1.26

45.62

3.5

4.4

16.29

29.00

ug/l

2.96

4079

25784

Other chronic obstructive pulmonary disease, including avohilmo

3887

25304

1.30

45.54

3.2

4.4

40.67

24.78

ug/l

1.10

3437

20866

Small cell lung cancer, helper endpoint

264

1077

2.89

45.27

2.1

4.2

32.34

26.25

ug/l

0.20

242

920

Leiomyosarcoma, including Hilmo

154

6.76

45.15

2.3

1.5

2.50

2.65

ug/l

0.19

119

Alcohol-induced chronic pancreatitis

464

2366

2.17

45.11

3.5

4.7

25.70

21.59

ug/l

0.10

419

1963

Squamous cell neoplasms and carcinoma of rectum

64.98

45.09

3.2

1.5

2.09

2.99

ug/l

0.78

3475

24259

1.31

44.85

3.5

4.5

23.14

28.91

ug/l

0.52

3020

19658

Disorders of eyelid, lacrimal system and orbit

5750

34743

1.24

44.81

3.7

4.3

22.74

26.34

ug/l

0.24

4573

28063

Abscess of anal and rectal regions

496

2569

2.06

44.56

5.9

4.4

26.51

32.33

ug/l

0.18

398

2101

Ulcerative colitis (strict definition, all Crohn cases excluded)

809

4853

1.76

44.53

5.4

4.3

8.67

31.52

ug/l

2.14

633

3853

Other antidepressants

6512

27583

1.23

44.49

3.9

4.5

25.01

27.92

ug/l

0.17

5275

22206

Cystitis

5438

26454

1.25

44.35

3.8

4.2

13.72

29.39

ug/l

4.88

4285

21335

Bacterial intestinal infections, IBD co-morbidities

1278

8582

1.57

44.21

3.9

4.2

19.95

25.42

ug/l

0.45

1055

7030

Unspecified misadventure during surgical and medical care

448

2281

2.19

44.04

5.3

4.3

33.24

20.45

ug/l

0.20

376

1879

Other reaction to severe stress, and adjustment disorders

1890

13555

1.43

43.97

4.4

4.3

23.18

25.49

ug/l

0.13

1506

10435

3624

24829

1.30

43.81

3.5

4.5

22.66

28.77

ug/l

0.58

3147

20060

Vascular disorders of the intestines

522

2796

2.04

43.58

3.3

4.0

8.58

25.23

ug/l

2.76

439

2343

Chronic lymphocytic leukaemia, helper endpoint

170

547

3.46

43.45

3.4

1.4

7.84

2.78

ug/l

0.88

129

406

Chronic lymphocytic leukaemia

170

547

3.46

43.45

3.4

1.4

7.84

2.78

ug/l

0.88

129

406

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

170

547

3.46

43.45

3.4

1.4

7.84

2.78

ug/l

0.88

129

406

Irritable bowel syndrome

1556

10834

1.49

43.45

2.8

4.1

14.00

28.61

ug/l

1.49

1160

8598

Unspecified lump in breast

1076

7016

1.63

43.04

4.1

4.0

8.06

25.10

ug/l

2.27

838

5547

Myelodysplastic syndrome, including Hilmo

172

560

3.41

43.04

2.7

1.4

10.81

2.83

ug/l

0.59

134

419

Other Crohn's disease

406

1987

2.20

42.96

5.1

4.4

9.31

16.23

ug/l

0.78

312

1568

Used for control exclusion in common control thyroid runs

6411

26863

1.22

42.82

4.1

4.4

21.05

26.69

ug/l

0.51

5148

21600

Malignant neoplasm of cervix uteri, including Hilmo

131

360

4.04

42.55

3.7

1.5

21.94

2.59

ug/l

0.68

105

265

Pneumothorax

506

2709

2.04

42.33

4.4

4.5

36.15

24.04

ug/l

0.33

433

2254

790

4769

1.74

42.29

4.5

4.1

6.73

32.99

ug/l

2.48

610

3783

Dialysis, with operation codes

847

5247

1.72

42.21

3.2

4.6

9.97

24.93

ug/l

2.40

720

4358

Cutaneous abscess, furuncle and carbuncle

1525

10659

1.48

41.98

4.2

4.4

17.93

27.87

ug/l

1.04

1265

8569

COPD, hospital admissions

3237

21399

1.32

41.62

3.1

4.4

39.15

25.91

ug/l

0.71

2878

17782

COPD, early/later onset

3268

21570

1.31

41.29

3.1

4.4

39.47

25.68

ug/l

0.76

2907

17921

Dorsalgia

6034

26541

1.22

41.18

3.6

4.5

22.34

27.06

ug/l

0.37

4814

21226

Other CVD

1507

10622

1.49

40.96

3.5

4.1

14.64

26.10

ug/l

1.12

1247

8844

Asthma (diagnoses ohter than nonallergic)

5430

36312

1.23

40.87

3.5

4.3

16.84

27.14

ug/l

1.60

4470

29040

Rare circulating lymphoid malignancy, including Hilmo

144

434

3.64

40.57

3.1

1.5

13.87

2.71

ug/l

0.53

107

320

Autoimmune diseases

6786

28925

1.21

40.52

4.1

4.4

25.95

25.84

ug/l

0.01

5463

23217

DVT of lower extremities

1333

9200

1.53

40.39

4.7

4.2

59.92

25.90

ug/l

0.87

1102

7535

Urinary track infection

3442

13513

1.30

39.56

3.8

4.0

10.90

26.77

ug/l

3.28

2650

10373

Insulin, fast-acting or short human

2237

16824

1.37

39.41

4.1

4.3

17.02

28.18

ug/l

1.35

1925

13716

Benign neoplasm: Endocrine pancreas

245

6.17

39.31

3.3

4.9

2.81

25.27

ug/l

0.75

210

Nephropathy related operations

806

5029

1.71

39.12

3.3

4.6

10.24

25.72

ug/l

2.33

682

4166

Diseases of the skin and subcutaneous tissue

6139

25719

1.22

39.09

4.0

4.4

29.77

27.27

ug/l

0.14

4936

20691

Benign neoplasm: Adrenal gland

603

3509

1.89

39.07

3.8

4.3

25.40

22.03

ug/l

0.09

504

2873

Malignant neoplasm of tonsil and base of tongue, including Hilmo

134

398

3.77

38.99

3.8

1.5

19.90

2.67

ug/l

0.88

113

295

Malignant neoplasm of tongue, including Hilmo

142

437

3.61

38.99

3.7

1.5

4.84

2.75

ug/l

1.92

129

327

Other metabolic disorders

852

5371

1.67

38.99

3.9

4.3

63.24

21.87

ug/l

0.50

656

4239

Leiomyosarcoma

124

7.09

38.98

2.2

1.5

2.68

2.59

ug/l

0.09

Hypercalcemia

378

1907

2.26

38.88

3.4

4.2

35.28

19.15

ug/l

0.90

317

1579

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

596

3439

1.86

38.62

5.7

4.1

62.32

18.64

ug/l

0.40

502

2762

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

205

5.20

38.35

4.4

1.6

42.44

2.58

ug/l

0.84

151

Atrial fibrillation and flutter with reimbursement

1627

7287

1.46

38.33

3.6

4.9

8.76

27.09

ug/l

4.40

1319

5889

ILD medications: immunosuppressive drugs

3859

28181

1.27

38.30

3.5

4.5

25.78

24.33

ug/l

0.08

3071

22456

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

558

3191

1.90

37.93

4.5

4.2

9.44

24.12

ug/l

1.92

464

2588

Azathioprine

837

5278

1.66

37.84

4.3

4.5

13.62

26.68

ug/l

0.96

670

4158

ILD medications: azathioprine

837

5290

1.66

37.49

4.3

4.5

13.62

26.66

ug/l

0.96

670

4186

Use of anticholinesterases

1631

17199

0.70

37.49

3.0

4.0

12.99

25.57

ug/l

2.00

1325

14483

N06DA Anticholinesterases

1631

17199

0.70

37.49

3.0

4.0

12.99

25.57

ug/l

2.00

1325

14483

Liposarcoma, including Hilmo

166

5.76

37.26

3.5

1.5

3.20

2.66

ug/l

0.62

125

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

6329

34272

1.20

37.12

4.1

4.2

16.37

27.86

ug/l

3.15

5015

27578

Vocal cord dysfunction

890

5022

1.63

36.79

4.4

5.1

9.69

41.57

ug/l

3.47

740

3964

Follow-up care involving plastic surgery

279

1267

2.45

36.65

3.9

3.8

22.33

15.98

ug/l

0.18

206

994

Adjustment and management of implanted device

1133

7706

1.54

36.58

3.0

4.0

17.27

17.31

ug/l

0.00

883

6304

Postprocedural endocrine and metabolic disorders, not elsewhere classified

786

4940

1.68

36.49

4.0

4.3

68.11

21.45

ug/l

0.53

606

3891

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

682

4164

1.76

36.28

4.7

4.3

14.50

21.41

ug/l

0.36

563

3384

Spondylopathies

5205

25587

1.23

36.26

3.5

4.6

34.93

27.61

ug/l

0.36

4287

20679

Other other unspecified disorders of the circulatory system

302

1439

2.39

35.96

4.0

4.3

9.98

24.13

ug/l

1.35

240

1187

Carcinoid syndrome

125

398

4.39

35.79

3.6

4.7

11.87

41.20

ug/l

0.80

341

Malignant neoplasm of brain, including Hilmo

198

763

2.76

35.78

2.8

1.5

32.68

2.72

ug/l

0.64

149

567

Crohn's disease NAS

387

1994

2.09

35.75

4.9

4.3

12.88

21.70

ug/l

0.64

306

1590

Suppurative and necrotic conditions of lower respiratory tract

420

2259

2.05

35.12

3.2

4.3

7.69

27.96

ug/l

2.86

361

1881

Primary biliary cholangitis (PBC)

217

920

2.81

34.79

4.2

4.3

9.08

22.60

ug/l

0.67

171

745

Other and unspecified abdominal hernia

330

1652

2.24

34.32

6.9

4.2

14.88

14.37

ug/l

0.03

286

1358

Malignant neoplasm of eye, brain and central nervous system

182

688

2.82

34.26

2.5

1.6

2.98

2.74

ug/l

0.36

132

516

7273

31604

1.18

34.25

4.0

4.3

21.14

26.70

ug/l

0.65

5789

25410

Benign neoplasm: Stomach

725

4585

1.71

34.03

3.5

4.2

4.29

24.50

ug/l

5.32

590

3747

Other arrhythmias

3969

24219

1.25

34.02

3.7

4.6

14.28

29.97

ug/l

4.01

3149

19441

Other and unspecified drugs and medicaments

569

3372

1.81

33.78

5.8

4.1

65.12

19.18

ug/l

0.40

479

2707

Duodenal ulcer

758

4827

1.67

33.75

3.9

4.4

18.40

29.35

ug/l

0.62

648

4049

Cough

2623

19208

1.31

33.45

3.7

4.5

23.40

29.11

ug/l

0.21

2068

15606

Enterocolitis due to Clostridium difficile

759

4849

1.67

33.45

3.6

4.0

26.25

22.48

ug/l

0.19

634

3977

Hyperkalaemia

456

2553

1.95

33.44

4.4

4.2

74.00

27.40

ug/l

0.31

388

2111

Exposure to unspecified factor

6236

36115

1.19

33.43

4.0

4.3

15.23

27.54

ug/l

3.47

4973

29018

Heartburn

655

4019

1.71

33.25

3.9

4.3

6.48

24.58

ug/l

3.21

520

3233

Heart failure, strict

4197

24083

1.24

33.17

3.3

4.5

13.62

28.23

ug/l

5.40

3532

20058

All-cause Heart Failure

4144

23777

1.24

33.08

3.3

4.5

13.49

28.47

ug/l

5.53

3483

19806

Collagenous colitis

632

3875

1.75

33.07

4.2

11.03

21.43

ug/l

1.12

493

3120

Disorders of lens

4484

23060

1.23

32.78

4.1

4.5

18.26

30.43

ug/l

2.32

3715

18781

Malignant neoplasm of tonsil and base of tongue

112

333

3.76

32.61

3.9

1.5

19.74

2.66

ug/l

0.69

250

Granulosa cell carcinoma of ovary

9.38

32.43

1.7

1.8

5.54

2.41

ug/l

0.46

Mental and behavioural disorders due to tobacco

572

3432

1.78

32.41

3.1

4.5

9.57

25.25

ug/l

2.37

511

2790

Malignant neoplasm of testis, including Hilmo

195

4.60

32.32

5.6

2.0

4.01

2.56

ug/l

1.81

153

Smoking dependency

572

3438

1.78

32.20

3.1

4.5

9.57

25.15

ug/l

2.35

511

2789

Purpura and other haemorrhagic conditions

856

5655

1.60

32.14

4.0

4.2

13.83

20.97

ug/l

0.75

695

4605

Malignant neoplasm of bone and articular cartilage

150

5.52

32.10

4.4

1.7

4.93

2.61

ug/l

1.17

111

Congenital malformations of gallbladder, bile ducts and liver

110

340

4.19

32.08

3.4

4.3

3.73

22.40

ug/l

0.86

279

Chronic lower respiratory diseases

7278

33036

1.18

32.03

3.5

4.4

26.04

25.30

ug/l

0.05

6018

26204

Malignant neoplasm of renal pelvis, including Hilmo

196

4.81

31.90

3.7

1.3

36.23

2.83

ug/l

0.69

150

Fissure and fistula of anal and rectal regions

1345

9659

1.44

31.86

4.0

4.2

16.17

34.36

ug/l

1.86

1044

7822

Malignant neoplasm of larynx, including Hilmo

109

323

3.74

31.81

3.4

1.4

8.18

2.70

ug/l

1.88

241

Other diseases of pericardium

360

1906

2.09

31.78

3.6

4.8

14.14

26.66

ug/l

0.83

295

1584

Autoimmune hepatitis, wide definition

340

1761

2.12

31.69

4.3

4.5

5.90

25.25

ug/l

2.58

274

1414

Anaemia in chronic diseases classified elsewhere

211

919

2.66

31.44

3.0

4.3

165.90

23.90

ug/l

0.55

182

761

Marginal zone B-cell lymphoma

187

5.02

31.43

3.1

1.4

2.77

2.66

ug/l

0.12

138

Bacterial pneumoniae

2589

17944

1.30

31.33

3.9

4.3

27.93

29.07

ug/l

0.06

2190

14640

Asthma, hospital admissions 3, pneumonia

2406

18816

1.31

31.31

3.5

4.1

18.50

24.87

ug/l

0.41

2062

15315

Asthma-related pneumonia or sepsis

2406

18816

1.31

31.31

3.5

4.1

18.50

24.87

ug/l

0.41

2062

15315

Asthma-related pneumonia

2403

18791

1.31

31.30

3.5

4.1

18.52

24.89

ug/l

0.41

2060

15299

Osteoporosis

1974

13924

1.36

30.94

3.5

4.0

25.58

21.13

ug/l

0.13

1653

11466

Ulcerative enterocolitis

214

934

2.55

30.86

5.7

4.5

4.17

25.14

ug/l

1.60

166

762

Diseases of arteries, arterioles and capillaries

4577

28127

1.22

30.84

3.6

4.4

25.32

26.06

ug/l

0.05

3915

23129

Faecal incontinence

616

3817

1.72

30.75

3.8

4.2

6.87

19.00

ug/l

2.11

481

3126

Abnormalities of heart beat

2270

17161

1.32

30.71

3.6

4.5

15.60

27.24

ug/l

1.87

1769

13946

Coagulation defects, purpura and other haemorrhagic conditions

1182

8377

1.47

30.70

3.9

4.3

11.93

27.41

ug/l

2.07

936

6801

Polyneuropathies and other disorders of the peripheral nervous system

1469

10825

1.42

30.69

3.5

4.4

77.82

23.37

ug/l

1.16

1209

9032

Brain meningioma, including Hilmo

219

954

2.44

30.68

3.8

1.4

20.64

2.70

ug/l

0.61

180

723

Mantle cell lymphoma, including Hilmo

229

4.35

30.50

3.4

1.5

20.31

2.82

ug/l

0.53

177

Presence of other functional implants

4029

22839

1.23

30.49

3.9

4.2

26.18

30.73

ug/l

0.24

3335

18834

Paroxysmal tachycardia

1239

7311

1.45

30.35

3.8

4.7

22.74

29.27

ug/l

0.22

974

5760

Leiomyoma of uterus

3871

17875

1.24

30.03

3.7

4.0

19.20

22.08

ug/l

0.25

2959

14044

Other symptoms and signs involving the urinary system

697

4488

1.65

29.68

3.8

4.5

19.59

23.89

ug/l

0.16

613

3719

Abnormal serum enzyme levels

1994

14870

1.34

29.58

4.0

4.6

19.41

30.84

ug/l

1.28

1644

12517

Malignant neoplasm of cervix uteri

223

4.20

29.52

3.8

1.5

5.49

2.67

ug/l

1.04

158

Care involving dialysis

453

2613

1.85

29.34

2.7

4.2

10.03

11.24

ug/l

0.07

387

2108

Malignant neoplasm of thymus, including Hilmo

8.64

29.33

3.2

1.7

2.26

2.35

ug/l

0.13

Malignant neoplasm of testis

167

4.72

29.33

5.8

2.2

4.29

2.54

ug/l

1.96

134

Endometriosis

1839

8066

1.36

29.21

3.5

4.4

13.92

31.29

ug/l

1.89

1390

6380

All influenza

1545

11516

1.38

29.13

3.9

4.3

18.08

28.62

ug/l

0.84

1281

9376

Diseases of spleen

160

637

2.96

29.02

3.4

4.6

21.70

28.46

ug/l

0.13

130

532

Thrombocytopenia, unspecified

494

2947

1.81

28.89

4.0

4.3

17.77

22.68

ug/l

0.25

400

2420

Malignant neoplasm of tongue

106

329

3.58

28.85

3.7

1.5

4.39

2.74

ug/l

1.46

246

Bacterial pneumonia, not elsewhere classified

2455

17090

1.29

28.77

3.9

4.3

25.46

28.93

ug/l

0.23

2079

13964

Non-ischemic cardiomyopathy

2326

14567

1.31

28.71

3.5

4.6

21.68

29.80

ug/l

0.67

1973

12178

Brain meningioma

210

925

2.41

28.70

3.6

1.4

21.33

2.69

ug/l

0.60

171

701

Drug-induced polyneuropathy

102

325

4.12

28.62

7.0

4.2

4.32

21.25

ug/l

0.71

271

Polyp of the female genital tract

1843

7913

1.36

28.57

3.7

4.4

17.11

31.57

ug/l

1.18

1403

6318

Adenocarcinoma and Papillary adenocarcinoma of kidney

182

4.71

28.53

3.8

1.5

3.10

2.75

ug/l

0.31

133

Candidiasis, including avohilmo

1800

13766

1.35

28.50

3.5

4.2

45.60

23.77

ug/l

0.57

1416

11004

Other congenital malformations of the digestive system, including avohilmo

286

1424

2.14

28.50

3.6

4.3

3.91

22.26

ug/l

2.27

213

1149

Malignant neoplasm of eye and adnexa, including Hilmo

269

3.89

28.37

3.7

1.5

10.93

2.82

ug/l

0.99

204

External causes of morbidity and mortality

3844

15874

1.23

28.26

4.1

4.3

28.21

31.68

ug/l

0.14

3065

12636

Other dorsopathies, not elsewhere classified

5962

26545

1.18

28.18

3.6

4.5

20.74

27.05

ug/l

0.56

4764

21228

Liposarcoma

123

5.81

28.15

3.9

1.7

3.30

2.60

ug/l

0.76

Unspecific neurodegenerative disorder

2160

18715

0.77

27.83

3.1

4.2

12.02

27.05

ug/l

3.33

1775

15770

Substance abuse, excluding more controls

3261

22323

1.24

27.77

3.4

4.6

23.47

28.03

ug/l

0.36

2827

18012

Asthma-related infections

3574

28867

1.23

27.73

3.4

4.3

16.92

27.03

ug/l

1.14

2975

23147

Asthma, hospital admission 2, infections

3574

28867

1.23

27.73

3.4

4.3

16.92

27.03

ug/l

1.14

2975

23147

Crohn's disease of large intestine

296

1523

2.09

27.60

5.0

4.4

6.66

22.88

ug/l

1.54

240

1217

Senile cataract

4239

21619

1.22

27.56

4.2

4.5

18.26

29.50

ug/l

2.06

3524

17715

Alcohol-induced acute pancreatitis

253

1245

2.25

27.38

3.4

4.9

5.18

24.23

ug/l

1.99

218

1038

Implicit fungal Sepsis, including avohilmo

513

3138

1.76

27.38

3.3

4.2

94.54

23.01

ug/l

0.67

409

2553

Fungal Sepsis

317

1690

2.07

27.36

3.8

4.2

138.78

25.00

ug/l

0.68

258

1381

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

109

356

3.38

27.27

3.8

1.5

5.24

2.72

ug/l

1.75

100

270

Malignant neoplasm of larynx

242

3.95

27.20

3.1

1.4

8.43

2.81

ug/l

1.35

181

Malignant neoplasm of ureter, including Hilmo

147

5.21

27.19

4.4

1.3

52.69

2.81

ug/l

0.99

113

Other congenital malformations of the digestive system

242

1157

2.24

26.95

3.8

4.3

4.04

23.69

ug/l

1.89

182

936

Other disorders of kidney and ureter

866

5967

1.53

26.87

3.3

4.4

30.04

23.55

ug/l

0.18

701

4910

Substance use, excluding alcohol

981

6866

1.47

26.85

3.0

4.7

9.09

30.80

ug/l

3.08

845

5432

Benign neoplasm of other and unspecified endocrine glands

854

5871

1.53

26.70

3.9

4.3

26.18

22.83

ug/l

0.11

698

4762

Disorders of choroid and retina

5350

32150

1.18

26.63

3.9

4.3

26.19

27.15

ug/l

0.06

4406

26243

Other infectious diseases, including avohilmo

583

3697

1.67

26.54

4.8

4.2

29.50

18.08

ug/l

0.52

491

3032

Barrett oesophagus

374

2125

1.93

26.45

3.9

4.6

8.36

23.60

ug/l

1.92

306

1746

Alzheimer disease, including avohilmo

1879

16621

0.76

26.31

3.0

4.1

14.59

24.74

ug/l

1.45

1537

13990

Convulsions, not elsewhere classified

1162

8289

1.42

26.29

4.0

4.3

11.33

30.90

ug/l

3.22

961

6680

Gout

1950

13072

1.32

26.29

3.4

4.7

21.43

29.95

ug/l

0.64

1611

11064

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

5436

36428

1.18

26.06

4.0

4.3

19.14

26.46

ug/l

0.56

4318

29254

Other diseases of gallbladder

315

1700

2.02

26.03

4.0

4.3

9.56

21.15

ug/l

1.05

251

1389

Unspecified kidney failure

740

4980

1.57

25.92

3.4

4.2

31.86

27.83

ug/l

0.10

635

4158

Malignant neoplasm of oropharynx, including Hilmo

105

346

3.35

25.91

3.7

1.5

24.60

2.64

ug/l

0.84

262

STROKE

3620

20281

1.23

25.91

3.7

4.7

26.18

29.95

ug/l

0.24

2959

16356

Valvular heart disease excluding rheumatic fever

3114

18267

1.25

25.86

3.7

4.7

23.78

31.55

ug/l

0.66

2560

15126

Early onset COPD

1384

10372

1.39

25.83

3.1

4.6

32.73

24.95

ug/l

0.27

1233

8574

Benign neoplasm: Other and unspecified parts of small intestine

156

656

2.87

25.79

4.0

4.3

6.04

30.56

ug/l

1.26

132

555

Polycythaemia vera

153

618

2.67

25.55

2.7

1.4

17.38

2.72

ug/l

0.53

124

457

Non-rheumatic valve diseases

3105

18234

1.24

25.34

3.7

4.7

23.82

31.57

ug/l

0.65

2554

15102

Pyothorax

315

1720

2.01

25.32

3.1

4.4

8.70

20.76

ug/l

1.32

269

1435

COPD related to multimorbidity

2727

18801

1.26

25.23

3.0

4.4

35.90

25.03

ug/l

0.48

2413

15682

Follicular adenocarcinoma of thyroid gland, including Hilmo

159

4.69

25.20

3.4

1.6

4.30

2.57

ug/l

0.54

121

Uterine polyps

1743

7815

1.34

25.12

3.8

4.4

15.19

31.83

ug/l

1.41

1319

6260

Substance abuse

3261

25122

1.23

24.93

3.4

4.5

23.47

27.77

ug/l

0.34

2827

20283

Osteonecrosis due to drugs

150

633

2.89

24.78

7.1

4.6

184.19

29.98

ug/l

0.49

135

534

Shoulder lesions

4940

25351

1.19

24.72

3.6

4.5

18.09

30.56

ug/l

2.26

4042

20572

Fistulae involving female genital tract

152

641

2.79

24.63

6.7

4.5

7.82

33.46

ug/l

0.75

126

517

Heart failure and bmi 25plus

2271

12097

1.29

24.56

3.4

4.5

15.40

25.75

ug/l

1.75

1902

10026

Mental and behavioural disorders due to psychoactive substance use

3355

25583

1.22

24.54

3.4

4.5

23.26

28.01

ug/l

0.39

2908

20639

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

147

5.00

24.52

2.7

1.4

2.67

2.81

ug/l

0.14

114

Malignant neoplasm of tonsil, including Hilmo

280

3.57

24.49

3.7

1.5

27.92

2.64

ug/l

0.83

212

Dementia in Alzheimer disease

746

9026

0.66

24.24

2.8

3.8

22.46

27.09

ug/l

0.20

590

7640

Degenerative diseases of the nervous system

1816

16583

0.77

24.18

2.9

4.1

15.28

25.29

ug/l

1.38

1497

13945

Candidiasis

854

5975

1.49

24.04

3.8

4.2

61.11

31.22

ug/l

0.41

683

4775

Other disorders of ear

5811

32642

1.17

23.98

3.8

4.3

17.89

28.71

ug/l

1.29

4715

26329

Implicit fungal Sepsis

288

1555

2.04

23.98

3.6

4.2

152.10

25.85

ug/l

0.67

229

1267

Localized swelling, mass and lump of skin and subcutaneous tissue

1981

15702

1.30

23.96

3.8

4.3

17.01

25.60

ug/l

0.99

1609

12703

Mantle cell lymphoma

144

4.83

23.94

3.1

1.4

2.98

2.85

ug/l

0.09

110

Secondary hypertension

451

2701

1.73

23.91

2.9

4.8

5.11

31.57

ug/l

2.72

362

2197

Malignant neoplasm of oropharynx

275

3.56

23.80

3.5

1.5

24.77

2.64

ug/l

0.66

208

Injuries to the thorax

2885

23806

1.24

23.69

3.6

4.3

21.13

25.73

ug/l

0.42

2387

19560

Congenital malformation of biliary tract

9.31

23.68

4.5

3.61

11.68

ug/l

1.09

Essential (haemorrhagic) thrombocythaemia

159

678

2.50

23.57

2.9

1.5

3.97

2.70

ug/l

0.90

115

511

Neuroendocrine tumor and carcinoma of stomach

6.29

23.55

2.8

1.4

14.23

2.63

ug/l

1.24

Disorders of magnesium metabolism

300

3.87

23.44

7.8

5.3

35.05

43.24

ug/l

0.10

251

Dementia

2313

19468

0.79

23.30

3.1

4.3

13.59

27.01

ug/l

2.74

1911

16385

Other intervertebral disc disorders

5090

26165

1.18

23.17

3.4

4.6

23.90

27.27

ug/l

0.21

4121

21009

Other infectious diseases

486

3054

1.69

23.13

4.9

4.1

24.07

20.20

ug/l

0.19

404

2519

Alzheimer disease

1620

14815

0.76

22.98

2.9

4.0

14.69

24.75

ug/l

1.24

1327

12469

Injuries to the head

6713

35015

1.15

22.93

3.8

4.3

15.60

27.81

ug/l

1.76

5450

28016

Cellulitis

1276

9597

1.37

22.92

4.0

4.4

17.31

27.29

ug/l

0.68

1049

7830

Acute myeloid leukaemia and myelodysplastic syndromes

111

404

2.97

22.84

3.1

1.5

3.17

2.89

ug/l

0.25

304

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

759

3642

1.53

22.80

3.4

5.6

23.95

49.94

ug/l

1.01

642

3000

Other and unspecified polyneuropathies, also in other diseases

1259

9496

1.38

22.75

3.2

4.4

88.39

23.16

ug/l

1.20

1036

7923

Malignant neoplasm of adrenal gland, including Hilmo

104

5.50

22.72

3.6

1.5

4.44

2.30

ug/l

0.90

Continuous positive airway pressure

1121

6881

1.40

22.49

3.3

5.0

20.86

26.63

ug/l

0.26

927

5549

Fracture of rib(s), sternum and thoracic spine

1974

15777

1.29

22.40

3.5

4.3

19.75

27.57

ug/l

0.62

1630

13074

Injury, poisoning and certain other consequences of external causes

3120

12932

1.23

22.30

4.2

4.4

30.41

33.34

ug/l

0.09

2507

10254

Abnormal results of function studies

504

3224

1.64

21.94

3.9

4.4

10.59

21.27

ug/l

1.29

413

2582

Other noninflammatory disorders of uterus, except cervix

1422

7260

1.35

21.81

3.8

4.4

13.39

33.25

ug/l

2.06

1120

5879

Malignant neoplasm of tonsil

251

3.55

21.55

3.7

1.5

26.77

2.70

ug/l

0.66

186

Viral hepatitis, IBD co-morbidity

282

1547

1.92

21.37

3.4

5.8

8.70

57.70

ug/l

1.29

247

1219

Other and unspecified types of non-Hodgkin lymphoma, hilmo

308

1779

1.90

20.85

2.7

4.2

9.83

20.57

ug/l

0.96

242

1472

Hypotension

1218

9268

1.37

20.76

3.3

4.0

15.90

26.12

ug/l

0.75

1019

7732

COPD, hospital admission 2, with asthma infections

2143

14997

1.26

20.61

3.0

4.4

45.52

24.56

ug/l

0.82

1896

12532

Other/unspecified dorsalgia

2283

18442

1.25

20.57

3.3

4.5

14.68

28.20

ug/l

2.63

1798

14839

Chronic periodontitis, complicated

3632

30225

1.19

20.56

4.2

4.4

23.64

27.57

ug/l

0.36

3066

24582

Use of memantine

1336

13856

0.75

20.47

2.8

3.9

10.67

24.29

ug/l

3.32

1087

11675

Use of other anti-dementia drugs

1336

13856

0.75

20.47

2.8

3.9

10.67

24.29

ug/l

3.32

1087

11675

Diseases of pulp and periapical tissues, including avohilmo

6303

28727

1.15

20.45

4.1

4.2

20.86

29.31

ug/l

1.34

5108

23076

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

114

4.98

20.37

3.4

1.4

9.25

2.75

ug/l

1.46

Malignant neoplasm of eye and adnexa

141

4.51

20.19

2.7

1.4

3.20

2.62

ug/l

0.54

111

Haemorrhage, not elsewhere classified

280

1582

1.92

20.12

4.5

4.1

7.58

19.99

ug/l

1.62

230

1311

Use of donepezil

892

11537

0.71

20.06

3.0

3.8

11.51

23.23

ug/l

2.12

719

9695

Malignant neoplasm of vagina, including Hilmo

7.27

19.94

3.7

1.3

3.77

2.77

ug/l

0.47

Cyst of kidney

499

3281

1.63

19.94

3.3

4.4

31.29

22.59

ug/l

0.19

400

2714

Bacterial pneumonia (organism specified)

2779

21029

1.22

19.92

3.9

4.2

27.08

25.94

ug/l

0.07

2343

17230

Special screening examination for neoplasms

419

2633

1.68

19.85

4.2

4.9

14.46

20.16

ug/l

0.28

354

2141

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

5.82

19.85

3.4

1.4

2.85

2.86

ug/l

0.01

Volvulus

191

955

2.20

19.83

4.3

4.0

10.53

30.64

ug/l

1.26

165

793

6-mercaptopurine

166

777

2.27

19.81

4.1

4.7

2.63

30.80

ug/l

1.58

126

618

Seminoma of testis, including Hilmo

107

4.88

19.80

6.8

2.0

4.00

2.52

ug/l

1.31

Other misadventures during surgical and medical care

183

909

2.26

19.70

4.7

4.4

8.42

27.39

ug/l

1.12

146

759

Malignant neoplasm of adrenal gland

6.73

19.59

3.4

1.8

3.40

2.55

ug/l

1.00

Scar conditions and fibrosis of skin

254

1401

1.95

19.50

3.8

4.3

3.21

23.45

ug/l

2.33

193

1116

Other abnormal uterine and vaginal bleeding

1349

7477

1.33

19.40

3.3

4.4

19.89

30.60

ug/l

0.52

1083

5988

Polyuria

1423

11145

1.32

19.35

3.6

4.4

31.13

28.21

ug/l

0.06

1139

9259

Malignant neoplasm of other and unspecified parts of tongue

247

3.40

19.33

3.5

1.6

4.85

2.78

ug/l

1.27

188

Oesophageal obstruction

254

1416

1.96

19.24

4.1

4.5

76.04

14.84

ug/l

0.63

230

1178

Undetermined asthma, excluding more controls

752

5345

1.46

19.21

3.6

4.5

22.82

30.95

ug/l

0.19

617

4254

Familial hypercholesterolemia

1004

7520

1.39

19.16

3.5

4.3

12.92

25.79

ug/l

2.11

858

6276

Dementia, including avohilmo

2509

20494

0.82

19.14

3.2

4.3

13.86

26.65

ug/l

2.78

2083

17232

Viral pneumonia

751

5351

1.46

19.14

3.5

4.4

8.66

29.20

ug/l

4.26

621

4373

Asthma/COPD (KELA code 203)

5612

33027

1.15

19.13

3.5

4.4

21.43

25.31

ug/l

0.36

4682

26198

Gout, FINNGEN

1950

15760

1.26

19.06

3.4

4.4

21.43

28.10

ug/l

0.48

1611

13300

Other noninfective disorders of lymphatic vessels and lymph nodes

246

1360

1.96

18.98

4.4

4.3

6.30

23.01

ug/l

1.64

197

1113

Menorrhagia

1814

8070

1.28

18.89

3.6

4.4

17.90

31.23

ug/l

1.07

1406

6403

Other retinal disorders

4258

28080

1.17

18.80

3.7

4.3

26.96

27.31

ug/l

0.02

3538

23130

Any dementia

2081

17504

0.80

18.77

3.0

4.1

14.06

26.92

ug/l

2.25

1727

14718

Intracranial trauma

3321

19046

1.19

18.71

3.7

4.8

12.24

31.70

ug/l

5.30

2677

15180

Soft tissue disorders

5864

26488

1.15

18.71

3.7

4.5

19.18

29.81

ug/l

1.86

4699

21268

Finngen Rheumatological endpoints

5494

27426

1.15

18.65

3.7

4.5

20.07

26.86

ug/l

0.91

4392

21871

Malignant neoplasm of thymus

7.22

18.61

2.4

1.8

2.01

2.33

ug/l

0.49

Oesophagitis

342

2083

1.75

18.60

3.7

4.6

6.15

16.31

ug/l

2.28

283

1714

Antihypertensive medication - note that there are other indications

2570

11088

1.22

18.54

3.9

4.6

17.90

31.68

ug/l

1.30

1983

8391

Diagnoses used for exclusion with ILD

1559

12402

1.29

18.54

3.5

4.3

33.15

26.32

ug/l

0.15

1253

10257

Any mental disorder

6688

29813

1.14

18.47

3.7

4.5

24.80

27.03

ug/l

0.17

5452

23897

Other viral hepatitis

271

1539

1.84

18.40

3.6

4.7

7.98

22.05

ug/l

1.22

237

1202

Other viral hepatitis, including avohilmo

284

1636

1.82

18.33

3.5

4.7

7.83

21.21

ug/l

1.23

245

1273

Caries of dentine, including avohilmo

5012

22421

1.16

18.29

4.2

4.3

24.42

30.61

ug/l

0.54

4083

18182

Alzheimer’s disease, strict definition

1204

12507

0.75

18.25

2.9

3.9

17.56

23.64

ug/l

0.44

978

10509

Persons encountering health services in circumstances related to reproduction

2796

15716

1.21

18.18

5.1

4.4

16.51

24.40

ug/l

0.96

2190

12466

Colonic or urogenital fistula

1548

12330

1.29

18.13

4.3

4.4

16.58

26.51

ug/l

1.05

1213

10050

Congenital ovarian cysts

204

1068

2.02

18.05

3.2

3.9

5.59

12.35

ug/l

0.75

155

783

Presence of cardiac and vascular implants and grafts

2838

17619

1.21

17.93

3.2

4.3

18.66

30.94

ug/l

1.60

2329

14779

Undetermined asthma

752

5413

1.44

17.90

3.6

4.4

22.82

30.77

ug/l

0.18

617

4312

Covid-19 suspected case

1020

7694

1.36

17.81

4.0

4.2

16.39

26.41

ug/l

0.48

811

5996

Benign neoplasm: Anus and anal canal

209

1128

2.05

17.75

4.6

4.2

3.60

23.26

ug/l

2.00

181

940

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2433

20136

1.22

17.75

3.4

4.6

27.27

30.21

ug/l

0.16

2116

16431

Dentofacial anomalies [including malocclusion]

2784

25734

0.84

17.59

3.5

4.3

11.13

23.85

ug/l

2.00

2104

20269

Acute posthaemorrhagic anaemia

238

1334

1.93

17.59

3.3

4.0

7.23

19.75

ug/l

1.22

197

1100

Missing teeth due to accident, extraction or parodontitis

4095

31879

1.17

17.54

3.9

4.3

24.73

27.23

ug/l

0.13

3360

26072

Chronic hepatitis NAS

106

445

2.77

17.37

4.4

4.7

3.47

24.39

ug/l

1.21

370

Zoster [herpes zoster], including avohilmo

3384

28113

1.18

17.35

4.1

4.2

11.22

25.71

ug/l

7.28

2743

22923

Neuroendocrine tumor and carcinoma of rectum

6.17

17.25

4.3

1.5

18.80

2.75

ug/l

0.49

Viral hepatitis

329

2010

1.71

17.20

3.5

4.6

8.02

21.29

ug/l

1.54

285

1593

Gout, idiopatic and unspecified

1631

13179

1.28

17.19

3.4

4.4

19.68

27.22

ug/l

0.49

1351

11127

Malignant neoplasm of base of tongue, including Hilmo

144

4.11

17.14

4.0

1.5

4.61

2.60

ug/l

1.36

101

Seminoma of testis

4.94

17.12

7.5

2.0

4.40

2.41

ug/l

1.66

Depression or dysthymia

4134

19604

1.17

17.10

3.7

4.7

18.65

30.09

ug/l

1.67

3342

15890

Other cataract

2914

18404

1.20

17.07

3.9

4.4

14.45

28.38

ug/l

3.19

2393

15127

Elevated blood glucose level

485

3259

1.56

17.07

4.0

4.4

32.32

24.07

ug/l

0.22

406

2653

Viral hepatitis, including avohilmo

341

2106

1.69

17.06

3.5

4.5

7.90

20.76

ug/l

1.57

293

1667

Pneumonia due to other infectious organisms, not elsewhere classified

223

1239

1.96

17.01

4.6

4.2

13.32

19.79

ug/l

0.26

178

1015

Disorders of thyroid, IBD co-morbidities

972

4978

1.37

16.98

3.5

5.4

26.69

43.87

ug/l

0.41

752

3892

Viral and other specified intestinal infections, including avohilmo

1111

8190

1.33

16.96

3.6

4.1

14.93

27.11

ug/l

0.96

855

6346

Gout, unspecified

1343

10639

1.31

16.91

3.4

4.4

22.60

25.13

ug/l

0.11

1112

8997

Autoimmune hepatitis

351

3.04

16.84

3.7

4.2

3.21

10.40

ug/l

2.90

287

Falls/tendency to fall

6135

27362

1.13

16.80

3.9

4.4

20.96

28.40

ug/l

0.75

4952

21799

Diseases of pulp and periapical tissues and dental caries

4257

19015

1.16

16.75

4.1

4.3

23.96

32.11

ug/l

0.79

3470

15493

Disorders of the thyroid gland

5624

32424

1.14

16.62

3.8

4.3

21.50

27.17

ug/l

0.58

4450

26155

Other diseases of oesophagus

574

4009

1.50

16.61

3.5

4.4

12.54

24.20

ug/l

1.15

486

3307

Crohn disease (strict definition, require KELA, min 2 HDR)

301

1816

1.74

16.60

4.0

4.4

12.05

20.04

ug/l

0.50

230

1435

Chromophobe cell carcinoma of kidney

5.16

16.55

3.1

1.4

38.62

2.48

ug/l

0.52

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

4.91

16.45

5.9

1.8

5.94

2.57

ug/l

1.10

Haemangioma and lymphangioma, any site

515

3531

1.53

16.41

3.6

4.2

21.21

22.70

ug/l

0.05

404

2830

Mycoses

1620

13119

1.26

16.40

3.7

4.4

39.32

25.40

ug/l

0.35

1304

10685

Inflammatory diseases of female pelvic organs

3453

20366

1.18

16.37

3.5

4.0

13.49

21.97

ug/l

1.46

2639

15761

Secondary thrombocytopenia

107

465

2.68

16.37

4.2

4.7

14.01

21.80

ug/l

0.28

390

Spinal stenosis

3501

22327

1.18

16.31

3.3

4.6

30.12

26.84

ug/l

0.11

2915

18383

Caries of enamel

4486

33313

0.87

16.25

3.9

4.4

12.36

26.99

ug/l

2.46

3419

26804

Myelodysplastic syndrome

214

3.34

16.21

2.0

1.4

3.13

2.82

ug/l

0.20

160

Urolithiasis

1919

15842

1.24

16.19

4.4

16.47

30.68

ug/l

2.03

1563

13195

Nerve, nerve root and plexus disorders

6496

34999

1.13

16.17

3.6

4.4

20.26

26.90

ug/l

0.68

5306

28086

Hyperplasia of prostate

2110

9815

1.24

16.16

4.3

4.8

22.39

38.57

ug/l

1.51

1760

8388

UC patients in KELA-register (code 208), prior to 1994

280

1688

1.79

16.15

5.9

4.4

6.68

19.58

ug/l

1.56

222

1387

Crohn's disease of small intestine

337

2108

1.67

16.14

4.1

4.4

5.40

19.96

ug/l

2.36

247

1677

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

323

1999

1.69

16.12

4.2

4.5

11.49

20.18

ug/l

0.61

245

1581

Pericarditis

237

1364

1.87

16.04

3.1

4.8

6.15

25.63

ug/l

2.09

185

1128

Alcohol use disorder, ICD-based

2228

18644

1.22

16.00

3.4

4.6

28.07

30.66

ug/l

0.12

1939

15230

Other endocrine disorders

221

1179

1.88

15.98

3.8

4.4

9.37

21.12

ug/l

0.85

163

935

Crohn disease (strict definition, require KELA)

301

1839

1.71

15.82

4.0

4.4

12.05

19.80

ug/l

0.48

230

1455

Congenital malformations of ovaries, fallopian tubes and broad ligaments

255

1492

1.79

15.77

3.5

4.0

5.31

34.99

ug/l

0.68

192

1111

Certain disorders involving the immune mechanism

1045

8076

1.33

15.76

3.8

4.4

18.36

28.96

ug/l

0.81

805

6552

Emphysema

483

3313

1.54

15.61

3.1

4.4

23.43

23.22

ug/l

0.01

425

2748

Gingivitis and periodontal diseases

6126

28324

1.13

15.53

4.1

4.3

21.72

29.73

ug/l

1.00

4926

22901

L02BX Other hormone antagonists and related agents

403

2685

1.62

15.51

3.1

4.5

18.04

27.42

ug/l

0.57

327

2293

Dermatitis

3817

32667

1.16

15.44

3.8

4.3

24.60

26.13

ug/l

0.07

3095

26324

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

144

3.85

15.44

4.0

1.5

54.18

2.60

ug/l

0.57

109

Malignant neoplasm of renal pelvis

4.66

15.43

2.4

1.3

58.58

2.82

ug/l

0.51

Dental caries, including avohilmo

4701

21228

1.15

15.39

4.1

4.3

24.13

31.77

ug/l

0.68

3824

17308

COPD, hospital admissions 3, with asthma pneumonia sepsis

1780

12555

1.25

15.35

3.0

4.3

48.64

24.40

ug/l

0.80

1582

10514

Non-seminoma of testis, including Hilmo

6.88

15.35

2.6

1.7

4.91

2.40

ug/l

1.06

Dental operations

3972

17826

1.16

15.32

4.1

4.3

30.70

31.07

ug/l

0.01

3225

14606

Cystic disease of liver

282

3.29

15.32

2.9

4.5

3.73

24.83

ug/l

0.81

236

Problems related to lifestyle

473

3217

1.52

15.30

3.1

4.5

22.74

34.99

ug/l

0.39

421

2589

Gout, strict definition

1186

9379

1.31

15.25

3.4

4.5

15.48

25.82

ug/l

0.80

989

7956

Malignant neoplasm of parotid gland, including Hilmo

156

3.71

15.14

3.5

1.4

22.25

2.75

ug/l

1.16

115

Salpingitis and oophoritis

1021

7921

1.33

15.13

4.0

4.2

19.22

23.75

ug/l

0.19

794

6217

Malignant neoplasm of brain

114

511

2.33

15.06

2.4

1.6

2.85

2.66

ug/l

0.21

376

Hypertensive Heart Disease

1529

9392

1.27

15.06

3.1

4.6

13.65

24.55

ug/l

1.76

1277

7876

Myalgia

1358

10889

1.28

14.99

3.3

4.5

13.75

25.42

ug/l

1.15

1037

8638

Dental pulpitis, including avohilmo

3994

29108

0.87

14.96

3.9

4.4

15.17

27.74

ug/l

2.68

3080

23144

Abscess of lung

120

566

2.39

14.93

3.2

4.9

5.39

29.50

ug/l

1.05

106

475

Complications following infusion, transfusion and therapeutic injection

110

500

2.48

14.92

5.6

4.2

6.71

18.67

ug/l

0.77

418

Haemangioma, any site

480

3314

1.52

14.84

3.5

4.2

22.43

21.30

ug/l

0.03

375

2659

Chronic viral hepatitis

213

1204

1.85

14.78

3.1

4.9

9.00

25.97

ug/l

1.15

191

949

Use of rivastigmine

654

8827

0.71

14.77

3.0

3.8

6.41

25.68

ug/l

5.49

525

7397

Hypocalcemia

166

885

2.07

14.68

3.5

4.4

60.15

26.41

ug/l

0.50

144

722

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

503

3523

1.50

14.64

3.0

4.1

9.31

19.06

ug/l

1.58

406

2894

Alzheimer’s disease (Late onset)

1133

11757

0.77

14.63

3.0

3.8

18.06

24.42

ug/l

0.44

923

9911

Disorders of skin appendages

2559

21706

1.19

14.62

3.8

4.3

15.02

26.23

ug/l

1.77

2000

17183

Viral infections characterized by skin and mucous membrane lesions

2350

19906

1.20

14.60

4.0

4.2

26.09

23.98

ug/l

0.05

1886

16038

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

112

4.22

14.56

3.9

1.4

11.76

2.66

ug/l

1.01

Diseases of oral cavity, salivary glands and jaws

3709

16668

1.16

14.42

4.0

4.3

19.92

31.06

ug/l

1.42

3017

13655

Spondylosis

3543

24202

1.16

14.36

3.4

4.6

27.59

27.69

ug/l

0.00

2925

19680

Hypertensive heart and/or renal disease

1660

9948

1.25

14.36

3.1

4.7

11.98

24.09

ug/l

2.38

1389

8342

Other acute lower respiratory infections

3011

24793

1.17

14.34

3.8

4.2

15.43

26.63

ug/l

1.73

2471

20101

Gestational diabetes (for exclusion)

809

7376

0.74

14.33

3.8

14.15

19.25

ug/l

0.26

563

5173

Presence of other devices

1577

12729

1.25

14.28

3.3

4.1

12.80

28.77

ug/l

2.65

1324

10612

Pneumocystosis, including avohilmo

150

787

2.15

14.20

5.5

4.4

16.78

30.60

ug/l

0.40

123

664

Pneumocystosis

150

787

2.15

14.20

5.5

4.4

16.78

30.60

ug/l

0.40

123

664

Other maternal disorders predominantly related to pregnancy

2107

15671

0.83

14.15

3.7

4.0

20.75

21.65

ug/l

0.05

1565

11930

Dorsopathies

5846

26558

1.12

14.15

3.7

4.5

21.91

27.04

ug/l

0.41

4709

21236

Bronchitis

6506

35264

1.12

14.14

4.0

4.2

16.54

27.24

ug/l

2.72

5219

28324

Calculus of kidney and ureter

1750

14520

1.23

14.11

4.4

17.55

31.00

ug/l

1.65

1417

12085

Polycystic ovarian syndrome, consortium definition

3919

19726

1.15

14.11

3.5

4.0

18.56

21.19

ug/l

0.21

3036

15219

Excessive, frequent and irregular menstruation

1855

8167

1.23

14.08

3.5

4.4

20.46

31.05

ug/l

0.75

1423

6445

Mental and behavioural disorders due to alcohol

2746

22507

1.18

13.95

3.5

4.5

26.27

28.73

ug/l

0.14

2387

18249

Malignant neoplasm of bone and articular cartilage of limbs

5.65

13.92

2.3

1.6

3.38

2.81

ug/l

0.17

Other disorders of breast

735

5508

1.38

13.87

3.6

4.0

10.69

25.54

ug/l

1.14

546

4302

Invasive ventilation

419

2860

1.54

13.84

3.9

4.4

14.88

23.74

ug/l

0.54

346

2350

Benign neoplasm: Ill-defined sites within the digestive system

239

3.38

13.83

4.6

4.5

13.23

9.40

ug/l

0.28

205

Zoster [herpes zoster]

1173

9367

1.29

13.81

3.9

4.2

9.96

24.56

ug/l

3.45

955

7687

Oxicams

1352

6151

1.27

13.80

3.5

4.6

23.11

25.45

ug/l

0.11

1114

5119

Malignant neoplasm of vulva, including Hilmo

259

2.92

13.72

4.1

1.4

12.67

2.64

ug/l

0.65

198

Magnesium deficiency

134

4.54

13.66

7.7

4.5

6.53

12.27

ug/l

0.79

114

Inguinal hernia

3240

18725

1.16

13.61

4.3

4.4

16.68

32.17

ug/l

3.32

2699

15412

Coronary artery bypass grafting

1214

11169

0.78

13.58

3.3

4.7

11.33

32.41

ug/l

5.23

1020

9449

Postmenopausal bleeding

1719

7423

1.24

13.55

3.7

4.4

17.57

28.56

ug/l

0.91

1349

6011

Other specific joint derangements/joint disorders

4006

22010

1.15

13.48

3.5

4.6

22.55

29.92

ug/l

0.57

3138

17584

Disorders of other endocrine glands

2399

20180

1.19

13.45

3.5

4.2

26.22

23.35

ug/l

0.09

1894

16223

Concussion

2832

18950

1.17

13.43

3.6

4.8

12.86

31.74

ug/l

4.40

2288

15115

Other/unspecified cytomegaloviral diseases

127

635

2.20

13.43

3.6

4.6

24.98

29.43

ug/l

0.09

105

523

Fibrosis of liver

276

3.05

13.38

3.9

4.5

3.46

23.43

ug/l

0.70

225

Other external causes of accidental injury

4718

21028

1.14

13.31

4.0

4.5

14.48

31.54

ug/l

4.71

3808

16833

Any dementia, excluding more controls

1936

15748

0.83

13.26

3.0

4.3

14.68

25.49

ug/l

1.63

1603

13217

Spondylopathies in diseases classified elsewhere

112

545

2.38

13.22

4.8

4.6

16.90

32.44

ug/l

0.44

447

Myocardial infarction, unclassifiable

912

10405

0.76

13.12

3.4

4.0

10.63

27.19

ug/l

4.15

772

8757

Degeneration of macula and posterior pole

3404

23078

1.16

13.11

3.7

4.2

26.44

25.11

ug/l

0.06

2832

19239

Other obstructive and reflux uropathy

224

1337

1.77

13.09

5.9

4.2

5.88

22.82

ug/l

1.65

191

1078

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1672

13899

1.23

13.05

3.5

4.3

10.27

27.94

ug/l

4.09

1365

11253

Pruritus

662

4934

1.39

13.04

3.6

4.1

5.69

28.17

ug/l

2.43

527

3937

Viral and other specified intestinal infections

742

5447

1.35

13.04

3.8

4.1

17.81

28.37

ug/l

0.49

574

4218

Other specified/unspecified bacterial intestinal infections

390

2660

1.54

13.01

4.3

4.2

11.81

16.81

ug/l

0.40

327

2186

Benign mammary dysplasia

848

6564

1.34

12.99

3.6

4.0

14.60

25.24

ug/l

0.79

670

5276

Other diseases of appendix

434

2.51

12.96

4.3

4.4

3.15

18.77

ug/l

0.91

350

Other and unspecified dermatitis

3153

27594

1.16

12.95

3.9

4.3

15.93

24.79

ug/l

2.01

2550

22213

ILD, hospital admissions 3, with pneumonia sepsis

547

3974

1.44

12.94

3.1

4.2

10.12

23.12

ug/l

1.82

454

3293

Other abnormalities of plasma proteins

124

628

2.22

12.94

4.1

4.5

259.29

32.30

ug/l

0.45

106

530

Accidents

4708

21028

1.13

12.83

4.1

4.5

14.64

31.54

ug/l

4.62

3795

16833

ILD, hospital admission 2, with pulmonary infections

625

4647

1.40

12.74

3.3

4.3

11.23

26.73

ug/l

2.47

521

3886

Osteonecrosis

399

2753

1.53

12.71

5.2

4.4

82.77

17.20

ug/l

0.52

333

2243

Cytomegalovirus infection, IBD co-morbidity

142

752

2.06

12.71

3.6

4.7

22.53

27.32

ug/l

0.11

119

623

Persons with potential health hazards related to communicable diseases

1449

11773

1.24

12.65

4.6

4.2

13.74

25.60

ug/l

1.16

1120

8983

Vitamin deficiency

280

1789

1.65

12.63

3.4

4.2

9.18

18.83

ug/l

1.11

232

1463

Vitamin deficiency, wide

280

1789

1.65

12.63

3.4

4.2

9.18

18.83

ug/l

1.11

232

1463

Disorders of oesophagus in diseases classified elsewhere

155

851

2.01

12.63

3.5

4.6

86.99

17.17

ug/l

0.45

131

701

Diseases of male genital organs

2477

10653

1.19

12.62

4.5

4.9

24.96

38.11

ug/l

1.12

2055

9006

Other benign neoplasms of skin

2288

19629

1.19

12.59

3.8

4.2

14.55

24.87

ug/l

1.73

1853

16026

Fibrosarcoma, including Hilmo

134

3.65

12.57

4.2

1.5

3.85

2.60

ug/l

0.35

100

Protozoal diseases, including avohilmo

199

1174

1.83

12.57

5.3

4.6

13.96

24.14

ug/l

0.41

162

978

Ulcerative proctitis

296

1913

1.61

12.48

3.3

4.3

16.00

21.17

ug/l

0.20

212

1524

Extracorporeal dialysis

348

2344

1.57

12.43

2.6

4.4

11.46

20.86

ug/l

0.58

295

1952

Protozoal diseases

194

1141

1.84

12.43

5.3

4.6

14.32

24.72

ug/l

0.41

157

953

Ulcer of oesophagus

413

2881

1.51

12.33

3.5

4.5

5.08

20.62

ug/l

4.09

360

2406

Sarcoidosis

732

5588

1.35

12.32

3.7

4.4

17.45

23.25

ug/l

0.38

558

4541

Conductive and sensorineural hearing loss

5059

30252

1.12

12.21

3.9

4.3

14.39

29.70

ug/l

4.53

4158

24677

Cytomegaloviral disease

144

777

2.01

12.17

3.6

4.6

22.18

26.33

ug/l

0.10

121

642

Cytomegaloviral disease, including avohilmo

145

785

2.00

12.12

3.6

4.6

22.02

26.19

ug/l

0.10

122

646

Acetic acid derivatives and related substances

1484

6283

1.24

12.07

3.7

4.5

20.52

25.11

ug/l

0.28

1172

5196

Dermatitis and eczema

6599

35620

1.11

12.03

3.8

4.3

24.53

26.02

ug/l

0.10

5284

28634

Tonsillectomy and adenotomy

1617

13496

0.82

12.00

3.9

4.3

20.50

23.72

ug/l

0.16

1173

10275

L04AA Selective immunosuppressants

1163

9412

1.26

12.00

3.4

4.5

29.84

27.69

ug/l

0.07

949

7558

Conduction disorders

1893

12845

1.20

11.88

3.5

4.6

14.59

31.73

ug/l

2.29

1528

10741

Malignant neoplasm of floor of mouth, including Hilmo

134

3.56

11.87

2.8

1.7

10.92

2.79

ug/l

0.68

104

Coxibs

1466

6305

1.24

11.85

3.6

4.5

36.86

25.06

ug/l

0.27

1178

5208

Injuries to the abdomen, lower back, lumbar spine and pelvis

2352

20001

1.18

11.83

3.7

4.2

16.57

24.87

ug/l

0.87

1923

16316

Other surgical follow-up care

161

902

1.88

11.73

4.0

6.26

17.03

ug/l

0.66

131

705

Benign thyroid growths and nodules

2093

16665

1.19

11.69

3.7

4.2

16.67

23.73

ug/l

0.71

1686

13481

Sensorineural hearing loss

4903

29481

1.12

11.60

3.9

4.3

14.07

29.67

ug/l

4.58

4044

24111

Diabetes mellitus in pregnancy

686

5737

0.75

11.54

3.4

3.8

34.69

20.00

ug/l

0.35

487

3971

Type of accident

1552

12972

1.22

11.52

3.4

4.3

9.16

26.47

ug/l

4.64

1266

10514

Open wound of head

3231

26792

1.15

11.50

3.7

4.4

24.55

29.18

ug/l

0.19

2672

21922

Acute bronchitis

2324

19685

1.17

11.50

3.6

4.1

15.95

25.33

ug/l

0.97

1908

15977

2337

20047

1.17

11.32

3.3

4.2

12.49

25.84

ug/l

2.46

1902

15937

Coeliac disease

599

4493

1.37

11.29

3.8

4.1

6.24

23.71

ug/l

3.75

491

3565

251

3842

0.63

11.27

2.5

4.5

13.41

26.96

ug/l

1.30

222

3230

Wilms' tumor, including Hilmo

4.24

11.22

1.6

1.5

3.16

2.60

ug/l

0.36

Small fibre neuropathy

199

1214

1.77

11.21

3.7

4.4

148.69

22.56

ug/l

0.42

164

1003

Congenital malformations of genital organs

339

2285

1.51

11.18

3.4

4.0

4.80

40.45

ug/l

1.45

249

1703

Oter anti-inflammatory and antirheumatic agents, non-steroids

1332

5997

1.24

11.17

3.9

4.5

27.23

25.76

ug/l

0.05

1084

5031

Follicular cysts of skin and subcutaneous tissue

993

7967

1.28

11.16

4.1

4.4

24.61

29.72

ug/l

0.20

801

6472

Other and unspecified local infections of skin and subcutaneous tissue

526

3881

1.40

11.15

4.1

4.2

19.08

22.42

ug/l

0.11

429

3144

Hodgkin lymphoma, hilmo

157

893

1.88

11.13

3.2

4.6

35.44

26.56

ug/l

0.20

130

740

Acute gastritis

421

3001

1.46

11.08

3.1

4.3

7.64

20.11

ug/l

2.62

355

2455

Reimbursement for rheumatic diseases

3322

29297

1.14

11.06

4.2

26.99

23.77

ug/l

0.17

2642

23611

Malignant neoplasm of hypopharynx, including Hilmo

3.98

11.06

2.5

1.4

2.78

2.69

ug/l

0.07

Visual disturbances and blindness

3115

27524

1.15

11.00

3.6

4.2

30.00

23.62

ug/l

0.33

2478

22339

Hypothyroidism, other/unspecified

5144

30643

1.11

10.94

3.8

4.3

22.77

25.54

ug/l

0.21

4032

24686

Ulcerative rectosigmoiditis

389

2735

1.47

10.89

4.3

5.63

19.09

ug/l

2.58

296

2191

Toxic liver disease

100

497

2.21

10.84

4.1

4.4

24.28

16.49

ug/l

0.13

404

Hepatomegaly and splenomegaly, not elsewhere classified

246

2.76

10.75

2.7

4.7

6.26

37.20

ug/l

0.59

206

Serous carcinoma of ovary

128

3.54

10.72

3.6

1.3

9.63

2.72

ug/l

0.74

100

Unspecified privation

559

4192

1.38

10.66

4.4

4.3

15.71

20.08

ug/l

0.26

456

3393

Infarction of spleen

253

2.90

10.65

4.0

4.5

10.14

23.50

ug/l

0.36

215

Other local infections of skin and subcutaneous tissue

555

4159

1.38

10.65

4.0

4.2

18.23

21.44

ug/l

0.11

452

3384

Selective serotonin reuptake inhibitors

5824

27605

1.11

10.51

3.7

4.5

20.77

27.91

ug/l

0.65

4671

22217

Endometriosis of ovary

872

6526

1.29

10.51

3.5

4.5

15.71

29.88

ug/l

0.88

636

5177

Somatoform disorder

823

6505

1.30

10.48

2.9

4.3

5.21

28.95

ug/l

3.45

634

5161

Vascular diseases of the intestine

260

1716

1.61

10.43

3.4

4.2

10.67

20.52

ug/l

0.79

223

1431

Other disorders of lacrimal gland

2222

19320

1.17

10.32

3.4

4.3

14.38

23.62

ug/l

0.89

1723

15628

Chronic diseases of tonsils and adenoids

3495

24687

0.88

10.27

3.9

4.5

28.54

25.82

ug/l

0.10

2699

19709

Pain associated with micturition

676

5237

1.33

10.27

3.2

4.2

9.68

24.71

ug/l

1.56

528

4238

Rotator cuff syndrome

3955

24464

1.13

10.23

3.6

4.6

15.65

30.80

ug/l

3.32

3239

19937

Fenamates

812

4350

1.30

10.16

3.6

4.5

7.05

21.94

ug/l

5.26

640

3577

Cerebrovascular diseases

4768

30012

1.11

10.14

3.7

4.4

29.14

26.45

ug/l

0.13

3993

24610

Injuries to the elbow and forearm

4029

31098

1.12

10.07

3.9

4.2

24.45

24.67

ug/l

0.01

3249

24899

Primary hyperparathyroidism

689

5384

1.33

10.05

3.6

4.1

43.59

24.00

ug/l

0.22

553

4381

Organic, including symptomatic, mental disorders

2868

22748

0.87

10.00

3.3

4.3

11.67

27.69

ug/l

6.01

2385

19043

Non-allergic asthma (mode), excluding more controls

973

7804

1.26

9.98

3.3

4.5

39.02

28.17

ug/l

0.31

806

6225

Other disorders of glucose regulation and pancreatic internal secretion

416

3009

1.43

9.97

3.4

4.2

19.29

19.62

ug/l

0.01

361

2445

Other aneurysm

334

2337

1.50

9.95

4.1

4.3

13.69

22.28

ug/l

0.51

285

1938

Acute myeloid leukaemia

205

2.77

9.92

4.3

1.4

3.10

2.70

ug/l

0.29

151

Acute myeloid leukaemia, helper endpoint

205

2.77

9.92

4.3

1.4

3.10

2.70

ug/l

0.29

151

Acute myeloid leukaemia, including Hilmo

205

2.77

9.92

4.3

1.4

3.10

2.70

ug/l

0.29

151

Other diseases of peritoneum

261

1741

1.58

9.92

3.6

4.3

29.18

17.33

ug/l

0.20

196

1426

Hypothyroidism, strict autoimmune

4262

25241

1.12

9.90

3.8

4.3

18.24

25.64

ug/l

0.96

3355

20280

Hypothyreosis and Thyroxine purchase for inclusion criteria

5357

32020

1.10

9.89

3.8

4.2

23.07

24.65

ug/l

0.11

4195

25793

Fracture of lumbar spine and pelvis

1385

11622

1.21

9.85

3.8

4.1

10.90

24.39

ug/l

2.91

1150

9595

Impotence

322

2242

1.50

9.79

4.6

5.0

26.25

27.54

ug/l

0.03

269

1934

Other disorders of adrenal gland

238

1557

1.60

9.76

3.5

4.4

18.09

19.37

ug/l

0.04

200

1254

Respiratory conditions due to other external agents

147

862

1.87

9.76

3.5

4.1

6.46

27.68

ug/l

1.46

123

719

Triptan medication for migraine, min. 3 purchases

1985

17159

0.86

9.75

3.5

4.2

12.59

22.83

ug/l

1.24

1442

13090

Colitis due to radiation

420

2.31

9.70

4.1

4.5

3.54

38.19

ug/l

1.17

355

Malignant neoplasm of uterus, part unspecified, including Hilmo

3.85

9.68

4.3

1.2

6.18

2.73

ug/l

0.54

Malignant neoplasm of ureter

5.13

9.67

3.3

1.4

5.34

2.97

ug/l

0.51

2105

15746

1.17

9.63

3.5

4.1

31.30

23.20

ug/l

0.28

1764

13203

Haemolytic anaemias

198

1249

1.68

9.63

3.7

4.3

7.41

23.12

ug/l

1.27

165

1027

Later onset COPD

1908

13245

1.18

9.58

3.1

4.3

44.13

24.85

ug/l

0.73

1694

11126

Peripheral artery disease

2842

19918

1.14

9.51

3.2

4.3

25.51

25.81

ug/l

0.02

2481

16629

Acidosis

138

798

1.87

9.49

4.6

5.18

28.18

ug/l

1.43

123

652

Combinations of oral blood glucose lowering drugs

1700

14604

1.19

9.44

4.0

4.6

32.63

28.27

ug/l

0.19

1437

12127

Psychiatric diseases

5873

26971

1.10

9.43

3.7

4.6

21.35

28.21

ug/l

0.96

4781

21720

Parkinson's disease

629

8027

0.76

9.41

2.9

4.2

51.45

23.62

ug/l

0.29

505

6722

Migraine, single triptan purchase ok & required. ICD-code if available is included

3131

23764

0.88

9.40

3.6

4.3

15.44

24.95

ug/l

1.28

2348

18733

Triptan medication for migraine, single purchase ok

3131

23764

0.88

9.40

3.6

4.3

15.44

24.95

ug/l

1.28

2348

18733

COPD-related respiratory insufficiency

712

5632

1.31

9.35

3.0

4.4

54.00

20.37

ug/l

0.48

626

4697

L02BB Anti-androgens

573

4416

1.35

9.31

3.4

4.3

22.40

31.71

ug/l

0.45

472

3752

Anxiety disorders, excluding more controls

4652

27018

1.11

9.30

3.8

4.5

17.62

26.94

ug/l

1.59

3681

21514

Adrenocortical insufficiency

204

1308

1.65

9.26

3.6

4.4

8.51

21.44

ug/l

1.05

170

1064

All influenza (not pneumonia)

688

5404

1.30

9.22

4.0

4.4

24.11

27.57

ug/l

0.10

571

4377

Other diseases of hard tissues of teeth

3556

16508

1.13

9.21

4.1

4.4

14.87

31.21

ug/l

3.40

2873

13523

Sequelae of other external causes

303

2109

1.50

9.17

4.9

4.2

6.02

18.75

ug/l

2.22

243

1715

Parkinson's disease, excluding more controls

629

7355

0.76

9.09

2.9

4.9

51.45

33.40

ug/l

0.18

505

6208

Follicular lymphoma, hilmo

273

1880

1.54

9.08

3.1

4.4

21.83

18.84

ug/l

0.11

214

1562

Fracture of shoulder and upper arm

2102

18342

1.16

9.08

3.8

4.2

23.31

23.90

ug/l

0.03

1745

14983

Malignant neoplasm of parotid gland

136

3.13

8.96

3.7

1.4

10.34

2.73

ug/l

0.66

Fracture of femur

1750

13616

1.18

8.96

3.7

4.0

21.59

24.83

ug/l

0.22

1515

11314

Mycoses, including avohilmo

5241

36578

1.10

8.93

3.7

4.3

27.03

25.41

ug/l

0.08

4124

29423

Osteopathy in diseases classified elsewhere

286

2.55

8.93

6.8

4.4

7.79

24.02

ug/l

0.56

236

Fibrosarcoma

115

3.35

8.93

4.9

1.5

4.19

2.55

ug/l

0.40

Benign neoplasm: Extrahepatic bile ducts

138

3.57

8.85

2.4

4.8

2.77

10.73

ug/l

1.53

108

Non-allergic asthma (mode)

973

7912

1.24

8.83

3.3

4.4

39.02

26.97

ug/l

0.35

806

6332

Parkinson's disease, including avohilmo

669

8405

0.77

8.81

2.9

4.3

48.39

23.03

ug/l

0.29

540

7034

Alzheimer’s disease (Late onset), excluding more controls

810

6493

0.79

8.75

3.3

4.7

12.21

31.78

ug/l

2.69

667

5491

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1848

16054

1.17

8.72

3.8

4.2

25.50

22.13

ug/l

0.12

1442

12873

Lung diseases due to external agents

795

6414

1.27

8.71

3.4

4.1

38.46

21.41

ug/l

0.23

665

5332

Infection of intervertebral disc (pyogenic)

103

565

2.02

8.64

4.4

4.8

11.99

28.86

ug/l

0.56

477

Unspecified/other endometriosis

352

2478

1.42

8.60

2.9

4.4

3.21

41.25

ug/l

1.63

238

1884

Other disorders of bladder

699

5576

1.29

8.55

3.8

4.5

11.07

32.04

ug/l

2.63

571

4638

Alcohol dependence

1372

11668

1.20

8.53

3.2

4.7

33.67

30.53

ug/l

0.11

1189

9600

Disorders of lacrimal system

2668

23384

1.14

8.51

3.5

4.2

13.95

24.48

ug/l

1.38

2088

18899

Umbilical hernia

1412

12042

1.19

8.49

4.0

4.5

35.67

34.85

ug/l

0.03

1166

9839

Melanocytic naevi of trunk

606

4746

1.31

8.48

4.0

4.3

5.93

29.98

ug/l

2.56

466

3798

Osteosarcoma, including Hilmo

4.91

8.46

3.8

1.8

28.71

2.50

ug/l

0.49

Personal history of other diseases and conditions

379

2750

1.40

8.46

4.2

4.1

8.57

28.76

ug/l

0.92

290

2087

Pyoderma gangrenosum

265

2.52

8.45

4.9

4.5

5.20

9.31

ug/l

0.99

218

Tobacco use

267

1844

1.51

8.44

3.0

4.5

17.71

20.75

ug/l

0.12

248

1487

Torsion of ovary, ovarian pedicle and fallopian tube

115

648

1.88

8.43

3.4

4.5

48.16

73.48

ug/l

0.15

502

Multiple myeloma and malignant plasma cell neoplasms

304

2166

1.48

8.40

2.9

4.2

5.30

22.47

ug/l

3.08

239

1798

Other viral diseases

1194

9991

1.21

8.40

4.1

4.3

32.88

26.46

ug/l

0.16

944

7793

Visual disturbances

2820

25230

1.13

8.39

3.6

4.3

29.84

24.40

ug/l

0.25

2234

20456

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

206

2.85

8.39

3.3

4.3

5.05

9.02

ug/l

0.77

162

Respiratory insufficiency

462

3492

1.36

8.34

2.8

4.3

74.26

22.39

ug/l

0.46

386

2895

Chondrosarcoma

4.96

8.33

2.3

2.0

1.83

2.95

ug/l

1.90

Abnormal findings on diagnostic imaging of central nervous system

241

1635

1.53

8.32

3.3

4.5

7.42

19.70

ug/l

1.27

192

1310

Other ill-defined and unspecified causes of mortality

555

4328

1.33

8.28

4.4

4.1

67.93

22.09

ug/l

0.81

480

3623

Abnormal findings on diagnostic imaging of breast

102

564

1.98

8.27

4.5

4.0

44.40

8.08

ug/l

0.64

450

Other abnormal findings of blood chemistry

258

1781

1.51

8.26

3.7

4.3

33.34

20.87

ug/l

0.32

200

1447

Parkinson's disease, strict definition, excluding more controls

589

6949

0.77

8.24

2.9

4.9

54.46

33.18

ug/l

0.19

469

5872

Acquired haemolytic anaemia

149

916

1.74

8.22

3.7

4.4

8.18

24.56

ug/l

0.95

126

768

Other skin changes

1194

10090

1.21

8.20

3.6

4.3

6.48

31.42

ug/l

5.48

983

8273

Chondrosarcoma, including Hilmo

3.90

8.19

2.6

1.8

3.35

2.76

ug/l

0.16

Other disorders of skin and subcutaneous tissue, not elsewhere classified

812

6615

1.26

8.17

3.4

4.3

8.72

27.09

ug/l

2.72

668

5427

Viral pneumonia (unknown virus, not influenza)

328

2366

1.43

8.11

3.6

4.4

4.84

17.22

ug/l

2.68

267

1925

Other and unspecified glaucoma

448

3409

1.37

8.10

4.1

4.0

18.92

23.19

ug/l

0.23

371

2822

Injuries to the shoulder and upper arm

5048

35819

1.10

8.10

3.7

4.3

22.96

26.67

ug/l

0.24

4119

28944

Melanocytic naevi

1578

13626

1.17

8.07

3.8

4.3

10.18

22.66

ug/l

2.04

1212

10876

Crohn disease (strict definition, all UC cases excluded)

221

1481

1.55

8.05

3.7

4.4

8.35

18.77

ug/l

1.05

175

1181

Parkinson's disease, strict definition

589

7421

0.77

8.00

2.9

4.2

54.46

24.17

ug/l

0.30

469

6205

Endometriosis ASRM stages 3,4

1130

9513

1.21

7.98

3.4

3.9

16.76

21.84

ug/l

0.30

831

7372

COPD, hospital admissions 1, only main diagnosis

2147

16293

1.15

7.96

2.9

4.3

38.91

24.40

ug/l

0.52

1886

13654

Sciatica+with lumbago

3022

24068

1.12

7.96

3.3

4.6

13.92

26.88

ug/l

2.61

2418

19312

Malignant neoplasm of vulva

193

2.64

7.95

4.2

1.4

5.52

2.65

ug/l

0.60

148

Malignant neoplasm of gum, including Hilmo

157

2.81

7.93

3.7

1.4

3.48

2.65

ug/l

0.43

119

Phobic anxiety disorders

423

3162

1.36

7.90

3.5

4.4

19.91

29.27

ug/l

0.28

309

2369

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

157

2.80

7.90

4.0

1.5

3.50

2.64

ug/l

0.52

114

Other inflammation of eyelid

806

6587

1.25

7.88

3.4

4.3

7.46

23.57

ug/l

3.60

626

5336

Use of levodopa decarboxylase inhibitor

582

7327

0.77

7.87

2.8

4.2

9.89

22.74

ug/l

1.52

452

6122

Other neurological diseases

4489

31921

1.10

7.86

3.5

4.3

23.96

27.02

ug/l

0.16

3688

26090

Status post-ami

1302

11539

0.84

7.84

3.1

4.6

19.43

32.75

ug/l

1.25

1100

9751

Other diseases of the respiratory system

1195

10137

1.20

7.84

3.2

4.2

36.65

23.98

ug/l

0.26

1009

8461

Other respiratory disorders and diseases

1195

10137

1.20

7.84

3.2

4.2

36.65

23.98

ug/l

0.26

1009

8461

Panic disorder

530

4108

1.31

7.83

3.4

4.3

16.21

27.95

ug/l

0.49

407

3112

Adverse effects, not elsewhere classified

901

7434

1.23

7.82

4.1

4.2

19.02

26.78

ug/l

0.29

704

5851

Congenital malformations, deformations and chromosomal abnormalities

2721

23094

1.13

7.72

3.7

4.3

15.24

25.15

ug/l

1.25

2082

18197

Tubulo-interstitial nephritis, not specified as acute or chronic

367

2722

1.39

7.72

3.7

4.1

30.69

22.61

ug/l

0.24

307

2234

ILD, hospital admissions

918

7630

1.24

7.71

3.4

4.2

14.37

28.79

ug/l

1.68

774

6352

Thiazolidinediones

670

5394

1.28

7.70

4.1

4.5

46.55

22.15

ug/l

0.78

576

4522

Carcinoma in situ of other and unspecified sites

259

1826

1.50

7.69

3.8

4.3

19.94

29.22

ug/l

0.36

218

1545

Osteoporosis with pathological fracture (FG)

507

3958

1.33

7.69

3.2

4.2

10.27

26.98

ug/l

1.75

427

3266

Alzheimer’s disease (Early onset)

118

1952

0.58

7.61

2.3

3.8

13.49

18.72

ug/l

0.24

1628

Alzheimer’s disease (Early onset), excluding more controls

118

1841

0.58

7.61

2.3

4.4

13.49

28.37

ug/l

0.85

1547

Leisure time condition

912

7572

1.23

7.52

3.4

4.3

5.71

28.36

ug/l

4.50

730

6130

Pleural plaque

563

4456

1.31

7.52

3.0

4.4

17.54

22.35

ug/l

0.29

493

3785

Arthropathy in ulcerative colitis

385

2.11

7.51

3.6

4.7

17.83

17.80

ug/l

0.00

310

Nosocomial condition (hospital)

196

2.69

7.50

3.9

4.4

6.41

43.95

ug/l

0.58

168

Single delivery by forceps and vacuum extractor

252

2152

0.69

7.47

3.3

3.6

26.13

6.96

ug/l

0.43

168

1433

Disorder of lipoprotein metabolism, unspecified

779

6389

1.25

7.46

3.3

4.4

8.24

25.26

ug/l

5.31

654

5323

Carcinoma in situ, bladder

241

1690

1.51

7.41

3.8

4.2

20.17

28.96

ug/l

0.31

202

1428

Dementia in other diseases classified elsewhere

138

2173

0.61

7.38

2.8

4.1

7.76

22.41

ug/l

1.73

107

1822

Convalescence

252

1767

1.48

7.38

3.1

3.9

15.96

14.61

ug/l

0.05

200

1377

Inflammatory disease of uterus

581

4606

1.29

7.31

3.4

4.0

23.62

28.58

ug/l

0.14

426

3460

Asthma, hospital admissions , main diagnosis only

4517

36148

1.09

7.31

3.5

4.3

23.41

25.45

ug/l

0.13

3701

28896

Other and unspecified effects of external causes

1218

10387

1.19

7.28

4.1

4.3

17.78

25.42

ug/l

0.41

964

8184

Deficiency of other B group vitamins

131

805

1.74

7.27

3.7

4.2

12.04

24.73

ug/l

0.61

113

668

Hard cardiovascular diseases

5026

27414

1.09

7.26

3.6

4.6

20.31

29.03

ug/l

1.20

4125

22162

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1469

9962

0.86

7.20

3.9

4.0

21.63

24.41

ug/l

0.12

1073

7404

Benign neoplasm: Oesophagus

474

2.01

7.18

2.9

4.6

7.54

36.43

ug/l

1.00

398

Interstitial lung disease endpoints

926

7757

1.22

7.17

3.4

4.2

14.28

29.72

ug/l

1.88

781

6465

Interstitial lung disease

926

7757

1.22

7.17

3.4

4.2

14.28

29.72

ug/l

1.88

781

6465

Other disorders of bone

921

7687

1.22

7.16

3.8

4.4

25.84

29.78

ug/l

0.13

757

6140

Alzheimer disease, excluding more controls

1004

7697

0.83

7.16

3.2

4.9

7.51

30.24

ug/l

6.84

817

6500

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1673

16557

0.87

7.13

3.4

4.0

12.27

21.55

ug/l

1.23

1233

12569

Respiratory tuberculosis, confirmed

112

664

1.81

7.11

2.8

4.5

21.32

26.89

ug/l

0.13

567

Diseases of inner ear

3352

29212

1.11

7.10

3.5

4.3

15.00

25.74

ug/l

2.15

2657

23894

Urticaria and erythema

1784

15680

1.15

7.09

3.8

4.2

23.74

22.36

ug/l

0.07

1410

12401

Disorders resulting from impaired renal tubular function

202

1376

1.55

7.08

3.1

4.5

4.50

21.21

ug/l

1.95

166

1144

Other interstitial pulmonary diseases

926

7768

1.22

7.07

3.4

4.2

14.28

28.73

ug/l

1.73

781

6478

Use of galantamine

303

4091

0.72

7.06

2.8

3.8

26.60

23.10

ug/l

0.07

254

3430

Intracranial injury

3292

27897

1.11

7.05

3.6

4.3

7.41

28.96

ug/l

15.82

2683

22621

Pneumonitis due to solids and liquids

463

3603

1.32

7.01

3.5

4.1

59.73

23.02

ug/l

0.30

384

3019

Subjective visual disturbances

1404

12169

1.17

6.99

3.5

4.3

11.91

24.15

ug/l

1.21

1080

9831

Respiratory tuberculosis, confirmed, including avohilmo

113

675

1.79

6.98

2.8

4.5

21.12

26.53

ug/l

0.13

576

Pregnancy hypertension

1423

14655

0.86

6.98

3.4

4.0

11.19

21.58

ug/l

1.45

1035

11030

Hypothyroidism, strict autoimmune, 3 medication purchases required

4823

29932

1.09

6.95

3.7

4.2

19.24

24.23

ug/l

0.61

3777

24067

Acute pharyngitis

520

4044

1.29

6.94

4.1

4.5

5.83

27.80

ug/l

1.86

364

3166

1481

12047

1.17

6.93

3.3

4.0

18.17

24.84

ug/l

0.62

1243

10067

Complications of labour and delivery

2618

16177

0.89

6.93

4.0

16.44

21.60

ug/l

0.45

2000

12466

Other joint disorders

4688

22514

1.09

6.92

3.8

4.6

19.26

29.76

ug/l

1.68

3717

18010

Normal-pressure hydrocephalus

150

2279

0.63

6.89

3.6

4.1

4.62

23.20

ug/l

3.36

124

1912

Dementia due to Parkinson's disease

1179

0.49

6.88

3.3

4.1

2.90

25.03

ug/l

2.48

1003

Complications of other internal prosthetic devices, implants and grafts

237

1674

1.48

6.85

4.0

4.1

8.73

17.80

ug/l

1.01

188

1376

Benign neoplasm: Skin of other and unspecified parts of face

584

4690

1.28

6.84

3.9

4.1

21.15

23.48

ug/l

0.08

484

3826

Dementia due to Parkinsons disease, excluding more controls

1173

0.50

6.77

3.3

4.7

2.90

31.35

ug/l

3.05

1001

Nonorganic sleeping disorders, excluding more controls

894

7473

1.21

6.77

3.3

4.5

7.49

29.42

ug/l

3.38

695

5808

Other female pelvic inflammatory diseases

822

6839

1.23

6.77

3.3

4.1

11.71

23.63

ug/l

1.11

637

5367

Other disorders of veins

2417

21374

1.13

6.75

3.8

4.2

19.10

24.26

ug/l

0.46

1882

17178

Stomatitis and related lesions

979

8265

1.20

6.75

4.0

4.3

45.97

27.46

ug/l

0.29

797

6642

Pain in thoracic spine

815

6771

1.23

6.75

3.6

4.6

6.36

32.77

ug/l

4.14

653

5362

Herpesviral [herpes simplex] infections

578

4636

1.28

6.74

4.4

4.2

74.80

22.80

ug/l

0.44

461

3695

Procedures for purposes other than remedying health state

119

725

1.73

6.71

3.7

3.6

2.91

14.82

ug/l

0.63

565

Obesity related asthma

1929

17123

1.14

6.71

3.2

4.4

29.06

27.48

ug/l

0.05

1574

13768

Respiratory tuberculosis, bacteriologically and histologically confirmed

113

683

1.77

6.69

2.8

4.5

21.12

26.22

ug/l

0.12

584

Unspecified acute lower respiratory infection

747

6160

1.24

6.66

4.3

4.4

12.95

27.63

ug/l

1.34

619

5028

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

141

898

1.65

6.64

2.9

4.4

6.66

67.74

ug/l

0.91

101

704

Ulcer of lower limb, not elsewhere classified

870

7302

1.22

6.61

3.2

4.3

19.38

26.48

ug/l

0.55

743

6087

Impaction of intestines

213

2.45

6.60

4.7

3.7

3.97

47.36

ug/l

0.75

179

therapeutic use

191

1311

1.54

6.56

3.5

4.2

5.82

22.16

ug/l

1.68

154

1081

Enteropathic arthropathies

117

715

1.73

6.55

4.0

4.8

12.55

22.28

ug/l

0.33

584

Hypoglycaemia, other or unspecified

313

2326

1.39

6.52

3.3

4.2

23.80

19.17

ug/l

0.15

268

1876

Abnormal findings in nipple discharge synovial fluid wound secretions

478

1.91

6.51

4.5

4.3

4.33

30.29

ug/l

0.93

398

Dermatitis due to substances taken internally

272

1981

1.42

6.49

5.0

4.3

16.13

18.89

ug/l

0.16

221

1610

Other complications of labour and delivery, not elsewhere classified

128

1793

0.62

6.47

2.8

3.7

8.04

31.49

ug/l

0.51

1145

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

994

8316

1.19

6.45

3.8

4.0

19.01

21.82

ug/l

0.14

755

6256

Endometriosis diagnosis and infertility diagnosis occurring together

402

3096

1.33

6.43

3.5

3.9

11.19

28.01

ug/l

0.67

288

2271

AV-block

1128

8264

1.19

6.43

3.1

4.6

15.70

33.51

ug/l

2.04

908

7009

Pilonidal cyst

289

2118

1.39

6.42

4.0

4.7

17.03

20.42

ug/l

0.18

226

1663

Adenocarcinomas of cervix

3.63

6.40

4.1

1.6

3.03

3.10

ug/l

0.03

Atherosclerosis, excluding cerebral and coronary sclerosis

2649

18835

1.12

6.39

3.1

4.3

26.40

25.73

ug/l

0.04

2303

15739

Redundant prepuce, phimosis and paraphimosis

862

7107

1.21

6.38

4.4

4.9

22.29

33.36

ug/l

0.50

712

5998

Benign neoplasm of urinary organs

280

2064

1.42

6.37

3.8

4.3

4.04

19.80

ug/l

3.25

212

1705

Other respiratory diseases principally affecting the interstitium

1074

9207

1.19

6.36

3.4

4.2

19.53

27.73

ug/l

0.47

909

7673

Diabetic retinopathy, strict definition

594

6474

0.80

6.36

3.4

4.0

19.09

24.77

ug/l

0.21

494

5413

Arterial embolism and thrombosis

327

2462

1.38

6.36

3.4

4.1

37.25

22.06

ug/l

0.30

277

2048

Immunodeficiency with predominantly antibody defects

131

831

1.66

6.35

3.2

4.4

15.46

21.83

ug/l

0.16

101

674

Mood disorders, excluding more controls

5359

29292

1.08

6.34

3.6

4.5

26.39

26.15

ug/l

0.01

4293

23453

Follicular adenocarcinoma of thyroid gland

3.06

6.34

3.7

1.5

2.52

2.77

ug/l

0.13

Anti-inflammatory and antirheumatic products, non-steroids

1453

6342

1.16

6.31

4.2

4.5

20.60

24.98

ug/l

0.28

1200

5226

Obstructed labour due to malposition and malpresentation of fetus

550

6328

0.79

6.31

3.7

3.9

21.73

21.56

ug/l

0.01

382

4511

Chronic laryngitis and laryngotracheitis

800

6692

1.22

6.29

3.4

4.4

18.57

30.75

ug/l

0.52

659

5452

Asthma, including avohilmo

6759

34897

1.07

6.24

3.5

4.4

20.16

27.04

ug/l

0.86

5512

27897

Malnutrition

122

767

1.69

6.21

3.4

4.0

5.93

26.33

ug/l

1.24

107

636

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3078

25568

1.10

6.20

3.7

4.3

16.65

26.07

ug/l

1.12

2353

20208

Malignant neoplasm of gum

3.20

6.18

4.1

1.4

2.72

2.67

ug/l

0.05

Benign neoplasm of mouth and pharynx

579

4701

1.26

6.18

3.9

4.3

12.56

23.62

ug/l

1.40

467

3828

Diseases of the eye and adnexa

3910

17993

1.10

6.17

4.1

4.6

22.64

32.02

ug/l

0.98

3080

14297

Postpartum haemorrhage

635

6403

0.81

6.17

3.6

3.9

17.60

21.21

ug/l

0.14

431

4605

Premature rupture of membranes

470

4230

0.78

6.15

3.8

4.59

21.35

ug/l

1.12

316

2961

Other and unspecified disorders of skin and subcutaneous tissue

345

2634

1.36

6.14

3.6

4.3

8.57

20.23

ug/l

1.93

280

2143

Injuries to unspecified part of trunk, limb or body region

512

4100

1.28

6.13

3.6

4.2

22.04

20.70

ug/l

0.05

405

3331

Gastrojejunal ulcer

429

1.94

6.12

5.5

4.6

15.29

17.72

ug/l

0.07

358

Fracture of skull and facial bones

1044

8936

1.19

6.12

3.7

4.6

10.57

30.44

ug/l

3.94

846

7267

Other shoulder lesions

484

3850

1.29

6.12

3.3

4.7

4.72

32.23

ug/l

2.51

381

3079

Benign neoplasm: Kidney

212

1504

1.48

6.12

3.7

4.2

3.91

20.39

ug/l

2.31

159

1239

Other viral diseases, including avohilmo

1535

13354

1.15

6.11

3.9

4.3

26.78

24.54

ug/l

0.06

1191

10394

Other disorders of eyelid

2882

24797

1.11

6.10

3.7

4.3

30.95

24.89

ug/l

0.23

2361

20446

Other symptoms and signs involving the circulatory and respiratory systems

343

2615

1.35

6.06

3.1

4.4

15.39

23.00

ug/l

0.45

279

2125

Other viral diseases, not elsewhere classified

775

6453

1.21

6.00

4.3

44.10

27.21

ug/l

0.30

621

5088

Disturbances of skin sensation

1324

11553

1.16

5.99

3.5

4.3

9.89

24.62

ug/l

2.91

1020

9086

Drug-induced adrenocortical insufficiency

105

643

1.74

5.98

3.5

4.3

10.30

26.01

ug/l

0.57

528

Neurotic, stress-related and somatoform disorders

4755

30425

1.08

5.96

3.8

4.3

17.58

25.39

ug/l

1.33

3747

24207

Chondrocostal junction syndrome [Tietze]

189

1315

1.50

5.94

3.4

4.2

33.93

12.32

ug/l

0.38

147

1063

Other and unspecified injuries of head

396

3090

1.32

5.93

3.8

4.3

5.67

24.21

ug/l

4.35

337

2514

Kidney transplant status

237

1715

1.43

5.92

2.7

4.6

5.27

18.39

ug/l

1.86

197

1400

Disorders of parathyroid gland

1247

10740

1.17

5.92

3.3

4.0

34.73

21.73

ug/l

0.26

1007

8798

Complications of internal orthopaedic prosthetic devices, implants and grafts

1359

11916

1.16

5.92

3.4

4.0

10.54

26.87

ug/l

4.12

1129

9846

Disorders of vestibular function (Vertigo)

2880

25618

1.11

5.91

3.5

4.2

14.69

24.92

ug/l

1.73

2270

20969

Malignant neoplasm of nasal cavity and sinuses

103

2.92

5.91

3.6

1.5

3.80

2.53

ug/l

0.51

Drug-induced osteoporosis with pathological fracture

110

688

1.73

5.90

3.2

4.1

5.26

16.15

ug/l

1.05

569

Femoral hernia, unilateral

159

1075

1.56

5.89

4.2

5.02

16.65

ug/l

1.67

133

883

Inguinal hernia, unilateral

159

1075

1.56

5.89

4.2

5.02

16.65

ug/l

1.67

133

883

Inguinal of femoral hernia, unilateral

159

1075

1.56

5.89

4.2

5.02

16.65

ug/l

1.67

133

883

Inflammatory diseases of prostate (prostatitis)

650

5364

1.24

5.89

3.8

4.8

15.77

32.25

ug/l

1.34

530

4597

Malignant neoplasm of lip, including Hilmo

169

2.43

5.86

4.4

1.4

4.47

2.82

ug/l

0.59

125

Superficial injury of head

1287

11218

1.16

5.86

3.4

4.2

10.32

30.31

ug/l

4.13

1031

9104

Alcohol abuse, main dg, excluding more controls

651

5365

1.23

5.86

3.4

4.9

18.84

34.47

ug/l

1.05

568

4329

Fracture of forearm

3132

25769

1.10

5.85

4.1

4.2

26.30

23.91

ug/l

0.10

2529

20692

Prolonged pregnancy

272

3127

0.73

5.83

3.6

3.7

8.69

21.36

ug/l

0.49

191

2098

Immunodeficiencies

225

1621

1.44

5.81

3.9

4.4

11.95

20.30

ug/l

0.43

176

1308

Inflammatory disorders of breast

250

1826

1.40

5.80

3.6

3.9

8.08

30.78

ug/l

0.62

197

1375

Malignant immunoproliferative diseases

419

1.96

5.79

2.7

4.4

7.62

39.95

ug/l

0.96

355

Systemic connective tissue disorders

2035

18297

1.13

5.78

3.1

4.2

19.03

24.01

ug/l

0.23

1617

14875

Ill-defined and unknown causes of mortality

580

4752

1.25

5.76

4.4

4.1

68.28

27.56

ug/l

0.72

502

3978

Other anxiety disorders

1998

15217

1.13

5.75

3.4

4.3

10.65

24.15

ug/l

3.17

1550

11756

Failure and rejection of transplanted organs and tissues

393

1.93

5.73

2.5

5.0

2.88

17.82

ug/l

0.74

313

Single spontaneous delivery

1750

10390

0.88

5.73

4.1

3.8

21.41

17.26

ug/l

0.29

1372

8182

Hydrocephalus

255

3419

0.72

5.71

3.9

4.2

13.40

20.65

ug/l

0.51

211

2832

Visual impairment including blindness (binocular or monocular)

377

2941

1.32

5.70

2.9

4.0

25.86

19.29

ug/l

0.14

304

2419

Additional codes for the location of defect, injury or illness

290

2182

1.37

5.70

3.2

4.3

6.23

18.75

ug/l

1.86

229

1770

Atopic dermatitis

2327

20477

0.90

5.70

3.6

4.3

26.01

24.36

ug/l

0.06

1782

15961

Hypertrophy of breast in women and men

930

7943

1.19

5.67

3.7

4.1

21.79

23.60

ug/l

0.07

713

6179

Preparatory care for dialysis

235

1718

1.43

5.67

2.8

4.4

4.66

19.98

ug/l

2.37

205

1435

ILD, hospital admissions 1, main diag only

804

6806

1.21

5.66

3.3

4.3

12.54

26.90

ug/l

1.80

673

5661

Hyperparathyroidism

1095

9384

1.18

5.66

3.3

4.0

31.78

21.97

ug/l

0.17

882

7697

Orchitis and epididymitis

440

3495

1.29

5.65

4.4

4.8

69.78

25.11

ug/l

0.36

369

3001

Other general symptoms and signs

210

1482

1.44

5.64

4.4

4.1

9.75

14.82

ug/l

0.56

167

1162

Diseases of appendix

3927

32502

1.09

5.61

4.3

15.96

26.58

ug/l

2.56

3145

25989

Wet age-related macular degeneration

1150

9652

1.17

5.61

3.5

3.8

41.15

20.53

ug/l

0.43

956

8062

Insomnia

4319

32307

0.92

5.61

3.4

4.3

11.48

25.69

ug/l

4.87

3294

25926

Hydrocele

589

4836

1.24

5.60

4.4

4.7

21.04

26.66

ug/l

0.24

488

4164

Injuries to the hip and thigh

2927

24027

1.10

5.60

3.7

4.2

16.67

25.94

ug/l

1.51

2468

19765

Coxarthrosis

3282

19462

1.10

5.57

3.9

4.6

26.49

31.57

ug/l

0.23

2726

16042

Other disorders of eye and adnexa

670

5572

1.22

5.57

3.5

4.2

10.21

27.81

ug/l

1.57

504

4430

Diseases of the ear and mastoid process

6386

30062

1.07

5.56

3.8

4.4

21.28

29.32

ug/l

0.81

5034

24119

Coxarthrosis [arthrosis of hip](FG)

3632

23074

1.09

5.56

3.9

4.5

27.17

27.90

ug/l

0.03

3016

18932

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

365

2.00

5.56

2.5

4.6

41.41

39.47

ug/l

0.02

306

Varicose veins

3772

26350

1.09

5.55

4.0

4.1

24.79

25.72

ug/l

0.06

3074

21427

Delivery, wide proxy

1432

8628

0.87

5.54

4.2

3.7

15.51

18.18

ug/l

0.27

1134

6794

Diseases of salivary glands

1736

15505

1.13

5.53

3.7

4.3

18.04

23.64

ug/l

0.52

1402

12449

Propionic acid derivatives

1439

6342

1.15

5.52

4.1

4.5

17.13

24.98

ug/l

0.70

1188

5226

Use of selegiline

131

1953

0.64

5.52

2.8

4.2

36.24

21.57

ug/l

0.25

1640

Poisoning by drugs, medicaments and biological substances

946

8098

1.18

5.52

3.5

4.3

13.20

29.64

ug/l

1.84

805

6306

Anxiety disorders

4810

30758

1.08

5.52

3.8

4.3

17.43

25.77

ug/l

1.49

3795

24482

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

101

2.84

5.50

3.5

1.7

3.82

2.57

ug/l

1.06

Nonhereditary hypogammaglobulinemia

364

1.97

5.49

3.4

4.4

3.66

7.00

ug/l

1.40

297

Drug-induced cataract

129

848

1.61

5.48

3.2

4.6

10.12

23.58

ug/l

0.69

109

705

Other diseases of arteries and capillaries

490

3964

1.27

5.47

4.1

4.3

6.27

19.11

ug/l

3.56

408

3238

Unspecified fall

2875

25848

1.10

5.47

3.6

4.2

21.07

25.43

ug/l

0.19

2349

21051

Congenital malformations of the urinary system, including avohilmo

262

1951

1.38

5.46

3.2

4.4

5.23

18.36

ug/l

2.07

204

1568

Fracture of lower leg, including ankle

3132

28270

1.10

5.46

3.8

4.4

24.58

27.26

ug/l

0.15

2541

22806

Systemic lupus erythematosus

176

1232

1.49

5.40

3.1

4.3

15.20

13.79

ug/l

0.07

134

978

Disorders of continuity of bone

477

3848

1.27

5.39

4.2

4.3

10.12

21.35

ug/l

1.57

382

3039

Urticaria

1378

12147

1.15

5.37

3.8

4.2

25.18

23.67

ug/l

0.06

1085

9505

Ocular pain

394

3110

1.30

5.37

3.2

4.3

13.40

21.79

ug/l

0.48

291

2458

Diplopia

696

5839

1.22

5.36

3.5

4.3

62.24

21.11

ug/l

0.73

569

4760

Second line medication for Crohn's disease

3104

28527

1.10

5.36

3.6

4.3

18.67

26.34

ug/l

0.86

2436

22885

Behavioural syndromes associated with physiological disturbances and physical factors

4634

33564

0.93

5.34

3.4

4.4

15.03

25.75

ug/l

1.88

3562

26997

Other disorders of white blood cells

275

2077

1.37

5.33

3.1

4.3

43.29

16.91

ug/l

0.55

222

1692

Obesity due to excess calories

2388

21726

1.11

5.30

3.5

4.4

17.84

25.52

ug/l

0.82

1898

17205

Other congenital malformations, including avohilmo

500

4052

1.25

5.30

3.5

4.3

23.55

28.43

ug/l

0.10

367

3143

Other degenerative diseases of the nervous system

1500

12305

0.88

5.28

3.2

4.8

9.79

33.66

ug/l

6.44

1229

10184

Femoral hernia

241

1790

1.40

5.27

3.9

4.2

22.71

17.64

ug/l

0.13

199

1478

Hidradenitis suppurativa

140

937

1.54

5.26

2.9

4.5

8.11

19.32

ug/l

0.79

118

719

Fibromyalgia

447

3590

1.27

5.26

2.7

4.4

4.04

25.54

ug/l

1.54

347

2756

Benign lipomatous neoplasm

1625

14517

1.13

5.24

3.6

4.3

32.54

25.21

ug/l

0.18

1302

11846

Other follicular disorders

306

2343

1.34

5.24

3.8

4.4

6.41

34.52

ug/l

1.23

251

1849

Carbimazole or st.post thyroidectomy, condition for graves disease

1068

9288

1.17

5.22

3.8

4.1

10.30

25.47

ug/l

2.37

824

7333

Diseases of middle ear and mastoid

2186

19690

0.90

5.21

3.8

4.2

13.16

24.02

ug/l

2.15

1671

15570

Postmenopausal osteoporosis with pathological fracture

417

3349

1.29

5.18

3.1

3.8

11.27

17.05

ug/l

0.50

349

2742

Foreign body in alimentary tract

258

1937

1.37

5.18

4.2

20.84

19.35

ug/l

0.04

212

1582

Other acute viral hepatitis

340

1.94

5.16

4.3

4.5

12.72

20.18

ug/l

0.19

278

Nontraumatic intracranial haemmorrhage

901

10446

0.85

5.16

3.4

4.2

20.54

28.21

ug/l

0.56

763

8682

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1093

9384

1.16

5.16

3.4

4.5

15.83

27.78

ug/l

1.20

896

7204

Diseases of the musculoskeletal system and connective tissue

2662

12161

1.10

5.14

3.9

4.9

17.02

33.37

ug/l

2.30

2091

9677

Shock, not elsewhere classified

329

1.97

5.10

4.3

5.0

42.48

9.77

ug/l

0.39

271

Spondyloarthritis

832

7106

1.19

5.09

3.6

4.3

66.56

27.78

ug/l

0.74

667

5746

Injury of unspecified body region

378

2993

1.30

5.09

3.8

4.2

24.13

22.72

ug/l

0.04

296

2429

Nontoxic goitre/thyroid nodule

1732

15568

1.13

5.08

3.8

4.1

18.59

22.70

ug/l

0.29

1393

12569

Congenital malformations of the urinary system

243

1811

1.38

5.08

3.0

4.4

4.07

19.07

ug/l

2.39

190

1459

Bacterial, viral and other infectious agents, including avohilmo

364

2864

1.30

5.07

4.3

4.5

65.58

18.61

ug/l

0.49

288

2307

Sleep disorders

4465

32890

0.93

5.06

3.4

4.4

11.56

25.97

ug/l

5.16

3415

26429

Other congenital malformations

307

2360

1.33

5.05

3.3

4.3

9.24

18.44

ug/l

0.94

216

1825

Other and unspecified diseases of spleen

153

2.55

5.04

2.2

4.5

4.38

5.90

ug/l

0.31

126

Discitis, unspecified

106

683

1.66

5.02

3.8

4.8

15.28

26.24

ug/l

0.36

559

Social phobias

240

1778

1.37

5.02

3.5

4.5

14.74

33.98

ug/l

0.40

175

1324

Other problems related to primary support group, including family circumstances

356

2713

1.30

5.01

4.9

4.2

12.76

27.51

ug/l

0.55

274

2044

Transepidermal elimination disorders

4.14

5.00

3.5

4.5

1.98

88.76

ug/l

0.52

Carcinoma in situ of skin of lower limb, including hip

146

1012

1.54

4.98

3.6

4.2

9.68

25.10

ug/l

0.95

124

853

Intussusception

111

721

1.62

4.96

4.6

4.2

4.47

25.01

ug/l

1.37

590

Cachexia

200

2.29

4.95

3.8

4.8

769.31

11.32

ug/l

0.50

168

Arterial embolism and thrombosis of lower extremity artery

198

1441

1.43

4.94

3.6

4.1

56.60

21.37

ug/l

0.46

164

1210

Other arthritis (FG)

1737

15625

1.12

4.94

3.5

4.5

10.44

26.66

ug/l

4.45

1384

12662

SLE, ICD10

163

1146

1.48

4.93

3.3

4.2

15.44

14.24

ug/l

0.06

125

918

SLE, strict definition

163

1146

1.48

4.93

3.3

4.2

15.44

14.24

ug/l

0.06

125

918

Acute appendicitis, with complications

978

8489

1.17

4.93

4.6

4.4

16.48

29.18

ug/l

1.22

799

6922

Alcoholic gastritis

482

1.77

4.91

2.9

5.1

13.63

19.43

ug/l

0.19

397

Delivery

1773

10394

0.89

4.90

4.1

3.8

21.31

17.26

ug/l

0.28

1381

8185

Injuries to the knee and lower leg

6805

34778

1.06

4.89

3.8

4.3

18.23

27.37

ug/l

1.68

5463

27922

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

114

2.62

4.89

2.4

1.6

3.98

2.61

ug/l

0.56

Other headache syndromes

2284

20757

1.11

4.88

3.3

4.4

22.51

27.15

ug/l

0.25

1805

16562

Other viral diseases, not elsewhere classified, including avohilmo

1078

9350

1.16

4.88

3.9

4.3

33.64

26.20

ug/l

0.16

835

7265

Poisoning by medicine

837

7178

1.18

4.84

3.4

4.3

11.94

25.54

ug/l

1.44

709

5591

Carcinoma in situ of breast, lobular

317

2.02

4.83

4.8

4.2

4.63

11.15

ug/l

1.79

264

Postmenopausal atrophic vaginitis

1531

7433

1.14

4.83

3.4

4.5

8.90

32.91

ug/l

3.49

1178

6007

Rash and other nonspecific skin eruption

487

3992

1.25

4.83

3.8

4.2

8.87

22.96

ug/l

2.04

400

3217

Ectropion of eyelid

242

1826

1.38

4.83

3.8

4.0

9.82

21.83

ug/l

1.12

213

1532

Maternal care for other known or suspected fetal problems

474

3656

0.81

4.82

3.4

3.7

19.78

20.29

ug/l

0.01

310

2451

Meniscus derangement

3342

20525

1.09

4.82

4.1

4.7

18.51

31.22

ug/l

1.39

2736

16762

Other diseases of upper respiratory tract

6465

31814

1.06

4.81

3.9

4.3

18.76

26.28

ug/l

1.49

5193

25753

Labour and delivery complicated by fetal stress [distress]

460

3688

0.80

4.80

3.4

3.7

18.01

20.40

ug/l

0.05

287

2446

Entropion and trichiasis of eyelid

511

4220

1.24

4.80

4.0

4.1

19.43

20.63

ug/l

0.04

436

3514

Other coagulation defects

337

2650

1.30

4.80

3.4

4.1

6.21

31.07

ug/l

1.24

253

2115

Acute upper respiratory infections

6119

34605

1.06

4.79

4.0

4.2

22.60

25.98

ug/l

0.30

4797

27973

Lumbar disc prolapse

3660

25187

1.08

4.78

3.4

4.6

27.28

27.18

ug/l

0.00

2951

20237

Other specified/unspecified arthritis

1516

13565

1.13

4.77

3.6

4.6

10.82

29.15

ug/l

4.32

1199

11039

Benign lipomatous neoplasm of other sites/unspecified

468

3833

1.25

4.75

3.6

4.2

8.65

22.97

ug/l

2.72

385

3152

Viral pneumonia (known virus, not influenza)

155

1090

1.49

4.75

3.9

4.3

4.55

23.62

ug/l

1.69

137

901

Other nutritional deficiencies

3524

29893

1.08

4.74

3.5

4.4

20.94

26.63

ug/l

0.62

2797

23750

Benign neoplasm of breast

624

5251

1.21

4.74

4.2

4.0

22.55

27.10

ug/l

0.14

488

4166

Unspecified dementia

483

5264

0.81

4.74

2.5

3.7

14.49

28.96

ug/l

1.05

409

4443

Decubitus ulcer and pressure area

353

2806

1.30

4.71

3.0

4.1

10.11

21.46

ug/l

1.22

293

2347

Noninflammatory disorders of female genital tract

1813

8172

1.12

4.71

3.6

4.4

11.52

31.04

ug/l

2.77

1371

6448

Nephrotic syndrome

146

1015

1.50

4.70

3.5

4.4

3.70

24.21

ug/l

1.78

116

840

Benign neoplasm of other and unspecified intrathoracic organs

422

1.83

4.70

3.2

4.4

3.70

41.69

ug/l

1.27

354

Malignant neoplasm of lip

116

2.55

4.70

2.6

1.5

3.16

2.77

ug/l

0.39

Acquired absence of organs, not elsewhere classified

459

1.78

4.69

4.2

4.4

36.07

18.85

ug/l

0.23

387

Other blood glucose lowering drugs, excl. Insulins

917

7971

1.17

4.67

3.6

4.4

15.22

28.06

ug/l

1.23

777

6619

Acute lymphadenitis

226

1688

1.37

4.65

3.9

4.3

14.83

20.31

ug/l

0.29

193

1325

Other and unspecified disorders of white blood cells

206

1525

1.40

4.65

3.1

4.3

25.87

17.95

ug/l

0.20

166

1240

Myocarditis

195

1423

1.41

4.64

4.0

4.8

8.97

28.10

ug/l

1.43

159

1140

Atrophic disorders of skin

862

7458

1.18

4.63

3.7

4.2

4.69

26.42

ug/l

3.85

660

5968

Generalized skin eruption due to drugs and medicaments

188

1371

1.42

4.62

4.9

4.3

15.31

19.90

ug/l

0.23

151

1104

Long labour

639

6417

0.84

4.60

3.5

3.9

41.78

23.54

ug/l

0.28

455

4645

Other diseases of blood and blood-forming organs

354

2822

1.29

4.60

3.4

4.3

4.39

18.05

ug/l

3.47

288

2316

Nonpyogenic thrombosis of intracranial venous system

289

1.97

4.58

5.8

4.2

5.89

33.11

ug/l

0.57

228

Bacterial, viral and other infectious agents

337

2663

1.29

4.58

4.4

4.5

71.01

19.29

ug/l

0.50

265

2145

Diseases of external ear

1920

17433

1.11

4.58

3.7

4.3

17.17

26.18

ug/l

0.95

1496

14252

Use of ropinirole

104

1553

0.64

4.56

3.3

4.4

4.04

21.62

ug/l

2.46

1284

Alzheimer’s disease (Atypical or mixed)

485

5773

0.81

4.55

2.8

3.7

7.74

27.75

ug/l

3.12

396

4864

Hypersplenism

147

2.47

4.52

2.6

5.1

2.69

35.07

ug/l

0.61

126

Acute appendicitis

3581

30946

1.08

4.51

4.3

17.00

26.73

ug/l

1.98

2869

24711

Disorders of porphyrin and bilirubin metabolism

334

1.88

4.50

3.6

4.9

2.91

38.77

ug/l

0.87

276

Medical abortion

3301

16557

1.09

4.49

3.9

14.70

21.20

ug/l

1.07

2603

12814

Open wound of lower leg

758

6505

1.18

4.49

3.1

4.3

11.80

29.91

ug/l

1.81

631

5294

Idiopathic gout

530

4425

1.23

4.47

3.4

4.5

10.25

23.02

ug/l

1.77

438

3746

Cerebral palsy and other paralytic syndromes

518

4306

1.23

4.44

3.0

4.3

80.46

21.95

ug/l

0.49

399

3481

2727

22663

1.09

4.44

3.6

4.2

18.30

26.14

ug/l

0.77

2182

19003

Endometriosis of pelvic peritoneum

693

5362

1.19

4.43

3.1

4.6

6.87

34.61

ug/l

2.84

506

4169

Nonorganic sleeping disorders

894

7766

1.16

4.42

3.3

4.2

7.49

26.43

ug/l

3.26

695

6056

Other disorders of penis

436

3563

1.25

4.39

4.0

4.9

10.14

24.66

ug/l

1.82

349

3050

Moderate visual impairment, binocular

166

1199

1.44

4.39

3.1

3.7

46.61

16.91

ug/l

0.33

139

997

Carcinoma in situ of skin

510

4256

1.23

4.38

3.8

4.0

23.32

21.34

ug/l

0.07

398

3519

Inflammatory disease of cervix uteri

323

2568

1.30

4.35

3.3

4.1

7.14

19.45

ug/l

1.39

265

2042

Kela-code for severe mental illness

1332

14905

0.89

4.34

3.2

4.3

18.29

25.14

ug/l

0.47

1108

11891

Calcific aortic valvular stenosis, diagnosis (helper)

1847

16174

1.11

4.32

3.4

4.1

19.90

26.34

ug/l

0.54

1551

13601

Operations 2 for CAVS

1847

16174

1.11

4.32

3.4

4.1

19.90

26.34

ug/l

0.54

1551

13601

Other and unspecified diseases of blood and blood-forming organs

143

1011

1.48

4.31

3.1

4.4

4.82

22.34

ug/l

1.39

118

832

Appendicitis, broad definition

3850

32299

1.08

4.31

4.3

16.23

26.68

ug/l

2.43

3079

25828

Calcific aortic valvular stenosis, operated

1848

16190

1.11

4.29

3.4

4.1

19.90

26.32

ug/l

0.54

1551

13613

Calcific aortic valvular stenosis

1848

16190

1.11

4.29

3.4

4.1

19.90

26.32

ug/l

0.54

1551

13613

Vitamin D deficiency

553

1.64

4.29

2.9

4.2

3.54

27.20

ug/l

1.01

463

Other and unspecified urticaria

871

7578

1.16

4.27

3.7

4.2

14.31

26.36

ug/l

1.06

693

5981

Carcinoma in situ of skin of other and unspecified parts of face

534

4488

1.22

4.27

3.4

4.0

25.50

24.12

ug/l

0.04

424

3760

Complications of genitourinary prosthetic devices, implants and grafts

130

904

1.50

4.25

4.3

4.2

4.97

22.34

ug/l

1.22

728

Sequelae of poliomyelitis, including avohilmo

375

1.84

4.23

5.0

4.2

16.12

46.54

ug/l

0.64

323

Pleural plaque with presence of asbestos

414

3401

1.25

4.20

3.2

4.4

21.31

26.05

ug/l

0.20

362

2904

Other diseases of lip and oral mucosa

2316

21307

1.10

4.19

3.6

4.3

23.23

24.55

ug/l

0.04

1858

17179

Symptoms and signs involving emotional state

129

895

1.49

4.19

2.9

4.6

19.95

26.75

ug/l

0.15

730

Benign neoplasm: Bronchus and lung

506

1.69

4.18

4.5

46.99

29.13

ug/l

0.17

424

145

1037

1.47

4.17

3.1

4.4

4.60

25.87

ug/l

1.91

131

874

Phakomatoses, not elsewhere classified

290

1.90

4.17

2.3

4.4

8.14

22.09

ug/l

0.43

233

Recurrent aphthous stomatitis , including avohilmo

691

5926

1.18

4.16

3.9

4.1

62.49

29.48

ug/l

0.38

555

4753

Other and unspecified aplastic anaemias

374

1.80

4.15

2.4

4.5

4.45

19.13

ug/l

0.71

312

Infection due to other mycobacteria, including avohilmo

608

1.61

4.14

3.5

3.8

28.34

8.86

ug/l

0.40

494

Pneumonia due to Streptococcus pneumoniae

190

1413

1.38

4.13

3.5

4.3

58.45

18.92

ug/l

0.43

157

1161

Radiodermatitis

2.94

4.13

4.0

5.1

5.55

7.35

ug/l

0.24

SLE (Finngen)

176

1297

1.41

4.12

3.1

4.5

15.20

20.37

ug/l

0.26

134

1020

Unstable angina pectoris

2017

17291

0.91

4.12

3.3

4.5

12.28

32.23

ug/l

5.93

1687

14520

Benign neoplasm: Long bones of lower limb

137

965

1.47

4.12

4.1

4.7

32.36

27.18

ug/l

0.06

112

784

Use of levodopa decarbox-comt-inhibitor

1436

0.65

4.12

3.2

4.3

3.41

22.62

ug/l

2.63

1206

Calculus of lower urinary tract

281

2214

1.31

4.11

4.7

4.3

5.02

24.62

ug/l

3.22

233

1874

Rheumatism, unspecified

776

6733

1.17

4.11

3.2

4.4

7.28

26.63

ug/l

2.71

628

5356

Localized skin eruption due to drugs and medicaments

399

1.77

4.08

6.5

4.3

10.70

35.77

ug/l

0.63

322

Special screening examination for other diseases and disorders

548

4612

1.20

4.06

3.8

4.7

25.20

33.13

ug/l

0.16

419

3740

Melanoma of uvea

410

1.77

4.05

3.9

4.5

8.28

33.85

ug/l

0.72

345

Calcific aortic valvular stenosis, including rheumatic fever

1850

16240

1.11

4.04

3.4

4.1

19.88

26.25

ug/l

0.53

1553

13659

Alzheimer’s disease (Atypical or mixed), excluding more controls

457

4096

0.82

4.04

2.9

4.5

7.98

29.21

ug/l

5.15

376

3495

Other disorders of nervous system

356

2889

1.27

4.03

3.4

4.5

90.22

22.30

ug/l

0.42

304

2371

Exclusions for E4_PCOS_BROAD

746

6444

1.17

4.01

3.5

4.4

30.56

25.43

ug/l

0.14

587

5141

Systemic lupus erythematosus, unspecified

138

981

1.46

4.01

3.4

4.2

16.98

14.06

ug/l

0.13

111

788

Cluster headache, strict

151

1087

1.43

4.00

3.3

4.9

10.22

26.24

ug/l

0.80

118

878

Endocarditis

189

1416

1.38

4.00

3.3

4.7

12.87

29.61

ug/l

1.10

153

1180

Senility

360

1.78

4.00

2.2

3.6

4.80

10.12

ug/l

1.31

305

Cysts of oral region, not elsewhere classified

273

2147

1.31

4.00

3.5

4.4

18.57

18.31

ug/l

0.01

226

1739

Benign neoplasm: Skin of trunk

206

1562

1.36

3.99

4.0

4.3

7.78

23.73

ug/l

1.61

166

1287

Impetigo

160

1161

1.41

3.99

4.0

4.4

34.35

20.54

ug/l

0.30

130

916

Personality disorders, excluding more controls

961

8429

1.15

3.98

3.2

4.6

10.91

28.78

ug/l

2.52

764

6481

Pyogenic arthritis

344

2781

1.27

3.98

3.3

4.7

41.44

27.31

ug/l

0.24

295

2345

Other and unspecified visual disturbances

544

4599

1.21

3.97

3.9

4.3

14.42

19.69

ug/l

0.25

429

3707

Other specified disorders of kidney and ureter

166

1221

1.41

3.97

3.8

4.4

59.60

20.76

ug/l

0.38

138

1013

Folate deficiency anaemia

380

1.78

3.97

2.8

4.6

6.53

26.99

ug/l

0.89

309

Palmar fascial fibromatosis [Dupuytren]

880

7722

1.16

3.96

4.1

4.6

24.06

29.16

ug/l

0.25

743

6507

Personal history of certain other diseases

270

1.87

3.96

5.3

4.1

3.65

6.18

ug/l

1.15

204

Encephalopathy

381

1.78

3.96

3.0

4.8

17.51

39.58

ug/l

0.45

319

Other and unspecified erythematous conditions

167

1231

1.41

3.94

3.7

4.4

13.79

25.16

ug/l

0.43

138

1007

Acute generalized exanthematous pustulosis

212

1619

1.35

3.91

4.5

4.3

22.36

18.60

ug/l

0.13

170

1309

Stroke, excluding SAH

3785

25629

1.07

3.90

3.6

4.4

29.11

27.27

ug/l

0.08

3183

21250

Endometriosis of intestine

309

1.81

3.90

2.1

4.5

1.83

137.16

ug/l

0.62

228

Chronic conjunctivitis

144

1037

1.44

3.89

2.7

4.3

10.93

24.72

ug/l

0.72

111

845

Non-selective monoamine reuptake inhibitors

2165

19121

1.10

3.88

3.1

4.4

31.62

27.24

ug/l

0.13

1770

15513

Other and unspecified hypertrophic disorders of skin

204

2.07

3.88

2.7

4.9

3.40

6.80

ug/l

1.30

159

Type 1 diabetes

1050

9294

1.14

3.88

3.8

4.5

25.73

31.43

ug/l

0.20

893

7415

Osteomyelitis

317

2549

1.28

3.88

2.9

4.4

9.79

20.39

ug/l

1.33

264

2122

Unknown and unspecified causes of morbidity

307

2454

1.28

3.88

3.9

4.1

14.24

18.75

ug/l

0.26

246

1956

Accessory breast

155

2.22

3.87

3.2

4.2

4.45

6.39

ug/l

0.34

115

Anomalies of dental arch relationship, including avohilmo

536

5730

0.84

3.87

3.5

4.3

6.93

32.16

ug/l

2.86

397

4442

Stroke, including SAH

3960

26716

1.07

3.83

3.6

4.4

29.29

26.85

ug/l

0.11

3331

22067

Achalasia of cardia

595

1.59

3.82

3.4

4.9

3.93

17.32

ug/l

1.18

498

Cushing syndrome

399

1.74

3.82

2.2

4.3

11.13

18.66

ug/l

0.27

331

Presbycusis

876

7609

1.16

3.82

3.7

3.9

11.17

25.41

ug/l

3.19

717

6369

Melanocytic naevi of lower limb, including hip

205

1564

1.35

3.80

4.3

4.4

13.20

22.45

ug/l

0.37

165

1270

Other renal tubulo-interstitial diseases

114

791

1.50

3.79

4.1

5.86

21.26

ug/l

0.87

647

Other congenital malformations of intestine, including avohilmo

369

1.76

3.78

4.2

2.98

20.10

ug/l

0.85

303

Algoneurodystrophy

134

956

1.45

3.78

3.3

4.6

3.15

20.13

ug/l

1.69

108

750

Cluster headache, strict, including avohilmo

190

1432

1.36

3.78

3.3

4.5

8.76

23.82

ug/l

0.99

146

1132

Right bundle-branch block

210

1613

1.35

3.77

4.1

4.7

44.96

29.17

ug/l

0.17

179

1346

Other erythematous conditions

182

1370

1.38

3.76

3.7

4.4

12.91

23.32

ug/l

0.43

150

1116

Glomerular diseases

887

7812

1.15

3.75

3.2

4.5

10.61

27.80

ug/l

2.63

743

6446

Endometriosis of rectovaginal septum and vagina

373

3062

1.25

3.75

3.3

4.5

19.39

36.59

ug/l

0.56

278

2454

Abnormalities of gait and mobility

682

5908

1.18

3.75

2.9

4.4

47.84

23.12

ug/l

0.28

548

4897

Other autoimmune haemolytic anaemias

514

1.65

3.73

4.1

4.3

4.11

36.22

ug/l

1.31

434

Other noninflammatory disorders of vagina

378

3109

1.24

3.71

3.7

4.5

5.80

36.58

ug/l

1.75

284

2459

Familial hypercholesterolemia, with ischemic heart disease

570

4882

1.20

3.71

3.3

4.5

12.23

27.69

ug/l

1.28

482

4097

Emergency coronary revascularization (for ACS)

5247

30026

1.06

3.70

3.5

4.5

16.35

29.58

ug/l

3.18

4272

24541

Other orthopaedic follow-up care

242

1893

1.31

3.69

3.9

37.69

12.34

ug/l

0.44

205

1491

Outcome of delivery

471

2405

1.21

3.69

3.5

101.78

10.75

ug/l

0.54

305

1705

Bronchiectasis

453

3804

1.22

3.69

3.3

4.2

16.44

21.76

ug/l

0.27

390

3109

Maternal care for known or suspected abnormality of pelvic organs

663

5192

0.85

3.67

3.5

3.9

29.09

20.13

ug/l

0.19

451

3709

Undefined dementia

485

5293

0.83

3.66

2.5

3.5

14.46

25.55

ug/l

0.73

410

4427

414

1.66

3.66

3.7

4.4

3.54

30.46

ug/l

1.06

320

Urethral stricture

304

2453

1.27

3.65

3.7

4.6

18.77

30.09

ug/l

0.36

243

2073

Disorders of plasma-protein metabolism, not elsewhere classified

216

2.00

3.65

3.1

5.3

4.26

57.58

ug/l

0.81

176

Varicella [chickenpox]

159

1172

1.39

3.65

3.9

4.8

15.14

30.80

ug/l

0.74

132

947

Hypertrophy of breast

780

6822

1.16

3.64

3.7

4.0

21.76

23.34

ug/l

0.06

586

5241

Special screening examination for infectious and parasitic diseases

798

5069

1.16

3.64

3.7

4.7

8.75

34.95

ug/l

2.38

559

3821

Diseases of tongue

339

2768

1.26

3.64

3.7

4.4

29.57

24.91

ug/l

0.08

288

2272

Cluster headache, wide

164

1218

1.38

3.63

3.2

4.8

63.23

26.31

ug/l

0.30

127

979

Adenomyosis (Endometriosis of uterus)

685

5933

1.17

3.63

3.5

4.5

13.13

31.59

ug/l

1.38

529

4772

Progressive vascular leukoencephalopathy

252

1999

1.31

3.62

2.7

4.0

5.65

24.51

ug/l

2.91

205

1676

Intracranial and intraspinal abscess and granuloma

429

1.69

3.62

2.9

4.7

4.74

32.67

ug/l

0.89

361

Pneumonia derived septicemia

165

1231

1.38

3.61

3.9

4.4

13.16

21.69

ug/l

0.43

138

1017

Percutaneous Coronary Intervention

4790

27567

1.06

3.61

3.5

4.6

16.11

29.93

ug/l

3.09

3886

22474

Neurological diseases, wide definition

1201

5379

1.13

3.60

3.7

5.4

11.12

41.65

ug/l

3.12

942

4172

Infections with a predominantly sexual mode of transmission

1100

9797

1.13

3.60

3.7

4.2

17.65

22.16

ug/l

0.21

836

7409

False labour

757

5395

0.86

3.60

3.3

3.8

10.85

22.51

ug/l

0.73

511

3788

Other condition

653

5645

1.17

3.60

3.5

4.4

13.57

30.40

ug/l

1.42

554

4532

Alcohol abuse, main dg

651

5626

1.17

3.58

3.4

4.7

18.84

31.94

ug/l

0.89

568

4581

Symptoms and signs involving speech and voice

1884

17323

1.10

3.56

3.6

4.2

9.99

25.10

ug/l

4.26

1487

14111

Agoraphobia

591

1.54

3.56

3.5

4.6

14.76

22.59

ug/l

0.24

449

L04AX Other immunosuppressants

2987

27911

1.08

3.56

3.6

4.3

19.27

25.90

ug/l

0.68

2348

22415

Flatulence and related conditions

298

1.81

3.55

3.4

4.5

63.55

11.03

ug/l

0.42

249

Postpartum hemorraghe, parous women as controls

635

6154

0.86

3.54

3.6

3.9

17.60

21.88

ug/l

0.16

431

4441

Horner syndrome

431

1.68

3.54

3.8

4.5

3.05

17.54

ug/l

0.84

353

Arthropathies in other diseases classified elsewhere

183

1392

1.36

3.54

3.6

4.8

52.35

26.14

ug/l

0.25

146

1157

Alcohol withdrawal state with delirium

321

2614

1.26

3.54

3.2

4.7

17.25

30.66

ug/l

0.79

278

2187

Other arterial embolism and thrombosis

148

1092

1.41

3.52

3.1

4.1

8.86

25.05

ug/l

1.17

129

913

Charcot foot

632

1.54

3.51

3.0

5.3

11.66

23.60

ug/l

0.46

517

Kela reimbursement Agammaglobulinemia (D80-84)

233

1.92

3.50

3.2

4.1

6.00

9.91

ug/l

0.62

186

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

3.06

3.49

3.0

1.5

2.16

2.53

ug/l

—

Benign neoplasm: Connective and other soft tissue of pelvis

2.79

3.48

2.3

4.7

2.49

11.43

ug/l

1.73

Benign neoplasm of major salivary glands

502

4275

1.20

3.46

3.9

4.2

24.79

21.68

ug/l

0.08

431

3501

Superficial injury of thorax

735

6431

1.16

3.45

3.5

4.4

22.49

26.84

ug/l

0.18

613

5239

Cervicalgia

1135

10201

1.13

3.45

3.1

4.5

12.76

27.68

ug/l

2.19

912

8222

Spontaneous abortion

1830

13344

0.91

3.45

4.0

28.13

21.88

ug/l

0.21

1392

10129

Cluster headache, wide,, including avohilmo

203

1567

1.32

3.44

3.2

4.5

52.28

24.45

ug/l

0.27

155

1238

Perineal laceration during delivery

315

3129

0.81

3.44

3.3

3.8

8.56

26.10

ug/l

0.73

212

2133

Hypertrophic disorders of skin

227

1778

1.30

3.44

3.3

4.5

7.92

23.32

ug/l

1.62

167

1389

Congenital iodine-deficiency syndrome/hypothyroidism

151

1123

1.40

3.43

3.6

4.1

25.09

20.57

ug/l

0.09

115

921

Acute upper respiratory infections of multiple and unspecified sites

4126

28412

1.06

3.42

4.1

4.2

16.84

25.39

ug/l

1.55

3230

22754

Subarachnoid haemorrhage

400

4771

0.82

3.42

3.5

4.2

23.38

20.14

ug/l

0.14

340

3913

Diabetic maculopathy

431

4822

0.83

3.41

3.7

3.9

42.97

24.60

ug/l

0.33

368

4039

Actinic keratosis

2512

21289

1.08

3.41

3.6

4.2

19.30

26.03

ug/l

0.56

2016

17901

Glomerulonephritis

449

3789

1.21

3.40

3.5

4.3

8.58

21.15

ug/l

2.31

357

3117

Biliary cirrhosis, NAS

147

2.32

3.40

3.9

4.9

2.97

55.78

ug/l

0.60

122

Impacted cerumen

627

5441

1.17

3.39

3.6

4.2

10.65

23.92

ug/l

2.01

464

4510

Diabetic retinopathy, excluding more controls

1346

6809

1.12

3.39

3.7

4.2

18.28

30.01

ug/l

1.01

1110

5611

Other and unspecified coagulation defects

209

1625

1.32

3.39

3.5

4.3

5.22

22.68

ug/l

2.06

150

1281

Soft tissue disorders related to use, overuse and pressure

1607

14712

1.10

3.38

3.3

4.6

20.88

29.63

ug/l

0.51

1291

11981

Other congenital malformations of intestine

251

1.87

3.37

4.8

4.5

2.82

10.02

ug/l

2.50

200

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

688

5821

1.16

3.37

3.3

4.5

8.86

29.10

ug/l

2.24

536

4663

Other peripheral vertigo

494

4213

1.20

3.37

3.2

4.2

10.25

24.59

ug/l

1.74

393

3451

Unspecified urinary incontinence

486

4139

1.20

3.37

3.3

4.0

13.74

25.42

ug/l

0.70

390

3360

Other systemic involvement of connective tissue

1540

14077

1.11

3.36

3.1

4.1

18.14

25.52

ug/l

0.28

1230

11396

Brain glioblastoma

249

1.83

3.35

2.2

1.4

3.22

2.62

ug/l

0.40

186

Other inflammation of eyelid, including avohilmo

2158

19985

1.09

3.35

3.6

4.3

7.59

24.09

ug/l

7.18

1590

15829

Polycystic kidney disease

121

871

1.44

3.35

2.3

4.5

3.19

29.75

ug/l

1.96

716

Other hearing loss

1742

15509

1.10

3.34

3.8

4.2

24.17

25.20

ug/l

0.02

1404

12924

Drug-induced osteoporosis

519

1.60

3.34

3.9

4.3

318.04

29.10

ug/l

0.45

437

Other arthrosis

3234

20334

1.07

3.33

3.4

4.7

11.19

31.11

ug/l

6.85

2614

16605

Other systemic involvement of connective tissue (FG)

1507

13514

1.11

3.32

3.1

4.3

18.46

23.96

ug/l

0.20

1203

10984

Skin changes due to chronic exposure to nonionizing radiation

2577

21780

1.08

3.31

3.6

4.2

19.16

26.27

ug/l

0.62

2061

18298

Maternal care for known or suspected malpresentation of fetus

375

3223

0.82

3.31

3.9

3.7

3.27

21.52

ug/l

0.87

245

2150

Benign neoplasm of other and unspecified sites

164

1242

1.37

3.31

3.8

4.4

52.81

23.86

ug/l

0.26

135

1020

Carcinoma in situ of skin of trunk

199

1553

1.33

3.31

3.1

4.0

10.03

27.33

ug/l

1.49

160

1306

Other maltreatment syndromes

101

702

1.48

3.29

3.8

5.1

12.33

19.98

ug/l

0.35

558

Sequelae of injuries of lower limb

407

3415

1.21

3.28

3.6

4.5

51.89

18.34

ug/l

0.37

325

2756

Hypoplasia of dental enamel

3.09

3.25

2.1

2.9

1.89

1.99

ug/l

—

Ovarian dysfunction

195

1505

1.31

3.24

3.1

3.8

7.49

35.92

ug/l

0.60

136

1065

Unspecified mental disorder

1517

16577

0.91

3.23

3.2

4.3

21.14

25.52

ug/l

0.24

1252

13171

Assault

414

3475

1.20

3.23

3.6

4.6

32.96

29.68

ug/l

0.05

342

2714

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

393

1.66

3.23

4.9

4.3

14.29

38.45

ug/l

0.56

321

Abnormal findings in peritoneal fluid saliva

141

2.22

3.23

4.6

4.1

4.95

10.36

ug/l

1.07

112

Other inflammation of vagina/vulva

134

983

1.40

3.22

3.3

4.2

7.11

43.09

ug/l

0.52

751

Primary ovarian failure

470

1.59

3.22

3.6

4.3

6.75

19.10

ug/l

0.58

348

Other and unspecified haemorrhagic conditions

554

1.55

3.22

3.5

4.4

24.58

20.41

ug/l

0.09

464

D07AA Corticosteroids, weak (group I)

568

4891

1.17

3.21

5.9

4.2

30.29

26.88

ug/l

0.10

463

3832

Benign neoplasm: Carotid body

101

2.47

3.19

2.7

4.7

12.86

49.06

ug/l

0.38

Chronic ulcer of skin, not elsewhere classified

367

3066

1.22

3.19

3.1

4.3

8.93

22.08

ug/l

2.31

309

2538

Benign neoplasm: Parotid gland

400

3369

1.21

3.18

4.0

4.3

27.86

24.77

ug/l

0.06

345

2758

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

462

3939

1.20

3.18

3.7

4.3

30.66

22.43

ug/l

0.20

383

3213

Benign neoplasm of bone and articular cartilage

355

2953

1.22

3.16

4.0

4.3

30.91

18.86

ug/l

0.36

281

2358

Herpesviral [herpes simplex] infections, including avohilmo

1150

10388

1.12

3.16

3.8

4.2

41.56

22.11

ug/l

0.29

882

8114

Allergic urticaria

327

2697

1.23

3.16

4.0

4.3

13.61

29.67

ug/l

0.63

259

2114

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1953

15535

0.92

3.15

3.8

4.0

15.80

21.44

ug/l

0.45

1439

11781

Alcoholic cardiomyopathy

194

0.29

3.14

3.0

4.3

2.83

74.01

ug/l

—

169

Exclusion endpoint for clefts

368

1.65

3.14

3.4

4.4

4.13

18.15

ug/l

0.61

290

Ischemic heart diseases

4960

28084

1.06

3.14

3.6

4.6

16.94

29.69

ug/l

2.71

4042

22832

Communicating hydrocephalus

814

0.60

3.13

3.3

4.3

11.43

23.95

ug/l

0.51

683

Other mental disorders due to brain damage and dysfunction and to physical disease

533

6157

0.85

3.13

3.4

4.2

5.33

28.85

ug/l

5.02

447

5100

Polymyalgia rheumatica

800

7105

1.15

3.13

3.0

4.1

28.80

23.87

ug/l

0.09

651

5899

Aneurysms, operations, SAH

714

8091

0.87

3.12

3.5

4.4

40.51

24.65

ug/l

0.31

605

6629

Endometriosis ASRM stages 1,2

714

6279

1.15

3.12

3.2

4.0

6.80

24.06

ug/l

1.79

522

4753

Benign neoplasm: salivary glands, exclude unknown (D119)

444

3781

1.20

3.11

3.9

4.3

25.86

23.29

ug/l

0.06

383

3082

Injury of muscle and tendon at shoulder and upper arm level

1757

19018

0.92

3.09

3.9

4.6

12.92

29.40

ug/l

3.30

1428

15713

Nontoxic multinodular goitre

1138

10311

1.12

3.08

3.9

4.1

12.82

24.04

ug/l

1.35

920

8382

ILD-related respiratory insufficiency

188

1471

1.33

3.07

3.8

4.2

14.42

22.96

ug/l

0.37

168

1229

Sequelae of poliomyelitis

323

1.74

3.06

5.5

4.3

19.08

41.48

ug/l

0.37

278

Respiratory tuberculosis, confirmed and not-confirmed

270

2197

1.26

3.06

3.3

4.0

52.08

20.06

ug/l

0.52

233

1843

Abnormal findings on examination of urine, without diagnosis

201

1581

1.31

3.06

3.5

4.3

42.84

20.27

ug/l

0.37

169

1303

Respiratory tuberculosis

270

2198

1.26

3.05

3.3

3.9

52.08

20.05

ug/l

0.52

233

1844

Deep endometriosis

411

3480

1.20

3.03

3.2

4.0

18.26

29.13

ug/l

0.37

297

2709

Suicide or other Intentional self-harm

981

8806

1.12

3.03

3.4

4.4

15.96

29.48

ug/l

1.34

834

6931

Hemiplegia

228

1821

1.28

3.03

3.2

4.1

27.30

19.95

ug/l

0.20

172

1485

Other infective otitis externa

278

2271

1.25

3.02

3.4

4.3

13.40

21.99

ug/l

0.42

222

1842

Other and/or unspecified nontoxic goitre

447

3821

1.19

3.02

3.7

4.1

27.07

24.04

ug/l

0.06

359

3088

Generalized anxiety disorder

519

4461

1.17

3.00

3.4

4.3

6.07

26.90

ug/l

1.75

402

3366

Cervical disc disorders

2066

19214

1.08

3.00

3.3

4.7

21.22

28.64

ug/l

0.25

1712

15620

Ischaemic Stroke, excluding all haemorrhages

3538

24611

1.06

2.99

3.6

4.4

30.88

27.02

ug/l

0.16

2977

20462

Other hereditary haemolytic anaemias

187

1.96

2.99

4.0

4.8

2.60

32.70

ug/l

0.70

150

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

631

5350

1.16

2.98

3.4

4.5

8.00

29.29

ug/l

2.21

496

4282

Benign neoplasm: Skin, unspecified

193

1517

1.31

2.98

3.1

4.3

4.00

20.96

ug/l

2.28

153

1242

Single delivery by caesarean section

436

2931

0.84

2.97

3.7

7.14

9.50

ug/l

0.33

297

2040

Other specified congenital malformation syndromes affecting multiple systems

289

1.71

2.97

3.2

4.5

4.67

19.78

ug/l

0.49

228

Other factor of the environment

418

1.61

2.96

3.0

4.7

3.89

34.92

ug/l

0.97

343

Pediculosis, acariasis and other infestations

237

1906

1.27

2.95

4.0

4.5

18.98

20.72

ug/l

0.07

199

1533

Drug-induced hypoglycaemia without coma

532

1.53

2.93

2.6

4.5

7.68

36.80

ug/l

1.12

442

Unspecified event, undetermined intent

101

721

1.44

2.93

4.1

4.5

2.93

26.77

ug/l

1.37

592

Other abnormal findings in urine

617

1.50

2.92

3.8

4.5

85.81

29.39

ug/l

0.45

521

Tuberculosis, wide

366

3083

1.21

2.92

3.3

4.0

41.34

20.75

ug/l

0.42

313

2580

Gestational [pregnancy-induced] hypertension

749

8426

0.88

2.92

3.4

4.0

4.53

20.90

ug/l

2.72

537

6215

Carrier of infectious disease

105

756

1.43

2.92

4.6

4.5

4.92

27.59

ug/l

1.34

619

Asthma mixed form (mode), excluding more controls

216

1720

1.28

2.91

3.6

4.0

5.00

45.49

ug/l

1.33

190

1371

Benign leiomyoma with endometriosis

845

7562

1.13

2.91

3.6

4.0

20.52

24.58

ug/l

0.17

653

6044

Dislocation, sprain and strain of joints and ligaments of knee

2648

25496

0.93

2.91

4.0

4.5

11.92

27.22

ug/l

5.00

2083

20181

Otitis externa

1085

9824

1.12

2.91

3.6

4.4

19.64

26.85

ug/l

0.38

855

7962

Transient ischemic attack

3290

24748

1.07

2.91

3.6

4.3

20.01

25.64

ug/l

0.55

2698

20524

Other/unspecified reactive arthropathies

279

2290

1.24

2.90

3.6

4.3

13.69

19.56

ug/l

0.28

207

1845

Disorders of conjunctiva

4439

32704

1.06

2.90

3.6

4.3

12.87

25.87

ug/l

4.29

3375

26201

Late syphilis

486

1.56

2.90

2.7

5.0

17.57

37.41

ug/l

0.53

405

Tuberculosis, IBD comorbidity

355

2985

1.21

2.89

3.2

4.0

42.60

19.78

ug/l

0.47

303

2493

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

575

5008

1.16

2.89

3.4

4.4

20.11

27.84

ug/l

0.34

491

3872

Deep bite

263

2826

0.81

2.88

3.9

4.3

7.42

19.01

ug/l

1.62

198

2200

Vulvovaginal ulceration/inflammation in other diseases

241

1945

1.26

2.88

3.2

4.0

2.93

36.76

ug/l

1.12

171

1458

Motor neuron disease (with DMD)

868

0.63

2.87

2.9

5.3

10.89

37.83

ug/l

1.21

731

Cerebral cysts

227

1824

1.27

2.85

2.8

4.3

10.92

21.48

ug/l

0.91

186

1458

Benign neoplasm: Mediastinum

127

2.21

2.85

2.9

4.9

2.41

10.94

ug/l

1.63

102

Other secondary coxarthrosis

176

1378

1.32

2.85

4.4

4.5

15.79

23.03

ug/l

0.24

148

1134

Monoamine oxidase A inhibitors

590

5169

1.16

2.83

3.8

4.6

37.03

34.41

ug/l

0.05

466

4176

Peripheral arterial reconstruction

977

8826

1.12

2.83

3.1

4.2

23.93

21.95

ug/l

0.09

854

7435

Fracture of foot, except ankle

1100

9978

1.11

2.83

3.7

4.4

20.90

26.26

ug/l

0.24

880

7910

Findings of drugs and other substances, not normally found in blood

148

2.08

2.83

2.5

5.1

6.44

81.27

ug/l

0.81

126

Tuberculosis, wide, including avohilmo

370

3130

1.21

2.82

3.3

4.0

40.99

20.55

ug/l

0.43

316

2616

Glomerular disorders in diseases classified elsewhere

554

4834

1.16

2.82

3.0

4.5

12.60

20.42

ug/l

0.75

476

4009

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1093

9907

1.11

2.82

3.4

4.3

15.83

27.22

ug/l

1.16

896

7635

Benign neoplasm: Other/unspecified site

580

1.50

2.81

3.3

4.3

95.85

31.12

ug/l

0.32

486

Motor neuron disease ALS

863

0.64

2.81

2.9

5.3

10.89

38.03

ug/l

1.22

727

Thyrotoxicosis with toxic multinodular goitre

335

2817

1.22

2.80

3.3

4.2

4.51

20.67

ug/l

3.31

276

2288

Corticotropin deficiency

290

1.73

2.80

3.3

4.2

2.95

24.63

ug/l

0.78

225

226

1813

1.26

2.80

3.7

3.6

31.21

30.73

ug/l

0.01

144

1201

Fibroblastic disorders

1340

12290

1.10

2.80

3.9

4.6

26.92

31.81

ug/l

0.19

1091

10165

Lung transplant status

244

1.80

2.80

2.6

4.8

17.85

36.53

ug/l

0.36

194

Lung transplantation

244

1.80

2.79

2.6

4.8

17.85

36.53

ug/l

0.36

194

Heart failure and coronary heart disease

2733

17997

1.07

2.79

3.0

4.6

8.97

31.05

ug/l

9.05

2301

15130

Late syphilis, including avohilmo

589

1.49

2.78

2.9

5.1

18.51

31.72

ug/l

0.39

495

Obesity and other hyperalimentation

3261

28974

1.06

2.78

3.5

4.4

24.81

25.64

ug/l

0.06

2579

23000

Disorders of phosphorus metabolism and phosphatases

163

2.00

2.78

4.2

5.0

7.58

34.44

ug/l

0.49

128

Other otitis externa (chronic)

309

2576

1.22

2.77

2.9

4.3

46.75

19.54

ug/l

0.51

238

2096

Circumscribed brain atrophy

931

0.65

2.77

2.9

4.4

15.95

30.21

ug/l

0.60

775

Pregnancy, childbirth and the puerperium

1278

7305

0.91

2.76

3.9

3.6

14.54

18.45

ug/l

0.56

1009

5723

Obesity

3241

28843

1.06

2.76

3.5

4.4

24.93

25.68

ug/l

0.05

2562

22896

Radiculopathy

894

8048

1.12

2.76

3.3

4.6

12.11

31.02

ug/l

2.68

707

6624

Migraine

2111

17598

0.93

2.74

3.2

4.4

11.35

24.36

ug/l

1.76

1537

13741

Other dermatomyositis

179

1.95

2.74

3.3

4.7

2.78

71.25

ug/l

0.89

147

Other immunodeficiencies

322

1.66

2.73

4.1

4.3

9.47

42.19

ug/l

0.68

261

Retinal vascular disorders

702

6242

1.14

2.73

3.9

4.2

15.13

22.71

ug/l

0.77

586

5217

Female infertility

1142

6209

1.11

2.73

3.7

4.6

10.52

33.40

ug/l

2.37

844

4806

Sulfasalazine

1412

12988

1.10

2.72

3.7

4.4

37.30

24.67

ug/l

0.39

1121

10407

Extrapyramidal and movement disorders

2005

21477

0.93

2.72

3.3

4.2

31.10

23.67

ug/l

0.20

1609

17702

Persistent mood disorders

899

8095

1.12

2.71

3.1

4.4

40.59

27.19

ug/l

0.19

735

6510

Pneumococcal septicemia

154

1192

1.33

2.71

3.8

4.3

13.94

23.20

ug/l

0.44

127

989

Acute appendicitis, no complications

2603

24324

1.07

2.69

4.2

4.3

17.20

27.16

ug/l

1.53

2070

19280

Lesion of lateral popliteal nerve

231

1879

1.26

2.68

3.6

4.6

9.70

18.48

ug/l

0.71

198

1548

Gonarthrosis [arthrosis of knee](FG)

4641

25472

1.05

2.67

3.7

4.5

27.25

27.81

ug/l

0.03

3762

20670

Other necrotizing vasculopathies

378

3225

1.20

2.67

2.9

4.2

24.16

24.07

ug/l

0.00

298

2655

Other and unspecified injuries of lower leg

310

2591

1.21

2.67

3.5

4.2

10.64

18.95

ug/l

0.56

245

2046

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

579

1.46

2.66

3.3

4.5

36.95

14.18

ug/l

0.30

455

Brain glioblastoma and astrocytoma

283

1.67

2.65

2.1

1.6

3.24

2.67

ug/l

0.39

211

Lagophthalmos

514

1.52

2.64

3.8

4.5

3.44

31.60

ug/l

1.18

435

Melanocytic naevi, other sites/unspecified

360

3056

1.20

2.63

4.0

4.4

5.15

19.25

ug/l

3.51

280

2436

Tongue abnormality

310

2604

1.22

2.63

3.9

4.2

31.72

17.43

ug/l

0.27

265

2122

Glaucoma suspect

1942

20776

0.93

2.62

4.2

19.15

24.81

ug/l

0.37

1604

17107

Ovarian dysfunction, other/unspecified

158

1.95

2.62

3.1

4.5

16.96

9.36

ug/l

0.21

125

Cystic kidney disease

141

1084

1.34

2.62

2.4

4.5

3.24

25.51

ug/l

2.11

108

896

Polyarthrosis

1319

10922

1.10

2.61

3.4

4.5

6.09

27.31

ug/l

10.86

1105

8987

Asthma mixed form (mode)

216

1746

1.26

2.60

3.6

4.1

5.00

41.36

ug/l

1.19

190

1403

Congenital malformations of oesophagus, including avohilmo

174

1.92

2.60

3.3

4.2

6.51

31.04

ug/l

0.51

146

Intracerebral haemorrhage

554

6292

0.87

2.59

3.4

4.2

17.55

27.12

ug/l

0.55

467

5238

Carcinoma in situ of skin of ear and external auricular canal

650

1.45

2.59

3.5

4.3

4.39

41.32

ug/l

1.84

556

Chondropathies

635

5622

1.14

2.58

3.6

4.4

34.41

28.33

ug/l

0.15

519

4478

Esophageal diverticulum (pouch), including avohilmo

140

2.09

2.57

3.5

4.5

6.96

37.02

ug/l

0.49

116

Lack of expected normal physiological development

2.14

2.57

3.0

3.8

2.22

1.97

ug/l

0.24

Voice disturbances

1442

13321

1.09

2.57

3.6

4.2

7.83

23.57

ug/l

4.80

1135

10744

Congenital malformations of breast

325

1.61

2.57

3.4

3.9

11.07

6.19

ug/l

0.34

233

Herpesviral keratitis and keratoconjunctivitis

208

1683

1.27

2.56

3.7

4.5

5.48

18.75

ug/l

1.69

171

1391

Type 1 diabetes, wide definition, subgroup 1

786

7037

1.12

2.56

3.8

4.5

22.49

30.42

ug/l

0.26

667

5580

Episodal and paroxysmal disorders

6053

29467

1.05

2.56

3.6

4.5

15.82

28.75

ug/l

2.92

4758

23771

Gingival hyperplasia

159

1246

1.31

2.55

3.8

4.4

7.38

21.76

ug/l

1.25

128

1022

Retinal vascular occlusion

689

6151

1.14

2.54

3.9

4.2

15.36

22.84

ug/l

0.74

574

5141

Thyrotoxicosis, other and/or unspecified

1018

9266

1.11

2.53

3.4

4.2

25.77

24.13

ug/l

0.03

805

7384

Panniculitis affecting regions of neck and back

167

1319

1.30

2.52

3.0

4.8

3.71

20.59

ug/l

1.75

132

1072

Melanoma in situ of trunk

663

1.44

2.51

4.5

4.6

3.90

29.25

ug/l

1.36

557

Other specified and unspecified retinal disorders

182

1456

1.29

2.51

3.6

4.3

14.08

16.13

ug/l

0.09

145

1198

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

132

1010

1.34

2.50

2.8

4.5

6.76

23.64

ug/l

1.18

811

Recurrent or chronic depression

1939

12541

1.08

2.50

3.6

4.8

13.58

28.54

ug/l

2.52

1499

9900

Benign neoplasm: Skin of eyelid, including canthus

842

7606

1.12

2.50

3.8

4.2

13.81

24.54

ug/l

1.21

684

6233

Endovascular or surgical operations to intracerebral aneurysms

210

2572

0.80

2.50

3.5

4.4

29.50

18.25

ug/l

0.44

188

2075

Sleep disorders (combined)

6358

31929

1.04

2.49

3.5

4.4

16.91

27.74

ug/l

2.09

4978

25922

Tuberculosis

305

2570

1.21

2.49

3.3

3.9

53.79

21.50

ug/l

0.60

266

2154

Pain and other conditions associated with female genital organs and menstrual cycle

766

5731

1.13

2.48

2.8

4.5

11.74

33.71

ug/l

1.71

545

4409

Benign paroxysmal vertigo

1696

15794

1.08

2.48

3.5

4.2

14.27

24.27

ug/l

1.63

1324

12924

Use of rasagiline

1140

0.70

2.48

3.1

4.4

3.31

25.22

ug/l

2.24

950

Coronary revascularization (ANGIO or CABG)

4745

27571

1.05

2.46

3.5

4.6

16.32

29.93

ug/l

2.98

3853

22477

Cystic kidney disease, including avohilmo

152

1191

1.31

2.46

2.6

4.5

5.38

23.67

ug/l

1.69

118

979

Vitiligo

339

1.60

2.45

3.4

4.7

3.11

20.42

ug/l

0.77

279

Viral agents as the cause of diseases classified to other chapters, including avohilmo

103

764

1.39

2.45

4.0

4.6

19.22

16.84

ug/l

0.05

624

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

389

3351

1.18

2.44

3.4

4.4

33.40

23.00

ug/l

0.25

318

2704

Inflammatory diseases of the central nervous system

366

3134

1.19

2.44

3.9

4.3

10.62

20.16

ug/l

0.97

287

2539

Other necrotizing vasculopathies (FG)

327

2781

1.20

2.44

2.9

4.5

24.70

24.58

ug/l

0.00

261

2304

Peptic ulcer

341

1.60

2.43

3.6

4.4

3.34

20.75

ug/l

0.79

283

Other and unspecified acquired haemolytic anaemias

350

1.60

2.43

3.1

4.3

3.03

41.25

ug/l

1.03

290

Reactive arthropathies, FINNGEN

314

2657

1.20

2.42

3.6

4.7

12.76

26.61

ug/l

0.94

234

2150

Lifestyle-related condition

398

1.56

2.42

2.9

4.5

3.85

36.24

ug/l

0.96

326

Thyrotoxicosis

1304

12030

1.09

2.42

3.4

4.1

22.60

23.18

ug/l

0.01

1034

9589

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

102

762

1.40

2.40

3.5

4.2

7.97

28.31

ug/l

1.10

651

Gonarthrosis

3893

20955

1.05

2.40

3.7

4.6

27.46

30.77

ug/l

0.17

3151

17087

Other specified and unspecified personality disorders

323

2739

1.19

2.39

2.8

4.5

10.07

30.81

ug/l

0.95

259

2149

Scabies

173

1379

1.28

2.39

4.1

4.6

21.08

19.54

ug/l

0.05

143

1114

Other and unspecified psoriasis

327

2784

1.20

2.38

4.3

4.4

4.13

23.06

ug/l

4.35

279

2267

Meralgia paraesthetica

164

1304

1.29

2.38

3.5

4.5

11.98

21.80

ug/l

0.48

137

1051

Perforation of tympanic membrane

454

3960

1.16

2.38

3.7

4.2

25.80

22.84

ug/l

0.10

368

3218

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

733

6583

1.13

2.37

4.5

4.4

13.44

25.25

ug/l

1.43

599

5351

Conjunctivitis (acute, non atopic)

1287

11816

1.09

2.37

3.6

4.3

9.81

25.49

ug/l

3.45

1008

9418

Viral agents as the cause of diseases classified to other chapters

692

1.40

2.37

4.2

4.6

20.93

17.57

ug/l

0.07

570

Seborrhoeic dermatitis

478

4188

1.16

2.36

3.7

4.4

6.89

25.71

ug/l

3.53

388

3420

Other and unspecified mood [affective] disorders

216

1764

1.24

2.36

2.4

4.5

14.11

38.10

ug/l

0.61

157

1342

Use of disulfiram, acamprosate or naltrexone

335

2857

1.19

2.34

3.3

4.8

11.93

22.89

ug/l

1.17

290

2328

Other specified/unspecified deforming dorsopathies

549

1.45

2.34

3.3

4.6

14.00

15.98

ug/l

0.06

433

Allergic rhinitis

967

10473

0.91

2.34

3.5

4.2

27.54

25.75

ug/l

0.05

734

8054

Aspergillosis

338

1.60

2.33

4.1

4.6

3.92

49.22

ug/l

1.19

284

Other disorders of Eustachian tube

140

1095

1.31

2.33

4.1

4.4

5.63

21.33

ug/l

1.31

105

900

Hordeolum and other deep inflammation of eyelid

251

2090

1.22

2.32

3.6

4.5

4.46

19.28

ug/l

2.41

197

1666

Aortic aneurysm

1299

11772

1.09

2.32

3.9

4.5

35.80

26.75

ug/l

0.29

1090

9925

Benign neoplasm of eye and adnexa

545

4827

1.15

2.32

4.7

4.2

10.75

22.61

ug/l

1.62

448

3919

Congenital malformations of breast, including avohilmo

342

1.56

2.31

3.4

3.8

11.07

6.52

ug/l

0.31

243

Scoliosis

350

2999

1.18

2.31

3.1

4.4

92.70

20.90

ug/l

0.44

271

2358

Carcinoma in situ of skin of scalp and neck

164

1315

1.29

2.31

3.8

4.1

7.30

28.52

ug/l

2.03

122

1113

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

204

1.78

2.31

5.1

4.8

21.65

30.15

ug/l

0.12

167

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

832

7536

1.12

2.30

4.5

4.4

12.84

26.70

ug/l

2.07

684

6126

Other/unspecified soft tissue disorders related to use, overuse and pressure

135

1052

1.32

2.30

3.6

4.9

3.14

25.34

ug/l

1.98

115

854

All anxiety disorders

2801

20567

1.06

2.30

3.4

4.3

12.35

24.58

ug/l

3.38

2183

16047

Fall on and from stairs and steps

1340

12405

1.09

2.29

3.6

4.3

11.76

26.27

ug/l

2.86

1076

10088

Nail disorders

365

3143

1.18

2.29

3.9

4.3

6.55

22.84

ug/l

2.60

280

2518

Other and unspecified vascular occlusions

530

4693

1.15

2.29

3.9

4.1

18.00

18.53

ug/l

0.03

439

3926

Other and unspecified immunodeficiencies with predominantly antibody defects

370

1.55

2.28

3.9

4.3

28.73

19.63

ug/l

0.13

303

Mental and behavioural disorders due to opioids

718

1.37

2.28

3.1

5.1

23.63

24.47

ug/l

0.02

564

Superficial injury of wrist and hand

839

7602

1.11

2.28

3.4

4.4

11.77

30.26

ug/l

1.84

632

5997

Speech disturbances, not elsewhere classified

467

4100

1.16

2.28

3.4

4.1

16.11

21.03

ug/l

0.27

373

3370

Campylobacter enteritis

121

931

1.34

2.28

3.4

4.6

3.24

23.95

ug/l

1.60

764

Varicose veins of other sites

276

2325

1.21

2.27

4.6

10.09

22.21

ug/l

1.38

242

1925

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

437

1.51

2.27

4.6

4.3

46.44

39.26

ug/l

0.06

358

Central retinal artery occlusion

120

926

1.34

2.27

3.0

4.1

5.52

16.88

ug/l

1.42

104

785

Sequelae of injuries, of poisoning and of other consequences of external causes

1073

9845

1.10

2.27

3.6

4.5

30.73

28.33

ug/l

0.05

846

7968

Liver disorders in diseases classified elsewhere

2.25

2.27

2.7

3.9

3.42

58.77

ug/l

0.59

Other disorders of peripheral nervous system

269

1.68

2.26

4.2

4.7

22.43

23.16

ug/l

0.01

222

Other protozoal intestinal diseases

395

1.52

2.25

3.1

4.5

5.16

18.14

ug/l

0.63

323

Degenerative macular diseases

685

6164

1.13

2.25

3.7

4.1

24.23

23.85

ug/l

0.01

556

5129

Delirium, not induced by alcohol and other psychoactive substances

715

6430

1.12

2.25

3.4

4.1

11.88

25.29

ug/l

1.38

599

5380

Diabetic nephropathy, excluding more controls

742

5449

1.12

2.24

3.0

4.2

12.95

33.54

ug/l

2.75

644

4520

Hypertrichosis

468

1.46

2.24

2.4

4.1

18.80

17.61

ug/l

0.03

343

Complications of cardiac and vascular prosthetic devices, implants and grafts

106

805

1.36

2.23

3.5

4.2

19.17

25.66

ug/l

0.14

671

Nontoxic single thyroid nodule

364

3146

1.18

2.23

3.7

4.2

20.90

18.36

ug/l

0.10

282

2522

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

387

1.52

2.23

4.4

4.3

2.61

37.05

ug/l

1.00

315

Obsessive-compulsive disorder

161

1280

1.27

2.23

3.1

4.5

14.07

45.30

ug/l

0.55

123

939

Lymphangioma, anys site

205

1.74

2.23

4.8

3.9

5.34

10.43

ug/l

0.74

162

Open wound of abdomen, lower back and pelvis

118

907

1.33

2.21

3.0

4.8

31.84

28.55

ug/l

0.07

742

Superficial injury of forearm

396

3438

1.17

2.21

3.4

4.2

12.88

19.26

ug/l

0.42

307

2716

Alcohol abuse counselling and surveillance

480

1.47

2.21

2.1

5.0

4.39

34.70

ug/l

1.07

395

Septal defects

202

1619

1.24

2.20

3.4

4.3

13.82

23.78

ug/l

0.45

160

1281

Other disorders of conjunctiva

760

6881

1.12

2.20

3.6

4.3

15.80

27.05

ug/l

0.89

603

5679

Personal history of allergy to drugs, medicaments and biological substances

316

1.58

2.19

4.5

4.3

24.40

21.26

ug/l

0.06

265

Abnormal blood-pressure reading, without diagnosis

214

1768

1.23

2.19

4.2

4.5

9.46

20.81

ug/l

0.86

156

1404

Anxiety (asthma-related co-morbidities)

2785

20059

1.06

2.19

3.4

4.4

12.38

26.14

ug/l

3.74

2177

15599

Bronchitis, not specified as acute or chronic

384

3333

1.17

2.18

3.7

4.4

29.58

22.79

ug/l

0.12

326

2694

All dysplastic lesions of the vulva

191

1563

1.25

2.17

3.5

4.1

3.46

12.14

ug/l

2.17

152

1225

Ménière disease

488

4315

1.15

2.17

3.5

4.2

10.82

24.83

ug/l

1.37

390

3537

Neuralgia and neuritis, unspecified

247

2072

1.22

2.17

3.3

4.6

8.67

26.67

ug/l

2.08

205

1666

Chronic rhinitis, nasopharyngitis and pharyngitis

1630

15228

1.08

2.16

3.4

4.4

8.98

25.35

ug/l

5.20

1254

12175

Aspergillosis, including avohilmo

344

1.57

2.16

4.1

4.6

3.92

48.56

ug/l

1.19

288

Injuries to the wrist and hand

5234

36028

0.96

2.16

3.9

4.3

15.81

27.09

ug/l

2.54

4200

28865

Open wound of forearm

413

3606

1.16

2.15

3.5

4.3

34.83

20.84

ug/l

0.51

346

2928

Temporal arteritis

204

1687

1.24

2.15

3.0

4.2

17.67

21.89

ug/l

0.13

168

1389

Open wound of shoulder and upper arm

609

1.40

2.15

3.4

4.7

4.59

28.88

ug/l

1.15

505

Hypertrophy of tongue papillae

484

1.46

2.15

4.4

4.7

5.01

15.18

ug/l

0.61

402

Intestinal helminthiases, other/unspecified, including avohilmo

120

2.06

2.13

3.7

4.4

3.61

46.05

ug/l

0.63

Other and unspecified degenerative diseases of nervous system

1225

0.74

2.12

3.2

4.2

30.67

24.22

ug/l

0.11

1038

Multiple delivery

258

3049

0.83

2.12

3.7

3.8

21.98

10.46

ug/l

0.49

192

2292

Papilloedema, unspecified

662

1.38

2.12

4.8

4.6

107.67

30.95

ug/l

0.34

540

Allergic asthma (mode), excluding more controls

860

7639

1.10

2.12

3.3

4.4

10.56

26.72

ug/l

1.66

682

5826

Gonarthrosis, primary, with knee surgery

3465

28202

0.95

2.11

3.6

4.4

26.04

25.99

ug/l

0.00

2785

23287

Giant cell arteritis with polymyalgia rheumatica

204

1691

1.24

2.11

3.0

4.1

17.67

20.01

ug/l

0.07

168

1405

Selective deficiency of immunoglobulin G [IgG] subclasses

233

1.69

2.11

3.4

4.3

3.88

26.18

ug/l

0.63

188

Other specified and unspecified disorders of eye and adnexa

169

1370

1.26

2.11

3.4

4.3

15.87

20.91

ug/l

0.15

127

1121

Atopic conjunctivitis

168

1358

1.26

2.10

3.9

4.4

20.42

17.36

ug/l

0.09

130

1068

Sequelae of infectious and parasitic diseases, including avohilmo

321

2758

1.18

2.10

4.3

4.2

77.53

18.03

ug/l

0.62

272

2250

Other bursitis of elbow

338

1.56

2.10

3.3

5.0

241.67

48.86

ug/l

0.51

279

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

343

2938

1.17

2.10

3.8

4.3

3.63

29.83

ug/l

1.52

254

2268

Cardiac murmurs and other cardiac sounds

365

3126

1.17

2.10

3.8

4.3

30.39

25.65

ug/l

0.12

294

2474

Other salmonella infections, including avohilmo

180

1468

1.25

2.10

4.9

4.4

27.97

20.91

ug/l

0.17

140

1199

Other protozoal intestinal diseases, including avohilmo

594

1.40

2.09

3.2

4.6

4.67

26.24

ug/l

1.25

485

Idiopathic urticaria

586

1.40

2.09

4.6

4.2

49.23

26.03

ug/l

0.30

470

Other disorders of the genitourinary system

702

6356

1.12

2.08

3.3

4.1

10.35

25.56

ug/l

1.82

567

5174

Idiopathic thrombocytopenic purpura

132

1042

1.30

2.07

4.0

4.4

17.02

26.97

ug/l

0.37

112

855

Other menopausal disorders

1213

7308

0.92

2.07

3.3

4.5

14.00

33.15

ug/l

1.32

904

5861

Melanocytic naevi of upper limb, including shoulder

103

787

1.35

2.07

2.9

4.4

21.35

24.23

ug/l

0.06

649

Nummular dermatitis

415

3642

1.16

2.07

3.9

4.4

18.31

23.27

ug/l

0.32

345

2991

Superficial injury of hip and thigh

775

7041

1.11

2.07

3.3

4.1

9.82

22.18

ug/l

2.29

642

5765

Eosinophilic disease (BM)

487

1.45

2.07

3.4

4.4

94.98

34.94

ug/l

0.31

392

Lactose intolerance

118

917

1.31

2.06

3.8

4.4

3.88

23.56

ug/l

1.50

742

Other infestations, including avohilmo

703

1.37

2.06

3.9

4.5

11.75

17.96

ug/l

0.29

582

Varicella [chickenpox], including avohilmo

163

1314

1.26

2.06

4.0

4.8

14.95

32.92

ug/l

0.95

134

1052

Vascular dementia

435

4754

0.87

2.05

2.8

3.7

11.36

30.78

ug/l

1.63

368

4012

LSIL lesion of the vulva

124

973

1.31

2.05

3.8

4.0

3.54

14.13

ug/l

1.50

765

Schizophrenia

495

5574

0.88

2.04

3.1

4.6

25.59

33.12

ug/l

0.18

417

4471

Retinal detachments and breaks

2111

19951

1.07

2.04

4.0

4.3

35.10

24.20

ug/l

0.39

1709

16526

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2771

25403

1.06

2.03

3.9

4.5

15.11

26.66

ug/l

1.66

2221

20567

Artificial joint operation, meniscal resection

5488

33835

1.04

2.03

3.9

4.3

22.66

27.04

ug/l

0.31

4426

27637

Other and unspecified follicular disorders

164

1330

1.26

2.02

4.5

4.4

6.72

21.41

ug/l

1.36

132

1071

Other congenital malformations of skin, including avohilmo

310

2665

1.18

2.02

3.7

4.3

32.31

18.21

ug/l

0.26

241

2097

Disorders of adult personality and behaviour

1016

9349

1.09

2.01

3.1

4.4

11.66

28.39

ug/l

2.56

800

7210

Giant cell arteritis

231

1947

1.22

2.01

3.0

4.2

19.69

19.74

ug/l

0.00

184

1599

Hereditary deficiency of other clotting factors

259

1.61

2.00

3.1

4.3

2.34

8.16

ug/l

2.18

205

Melanocytic naevi of ear and external auricular canal

189

1.74

2.00

3.6

4.9

2.70

30.63

ug/l

0.68

157

Asthma and opportunity respiratory infection

248

2103

1.21

2.00

3.1

4.2

4.29

19.37

ug/l

3.07

217

1720

Disorders of muscles

479

4249

1.14

2.00

3.1

4.7

8.64

34.95

ug/l

2.44

376

3430

Prurigo nodularis

129

1024

1.30

1.99

3.4

4.4

4.40

24.45

ug/l

1.81

107

865

Female infertility, cervical, vaginal, other or unspecified origin

1043

6133

1.09

1.99

3.8

4.6

10.68

33.70

ug/l

2.31

761

4750

Use of amantadine

625

0.65

1.99

3.8

4.5

3.99

30.01

ug/l

1.28

520

Vasomotor and allergic rhinitis

1459

15257

0.93

1.99

3.6

4.4

21.61

26.23

ug/l

0.20

1125

11977

Benign neoplasm: Lip

105

812

1.34

1.98

3.1

4.5

7.96

26.51

ug/l

1.03

679

Cardiomyopathy

906

8310

1.10

1.98

3.3

4.8

9.76

32.98

ug/l

5.28

752

6991

Bursitis of shoulder

125

988

1.30

1.98

3.7

4.7

6.13

21.68

ug/l

1.13

105

799

Arthrosis

4114

21613

1.05

1.97

3.7

4.6

24.14

30.46

ug/l

0.38

3349

17512

Other mycoses, not elsewhere classified/unspecified, including avohilmo

594

1.39

1.97

3.8

4.7

52.98

30.62

ug/l

0.19

497

Injury of intra-abdominal organs

731

1.35

1.97

3.9

4.7

27.33

27.34

ug/l

0.00

616

Torticollis

406

1.47

1.97

3.6

5.3

2.71

17.91

ug/l

0.81

328

Bilateral sagittal split ramus osteotomy operation

852

0.70

1.97

4.3

4.7

12.04

18.30

ug/l

0.22

655

Helminthiases, including avohilmo

136

1082

1.28

1.97

3.9

4.3

4.29

23.12

ug/l

1.60

848

Benign neoplasm: Tongue

138

1106

1.28

1.96

4.1

4.5

8.67

22.61

ug/l

0.99

118

915

Lymphoid leukaemia

271

2317

1.19

1.96

3.2

4.2

6.25

23.45

ug/l

2.95

199

1927

Other abnormal immunological findings in serum

611

1.38

1.96

4.3

3.49

29.60

ug/l

1.26

495

Focal epilepsy, mode (most common among epilepsy diagnosis)

869

7960

1.10

1.96

4.2

4.3

13.16

28.80

ug/l

1.92

714

6487

Type 1 diabetes, strict definition

1219

0.75

1.96

3.9

4.9

8.39

41.90

ug/l

0.56

861

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

234

1970

1.20

1.96

3.6

4.4

6.93

20.31

ug/l

1.59

194

1569

Motor- or nonmotor-vehicle accident in traffic area

174

1.74

1.95

2.3

4.5

1.96

8.90

ug/l

3.31

138

Bruxism

483

1.43

1.95

3.2

4.3

13.41

17.42

ug/l

0.13

377

Habitual aborter

340

1.50

1.93

3.9

4.4

20.81

133.22

ug/l

0.52

241

Hypertrophic scar

193

1599

1.23

1.93

3.4

4.5

8.59

21.35

ug/l

1.14

144

1253

Cardiomyopathy, other and unspecified

382

3353

1.16

1.93

3.0

4.8

7.03

22.98

ug/l

3.12

312

2786

Use of entacapone

313

0.52

1.92

2.6

4.5

2.59

47.94

ug/l

—

269

Benign neoplasm: Peripheral nerves and autonomic nervous system

581

1.39

1.92

4.3

4.2

5.82

31.24

ug/l

1.09

482

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

307

2655

1.18

1.92

3.8

4.4

98.51

19.47

ug/l

0.44

244

2171

Striae atrophicae

294

1.55

1.91

4.5

4.4

3.17

22.60

ug/l

0.72

237

Examination and encounter for administrative purposes

397

3494

1.15

1.91

4.1

4.9

6.83

30.22

ug/l

1.78

338

2907

Melanocytic naevi of other and unspecified parts of face

248

2107

1.20

1.91

3.6

4.2

24.53

18.91

ug/l

0.11

188

1676

LSIL lesion of the cervix uteri, vagina or vulva

505

4504

1.13

1.91

3.7

3.9

20.71

24.03

ug/l

0.08

382

3330

Acute nasopharyngitis (common cold)

420

3674

1.14

1.90

4.5

4.9

7.30

27.00

ug/l

3.19

339

2989

Other disorders of amniotic fluid and membranes

287

3223

0.85

1.90

3.5

3.8

12.41

21.86

ug/l

0.29

197

2200

Fatigue fracture of vertebra

177

1.75

1.90

4.4

4.9

13.15

9.18

ug/l

0.18

147

Allergic asthma (mode)

860

7687

1.10

1.90

3.3

4.4

10.56

26.12

ug/l

1.58

682

5871

Dermatopolymyositis, unspecified

193

1.72

1.89

2.7

4.8

2.95

30.44

ug/l

0.69

162

Neurofibromatosis, type 2

2.59

1.89

1.7

4.3

1.98

10.40

ug/l

—

Cervical polyps

482

4299

1.14

1.88

3.5

4.6

23.07

34.16

ug/l

0.39

354

3425

Other pulmonary heart/vessel disease

225

1902

1.21

1.88

2.6

4.0

19.52

20.21

ug/l

0.02

175

1583

Injury of other and unspecified intrathoracic organs

290

2500

1.18

1.88

3.9

4.5

44.52

26.17

ug/l

0.38

248

2071

248

1.61

1.88

1.9

4.3

2.48

7.34

ug/l

2.56

200

Systemic atrophies primarily affecting the central nervous system

142

1748

0.80

1.88

3.3

4.3

10.79

19.36

ug/l

0.62

115

1450

Mental and behavioural disorders due to sedatives or hypnotics

242

2053

1.19

1.87

3.0

4.5

6.04

19.14

ug/l

1.78

207

1646

Hypertensive Renal Disease

185

1536

1.23

1.87

2.8

4.4

7.11

20.77

ug/l

1.66

163

1292

Asthma and allergy, excluding more controls

396

3435

1.15

1.87

3.3

4.2

14.21

32.00

ug/l

0.62

297

2538

Lesion of radial nerve

171

1409

1.24

1.87

3.2

4.6

6.90

21.44

ug/l

1.51

131

1147

Other nonscarring hair loss

329

1.51

1.86

2.8

4.1

4.43

10.17

ug/l

1.46

263

Mixed and other personality disorders

266

2275

1.18

1.86

3.3

4.6

7.32

32.03

ug/l

0.97

216

1776

Otalgia

361

3162

1.16

1.85

3.4

4.2

14.30

23.45

ug/l

0.52

276

2503

Type1 diabetes, definitions combined, early onset

842

0.72

1.84

4.0

4.5

10.60

17.00

ug/l

0.29

573

Ulcer of vagina/vulva

114

898

1.30

1.84

3.0

4.1

10.42

10.43

ug/l

0.00

708

Other bacterial agents as the cause of diseases classified to other chapters

373

1.49

1.84

4.8

4.4

53.64

42.59

ug/l

0.08

312

Obesity, other/unspecified

1533

14388

1.07

1.84

3.3

4.3

33.04

22.16

ug/l

0.64

1198

11287

Atypical facial pain

242

2062

1.20

1.84

3.2

4.4

6.17

22.71

ug/l

2.24

181

1632

Thoracic aortic aneurysm

768

7032

1.10

1.83

3.8

4.8

11.68

24.15

ug/l

1.74

625

5918

Benign neoplasm of middle ear and respiratory system

369

3244

1.15

1.83

3.9

4.3

38.53

22.53

ug/l

0.31

308

2674

Bacterial meningitis

145

1177

1.26

1.83

4.4

4.6

18.18

20.43

ug/l

0.07

113

966

Postpartum hemorraghe, all women as controls

635

6837

0.90

1.83

3.6

3.8

17.60

19.46

ug/l

0.07

431

4862

Injury of muscle and tendon at hip and thigh level

360

4096

0.87

1.82

4.6

4.5

13.60

23.82

ug/l

0.62

294

3325

Tic and related disorders

176

1.68

1.82

3.2

4.8

6.08

5.14

ug/l

0.10

140

Sacrococcygeal disorders, not elsewhere classified

131

1052

1.27

1.81

3.3

4.7

6.40

26.17

ug/l

1.33

826

Hypotension due to drugs

597

1.38

1.80

3.8

4.5

3.99

31.96

ug/l

1.37

511

Monoarthritis, not elsewhere classified

190

1587

1.22

1.80

3.6

4.7

13.87

26.18

ug/l

0.53

164

1293

Secondary right heart disease

204

1718

1.21

1.80

2.5

4.0

21.40

21.93

ug/l

0.01

157

1431

Event of undetermined intent

226

1914

1.20

1.80

3.8

4.5

4.72

20.83

ug/l

2.40

183

1534

Seborrhoeic keratosis

1498

14080

1.07

1.80

3.8

4.3

24.05

22.59

ug/l

0.07

1219

11588

Disorders of iron metabolism

509

1.40

1.80

2.8

5.2

2.96

29.48

ug/l

1.02

416

Asthma and allergy

396

3447

1.14

1.78

3.3

4.2

14.21

29.73

ug/l

0.52

297

2557

Cervicocranial syndrome

539

4855

1.12

1.78

3.2

4.6

24.35

31.52

ug/l

0.19

427

3902

Ptosis of eyelid

610

5536

1.12

1.78

3.4

4.2

69.01

25.90

ug/l

0.48

489

4564

Complications predominantly related to the puerperium

848

9217

0.91

1.78

3.9

39.88

21.30

ug/l

0.52

625

6930

Syphilis, including avohilmo

108

851

1.30

1.77

2.8

4.9

15.46

24.82

ug/l

0.38

704

Syphilis

108

851

1.30

1.77

2.8

4.9

15.46

24.82

ug/l

0.38

704

Hirsutism in women

381

1.45

1.77

2.2

4.1

23.73

20.84

ug/l

0.05

275

Congenital malformations of cardiac septa

212

1731

1.20

1.77

3.2

4.3

14.05

22.51

ug/l

0.39

168

1372

Meningitis

202

1700

1.21

1.76

4.3

4.4

15.70

17.65

ug/l

0.08

154

1386

Disorders of purine and pyrimidine metabolism

221

1.64

1.76

4.3

5.2

4.47

53.36

ug/l

0.79

189

Coxarthrosis, primary

3804

30368

1.04

1.76

3.8

4.3

23.40

26.36

ug/l

0.15

3171

25077

Abrasion of teeth

1690

17905

0.94

1.75

4.0

4.3

8.74

24.56

ug/l

6.00

1308

14342

Congenital lactase deficiency

2.34

1.75

4.7

3.8

2.66

6.50

ug/l

0.75

Focal epilepsy, strict definition

923

8526

1.09

1.75

4.2

4.3

11.84

30.51

ug/l

2.57

751

6967

Chronic thyroiditis

143

1.81

1.74

3.3

4.0

24.55

8.77

ug/l

0.34

113

General- and plastic-surgery devices associated with adverse incidents

106

1.99

1.74

4.3

5.2

19.09

49.37

ug/l

0.31

Other specified/unspecified spondylopathies

130

1052

1.27

1.74

2.9

4.4

3.71

21.91

ug/l

1.60

109

871

Carcinoma in situ of breast, other/unspecified

611

1.37

1.74

5.1

4.2

4.19

10.48

ug/l

2.34

503

Other specified/unspecified dorsopathies

160

1322

1.24

1.72

2.7

4.7

5.70

24.99

ug/l

1.84

125

1067

Sequelae of infectious and parasitic diseases

307

2676

1.16

1.72

4.3

4.2

81.00

18.33

ug/l

0.62

260

2180

Vasculitis limited to skin, not elsewhere classified

127

1026

1.27

1.72

3.8

4.4

65.98

25.57

ug/l

0.46

849

Gilbert syndrome

221

1.61

1.72

2.9

5.0

2.50

25.48

ug/l

0.64

183

LeFortI or BSSO operation

1035

0.75

1.71

3.9

4.5

10.07

19.12

ug/l

0.44

794

Chronic tubulo-interstitial nephritis

172

1432

1.23

1.71

4.1

4.2

4.04

20.12

ug/l

2.04

149

1171

Pre-eclampsia or eclampsia

746

8134

0.91

1.71

3.4

4.0

17.12

22.20

ug/l

0.25

542

6169

Superficial injury of ankle and foot

437

3894

1.13

1.71

3.3

4.3

11.45

29.48

ug/l

0.97

344

3013

Contusion of other and unspecified parts of foot

171

1419

1.22

1.71

3.5

4.5

3.75

22.77

ug/l

2.01

129

1118

Disorders of vitreous body and globe

3158

28636

1.05

1.71

3.8

4.3

18.81

26.63

ug/l

0.66

2538

23487

Melanoma in situ

239

2053

1.19

1.71

4.0

4.2

5.96

22.06

ug/l

2.34

195

1700

Depression

5113

33030

1.04

1.70

3.6

4.4

21.80

25.24

ug/l

0.36

4060

26391

Panniculitis, unspecified

379

1.46

1.70

4.2

4.6

2.93

38.07

ug/l

1.01

312

Myeloid leukaemia

131

1064

1.26

1.70

3.8

4.3

12.56

23.14

ug/l

0.43

100

883

Spermatocele

359

3170

1.15

1.69

4.5

4.8

9.44

25.03

ug/l

2.58

299

2726

Suggestive for eosinophilic asthma

441

3945

1.13

1.68

4.0

4.4

39.41

24.49

ug/l

0.23

373

3201

Blindness, monocular

372

1.46

1.68

3.3

4.0

3.06

13.22

ug/l

1.78

321

Disorders of aromatic amino-acid metabolism

2.09

1.68

4.3

5.1

6.37

93.26

ug/l

0.51

Crushed, pushed or stepped on by crowd or human stampede

212

1796

1.19

1.68

3.5

4.5

18.02

21.24

ug/l

0.12

162

1399

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2708

21989

0.95

1.68

3.9

4.2

13.63

24.34

ug/l

1.73

2055

17286

Delayed milestone in childhood

1.93

1.67

2.9

2.7

1.98

1.68

ug/l

—

Other and unspecified vasculitis limited to skin

114

913

1.28

1.67

3.9

4.5

72.34

27.15

ug/l

0.47

759

Lesion of ulnar nerve

655

5979

1.11

1.67

3.4

4.7

40.16

29.81

ug/l

0.23

552

4862

Foreign body entering into or through eye or natural orifice

304

2654

1.16

1.67

3.6

4.5

19.53

24.16

ug/l

0.15

238

2157

Pathological resorption of teeth

155

1281

1.23

1.67

4.0

4.5

4.15

22.63

ug/l

1.98

121

1053

Disorders of vitreous body

3080

28103

1.05

1.66

3.8

4.3

19.19

26.78

ug/l

0.61

2477

23045

Injuries to the ankle and foot

3262

28999

0.96

1.66

3.8

4.3

14.62

25.83

ug/l

2.30

2541

23005

Other disorders of prostate

164

1365

1.23

1.66

3.7

4.6

7.49

30.13

ug/l

2.24

138

1181

Other abnormal products of conception

946

6706

0.92

1.66

3.7

3.9

11.27

22.56

ug/l

0.90

662

4749

Prolapse and hernia of ovary and fallopian tube

194

1625

1.21

1.65

3.6

3.9

5.74

15.77

ug/l

2.49

154

1352

Seropositive rheumatoid arthritis, wide

1284

13678

0.93

1.64

3.2

4.2

25.51

24.68

ug/l

0.03

1054

11134

Failed attempted abortion

190

1.62

1.64

2.5

3.6

2.19

3.96

ug/l

1.18

136

L01XX Other antineoplastic agents

304

2666

1.16

1.64

2.9

4.2

19.45

22.21

ug/l

0.11

245

2226

Focal epilepsy

980

9100

1.08

1.64

4.2

4.3

12.60

29.67

ug/l

2.41

796

7417

Other/unspecified seropositive rheumatoid arthritis

1269

13521

0.93

1.64

3.2

4.2

25.75

24.86

ug/l

0.03

1043

11006

Nontoxic diffuse goitre

159

1324

1.23

1.63

3.4

4.1

14.42

21.31

ug/l

0.32

129

1067

Viral warts

383

3402

1.14

1.62

3.0

4.3

10.66

23.06

ug/l

1.47

308

2712

Myocardial infarction, strict

2601

19239

0.95

1.62

3.6

4.7

14.45

30.09

ug/l

3.53

2154

16080

Mixed hyperlipidaemia

183

1543

1.21

1.61

3.6

4.5

101.18

29.45

ug/l

0.53

149

1285

Pre-eclampsia

672

7337

0.91

1.61

3.4

4.0

17.54

22.68

ug/l

0.23

488

5527

Dislocation, sprain and strain of joints and ligaments of thorax

144

1186

1.24

1.61

4.2

4.4

51.49

19.68

ug/l

0.43

115

976

Viral meningitis

120

968

1.26

1.61

4.3

4.4

31.99

16.85

ug/l

0.35

775

Fluid overload

116

1.87

1.61

2.7

5.2

3.68

101.36

ug/l

0.84

Epilepsy

1560

14681

1.06

1.60

4.0

4.5

13.85

29.18

ug/l

2.91

1280

12058

Atrial septal defect

123

989

1.26

1.60

3.2

4.5

18.25

15.36

ug/l

0.07

100

800

Other disorders of thyroid

504

1.38

1.60

3.1

4.0

46.76

17.50

ug/l

0.28

420

Dissociative [conversion] disorders

114

914

1.26

1.60

2.9

4.3

37.27

17.40

ug/l

0.46

718

Intercostal neuropathy

292

1.51

1.60

2.7

4.6

2.93

45.91

ug/l

0.94

242

Iridocyclitis

1088

10161

1.08

1.59

3.7

4.4

61.86

26.44

ug/l

0.91

863

8244

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

450

1.38

1.58

3.9

4.4

6.10

16.51

ug/l

0.53

359

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

175

1466

1.20

1.58

2.3

4.8

7.15

23.81

ug/l

1.40

146

1139

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

332

1.46

1.58

3.3

4.4

4.70

41.48

ug/l

0.89

273

Car occupant injured in noncollision transport accident

122

988

1.26

1.58

4.2

4.5

8.82

26.62

ug/l

1.02

104

797

Pseudopolyposis of colon

2.04

1.58

7.6

5.2

2.74

62.31

ug/l

—

Acquired absence of limb

368

1.44

1.58

3.4

4.8

22.83

26.99

ug/l

0.07

312

Marfan's syndrome

131

1.76

1.57

2.9

5.0

4.83

42.80

ug/l

0.53

Other/unspecified disorders of vestibular function

203

1733

1.19

1.57

2.7

4.3

52.55

18.64

ug/l

0.35

155

1444

Xerosis cutis

681

1.32

1.57

3.7

4.7

13.04

26.48

ug/l

0.46

578

Hyperkinetic disorders, excluding more controls

202

1596

1.19

1.57

3.1

4.4

2.15

39.00

ug/l

0.83

129

1042

Other/unspecified enthesopathies, not elsewhere classified

414

3708

1.13

1.57

3.3

4.5

32.89

22.75

ug/l

0.15

339

3025

Metabolic disorder, other/unspecified

2.08

1.57

2.7

4.8

7.84

66.30

ug/l

—

Abdominal aortic aneurysm (AAA)

506

4543

1.12

1.56

3.8

4.1

67.95

25.59

ug/l

0.69

445

3846

Diving or jumping into water causing injury other than drowning or submersion

128

0.37

1.56

1.6

5.4

1.68

40.95

ug/l

—

103

Viral meningitis, including avohilmo

123

999

1.25

1.56

4.3

4.4

31.04

16.51

ug/l

0.34

794

Thiamine deficiency

220

1.59

1.55

3.7

5.4

12.95

57.00

ug/l

0.63

183

Orthopaedic devices associated with adverse incidents

105

845

1.29

1.55

2.5

4.4

4.03

27.04

ug/l

1.63

701

Chronic Coagulation defects

662

1.31

1.55

2.8

4.4

2.86

34.88

ug/l

1.54

533

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1482

13796

1.06

1.55

3.7

4.3

7.40

24.03

ug/l

4.86

1112

10707

Hypothyroidism due to medicaments and other exogenous substances

473

1.38

1.54

4.3

4.2

3.66

24.15

ug/l

0.81

390

Benign neoplasm: Choroid

331

2932

1.15

1.54

5.0

4.3

15.15

18.99

ug/l

0.22

276

2399

Otorrhagia

261

1.53

1.54

3.3

4.3

2.85

49.67

ug/l

0.95

225

Pediculosis, acariasis and other infestations, including avohilmo

610

5568

1.10

1.54

3.6

4.4

11.81

26.41

ug/l

1.25

471

4361

Benign neoplasm: other/unspecified salivary gland

130

1069

1.25

1.53

3.2

4.2

10.52

25.86

ug/l

0.99

110

891

All dysplastic lesions of the cervix uteri

861

7850

1.08

1.53

3.5

3.9

14.80

22.92

ug/l

0.41

644

5680

Benign neoplasm: Skin of lip

491

1.37

1.52

3.8

4.2

4.93

34.02

ug/l

1.10

407

Fall involving bed

171

1444

1.21

1.52

3.3

3.9

13.26

19.73

ug/l

0.24

143

1208

Sequelae of other and unspecified effects of external causes

180

1.64

1.52

3.1

4.5

12.13

31.73

ug/l

0.36

147

Abnormal spermatozoa

639

5865

1.10

1.52

4.4

4.7

9.20

27.27

ug/l

4.46

523

5011

Other and specified injuries of hip and thigh

108

871

1.27

1.51

3.3

4.2

9.94

25.77

ug/l

0.83

732

Psychotic depression

241

2087

1.17

1.51

3.3

4.6

13.41

43.18

ug/l

1.03

190

1669

Hypoparathyroidism

176

1491

1.21

1.51

3.3

4.2

47.62

19.72

ug/l

0.28

148

1218

Injury of nerves and spinal cord at neck level

102

818

1.28

1.51

4.0

4.8

3.03

26.79

ug/l

1.65

682

Gout due to impairment of renal function

441

1.40

1.50

2.9

4.6

3.59

41.22

ug/l

1.35

376

Other specified/unspecified hearing loss

461

4166

1.12

1.50

3.8

4.1

5.79

26.86

ug/l

4.83

368

3444

Infective dermatitis

533

4850

1.11

1.50

3.8

4.4

33.48

22.02

ug/l

0.31

443

3936

Allergic conjunctivitis

2725

25131

1.05

1.49

3.6

4.2

12.48

22.55

ug/l

1.84

2023

19770

Complications associated with artificial fertilization

293

1.46

1.49

4.2

4.3

2.95

149.44

ug/l

0.60

205

Mood disorders

5565

34516

1.03

1.49

3.6

4.4

25.83

24.84

ug/l

0.06

4436

27673

Moderate visual impairment, monocular

174

1.65

1.48

2.6

4.6

17.04

8.06

ug/l

0.26

145

Benign neoplasm: Skin of lower limb, including hip

125

1027

1.24

1.48

4.2

29.89

24.66

ug/l

0.12

103

847

Granuloma annulare

510

1.35

1.48

3.7

4.1

8.07

22.57

ug/l

0.73

417

Dislocation of lens

643

1.32

1.48

3.2

4.5

25.87

23.55

ug/l

0.04

538

Otitis externa, unspecified

466

4213

1.12

1.48

3.9

4.3

11.18

30.92

ug/l

1.28

371

3377

Ventricular septal defect, a heart condition

377

1.40

1.47

3.0

4.2

9.77

19.47

ug/l

0.34

286

Exposure to other and unspecified inanimate mechanical forces

283

2484

1.15

1.47

4.4

4.5

17.94

21.81

ug/l

0.12

222

1999

Inflammation of lacrimal passages (chronic)

620

0.70

1.47

2.9

4.3

7.94

27.63

ug/l

0.87

518

Reactive arthropathies

391

3504

1.13

1.47

3.6

4.8

14.40

28.82

ug/l

1.10

293

2872

Mandibular retrognathia AND surgery (BSSO)

647

0.71

1.47

4.0

4.6

14.66

22.18

ug/l

0.20

502

Cardiodefibrillation

2071

19712

1.05

1.47

3.7

4.4

10.55

27.54

ug/l

7.12

1678

16588

Left bundle-branch block

393

3527

1.13

1.47

4.1

4.6

6.64

36.80

ug/l

2.99

316

2921

HSIL lesion of the cervix uteri

576

5258

1.10

1.47

3.4

3.9

5.77

21.19

ug/l

1.38

430

3774

Dialysis

160

1346

1.21

1.47

2.1

4.5

5.06

21.38

ug/l

1.91

137

1115

Antenatal screening

685

3514

1.10

1.46

4.0

3.7

23.18

16.66

ug/l

0.24

485

2548

Pre-eclampsia or poor fetal growth

962

10263

0.93

1.46

3.5

3.9

14.81

20.09

ug/l

0.35

696

7570

Other primary thrombocytopenia

127

1.76

1.46

3.2

4.7

2.65

10.46

ug/l

1.37

Gonarthrosis,primary

5556

32520

1.03

1.46

3.7

4.4

23.72

27.09

ug/l

0.24

4524

26547

All dysplastic lesions of the cervix uteri, vagina or vulva

1065

9719

1.07

1.46

3.6

3.9

12.73

20.81

ug/l

0.55

809

7147

Other salmonella infections

155

1302

1.21

1.45

4.7

4.3

32.48

21.93

ug/l

0.23

119

1070

Hyperhidrosis

111

900

1.25

1.45

2.9

4.2

4.12

7.87

ug/l

1.20

701

Thyroiditis, ILD-related definition

490

4448

1.11

1.45

3.4

4.2

44.30

29.18

ug/l

0.30

379

3486

Lichen ruber planus, wide definition including periferal and oral lichen planus

1074

11447

0.93

1.44

3.5

4.3

20.69

22.64

ug/l

0.06

847

9300

Benign neoplasm: Cerebral meninges

494

4494

1.11

1.44

3.7

4.1

12.48

22.17

ug/l

0.63

397

3653

Other epidermal thickening

206

1774

1.18

1.44

3.5

4.4

11.13

19.42

ug/l

0.65

167

1470

Conjunctivitis

3839

29834

1.04

1.44

3.6

4.2

12.02

26.53

ug/l

4.66

2901

23764

Benign neoplasm: Skin of ear and external auricular canal

183

1563

1.19

1.43

3.3

4.1

4.78

19.50

ug/l

2.02

150

1290

Pregnancy with abortive outcome

3325

16670

1.04

1.43

3.9

20.09

21.09

ug/l

0.06

2601

12905

Mood [affective] disorders

5547

34491

1.03

1.43

3.6

4.4

25.87

24.85

ug/l

0.06

4422

27653

Other disorders of male genital organs

140

1166

1.22

1.42

5.1

5.0

3.75

30.16

ug/l

2.75

116

995

Arthropathies

4605

22520

1.04

1.42

3.8

4.6

16.42

29.76

ug/l

2.55

3614

18012

Arthropathy in Crohn disease

307

1.45

1.42

3.9

4.7

3.60

23.17

ug/l

0.76

244

Sequelae of other accidents

547

0.69

1.41

2.7

4.3

2.14

30.44

ug/l

1.27

458

Other symptoms and signs involving the nervous and musculoskeletal systems

1969

20626

0.95

1.41

3.1

4.3

23.63

25.06

ug/l

0.04

1526

16652

Olecranon bursitis

291

2573

1.15

1.41

3.5

5.2

13.85

35.05

ug/l

1.42

248

2161

Oral lichen planus, including avohilmo , including avohilmo

269

3051

0.87

1.40

3.1

4.3

3.01

23.14

ug/l

3.49

208

2451

Transient global amnesia

426

4701

0.89

1.40

4.1

4.3

10.29

25.43

ug/l

2.47

357

3864

Polyarteritis nodosa and related conditions

445

1.37

1.40

3.3

4.1

9.98

36.51

ug/l

0.77

363

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.91

1.39

5.0

4.0

2.27

82.66

ug/l

0.56

Erosion and ectropion of cervix uteri

140

1173

1.22

1.39

3.3

4.3

23.90

40.09

ug/l

0.35

111

943

Benign neoplasm: Ciliary body

133

0.42

1.39

2.7

5.1

2.63

9.50

ug/l

—

107

Female infertility, uterine origin

1.94

1.39

2.1

4.5

2.08

65.96

ug/l

—

Congenital malformations and deformations of the musculoskeletal system

243

2107

1.16

1.38

4.0

4.3

3.37

20.25

ug/l

2.87

183

1609

Other forms of systemic lupus erythematosus

267

1.48

1.38

3.3

4.1

34.59

6.72

ug/l

0.51

217

Personality disorders

961

8983

1.07

1.38

3.2

4.4

10.91

28.85

ug/l

2.74

764

6949

Selective deficiency of immunoglobulin M [IgM]

3.38

1.38

1.8

6.0

1.96

21.38

ug/l

—

Other noninflammatory disorders of vulva and perineum

406

3661

1.12

1.38

3.4

4.5

7.46

33.46

ug/l

1.64

297

2872

Maternal care for other conditions predominantly related to pregnancy

554

5899

0.91

1.37

4.3

3.9

6.03

20.45

ug/l

1.41

382

4191

Tic and related disorders

191

1.55

1.37

3.2

4.4

6.08

6.85

ug/l

0.08

149

Benign neoplasm of meninges

543

4976

1.10

1.37

3.7

4.1

12.74

22.48

ug/l

0.71

434

4054

Other disorders originating in the perinatal period

1.79

1.37

5.3

3.9

2.57

6.57

ug/l

—

Use of cabergoline

368

0.64

1.37

3.3

4.8

2.44

26.73

ug/l

1.11

299

Secondary polycythaemia

105

856

1.25

1.36

3.9

4.7

4.42

23.98

ug/l

1.35

721

Acne

200

1710

1.17

1.36

4.4

4.3

5.22

38.50

ug/l

0.87

155

1203

Benign neoplasm: Other parts of oropharynx

319

1.43

1.36

2.5

4.7

3.92

21.67

ug/l

0.71

257

Bus occupant injured in other and unspecified transport accidents

235

1.51

1.36

2.8

4.5

2.24

26.85

ug/l

0.73

189

Exposure to smoke, fire and flames

783

0.75

1.35

3.7

4.6

19.60

26.21

ug/l

0.18

647

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

461

0.68

1.35

4.1

4.5

6.82

31.84

ug/l

0.80

380

LSIL lesion of the cervix uteri

363

3254

1.12

1.35

3.7

4.0

27.08

27.07

ug/l

0.00

270

2393

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

655

4481

0.92

1.35

3.7

3.6

14.48

17.42

ug/l

0.09

404

2980

Whooping cough

1.79

1.34

5.1

4.0

5.89

4.51

ug/l

0.27

conjunctival haemorrhage

393

3550

1.12

1.34

3.5

4.3

6.70

24.62

ug/l

3.67

310

2930

Granulomatous disorders of skin and subcutaneous tissue

106

866

1.25

1.34

3.3

4.5

8.25

25.00

ug/l

0.98

713

Other and unspecified tonsillitis

1049

8172

1.07

1.34

4.4

4.6

37.41

27.07

ug/l

0.22

797

6288

Cauda equina syndrome

449

1.35

1.33

3.2

4.5

3.94

16.18

ug/l

0.69

367

Defect, injury or illness of neck

178

1.58

1.33

3.8

4.2

9.37

34.19

ug/l

0.48

141

Other nutritional anaemias

345

1.41

1.33

3.3

4.2

14.49

24.89

ug/l

0.27

292

Aggressive periodontitis

104

850

1.25

1.33

4.5

4.6

4.45

28.13

ug/l

1.63

710

Ingrowing nail

198

1710

1.17

1.33

4.1

4.4

5.59

21.88

ug/l

2.11

154

1388

Macular hole

328

2939

1.14

1.33

3.6

4.3

16.40

19.45

ug/l

0.17

280

2423

Seropositive rheumatoid arthritis

1284

13493

0.94

1.33

3.2

4.4

25.51

25.79

ug/l

0.01

1054

11015

Gonococcal infection

136

1141

1.21

1.32

3.5

4.6

9.81

10.87

ug/l

0.06

100

927

Dermatophytosis

658

6087

1.09

1.32

3.6

4.5

16.96

24.75

ug/l

0.70

537

5030

Other specified/unspecified disorders of bone/cartilage

115

950

1.24

1.31

4.0

4.4

11.06

15.14

ug/l

0.22

777

Other disorders of electrolyte and fluid balance, not elsewhere classified

347

1.41

1.31

3.0

4.3

94.85

41.36

ug/l

0.25

295

Benign neoplasm: Conjunctiva

145

1225

1.21

1.31

4.7

4.5

3.89

20.16

ug/l

1.67

116

1007

Viral warts, including avohilmo

876

8183

1.08

1.31

3.5

4.4

21.62

25.53

ug/l

0.15

684

6470

Calcific tendinitis of shoulder

270

2389

1.15

1.31

3.7

4.7

38.67

20.93

ug/l

0.26

226

1924

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

241

1.47

1.31

3.4

4.6

2.61

7.68

ug/l

2.02

185

Coarctation of the aorta

227

1.49

1.31

4.7

4.9

14.61

25.12

ug/l

0.20

184

Loose body in joint

834

0.76

1.31

3.9

4.8

14.57

24.84

ug/l

0.42

710

Superficial injury of lower leg

1213

11454

1.06

1.31

3.4

4.3

10.30

26.64

ug/l

2.87

952

9121

Other obstetric conditions, not elsewhere classified

686

4684

0.92

1.31

3.7

3.6

13.86

17.61

ug/l

0.12

428

3142

Ovarian hyperstimulation (induction)

268

1.44

1.30

4.6

3.8

2.97

24.71

ug/l

0.57

183

MS-disease / Multiple Sclerosis

185

2144

0.85

1.30

4.0

4.4

6.81

30.90

ug/l

0.86

145

1652

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2618

24107

1.04

1.29

3.6

4.2

12.66

22.66

ug/l

1.72

1935

18974

Assault by bodily force

214

1861

1.16

1.29

3.3

4.7

6.79

19.18

ug/l

1.59

170

1458

Other noninflammatory disorders of cervix uteri

253

2235

1.15

1.29

3.7

4.6

17.98

28.59

ug/l

0.44

194

1812

Other and unspecified primary disorders of muscles

221

1.51

1.28

1.9

4.5

25.27

26.39

ug/l

0.01

174

Benign neoplasm of thyroid gland

150

1275

1.20

1.28

4.6

4.1

12.84

17.99

ug/l

0.28

116

1038

Demyelinating diseases of the central nervous system

234

2664

0.87

1.28

3.8

4.3

6.86

34.61

ug/l

1.31

182

2053

Habit and impulse disorders

355

1.38

1.28

3.5

5.4

3.89

26.65

ug/l

0.98

292

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

303

2709

1.14

1.27

3.1

4.2

43.52

19.64

ug/l

0.26

229

2183

Pleural plaque without asbestos

189

1639

1.18

1.27

2.5

4.1

6.52

28.91

ug/l

2.57

167

1392

Autoimmune hyperthyroidism

270

2393

1.14

1.27

3.6

4.2

72.37

34.51

ug/l

0.25

211

1878

Shoulder region

541

1.31

1.27

2.5

4.4

3.07

29.80

ug/l

1.12

447

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1557

14822

1.06

1.27

3.3

4.6

15.87

27.50

ug/l

0.96

1260

11934

Glucagon-like peptide-1 (GLP-1) analogues

1557

14822

1.06

1.27

3.3

4.6

15.87

27.50

ug/l

0.96

1260

11934

Endometriosis of fallopian tube

213

1.51

1.27

2.9

4.4

4.03

6.45

ug/l

0.75

170

Neurofibromatosis, type 1

172

1.57

1.26

2.0

4.1

2.48

35.27

ug/l

0.68

134

Sleep disorders, other/unspecified

115

952

1.22

1.26

3.2

4.7

7.93

25.24

ug/l

0.94

743

Sicca syndrome [Sjögren]

413

3754

1.11

1.26

2.9

4.2

6.20

21.97

ug/l

2.71

326

3000

Other appendicitis

355

3199

1.12

1.26

3.9

4.3

7.04

22.17

ug/l

2.30

282

2561

Benign neoplasm: Other and unspecified parts of mouth

153

1306

1.19

1.25

3.9

4.4

25.89

21.14

ug/l

0.13

122

1079

Inguinal hernia, bilateral

500

4586

1.10

1.25

4.7

4.5

9.06

32.00

ug/l

2.83

412

3900

Benign neoplasm: Skin of upper limb, including shoulder

712

1.27

1.25

3.5

4.5

16.56

28.25

ug/l

0.32

594

Drug-induced systemic lupus erythematosus

240

1.48

1.25

1.6

4.1

18.99

9.82

ug/l

0.23

190

Speech and linguistic disorders, excluding more controls

179

1443

1.17

1.24

3.5

4.5

54.66

20.78

ug/l

0.30

130

1083

Inguinal or femoral hernia, bilateral

509

4673

1.10

1.24

4.6

4.5

8.95

31.93

ug/l

2.92

420

3969

Other cestode infections

129

0.44

1.24

5.3

4.3

2.07

67.27

ug/l

—

102

Oligomenorrhoea

113

936

1.22

1.24

2.9

4.4

5.48

54.07

ug/l

0.74

726

Diseases of the myoneural junction and muscle

593

5481

1.09

1.24

3.2

4.2

58.05

23.68

ug/l

0.35

471

4517

Superficial injury of abdomen, lower back and pelvis

665

6169

1.09

1.24

3.5

4.2

28.71

26.91

ug/l

0.04

533

4931

Autonomic disorders

103

848

1.24

1.23

3.3

4.6

2.88

21.44

ug/l

1.28

695

Nonspecific lymphadenitis

227

1994

1.15

1.23

3.5

4.3

8.73

19.50

ug/l

0.94

171

1583

Chronic iridocyclitis

203

1771

1.16

1.23

4.4

23.07

20.12

ug/l

0.08

160

1434

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

150

1.62

1.23

2.0

4.1

3.41

37.85

ug/l

0.67

126

Amyloidosis, other/unspecified

769

1.26

1.23

3.0

4.5

3.74

29.56

ug/l

1.68

643

Nail dystrophy

224

1.50

1.22

4.0

4.8

12.86

25.98

ug/l

0.26

185

Fall on same level involving ice and snow

3153

30459

1.04

1.22

3.9

4.3

30.92

24.49

ug/l

0.32

2525

24619

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1258

13263

0.94

1.22

3.2

4.2

15.97

25.03

ug/l

0.97

1034

10783

Deforming dorsopathies

1430

13592

1.06

1.22

3.2

4.6

27.32

28.15

ug/l

0.02

1158

10956

Astigmatism

223

1954

1.15

1.22

3.9

4.3

7.85

20.92

ug/l

1.54

167

1561

Other acute skin changes due to ultraviolet radiation

154

1318

1.19

1.22

3.3

4.3

3.49

21.25

ug/l

2.04

125

1088

Pacemaker

2165

19319

1.05

1.22

3.1

4.2

14.48

27.28

ug/l

2.92

1752

16262

Post-traumatic stress disorder

206

1795

1.15

1.21

3.1

4.2

54.75

32.55

ug/l

0.18

145

1296

Injury of nerves and spinal cord at thorax level

183

1.55

1.21

2.3

5.8

3.35

30.56

ug/l

0.63

152

Brain glioblastoma, helper endpoint

586

0.73

1.21

2.2

4.6

3.22

29.67

ug/l

1.24

499

Excessive attrition of teeth

2763

28332

0.96

1.21

3.9

4.4

26.50

24.69

ug/l

0.05

2169

22450

Hyperaldosteronism

132

1117

1.21

3.7

4.5

9.35

25.34

ug/l

1.18

100

940

Contracture of joint

448

1.33

1.21

3.8

4.6

15.66

29.35

ug/l

0.38

384

Lactose intolerance, other/unspecified

813

1.24

1.20

3.7

4.4

4.04

25.42

ug/l

1.43

662

Evidence of alcohol involvement determined by blood alcohol level

412

1.34

1.20

3.5

5.4

4.76

38.85

ug/l

1.05

346

Infective bursitis

129

1089

1.21

1.20

3.2

4.8

5.36

26.78

ug/l

1.94

106

905

Other specified/unspecified soft tissue disorders

233

2057

1.15

1.20

3.0

4.3

16.83

21.12

ug/l

0.12

193

1652

Amenorrhoea

173

1490

1.17

1.20

3.1

4.4

8.49

46.95

ug/l

0.89

123

1110

Atrial septal defect, secundum type

693

1.26

1.20

2.7

4.3

25.67

24.64

ug/l

0.02

553

Bell's palsy

547

5047

1.09

1.19

3.7

4.4

58.56

23.15

ug/l

0.35

452

4078

Acute nephritic syndrome

707

1.26

1.19

3.5

4.7

21.23

23.28

ug/l

0.04

597

Other and unspecified mononeuropathies of upper limb

127

1071

1.21

1.19

3.7

4.8

7.33

22.16

ug/l

1.09

111

874

Mental retardation, excluding more controls

106

845

1.22

1.19

2.5

5.1

92.53

19.32

ug/l

0.48

660

Paraplegia, diplegia of upper limbs

789

1.24

1.19

2.4

4.4

322.23

23.45

ug/l

0.47

654

Puerperal sepsis

504

5474

0.91

1.19

4.1

60.53

25.19

ug/l

0.66

389

4305

Carcinoma in situ of cervix uteri

284

2533

1.13

1.19

3.7

3.8

9.86

27.31

ug/l

0.60

220

1829

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

369

1.36

1.19

3.9

4.7

7.90

26.05

ug/l

0.66

293

Juvenile rheumatoid arthirtis

508

0.72

1.19

3.8

4.7

13.96

16.21

ug/l

0.07

400

Anorexia

422

1.33

1.18

3.5

4.0

23.81

19.00

ug/l

0.12

338

Major coronary heart disease event

5015

29188

1.03

1.18

3.6

4.5

16.61

30.10

ug/l

3.13

4093

23795

Other assisted single delivery

343

1.37

1.18

3.8

3.9

9.17

6.08

ug/l

0.31

237

Other dialysis

126

1064

1.21

1.18

2.0

4.7

4.71

24.64

ug/l

1.74

108

886

Dermatopolymyositis

530

1.30

1.17

2.8

4.4

2.76

34.14

ug/l

1.30

435

Postviral fatigue syndrome

142

1.59

1.17

3.9

4.5

2.13

8.83

ug/l

2.09

108

Neuromuscular dysfunction of bladder

426

3894

1.10

1.17

3.2

4.3

8.89

27.07

ug/l

2.57

350

3190

Hallux rigidus

704

7538

0.93

1.17

3.5

4.7

12.26

25.94

ug/l

1.80

564

6249

Disorders of sclera, cornea, iris and ciliary body

2846

27495

1.04

1.17

3.8

4.3

29.87

25.90

ug/l

0.18

2265

22166

Other cestode infections, including avohilmo

140

0.47

1.16

4.7

4.4

2.74

63.16

ug/l

—

110

Other bursopathies

671

6252

1.08

1.16

3.5

4.7

11.01

27.26

ug/l

2.01

548

5132

Bicipital tendinitis

224

1979

1.15

1.16

3.3

4.8

5.57

25.46

ug/l

3.10

177

1620

Other and unspecified nerve root and plexus disorders, also in other diseases

1000

9439

1.07

1.15

3.3

4.6

14.04

27.73

ug/l

1.10

791

7614

Assault by other and unspecified firearm discharge

2.41

1.14

4.7

3.0

4.67

2.37

ug/l

—

Other injuries of spine and trunk, level unspecified

295

1.40

1.14

3.7

4.4

4.54

46.89

ug/l

0.91

241

Radial styloid tenosynovitis [de Quervain]

237

2101

1.14

3.1

4.6

3.25

37.26

ug/l

1.38

179

1639

Residual foreign body in soft tissue

204

1792

1.15

1.13

4.4

4.8

13.11

23.08

ug/l

0.71

160

1445

Adhesive capsulitis of shoulder

881

8292

1.07

1.13

3.5

4.6

15.86

28.25

ug/l

0.64

731

6735

Unspecified chronic bronchitis

160

1383

1.17

1.12

3.8

4.2

6.41

21.96

ug/l

1.61

130

1130

Other and unspecified disease of Bartholin gland

125

1061

1.20

1.12

3.4

4.3

3.70

11.24

ug/l

3.52

106

851

Effects of foreign body entering through natural orifice

1000

9443

1.06

1.12

3.7

4.6

17.56

29.24

ug/l

0.88

806

7718

Vestibular neuronitis

415

3799

1.10

1.12

4.0

4.3

6.68

22.64

ug/l

3.35

335

3098

Microscopic polyangiitis

255

1.44

1.12

2.4

5.0

2.75

22.33

ug/l

0.64

215

Necrotizing fasciitis

195

1.50

1.12

4.5

5.0

41.80

63.63

ug/l

0.16

164

Benign neoplasm: Skin of scalp and neck

111

932

1.21

1.12

3.4

4.5

7.07

25.85

ug/l

1.31

775

Need for immunization against other single viral diseases

632

1.26

1.12

4.7

5.78

17.28

ug/l

0.83

522

Primary adrenocortical insufficiency

357

1.36

1.11

3.1

3.9

6.22

39.57

ug/l

0.86

295

Cardiac arrest

301

2298

1.12

1.11

3.4

5.0

6.27

32.28

ug/l

2.86

259

1911

Postpartum care and examination

259

1826

0.89

1.11

3.6

3.3

6.60

11.26

ug/l

0.68

185

1251

Spinal instabilities

121

1025

1.20

1.10

3.2

4.7

6.99

19.84

ug/l

1.29

107

812

Schizophrenia, schizotypal and delusional disorders

1169

12316

0.95

1.10

3.2

4.4

20.34

26.36

ug/l

0.33

961

9844

Benign neoplasm: Heart

147

1.60

1.10

2.3

4.4

3.26

36.05

ug/l

0.63

126

Amyloidosis

110

926

1.21

1.10

3.1

4.4

3.72

26.34

ug/l

1.79

766

Other osteochondrodysplasias, including avohilmo

349

1.35

1.09

4.0

4.7

4.14

7.24

ug/l

0.81

288

Melanocytic naevi of lip

298

1.39

1.09

3.6

4.0

2.15

46.14

ug/l

0.97

242

Other disorders of bone density and structure

787

1.23

1.09

3.2

4.6

7.64

14.41

ug/l

0.57

635

Other and unspecified paralytic syndromes

473

1.30

1.09

2.5

4.6

9.23

34.18

ug/l

0.80

390

Specific personality disorders

812

7625

1.07

1.09

3.1

4.4

13.36

29.88

ug/l

1.88

642

5869

Endocrine disorders, other/unspecified

625

1.26

1.09

4.4

4.6

6.18

26.40

ug/l

0.92

517

Retinal haemorrhage

125

1065

1.20

1.09

3.4

4.2

19.81

19.39

ug/l

0.01

100

898

Benign neoplasm: Lower jaw bone

130

1.61

1.09

2.5

4.1

3.99

11.35

ug/l

1.24

103

Superficial injury of shoulder and upper arm

439

4776

0.91

1.09

3.0

4.4

17.45

21.77

ug/l

0.15

350

3843

Other and unspecified acute skin changes due to ultraviolet radiation

119

1010

1.20

1.08

3.3

4.4

3.40

25.67

ug/l

1.97

848

Car occupant injured in other and unspecified transport accidents

715

6689

1.07

1.08

3.7

4.3

11.27

28.20

ug/l

1.71

562

5271

Emotionally unstable personality disorder

336

3044

1.11

1.08

3.1

4.2

11.40

26.42

ug/l

0.65

262

2255

Other degenerative diseases of the basal ganglia

862

0.79

1.08

2.7

4.5

3.11

30.21

ug/l

2.07

727

Calcification and ossification of muscle

1.77

1.08

1.5

4.7

2.24

89.97

ug/l

—

Oral leukoplakia, including avohilmo

127

1084

1.19

1.08

3.3

4.4

76.81

21.77

ug/l

0.45

102

894

Other injuries of upper limb, level unspecified

394

1.33

1.08

2.6

4.4

34.94

19.92

ug/l

0.18

328

Chronic nephritic syndrome

163

1418

1.17

1.07

3.2

4.4

14.28

20.37

ug/l

0.29

132

1162

Erectile dysfunction

384

3514

1.11

1.07

5.1

4.6

7.72

28.03

ug/l

3.56

317

2995

Sacroiliitis, not elsewhere classified

144

1238

1.17

1.07

2.9

4.6

4.96

23.49

ug/l

1.52

110

937

Respiratory tuberculosis, clinically confirmed

448

1.31

1.07

3.2

4.5

8.95

42.85

ug/l

1.10

372

Lumbosacral root disorders, not elsewhere classified

458

1.31

1.06

3.3

5.0

4.40

17.95

ug/l

0.81

378

Other and unspecified nail disorders

818

1.22

1.06

3.6

4.6

3.25

25.11

ug/l

1.46

676

Disorders of synovium and tendon

2874

23584

1.04

1.06

3.7

4.6

15.22

29.47

ug/l

1.78

2302

18958

Type 1 diabetes, strict definition, subgroup 1

1053

0.82

1.06

4.1

4.7

8.66

48.07

ug/l

0.57

742

Female infertility, tubal origin

179

1567

1.15

1.06

3.6

4.6

3.47

49.99

ug/l

1.30

129

1195

Vascular dementia (subcortical)

144

1662

0.85

1.06

2.8

3.9

8.66

26.37

ug/l

1.46

126

1416

Traumatic amputation of forearm

0.00

1.05

0.0

4.5

—

12.91

—

Viral infections of central nervous system, not elsewhere classified/unspecified

356

0.68

1.05

4.5

4.8

3.73

27.42

ug/l

0.66

292

Blood alcohol or alcohol intoxication level

627

1.25

1.05

3.5

5.0

35.96

30.31

ug/l

0.07

512

Benign neoplasm of brain and other parts of central nervous system

277

2496

1.12

1.05

3.9

4.4

17.18

18.65

ug/l

0.06

227

2039

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

108

911

1.20

1.04

3.3

4.7

33.43

25.92

ug/l

0.12

752

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

124

1.62

1.04

2.4

5.3

23.33

41.86

ug/l

0.20

104

Benign neoplasm: Rectum/anal canal icd-9

318

1.36

1.04

3.6

4.0

8.00

34.50

ug/l

0.67

273

Dermatopolymyositis (FG)

540

1.27

1.04

2.8

4.6

2.76

37.24

ug/l

1.58

455

Trichomoniasis, including avohilmo

354

1.35

1.03

2.8

4.3

14.59

7.93

ug/l

0.40

296

Tarsal tunnel syndrome

407

1.32

1.03

3.8

4.2

12.93

26.44

ug/l

0.31

332

Benign neoplasm of other and unspecified female genital organs

194

1715

1.15

1.03

3.5

4.1

6.67

12.55

ug/l

1.20

151

1368

Sequelae of cerebrovascular disease

2022

17923

0.96

1.03

3.2

4.3

18.41

25.75

ug/l

0.70

1676

14980

Psoas tendinitis

173

1.50

1.03

3.8

4.9

2.04

34.35

ug/l

0.67

135

Ankylosing spondylitis

352

3211

1.11

1.03

3.5

4.9

113.68

25.66

ug/l

0.80

272

2601

Carcinoma in situ of oral cavity and pharynx

1.95

1.02

3.2

4.5

3.14

12.70

ug/l

—

Other specified/unspecified diseases of inner ear

182

1.49

1.02

3.2

4.3

2.16

46.20

ug/l

0.62

150

Pyoderma

621

1.25

1.02

3.7

4.7

7.51

27.67

ug/l

0.85

513

Metatarsalgia

457

4221

1.09

1.02

3.0

4.5

21.47

31.33

ug/l

0.26

350

3366

HSIL lesion of the cervix uteri, vagina or vulva

660

6173

1.07

1.02

3.4

3.9

5.43

24.49

ug/l

2.04

497

4494

Protein-energy malnutrition of moderate and mild degree

328

1.35

1.02

3.5

4.1

7.27

41.76

ug/l

0.81

275

Schizoid personality disorder

537

0.75

1.02

2.9

5.0

18.67

25.76

ug/l

0.17

433

Lupus nephritis

100

1.67

1.01

1.6

4.7

3.23

15.36

ug/l

1.66

Insulin, fast-acting (human)

410

4460

0.91

1.01

3.3

4.2

9.89

26.50

ug/l

1.36

347

3534

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

621

5805

1.08

1.01

3.7

4.3

13.82

28.73

ug/l

1.24

488

4688

Gonococcal infection, including avohilmo

137

1182

1.18

1.01

3.5

4.6

9.73

10.62

ug/l

0.05

101

955

Disorder of thyroid, unspecified

515

1.28

1.01

3.2

4.0

49.35

17.74

ug/l

0.29

423

Etanercept

193

2181

0.88

1.01

2.8

4.4

47.51

17.49

ug/l

0.59

144

1715

Vascular dementia (other)

303

1.37

1.01

3.7

3.8

5.08

47.46

ug/l

1.02

265

Other disorders involving the immune mechanism, not elsewhere classified

117

997

1.19

1.01

3.5

4.6

31.32

25.12

ug/l

0.11

827

Other superficial mycoses

658

1.24

1.00

3.4

4.8

3.37

28.18

ug/l

1.24

532

Mild mental retardation

585

1.25

1.00

2.5

4.6

135.42

19.96

ug/l

0.51

471

Other and unspecified myopathies

422

3892

1.09

0.99

3.2

4.2

14.35

21.32

ug/l

0.74

333

3221

Childhood asthma (age<16), excluding more controls

197

1356

1.14

0.99

3.7

4.3

4.00

37.11

ug/l

0.61

122

914

Trichomoniasis

340

1.35

0.98

2.9

4.4

15.25

7.80

ug/l

0.43

286

Congenital malformations of great veins

1.92

0.98

2.5

5.4

2.28

93.77

ug/l

—

Other symptoms and signs involving cognitive functions and awareness

2792

23983

1.04

0.98

3.4

4.4

9.53

29.27

ug/l

9.75

2257

19845

Alopecia areata

806

1.21

0.98

2.8

4.4

4.07

15.30

ug/l

1.31

643

Carcinoma in situ of skin of upper limb, including shoulder

142

1237

1.17

0.98

3.6

4.1

3.50

26.18

ug/l

2.69

116

1036

Dyshidrosis [pompholyx]

453

1.28

0.98

3.4

4.4

153.68

29.07

ug/l

0.38

371

Family history of other specific disorders

320

1.34

0.98

5.2

4.2

1.83

23.75

ug/l

0.98

262

Abnormality of red blood cells

184

1.47

0.97

2.9

4.2

3.05

33.69

ug/l

0.72

150

Benign neoplasm: Spinal meninges

447

1.29

0.97

3.2

4.2

2.79

18.73

ug/l

1.03

374

Traumatic subarachnoid haemorrhage

187

1657

1.14

0.97

4.4

5.0

5.52

27.10

ug/l

3.18

145

1393

Disorders of optic nerve, not elsewhere classified

828

1.21

0.97

3.4

4.4

5.25

25.98

ug/l

1.37

695

Benign neoplasm: Retina

210

1.44

0.97

3.2

4.6

4.99

10.62

ug/l

1.05

171

Intentional self-harm by unspecified means

242

1.39

0.97

3.1

4.3

3.01

6.63

ug/l

1.34

180

Supervision of high-risk pregnancy

602

3372

1.08

0.97

4.2

3.7

17.15

15.19

ug/l

0.08

426

2437

Ankle and foot

287

1.37

0.97

3.3

4.1

3.13

21.54

ug/l

0.66

232

Exophthalmic conditions

384

1.31

0.97

4.8

4.4

246.61

35.52

ug/l

0.42

323

Synovial cyst of popliteal space [Baker]

371

3409

1.10

0.97

3.6

4.5

6.27

28.30

ug/l

2.96

296

2786

Injury of urinary and pelvic organs

699

1.22

0.96

5.1

4.9

32.82

29.26

ug/l

0.04

581

Seropositive rheumatoid arthritis, strict definition

667

7097

0.93

0.96

3.5

4.2

22.01

29.65

ug/l

0.36

547

5741

Myeloproliferative diseases

405

3739

1.09

0.95

3.0

4.1

11.77

20.36

ug/l

0.64

314

3072

Toxic effect of carbon monoxide

591

1.24

0.95

3.0

4.7

12.38

30.24

ug/l

0.60

495

Lichenoid drug reaction

128

1.60

0.95

3.2

4.4

6.09

13.48

ug/l

0.74

104

Suppurative and unspecified otitis media

1111

10330

0.95

3.8

4.3

11.00

27.10

ug/l

2.53

828

7985

Dronedarone medication

155

1362

1.16

0.95

3.7

4.6

13.08

28.06

ug/l

0.90

127

1132

General hospital and personal-use devices associated with adverse incidents

1.95

0.95

1.3

4.4

3.02

20.96

ug/l

—

Rheumatoid arthritis, including avohilmo

1931

20017

0.96

0.94

3.4

4.2

22.05

23.43

ug/l

0.07

1570

16280

Other and unspecified injuries of wrist and hand

137

1189

1.17

0.94

4.0

4.5

3.54

22.16

ug/l

1.78

107

951

Secondary parkinsonism

1142

0.83

0.94

2.3

4.2

5.37

25.34

ug/l

1.90

954

Right side

238

1.41

0.94

2.8

4.8

25.98

25.16

ug/l

0.01

205

Other and unspecified nonscarring hair loss

236

1.39

0.94

3.2

4.1

3.04

10.61

ug/l

1.96

184

Congenital malformations of the respiratory system

537

1.25

0.94

3.0

4.4

11.25

28.71

ug/l

0.55

439

Actinomycosis, including avohilmo

127

1.56

0.93

4.8

5.1

4.14

5.90

ug/l

0.45

102

Childhood asthma (age<16)

197

1363

1.13

0.93

3.7

4.2

4.00

36.77

ug/l

0.61

122

923

Unspecified contracted kidney

203

1.44

0.93

4.3

4.5

9.03

29.85

ug/l

0.49

167

Other or ill-defined heart diseases

217

1943

1.13

0.93

4.0

4.6

11.28

23.69

ug/l

1.17

179

1604

Crystal arthropathies, rheuma endpoint

103

879

1.20

0.93

3.0

4.6

22.11

30.34

ug/l

0.16

753

Allergic colitis

226

1.38

0.93

4.6

3.8

3.72

9.04

ug/l

1.24

160

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

253

1.37

0.93

4.7

4.8

3.10

51.13

ug/l

0.83

199

Medical treatment for female infertility

562

5198

1.07

0.92

3.4

3.8

4.26

21.46

ug/l

1.52

370

3604

Other specified/unspecified systemic involvement of connective tissue

243

2193

1.12

0.92

3.2

4.4

6.90

20.95

ug/l

1.60

186

1750

Palindromic rheumatism

387

1.30

0.92

2.1

4.5

3.39

32.51

ug/l

0.93

324

Erythema nodosum

120

1035

1.18

0.92

3.8

4.1

35.36

19.50

ug/l

0.28

848

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

549

1.25

0.92

3.3

4.8

2.87

35.47

ug/l

1.42

446

Spirochaetal infections, other/unspecified

419

3880

1.09

0.92

3.7

4.3

26.38

27.20

ug/l

0.01

334

3158

Carcinoma in situ of skin of eyelid, including canthus

1.71

0.91

4.1

3.9

2.80

9.40

ug/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

169

1496

1.15

0.91

3.6

4.4

5.12

19.00

ug/l

1.61

137

1231

Anterior Iridocyclitis

923

8768

1.06

0.91

3.8

4.4

71.83

25.97

ug/l

1.05

733

7114

Mental retardation

106

896

1.18

0.91

2.5

4.6

92.53

15.55

ug/l

0.51

713

Hydatidiform mole

351

1.31

0.91

3.0

4.2

2.75

11.10

ug/l

1.88

271

Other prurigo

424

1.28

0.90

3.4

4.5

5.10

41.18

ug/l

1.20

359

Congenital malformations of trachea and bronchus

353

1.31

0.90

3.3

4.3

6.16

40.56

ug/l

0.88

291

Thyroiditis

293

2673

1.11

0.90

3.5

4.3

12.97

22.21

ug/l

0.57

230

2115

Contusion of toe(s) without damage to nail

685

1.21

0.90

3.8

4.4

3.36

16.53

ug/l

1.11

551

Fracture at wrist and hand level

1542

14772

1.04

0.90

4.0

4.5

23.83

29.08

ug/l

0.27

1261

11905

Other specified disorders of external ear

175

1555

1.14

0.90

4.0

4.5

15.04

25.64

ug/l

0.41

137

1303

Amputation of toe

346

3184

1.10

0.89

3.0

4.2

4.78

23.47

ug/l

4.91

297

2670

Congenital malformations of the circulatory system

514

4656

1.08

0.89

3.6

4.4

10.13

28.67

ug/l

1.46

398

3717

Nonischemic cardiomyopathy

499

4653

1.08

0.89

3.8

4.7

9.40

25.80

ug/l

3.10

421

3880

Schizophrenia or delusion

1168

12221

0.95

0.89

3.2

4.4

20.27

26.67

ug/l

0.36

959

9770

Other and unspecified disorders of vitreous body

2549

24181

1.03

0.89

3.9

4.3

21.06

24.22

ug/l

0.17

2029

19803

Obstructed labour due to maternal pelvic abnormality

624

6633

0.93

0.89

4.3

4.1

8.02

25.93

ug/l

1.99

500

5173

Other, unspecified and serous retinal detachments

149

1311

1.15

0.89

4.1

4.2

13.78

16.41

ug/l

0.18

121

1080

Other benign neoplasm of uterus: Cervix uteri

222

1.40

0.89

2.6

4.1

4.56

7.73

ug/l

0.51

178

Benign neoplasm: Tonsil

452

1.27

0.89

3.6

4.5

11.42

23.29

ug/l

0.51

376

Whooping cough, including avohilmo

325

1.31

0.89

3.7

4.0

5.72

5.38

ug/l

0.05

249

Galactorrhea

221

1.39

0.88

3.8

4.5

16.66

7.51

ug/l

0.29

168

Exposure to other and unspecified man-made environmental factors

536

0.77

0.88

3.8

4.4

15.31

32.58

ug/l

0.41

441

Open wound of ankle and foot

406

3760

1.09

0.88

3.9

4.4

14.71

22.75

ug/l

0.56

328

3042

Striking against or struck by other objects

1341

12837

1.05

0.88

3.8

4.5

9.07

28.31

ug/l

5.07

1051

10307

Secondary parkinsonism+Parkinsonism in other disease

101

1176

0.84

0.87

2.5

4.2

5.47

24.45

ug/l

1.85

986

Other bursitis of hip

104

893

1.19

0.87

3.7

4.6

9.15

27.84

ug/l

1.10

726

Bullous disorders

266

2422

1.11

0.87

3.9

4.2

5.42

22.31

ug/l

2.93

215

2009

Antepartum haemorrhage, not elsewhere classified

186

2085

0.89

0.87

2.7

3.7

7.01

26.29

ug/l

0.53

125

1444

Melanocytic naevi of scalp and neck

725

1.20

0.87

4.2

4.5

3.68

27.56

ug/l

1.38

597

Eosinophilia

562

1.24

0.86

3.4

4.4

94.98

27.07

ug/l

0.37

469

Oral lichen planus and hypothyroidism or thyroxine medication

802

1.20

0.86

2.8

4.2

3.03

10.55

ug/l

3.85

647

Traumatic subcutaneous emphysema

1.84

0.86

5.4

4.7

6.59

15.13

ug/l

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

1.84

0.86

5.3

5.7

4.54

99.10

ug/l

—

Other disorders of binocular movement

552

1.23

0.85

3.6

4.4

6.58

28.64

ug/l

0.81

440

Other predominantly sexually transmitted diseases, not elsewhere classified

520

4863

1.07

0.85

4.0

4.2

9.66

26.46

ug/l

1.30

388

3623

Hyperosmolality and hypernatraemia

527

1.24

0.85

3.2

4.1

20.97

32.81

ug/l

0.28

444

Effects of heat and light

241

1.37

0.85

4.7

4.4

7.32

52.75

ug/l

0.78

203

Other peripheral vascular diseases

354

3268

1.09

0.85

3.4

4.3

7.84

21.75

ug/l

2.33

300

2617

Other congenital malformations of skin

131

1145

1.16

0.84

3.6

4.6

11.83

12.20

ug/l

0.02

926

HSIL lesion of the vulva

637

1.22

0.84

3.1

3.9

3.32

8.67

ug/l

3.31

508

Injuries involving multiple body regions

133

1164

1.16

0.84

3.0

4.4

4.53

21.16

ug/l

1.58

956

Other crystal arthropathies

103

888

1.18

0.84

3.0

4.5

22.11

26.22

ug/l

0.07

754

Congenital musculoskeletal deformities of head, face, spine and chest

223

1.37

0.84

4.9

3.15

58.17

ug/l

0.83

174

Other superficial mycoses, including avohilmo

357

3295

1.09

0.84

3.4

4.4

8.23

27.60

ug/l

1.13

261

2595

Placenta praevia

118

1023

1.16

0.84

4.1

4.0

24.47

46.67

ug/l

0.24

728

Osteitis due to dental implant

322

1.32

0.84

4.5

22.69

21.41

ug/l

0.02

265

Acute and subacute iridocyclitis

866

8236

1.06

0.84

3.8

4.4

74.44

26.76

ug/l

1.02

688

6693

Tooth eruption problems

276

2428

1.10

0.84

3.7

4.2

3.73

33.28

ug/l

1.24

200

1754

Other benign neoplasms of uterus

271

2479

1.11

0.83

3.3

3.9

7.60

15.21

ug/l

1.01

220

2030

Acne vulgaris

140

1225

1.15

0.83

3.8

4.5

6.11

43.81

ug/l

0.65

107

853

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

174

1946

0.88

0.83

4.3

10.40

28.19

ug/l

0.78

139

1546

Lichen planus, including avohilmo

911

9556

0.95

0.83

3.5

4.3

23.80

22.76

ug/l

0.03

720

7784

Acute alcohol intoxication, ICD10

809

7682

1.06

0.82

3.4

4.7

25.23

31.66

ug/l

0.25

703

6272

Cholesteatoma of external ear

305

1.32

0.82

3.9

4.6

6.56

49.34

ug/l

0.99

266

Extreme obesity with alveolar hypoventilation

185

1660

1.13

0.82

3.1

4.4

33.10

19.92

ug/l

0.28

151

1352

Preterm labour and delivery

982

10282

0.95

0.82

4.0

4.1

10.78

23.12

ug/l

1.63

745

7840

Congenital deformities of hip, including avohilmo

400

1.26

0.82

5.2

4.2

2.68

7.29

ug/l

2.47

308

Carcinoma in situ of other/unspecified female genital organs

2.46

0.81

5.0

5.6

1.14

6.36

ug/l

—

L04AC Interleukin inhibitors

223

2019

1.11

0.81

3.1

4.5

65.26

19.84

ug/l

0.50

166

1603

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

336

3098

1.09

0.81

3.5

4.1

23.00

21.66

ug/l

0.03

284

2568

Exclusion endpoint for supernumerary teeth

207

1.37

0.81

2.9

4.6

98.47

30.85

ug/l

0.31

161

Other contact dermatitis

325

2996

1.09

0.81

3.7

4.3

80.69

17.99

ug/l

0.58

272

2397

Adalimumab

339

3129

1.09

0.81

3.6

4.5

73.79

30.10

ug/l

0.41

252

2453

Deviated nasal septum

1511

15656

0.96

0.81

3.7

4.7

14.01

31.38

ug/l

2.89

1221

12868

Other and unspecified acne

277

1.32

0.81

8.3

4.4

3.88

21.35

ug/l

0.54

212

Personality and behavioural disorders due to brain disease, damage and dysfunction

538

0.78

0.81

3.6

4.7

3.66

35.52

ug/l

1.38

451

Other disorders of optic [2nd] nerve and visual pathways

252

2299

1.11

0.80

4.1

4.3

42.13

19.97

ug/l

0.26

198

1860

conjunctival degenerations and deposits

101

873

1.18

0.80

3.5

4.4

11.36

24.41

ug/l

0.60

724

Other and unspecified injuries of thorax

585

1.22

0.80

3.3

4.6

8.08

26.56

ug/l

0.69

485

Other retinal disorders in diseases classified elsewhere

1.70

0.80

3.3

4.0

3.02

65.57

ug/l

0.62

Thyrotoxicosis from ectopic thyroid tissue

2.37

0.80

4.8

8.3

2.30

13.71

ug/l

—

Disorders of eyelid in diseases classified elsewhere

128

1124

1.15

0.80

4.1

4.4

15.72

19.19

ug/l

0.11

911

Ankylosing spondylitis, strict definition

134

1179

1.15

0.80

3.3

4.8

193.68

18.05

ug/l

0.72

102

939

Hypersomnia

438

0.76

0.79

3.4

4.7

5.33

32.94

ug/l

0.85

355

Cellulitis of external ear

368

1.28

0.79

4.4

5.0

2.91

35.86

ug/l

0.90

306

Occupational exposure to risk-factors

141

1248

1.15

0.79

3.6

4.5

43.10

23.62

ug/l

0.33

120

1031

Ankylosing spondylitis, ICD10

328

3029

1.09

0.79

3.5

4.5

119.50

18.94

ug/l

0.89

255

2442

Somnolence, stupor and coma

173

1549

1.13

0.79

3.8

4.5

17.95

23.31

ug/l

0.21

141

1288

Abnormal findings on antenatal screening of mother

123

1405

0.87

0.79

3.3

3.6

3.53

38.19

ug/l

0.63

895

Impingement syndrome of shoulder

1281

12318

1.04

0.79

3.5

4.8

18.76

32.48

ug/l

1.27

1068

10064

Biological medication for rheuma

630

5950

1.06

0.78

3.3

4.5

65.12

25.68

ug/l

0.67

469

4660

Other and unspecified epidermal thickening

109

948

1.17

0.78

3.4

4.5

17.20

26.08

ug/l

0.32

781

Mental disorders, not otherwise specified

261

2386

1.10

0.78

3.5

4.3

33.32

30.33

ug/l

0.03

205

1846

Fitting and adjustment of external prosthetic device

108

1.55

0.78

3.6

3.8

7.51

7.77

ug/l

—

Monoplegia

551

1.22

0.78

3.4

4.4

4.22

26.94

ug/l

0.94

461

Other infections specific to the perinatal period

0.00

0.78

0.0

3.4

—

5.40

—

Maltreatment syndromes

126

1105

1.15

0.78

3.8

4.7

8.01

19.18

ug/l

0.95

104

834

Sequelae of injuries of upper limb

398

3707

1.08

0.78

3.7

4.5

14.00

21.96

ug/l

0.55

314

2994

Myositis ossificans

100

1.58

0.78

3.3

4.6

3.77

45.41

ug/l

—

Vascular dementia (undefined)

166

1835

0.89

0.77

2.6

3.5

18.71

26.66

ug/l

0.21

135

1570

Exposure to other and unspecified animate mechanical forces

808

1.18

0.77

4.8

4.5

14.04

27.70

ug/l

0.41

648

Other and unspecified medical devices associated with adverse incidents

229

1.37

0.77

5.2

4.8

5.52

27.63

ug/l

0.66

195

Iron deficiency

641

1.20

0.77

3.3

4.0

3.42

28.87

ug/l

1.15

478

Periapical abscess

2313

22473

1.03

0.77

4.1

4.4

18.66

26.12

ug/l

0.87

1893

18075

Background retinopathy and retinal vascular changes

792

1.18

0.77

3.2

4.4

108.26

20.18

ug/l

0.40

671

Bitten or struck by other mammals

406

3784

1.08

0.77

4.0

4.3

28.55

26.61

ug/l

0.04

317

2961

Dysplasia of cervi uteri

902

6045

1.05

0.77

3.5

4.5

13.88

32.54

ug/l

1.18

691

4702

Diabetic retinopathy

1792

10753

1.04

0.76

3.6

4.0

21.80

25.23

ug/l

0.19

1488

8996

Embedded and impacted teeth

533

4602

0.94

0.76

3.9

4.2

3.81

24.37

ug/l

1.87

393

3339

Anogenital herpesviral [herpes simplex] infection

172

1541

1.12

0.76

4.2

4.4

5.03

39.32

ug/l

0.86

134

1154

Unspecified visual impairment (binocular)

534

1.22

0.76

2.6

4.2

4.66

20.68

ug/l

1.08

448

Ischaemic heart disease, wide definition

4636

27937

1.02

0.76

3.6

4.5

18.75

29.76

ug/l

1.40

3819

22902

Congenital malformations of uterus and cervix

405

1.25

0.76

2.2

4.1

3.35

20.41

ug/l

0.77

292

Crystalline deposits in vitreous body

399

1.27

0.76

3.2

4.7

18.81

42.49

ug/l

0.44

338

Hypermobility syndrome

148

1315

1.13

0.76

3.2

4.0

3.25

39.00

ug/l

0.72

114

959

Secondary parkinsonism, excluding more controls

1117

0.86

0.76

2.3

5.1

5.37

32.53

ug/l

2.49

936

Injuries to the neck

927

8857

1.05

0.75

3.7

4.4

13.49

26.24

ug/l

1.20

746

7082

Speech and linguistic disorders

180

1549

1.12

0.75

3.6

4.3

54.25

17.67

ug/l

0.33

131

1177

Benign neoplasm: Nasopharynx

327

1.29

0.75

4.8

4.5

3.34

43.28

ug/l

1.01

275

Burn and corrosion of shoulder and upper limb, except wrist and hand

654

0.81

0.74

3.1

4.9

2.56

30.43

ug/l

1.45

533

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1379

13293

1.04

0.74

3.6

4.5

30.21

27.34

ug/l

0.05

1091

10795

Other and unspecified disorders of pigmentation

238

1.34

0.74

5.5

4.6

11.11

37.24

ug/l

0.42

196

Rheumatic valve diseases

816

0.83

0.74

3.8

4.1

6.70

27.12

ug/l

1.29

701

Benign neoplasm: Orbit, unspecified

212

1.36

0.74

4.1

4.2

2.22

39.46

ug/l

0.60

173

Actinomycosis

109

1.53

0.74

3.8

5.1

4.41

6.48

ug/l

0.44

Acute drug-induced interstitial lung disorder

310

1.30

0.74

2.9

4.4

10.64

47.72

ug/l

0.83

267

Other/unspecified enthesopathies of lower limb, excluding foot

306

2828

1.09

0.74

3.7

4.6

29.78

30.41

ug/l

0.01

246

2240

Bartonellosis, including avohilmo

2.09

0.74

2.4

3.2

132.48

2.41

ug/l

—

Congenital malformations of eye, ear, face and neck

179

1611

1.12

0.74

3.0

4.3

12.63

18.51

ug/l

0.35

134

1265

Other and unspecified hydrocephalus

674

0.82

0.74

4.1

5.51

26.56

ug/l

1.10

564

Spondylopathies (FG)

547

5159

1.07

0.74

3.5

4.7

96.14

32.39

ug/l

0.79

423

4123

Male infertility

839

1.16

0.73

6.1

5.5

78.10

17.61

ug/l

0.60

690

Mental retardation, wide definition

116

1009

1.15

0.73

2.8

4.5

84.11

14.45

ug/l

0.51

813

Trochanteric bursitis

808

7710

1.05

0.73

3.2

4.4

5.85

28.67

ug/l

4.38

632

6195

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

187

1.39

0.73

4.1

5.0

5.10

61.05

ug/l

0.76

160

Acute alcohol intoxication

1130

10857

1.04

0.73

3.4

4.6

24.76

32.48

ug/l

0.42

982

8886

Benign neoplasm: Parathyroid gland

456

1.24

0.72

3.9

4.4

13.31

16.23

ug/l

0.09

381

Other specified/unspecified disorders of ear

110

1.52

0.72

1.8

4.9

4.02

9.84

ug/l

—

Other conjunctival vascular disorders and cysts

106

928

1.16

0.72

4.3

4.4

8.98

28.54

ug/l

1.22

765

Perichondritis of external ear

695

1.19

0.72

3.5

4.4

35.61

29.66

ug/l

0.09

591

Disturbance of activity and attention

195

1720

1.11

0.72

3.1

4.2

2.16

34.19

ug/l

0.77

124

1128

Schizotypal disorder

565

0.80

0.72

3.8

4.8

59.72

19.45

ug/l

0.41

449

Other neurotic disorders

201

1827

1.11

0.72

3.1

4.4

15.96

18.79

ug/l

0.10

167

1502

Overexertion and strenuous or repetitive movements

381

3556

1.08

0.72

3.6

4.5

7.40

20.83

ug/l

2.90

295

2888

Other encephalitis

105

918

1.16

0.72

3.7

4.4

6.87

24.35

ug/l

1.15

756

Other enthesopathy of foot (+metatarsalgia)

486

4575

1.07

0.72

3.0

4.5

20.68

33.06

ug/l

0.37

371

3639

Lichen simplex chronicus and prurigo

285

2633

1.09

0.72

3.2

4.3

4.22

19.40

ug/l

3.97

236

2144

Abnormal reflex

170

1.40

0.71

2.9

3.9

2.48

34.39

ug/l

0.66

134

Polyarthritis, unspecified

158

1419

1.13

0.71

3.3

4.7

9.36

21.52

ug/l

0.80

129

1177

Hallux valgus (acquired)

1946

13496

1.03

0.71

3.7

4.5

14.35

28.92

ug/l

2.65

1557

10929

Congenital hypothyroidism without goiter

144

1.43

0.71

3.7

3.9

4.28

56.54

ug/l

0.54

115

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

675

6411

1.06

0.71

3.3

4.0

5.51

23.39

ug/l

2.08

527

4844

Routine general health check-up of defined subpopulation

546

1.20

0.71

3.2

4.6

15.97

9.28

ug/l

0.26

414

Erythema intertrigo

114

1005

1.15

0.71

3.6

4.4

233.67

28.68

ug/l

0.44

841

Other congenital malformations of female genitalia

118

1.46

0.70

2.4

3.9

2.99

7.06

ug/l

1.00

Chalazion

477

4490

1.07

0.70

4.2

4.4

8.20

19.05

ug/l

1.44

372

3608

Carcinoma in situ of lip, oral cavity and pharynx

103

1.54

0.70

2.8

4.4

5.05

113.29

ug/l

0.81

Onycholysis

232

1.33

0.70

3.7

4.5

21.57

38.31

ug/l

0.20

189

Syndrome of inappropriate secretion of antidiuretic hormone

224

1.34

0.70

3.7

4.0

7.55

38.68

ug/l

0.53

190

Exposure to excessive heat of man-made origin

294

0.73

0.69

2.3

4.3

7.29

45.45

ug/l

0.81

247

Haemophilus septicemia

1.67

0.69

4.8

4.3

4.08

20.33

ug/l

1.43

Traumatic amputation of part of head

1.70

0.69

4.3

3.3

6.50

126.77

ug/l

—

Other eccrine sweat disorders

1.93

0.69

2.8

4.0

2.56

9.36

ug/l

—

Other osteochondropathies

246

2262

1.10

0.69

4.2

4.5

36.23

16.46

ug/l

0.33

210

1816

Cerebral amyloid angiopathy

252

1.32

0.68

3.3

4.1

5.75

50.26

ug/l

0.83

215

Excessive earwax

3644

32313

1.02

0.68

3.9

4.3

11.12

28.45

ug/l

5.57

2891

26473

Polyarteritis nodosa

233

1.33

0.68

4.4

14.18

53.98

ug/l

0.60

198

Brachial plexus disorders

301

3243

0.92

0.68

3.7

4.4

4.67

29.45

ug/l

1.60

243

2516

Family history of other conditions

285

1.28

0.68

3.8

4.5

2.80

23.63

ug/l

0.75

227

Urethritis and urethral syndrome

745

1.17

0.68

3.4

4.4

3.13

24.92

ug/l

1.34

610

Other chondrocalcinosis

552

1.21

0.68

2.7

4.4

3.73

28.82

ug/l

1.13

473

Cardiomyopathy in other diseases

252

1.32

0.67

2.8

4.8

2.76

41.58

ug/l

0.84

214

Exposure to other specified electric current

549

0.81

0.67

3.0

4.8

9.58

20.49

ug/l

0.45

434

Foreign body in respiratory tract

192

1748

1.11

0.67

3.1

4.3

21.72

19.72

ug/l

0.04

151

1406

Dermatitis due to ingested food

336

0.76

0.67

3.5

3.9

3.41

4.89

ug/l

0.50

225

Dilated cardiomyopathy

498

5268

0.94

0.67

3.3

4.5

9.80

25.09

ug/l

3.20

411

4430

Benign neoplasm: Vulva

794

1.17

0.67

3.6

4.0

3.15

10.35

ug/l

4.23

641

Other and unspecified nonorganic psychotic disorders

562

5931

0.94

0.66

3.3

4.5

20.88

27.34

ug/l

0.16

444

4629

Burn and corrosion of ankle and foot

448

0.79

0.66

3.1

4.8

13.83

23.00

ug/l

0.29

371

Other enthesopathies

1542

14932

1.04

0.66

3.3

4.6

19.36

29.12

ug/l

0.55

1238

11945

Primary coxarthrosis, bilateral

1616

16660

0.97

0.66

3.6

4.2

24.60

22.65

ug/l

0.09

1347

13854

Otitis media in diseases classified elsewhere

1.84

0.66

6.8

4.6

3.58

15.33

ug/l

—

Carcinoma in situ of vulva

324

1.27

0.66

2.7

4.1

3.31

9.58

ug/l

2.20

261

Other corneal oedema

361

1.25

0.66

3.4

4.2

3.47

37.79

ug/l

0.98

312

Complications following abortion and ectopic and molar pregnancy

151

1362

1.12

0.66

4.1

8.61

12.93

ug/l

0.62

122

1080

Benign lipomatous neoplasm of spermatic cord

1.71

0.65

3.9

5.0

3.33

7.53

ug/l

—

Other lesions of median nerve

127

1135

1.13

0.65

2.7

4.4

18.00

24.95

ug/l

0.18

103

935

Hypermetropia

224

2434

0.91

0.65

4.0

4.3

3.04

18.36

ug/l

3.56

176

1934

Nonsuppurative otitis media, including avohilmo

1021

9179

0.96

0.65

3.7

4.3

11.37

26.71

ug/l

1.78

786

7138

Maternal care for known or suspected disproportion

1094

0.87

0.65

4.1

3.9

2.81

43.86

ug/l

0.65

778

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

681

1.17

0.65

4.0

4.4

11.71

14.00

ug/l

0.08

518

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

577

5474

1.06

0.65

4.1

4.2

9.12

25.42

ug/l

1.45

424

4040

Presbyopia

290

3119

0.92

0.65

3.9

4.5

46.52

22.07

ug/l

0.34

221

2498

Tic disorders

172

1.35

0.64

3.7

4.5

6.92

6.15

ug/l

0.06

133

228

2092

1.09

0.64

3.0

3.7

8.66

21.07

ug/l

1.21

194

1738

Golimumab

110

974

1.14

0.64

3.2

4.6

152.01

18.89

ug/l

0.42

764

Adrenogenital disorders

137

0.64

0.63

3.2

4.7

2.96

39.52

ug/l

—

120

Tooth agenesis EXCLUDE clefts and syndromes

542

1.19

0.63

4.1

4.2

6.36

16.04

ug/l

0.50

394

Disorders of myoneural junction and muscle in diseases classified elsewhere

299

1.27

0.63

3.0

4.4

3.98

22.31

ug/l

0.71

249

Amblyopia ex anopsia

124

1107

1.13

0.63

3.3

4.3

2.76

18.50

ug/l

2.37

893

Emotional disorders starting during childhood or adolescence

399

0.79

0.63

3.7

3.9

2.88

5.16

ug/l

0.77

253

Otitis media, unspecified

252

2509

0.92

0.63

3.4

4.3

12.18

31.01

ug/l

0.67

181

1934

Use of biperiden

175

1919

0.90

0.63

2.4

4.5

10.10

18.97

ug/l

0.87

144

1575

Patent foramen ovale

573

1.18

0.63

3.8

4.7

3.01

20.03

ug/l

1.24

462

Guttate psoriasis

426

1.22

0.63

3.8

4.6

3.52

17.62

ug/l

0.79

349

Achilles tendinitis

441

4669

0.94

0.62

3.6

4.8

4.43

30.66

ug/l

5.22

349

3798

Other specified and unspecified disorders of conjunctiva

363

1.24

0.62

3.1

4.3

100.84

19.24

ug/l

0.45

301

Thrombotic microangiopathy

201

1.33

0.62

2.8

4.6

2.90

65.35

ug/l

0.93

166

Meningitis, viral

131

1.42

0.62

5.4

4.1

18.73

59.93

ug/l

0.34

105

Benign intracranial hypertension

165

1.35

0.62

2.9

4.4

2.51

7.49

ug/l

1.25

125

Other congenital malformations of kidney

114

1.45

0.61

2.3

4.6

4.29

6.10

ug/l

—

Superficial injuries involving multiple body regions

789

1.15

0.61

3.0

4.6

4.96

23.90

ug/l

1.13

659

Mandibular retrognathia

144

1590

0.90

0.61

4.4

4.3

7.42

16.26

ug/l

0.85

111

1204

Cholesteatoma of middle ear

191

2082

0.91

0.61

4.1

4.3

8.04

19.69

ug/l

1.65

160

1737

Burns and corrosions of multiple and unspecified body regions

671

0.84

0.61

4.4

4.8

19.43

21.43

ug/l

0.05

555

Allergic contact dermatitis

554

5266

1.06

0.61

3.3

4.2

16.41

25.94

ug/l

0.51

433

4129

Central nervous system disorder causing precocious puberty

0.00

0.61

0.0

2.8

—

1.62

—

Spinal osteochondrosis

309

1.25

0.60

2.7

5.5

4.41

21.01

ug/l

0.65

257

Scabies, including avohilmo

457

4319

1.06

0.60

3.6

4.3

11.49

28.57

ug/l

1.15

343

3337

Short Achilles tendon (acquired)

1032

0.87

0.60

4.0

4.6

4.12

28.40

ug/l

2.05

822

Injury of eye and orbit

530

5034

1.06

0.60

4.2

4.7

11.04

35.51

ug/l

2.21

429

4055

Other benign neoplasms of connective and other soft tissue

420

3966

1.07

0.60

4.1

4.2

35.41

21.98

ug/l

0.27

343

3206

Certain zoonotic bacterial diseases, including avohilmo

118

1056

1.13

0.60

3.5

4.5

7.89

25.71

ug/l

1.28

879

Muscular dystrophy

265

1.28

0.60

3.1

4.6

24.77

23.54

ug/l

0.02

221

Congenital heart conduction disorder

0.00

0.59

0.0

5.9

—

10.12

—

Other specific arthropathies, wide

802

1.15

0.59

3.0

4.7

3.06

26.06

ug/l

1.54

663

Cyst of Bartholin Gland

136

1227

1.12

0.59

3.4

4.2

8.33

11.38

ug/l

0.31

107

947

Benign neoplasm: Larynx

133

1200

1.12

0.59

3.4

4.4

11.79

24.11

ug/l

0.62

110

1003

Otorrhoea

0.56

0.59

10.4

4.6

2.48

11.28

ug/l

—

Abscess of Bartholin gland

726

1.15

0.59

3.3

4.4

4.49

9.71

ug/l

1.75

569

Pure hyperglyceridaemia

822

1.15

0.58

3.7

4.6

5.57

27.08

ug/l

1.36

675

IgA nephropathy (IgA glomerulonephritis)

756

1.15

0.58

3.2

4.8

17.08

25.93

ug/l

0.23

625

Ototoxic hearing loss

1.60

0.58

2.2

4.0

7.49

15.29

ug/l

—

Pollen allergy

453

4716

0.94

0.58

3.4

4.3

5.70

26.18

ug/l

1.84

322

3521

Erythema multiforme

804

1.15

0.58

3.1

4.5

10.87

27.14

ug/l

0.64

662

Infectious mononucleosis, including avohilmo

164

1494

1.10

0.57

4.1

4.4

5.69

40.48

ug/l

0.80

119

1077

Infectious mononucleosis

164

1494

1.10

0.57

4.1

4.4

5.69

40.48

ug/l

0.80

119

1077

Superficial injury of neck

448

1.20

0.57

3.6

4.8

3.65

17.26

ug/l

0.79

361

Autoimmune thyroiditis

560

1.18

0.57

4.1

4.2

39.00

17.18

ug/l

0.35

449

Myositis

110

984

1.13

0.57

3.0

4.7

18.20

26.32

ug/l

0.29

807

Graves disease, strict definition

393

3709

1.07

0.57

3.4

4.2

11.95

30.15

ug/l

0.99

300

2874

Mature T/NK-cell lymphomas, hilmo

543

1.18

0.57

2.0

4.5

3.42

35.25

ug/l

1.41

459

Purulent endophthalmitis

249

1.28

0.57

4.8

4.0

3.57

54.54

ug/l

0.94

204

Reiter disease

186

1.33

0.57

3.3

5.4

6.70

29.90

ug/l

0.51

154

Glaucoma

3453

28759

1.02

0.57

4.0

4.2

16.93

27.19

ug/l

1.61

2864

23737

Other articular cartilage disorders

102

909

1.14

0.57

3.8

5.0

55.72

24.29

ug/l

0.27

762

Actinic reticuloid

1.67

0.57

4.8

4.6

6.18

2.60

ug/l

—

Ectopic pregnancy

707

6776

1.05

0.57

3.9

4.1

21.83

20.20

ug/l

0.05

532

5140

Melanoma in situ of scalp and neck

117

1.44

0.57

4.8

4.9

3.81

46.80

ug/l

0.60

Burn and corrosion of wrist and hand

116

1040

1.12

0.57

4.1

4.6

6.69

21.11

ug/l

1.02

849

Assault by blunt object

348

1.22

0.57

4.6

5.1

4.85

26.23

ug/l

0.85

282

Migraine with aura

968

9329

1.04

0.56

3.3

4.4

4.59

23.91

ug/l

4.43

700

7172

Pedestrian injured in transport accident

276

2577

1.08

0.56

3.4

4.3

11.62

17.05

ug/l

0.32

214

2095

Paralytic strabismus

316

2966

1.07

0.56

3.9

4.3

55.61

20.69

ug/l

0.31

267

2453

Fracture of neck

269

2511

1.08

0.56

3.4

4.2

32.04

22.49

ug/l

0.25

235

2086

Sixth [abducent] nerve palsy

147

1338

1.11

0.56

4.3

110.36

22.38

ug/l

0.39

125

1102

Thyrotoxicosis with diffuse goitre

624

5966

1.05

0.56

3.5

4.2

40.05

24.71

ug/l

0.23

489

4705

Symptoms and signs involving appearance and behaviour

249

1.27

0.56

3.3

5.0

3.23

8.95

ug/l

1.99

202

Pemphigoid

130

1177

1.12

0.56

3.9

4.0

4.02

22.88

ug/l

2.02

101

991

Hyperkinetic disorders

202

1813

1.09

0.56

3.1

4.2

2.15

35.37

ug/l

0.87

129

1196

Left ventricular outflow tract obstruction (LVOTO), broad definition

371

3499

1.07

0.56

3.7

4.7

32.91

21.00

ug/l

0.22

287

2869

Certain conditions originating in the perinatal period

127

1014

1.11

0.56

3.3

4.1

3.28

12.37

ug/l

1.17

724

Other specified/unspecified inflammatory spondylopathies

160

1461

1.10

0.56

3.7

4.7

77.73

42.09

ug/l

0.19

122

1138

Artificial joint re-operation

320

3402

0.93

0.56

2.9

4.2

9.80

20.08

ug/l

1.39

259

2796

Psoriatic and enteropathic arthropathies

521

4962

1.06

0.56

3.4

4.7

12.12

31.33

ug/l

1.61

417

4034

Neurological diseases

4457

21989

1.02

0.56

3.8

4.7

19.43

29.84

ug/l

1.50

3533

17616

Other and unspecified iridocyclitis

188

1731

1.09

0.56

3.5

4.5

6.67

20.71

ug/l

1.52

143

1412

Bicuspidal aortic valve syndrome

109

1215

0.89

0.55

3.9

4.6

3.09

22.45

ug/l

2.06

1006

Contact with other hot metals

488

1.19

0.55

3.3

4.7

3.58

35.05

ug/l

1.18

407

Miliary tuberculosis

1.50

0.55

2.1

3.2

2.27

6.29

ug/l

—

Tinnitus

1205

11678

1.04

0.55

3.8

4.4

9.20

28.04

ug/l

4.46

943

9529

Other congenital malformations of face and neck

740

1.15

0.55

3.0

4.5

10.52

24.25

ug/l

0.56

591

Ehlers-Danlos syndrome, including avohilmo

231

1.27

0.55

3.3

4.3

2.30

29.01

ug/l

0.70

173

Thyroiditis, unspecified

517

1.18

0.54

2.4

4.0

2.56

17.38

ug/l

1.08

412

Supernumerary ureter

1.59

0.54

7.0

4.9

3.03

9.11

ug/l

—

Chromomycosis and phaeomycotic abscess, including avohilmo

126

1.39

0.54

3.2

4.6

2.50

40.90

ug/l

0.57

101

Anomalies of pupillary function

610

1.16

0.54

4.6

4.4

8.89

15.20

ug/l

0.30

494

Eustachian salpingitis and obstruction

219

2030

1.08

0.54

4.1

4.4

10.58

36.54

ug/l

0.82

151

1551

Ehlers-Danlos syndrome

187

1.30

0.54

3.7

4.4

2.43

9.73

ug/l

1.58

142

Enthesopathies of lower limb, excluding foot

1106

10707

1.04

0.54

3.4

4.6

11.22

28.56

ug/l

1.50

876

8539

Epiphora

101

904

1.13

0.54

3.8

4.4

9.12

21.52

ug/l

0.72

742

Other and unspecified injuries of shoulder and upper arm

123

1112

1.12

0.54

2.8

4.5

12.82

24.96

ug/l

0.63

912

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

396

1.20

0.54

4.1

4.2

3.03

99.32

ug/l

0.54

285

Xanthelasma of eyelid

343

1.22

0.53

2.0

4.5

2.42

19.92

ug/l

0.82

287

Use of pramipexole

1171

11354

1.04

0.53

3.3

4.3

31.05

26.48

ug/l

0.08

946

9333

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

242

1.27

0.53

3.6

4.4

36.17

54.94

ug/l

0.16

199

Rheumatic fever incl heart disease

102

1137

0.89

0.53

3.4

4.1

5.64

25.62

ug/l

1.87

960

Erosion of teeth , including avohilmo

1022

9881

1.04

0.53

3.8

4.3

5.57

26.91

ug/l

5.10

775

7749

Other bursal cyst

638

0.85

0.53

3.0

4.9

56.10

34.58

ug/l

0.17

523

Burn and corrosion of head and neck

618

0.85

0.53

6.0

5.0

90.49

12.13

ug/l

0.49

508

Other and unspecified rosacea

391

3703

1.06

0.53

3.5

4.2

8.04

28.73

ug/l

1.39

295

2945

Problems related to social environment

104

932

1.13

0.53

2.5

4.1

5.51

24.71

ug/l

1.41

773

Major coronary heart disease event excluding revascularizations

3570

23965

0.98

0.53

3.6

4.6

12.27

29.19

ug/l

5.95

2961

19869

Cardiomyopathy, Hypertrophic obstructive

723

0.86

0.52

3.0

4.9

6.00

24.42

ug/l

1.11

599

Disorders of refraction and accommodation

1071

11019

0.97

0.52

3.9

4.4

19.47

24.66

ug/l

0.21

795

8692

Recurrent dislocation of patella

123

1112

1.11

0.52

3.4

4.5

9.02

43.02

ug/l

0.53

821

Vitreous haemorrhage

466

4437

1.06

0.52

3.7

4.3

11.72

22.49

ug/l

1.72

392

3627

Carcinoma in situ of other and unspecified genital organs

745

1.14

0.52

3.1

4.0

2.79

9.36

ug/l

4.36

598

Disorders of optic nerve and visual pathways

357

3373

1.06

0.52

3.8

4.3

30.60

27.18

ug/l

0.05

289

2673

Thromboangiitis obliterans

145

1.36

0.52

2.1

4.9

2.98

40.06

ug/l

0.72

124

Separation of retinal layers (serosa)

168

1546

1.10

0.52

3.9

4.5

7.21

16.20

ug/l

1.41

134

1262

Infections with a predominantly sexual mode of transmission, including avohilmo

1314

11666

1.03

0.52

3.7

4.2

17.15

23.18

ug/l

0.34

981

8805

Other and unspecified mental retardation

285

1.23

0.51

2.5

4.6

6.27

23.23

ug/l

0.51

214

Sequelae of malnutrition and other nutritional deficiencies

1.51

0.51

2.2

4.5

10.55

67.39

ug/l

—

Psoriasis vulgaris

835

8057

1.04

0.51

3.9

4.5

33.78

24.18

ug/l

0.34

702

6579

Spirochaetal infections, other/unspecified, including avohilmo

1648

16898

0.97

0.50

3.9

4.4

12.20

25.00

ug/l

1.30

1264

13731

Respiratory disorders in diseases classified elsewhere

531

1.17

0.50

2.3

4.4

3.49

28.93

ug/l

1.06

445

Unspecified hairloss

1.58

0.50

5.0

3.7

2.91

102.00

ug/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

105

1.37

0.50

1.1

3.2

3.81

2.93

ug/l

—

Chondromalacia

105

946

1.12

0.50

3.3

4.6

55.82

15.61

ug/l

0.53

768

Persistent delusional disorders

282

2999

0.93

0.50

3.3

4.3

47.21

16.11

ug/l

0.55

233

2431

Other localized connective tissue disorders

738

1.14

0.50

2.9

4.1

39.34

24.27

ug/l

0.16

606

Sexual assault by bodily force

1.60

0.50

3.6

4.8

23.79

8.20

ug/l

—

Chromosomal abnormalities, not elsewhere classified

306

1.22

0.50

3.5

4.6

2.38

21.06

ug/l

0.66

231

Unspecified threat to breathing

253

1.25

0.50

4.9

4.7

12.27

8.83

ug/l

0.14

197

Biological medicines for asthma

625

0.86

0.50

3.2

4.5

2.71

13.57

ug/l

0.92

504

Acute inflammation of orbit

181

1.30

0.50

2.7

5.2

2.71

32.64

ug/l

0.70

151

Embedded teeth, including avohilmo

195

1806

1.08

0.50

3.8

4.3

3.87

40.35

ug/l

1.15

146

1353

Migraine with aura and triptan purchases

507

4841

1.05

0.50

3.5

4.1

4.64

24.04

ug/l

1.82

376

3596

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

569

0.85

0.49

3.2

4.4

2.98

31.89

ug/l

1.37

488

Encephalitis

107

966

1.12

0.49

3.6

4.4

6.83

23.79

ug/l

1.17

793

Certain zoonotic bacterial diseases

635

1.15

0.49

3.4

4.6

10.62

30.67

ug/l

0.78

538

Other spirochaetal diseases, including avohilmo

1669

17103

0.97

0.49

3.9

4.4

12.13

24.90

ug/l

1.32

1279

13894

Complications following myocardial infarction

332

0.80

0.49

3.3

4.8

7.51

38.82

ug/l

0.79

273

Postprocedural musculoskeletal disorders, not elsewhere classified

354

3356

1.06

0.49

2.9

4.3

36.60

20.33

ug/l

0.29

302

2756

Vertigo of central origin

655

1.15

0.49

2.7

4.2

3.25

30.78

ug/l

1.55

558

Dysplastic lesion of the vagina of unknown severity

1.51

0.49

2.4

4.0

4.19

6.05

ug/l

—

Congenital deformities of hip

335

1.20

0.49

5.8

4.1

2.65

7.01

ug/l

1.99

256

Other disorders of the musculoskeletal system and connective tissue

715

6889

1.04

0.48

3.2

4.3

32.19

23.42

ug/l

0.22

595

5625

Embolism and thrombosis of abdominal aorta

1.50

0.48

4.0

4.4

7.03

99.41

ug/l

0.54

Other/unspecified synovitis and tenosynovitis

521

4986

1.05

0.48

3.8

4.6

31.74

31.73

ug/l

0.00

412

4028

All dysplastic lesions of the vagina

101

911

1.12

0.48

4.0

5.45

13.49

ug/l

0.78

716

Congenital malformations of the respiratory system, including avohilmo

598

1.15

0.48

3.0

4.3

10.92

26.07

ug/l

0.51

490

Diabetic neuropathy

529

5042

1.05

0.48

3.5

4.0

26.19

21.38

ug/l

0.12

440

4262

Exposure to sunlight

1.48

0.48

4.8

4.5

4.05

9.15

ug/l

0.92

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

347

1.20

0.47

3.1

4.3

11.98

8.02

ug/l

0.25

267

Retinal detachment with retinal break

649

6248

1.04

0.47

4.2

4.4

31.88

23.34

ug/l

0.35

516

5202

Postdysenteric arthropathy

283

1.22

0.47

3.6

4.5

70.23

22.40

ug/l

0.31

234

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

1.81

0.47

1.4

6.3

1.92

17.11

ug/l

—

Pulmonary eosinophilia, not elsewhere classified

479

1.17

0.47

3.0

4.4

128.17

40.15

ug/l

0.31

400

Infections of breast associated with childbirth

807

1.12

0.46

4.1

5.88

13.96

ug/l

0.64

583

Sulfonylureas

1958

15215

1.02

0.46

3.6

4.3

33.34

26.04

ug/l

0.37

1673

12742

Disturbances of smell and taste

187

1740

1.08

0.46

4.0

4.6

10.62

23.22

ug/l

0.94

161

1420

Type 1 diabetes, wide definition

806

7778

1.04

0.46

3.8

4.5

22.14

30.33

ug/l

0.28

684

6175

Methotrexate

601

6251

0.96

0.46

3.1

4.3

23.74

28.15

ug/l

0.18

485

4986

Bipolar affective disorders

642

6176

1.04

0.46

3.2

4.5

7.62

28.26

ug/l

2.63

516

4799

Mixed specific developmental disorders

127

1.32

0.46

3.7

3.6

2.60

1.97

ug/l

0.28

Acute laryngitis and tracheitis

296

2749

1.06

0.46

3.2

4.3

9.19

35.48

ug/l

1.19

213

2091

Other specified disorders of muscle

118

1077

1.11

0.46

3.6

4.6

8.29

27.23

ug/l

1.40

882

Other spirochaetal diseases

1652

16907

0.97

0.45

3.9

4.4

12.23

24.98

ug/l

1.30

1266

13743

Other disorders starting during childhood or adolecense, excluding more controls

437

1.16

0.45

3.2

4.6

2.55

5.98

ug/l

1.76

296

Female infertility, associated with anovulation

151

1391

1.09

0.45

3.2

4.3

6.55

44.70

ug/l

0.77

105

967

Contact with nonpowered hand tool

127

1385

0.91

0.45

4.7

4.47

22.14

ug/l

2.04

105

1147

Psoriatic arthropathies

419

4389

0.95

0.45

3.3

4.8

11.72

30.86

ug/l

1.94

342

3603

Amiodarone users

491

4706

1.05

0.45

3.2

4.4

14.91

20.71

ug/l

0.28

389

3927

Polyglandular dysfunction, other/unspecified

1.71

0.45

2.2

4.9

2.86

11.02

ug/l

—

Focal brain injury

260

2758

0.94

0.45

3.5

5.1

7.25

25.98

ug/l

3.39

209

2297

Labour and delivery complicated by umbilical cord complications

135

1468

0.91

0.45

4.3

4.2

9.44

45.09

ug/l

0.80

101

1113

Injury of nerves at wrist and hand level

129

1183

1.10

0.45

4.3

4.8

10.37

25.29

ug/l

1.00

106

967

Tularaemia

443

1.17

0.44

2.9

4.7

4.96

37.77

ug/l

1.12

377

Juvenile osteochondrosis

715

1.13

0.44

3.2

4.4

4.71

13.98

ug/l

0.83

564

Congenital malformations of anterior segment of eye

239

1.24

0.44

5.0

4.6

2.55

25.16

ug/l

0.69

197

Benign neoplasm: Vagina

481

1.16

0.44

3.0

4.3

14.80

10.05

ug/l

0.25

401

Isolated proteinuria

104

945

1.11

0.44

3.2

4.6

4.99

25.28

ug/l

1.48

778

Idiopathic pulmonary fibrosis

386

3682

1.05

0.44

3.3

4.1

17.26

21.45

ug/l

0.27

326

3081

Amoebiasis, including avohilmo

240

0.78

0.44

3.8

4.6

3.76

37.57

ug/l

0.63

198

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

323

1.20

0.44

3.9

4.4

35.98

41.28

ug/l

0.05

269

Schizoaffective disorder

222

2366

0.93

0.44

2.6

4.5

9.54

19.38

ug/l

1.13

194

1860

Parapsoriasis

651

1.13

0.44

2.7

4.5

90.81

28.70

ug/l

0.37

541

Failed induction of labour

998

0.90

0.44

4.0

3.7

3.14

49.73

ug/l

0.63

669

Chorioretinal inflammation

112

1023

1.11

0.43

3.3

4.4

46.05

18.61

ug/l

0.67

838

Chondrolysis

0.00

0.43

0.0

5.2

—

4.18

—

Congenital malformations of heart and great arteries

429

3976

1.05

0.43

3.6

4.4

48.54

20.31

ug/l

0.53

339

3155

Anogenital herpesviral [herpes simplex] infection, including avohilmo

295

2791

1.06

0.43

4.0

4.3

11.06

28.35

ug/l

0.62

219

2079

Rickettsioses, including avohilmo

1.45

0.43

6.1

4.3

3.82

97.29

ug/l

0.54

Injury of nerves at shoulder and upper arm level

379

1.18

0.43

3.2

5.1

10.52

42.28

ug/l

0.78

318

Systemic sclerosis, icd10

101

919

1.11

0.43

2.4

4.1

4.10

23.43

ug/l

1.47

738

Other nonthrombocytopenic purpura

361

1.18

0.43

3.5

4.4

3.64

35.89

ug/l

0.86

305

Accident to powered aircraft causing injury to occupant

0.00

0.43

0.0

4.6

—

7.42

—

Tibial collateral bursitis [Pellegrini-Stieda]

417

1.17

0.43

3.0

5.0

3.36

19.09

ug/l

0.87

336

Acne, including avohilmo

392

3326

0.95

0.42

3.7

4.1

40.01

29.38

ug/l

0.11

276

2320

Defects in the complement system

204

1.25

0.42

3.3

3.9

17.51

8.16

ug/l

0.27

158

Disorders of ocular muscles, binocular movement, accommodation and refraction

2083

21050

0.98

0.42

3.8

4.3

21.14

23.76

ug/l

0.10

1607

16703

Other hypertrichosis

1.43

0.42

2.4

4.2

1.85

8.75

ug/l

—

Other and unspecified injuries of neck

213

1.24

0.42

1.6

4.5

2.80

9.60

ug/l

1.88

170

Lumbosacral spina bifida and hydrocephalus

0.00

0.42

0.0

5.5

—

9.94

—

Behçet disease

1.41

0.42

1.8

4.3

2.28

9.74

ug/l

—

Ankyloglossia

122

1.31

0.42

3.2

3.8

1.70

3.20

ug/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

854

1.11

0.41

4.0

4.5

36.96

26.06

ug/l

0.17

713

Sub-endpoint used in defining T1D endpoints

1126

11374

0.97

0.41

3.7

4.2

24.51

30.09

ug/l

0.22

959

9213

Otosclerosis

337

3210

1.06

0.41

4.1

4.3

19.66

22.30

ug/l

0.10

291

2618

Anankastic personality disorder

1066

0.90

0.41

2.7

4.6

5.23

18.64

ug/l

1.31

825

Use of interferon beta-1a

508

0.86

0.41

3.1

4.7

4.46

16.48

ug/l

0.69

393

Sequelae of injuries of neck and trunk

110

1007

1.10

0.41

2.9

4.6

41.98

24.10

ug/l

0.19

829

Haemorrhagic disorder due to circulating anticoagulants

579

1.14

0.41

3.4

4.0

12.10

29.10

ug/l

0.53

498

Vasomotor rhinitis (mode)

276

2912

0.94

0.41

3.7

4.3

6.35

18.53

ug/l

2.30

213

2350

Benign neoplasm: Bladder

381

1.18

0.41

4.5

4.6

3.93

41.32

ug/l

1.15

326

Operations for atrial fibrillation

622

0.87

0.41

3.8

4.8

5.39

32.47

ug/l

1.34

530

Crossbite

140

1393

0.92

0.41

3.5

4.4

4.53

20.23

ug/l

1.60

103

1062

Other osteochondrodysplasias

223

1.23

0.41

4.4

5.0

5.27

6.75

ug/l

0.19

182

Ankylosis of joint

187

1.26

0.41

3.2

4.7

3.30

61.90

ug/l

1.00

172

Disorders of olfactory nerve

1.49

0.41

6.0

3.9

38.10

141.17

ug/l

—

Acute suppurative otitis media

690

6211

1.04

0.41

3.8

4.2

10.87

25.83

ug/l

1.30

496

4644

Corneal degeneration

717

0.88

0.41

4.3

3.81

27.97

ug/l

1.41

601

Acute poliomyelitis

485

1.15

0.41

5.1

4.3

27.35

22.08

ug/l

0.09

406

Other/unspecified rheumatoid arthritis

565

5860

0.96

0.41

3.3

4.1

43.97

24.09

ug/l

0.41

465

4800

Acute epiglottitis

485

0.86

0.40

4.7

5.0

5.76

29.16

ug/l

0.81

405

Specific development disorders of speech and language

132

1173

1.09

0.40

3.9

4.3

4.90

21.70

ug/l

1.50

102

920

Glaucoma, exfoliation

585

5644

1.04

0.40

3.8

3.9

28.91

25.88

ug/l

0.06

501

4679

Sudden idiopathic hearing loss

481

4623

1.05

0.40

4.0

4.3

62.80

20.70

ug/l

0.36

386

3796

Causalgia

527

0.86

0.40

4.3

4.7

3.13

21.79

ug/l

1.23

421

Chronic mastoiditis

106

971

1.10

0.40

3.2

4.2

17.56

25.19

ug/l

0.28

811

Cerebral oedema

1.41

0.40

5.1

4.3

6.98

8.57

ug/l

—

Myeloproliferative diseases (CML excluded)

355

3390

1.05

0.40

2.9

4.2

10.07

21.64

ug/l

0.89

268

2786

Lyme disease, including avohilmo

1643

16780

0.98

0.40

3.9

4.4

12.23

25.05

ug/l

1.30

1259

13635

Lyme disease

1643

16780

0.98

0.40

3.9

4.4

12.23

25.05

ug/l

1.30

1259

13635

Systemic sclerosis

102

933

1.10

0.40

2.4

4.3

4.10

26.09

ug/l

1.69

745

Cardiovascular disorders originating in the perinatal period

0.00

0.40

0.0

2.3

—

5.60

—

Cutaneous lupus erythematosus

100

914

1.11

0.40

4.0

4.3

9.03

25.42

ug/l

0.99

749

Other symptoms and signs involving general sensations and perceptions

170

1588

1.08

0.40

3.3

4.2

5.75

21.72

ug/l

2.15

139

1331

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

215

0.78

0.40

3.3

4.2

2.34

28.33

ug/l

0.68

169

Injury of nerves at lower leg level

326

1.18

0.40

3.2

4.9

4.10

28.28

ug/l

0.92

265

Acute poliomyelitis, including avohilmo

486

1.15

0.40

5.1

4.3

27.35

22.04

ug/l

0.10

407

Carcinoma in situ of skin, other sites/unspecified

705

1.12

0.40

3.1

4.0

3.13

30.27

ug/l

1.64

593

Specific development disorders of scholastic skills

446

1.15

0.40

2.7

4.4

213.22

5.56

ug/l

0.48

301

Other facial nerve disorders

1051

0.91

0.39

4.2

4.6

270.39

22.44

ug/l

0.45

854

Chloasma

188

1.25

0.39

3.4

4.2

2.98

8.63

ug/l

1.44

151

Other disorders of patella

723

7002

1.04

0.39

4.0

4.7

15.32

34.65

ug/l

1.53

573

5554

Melanocytic naevi of eyelid, including canthus

336

1.18

0.39

4.2

4.1

3.91

20.12

ug/l

0.67

270

Contact with sharp glass

979

0.90

0.39

4.3

4.7

32.05

27.90

ug/l

0.05

777

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

113

0.69

0.39

4.6

5.1

2.94

47.88

ug/l

—

Other bursitis of knee

524

1.14

0.39

3.1

5.1

19.56

34.51

ug/l

0.34

431

Nasal polyp

876

9014

0.97

0.39

3.9

4.6

37.05

28.75

ug/l

0.19

724

7481

Recurrent dislocation and subluxation of joint

218

2053

1.07

0.39

3.2

4.8

21.72

47.80

ug/l

0.68

174

1628

Graves ophthalmopathy, strict

768

0.89

0.39

3.1

4.3

252.53

15.52

ug/l

0.48

617

Other puerperal infections

138

1489

0.92

0.39

3.5

3.7

6.21

35.47

ug/l

0.59

1024

Psoriasis

1356

13254

1.03

0.39

3.6

4.4

25.37

24.38

ug/l

0.04

1118

10747

Keratopathy (bullous aphakic) following cataract surgery

1.57

0.39

3.8

3.7

7.15

9.05

ug/l

—

Scleritis

430

1.15

0.39

4.1

4.5

3.87

19.37

ug/l

0.89

350

Allergic purpura

886

1.10

0.39

4.7

4.5

7.55

23.06

ug/l

0.94

723

Leukaemia of unspecified cell type

346

1.18

0.39

4.3

4.5

3.44

51.41

ug/l

1.32

291

Bicornuate uterus

136

0.73

0.38

1.9

4.6

1.72

9.45

ug/l

—

103

Hereditary motor and sensory neuropathy

300

0.82

0.38

3.4

4.7

9.22

21.58

ug/l

0.39

252

Pneumoconiosis due to asbestos and other mineral fibres

819

0.89

0.38

2.6

4.1

11.10

39.66

ug/l

1.33

684

Blepharochalasis

1724

16905

1.02

0.38

3.7

4.3

18.68

22.37

ug/l

0.34

1384

13957

Iliotibial band syndrome

393

1.16

0.38

3.7

4.9

2.59

8.01

ug/l

3.24

315

Maxillary retrognathism

333

0.83

0.38

3.2

4.6

7.48

20.20

ug/l

0.46

264

Molar incisor enamel hypoplasia

374

1.15

0.38

2.9

4.2

1.93

6.50

ug/l

1.83

249

Viral infections of the central nervous system

258

2447

1.06

0.38

3.8

4.3

20.49

19.77

ug/l

0.02

202

1963

Hypopituitarism

225

2124

1.06

0.38

3.4

4.8

33.34

18.47

ug/l

0.30

167

1730

Disorders of speech understanding and production

109

982

1.09

0.38

3.6

4.2

5.39

23.69

ug/l

1.36

790

Graves ophthalmopathy

860

0.90

0.38

2.9

4.2

221.36

19.58

ug/l

0.46

691

Systemic sclerosis,strict definition

342

0.83

0.38

2.0

4.2

3.31

19.87

ug/l

0.73

280

Injury of muscle and tendon at wrist and hand level

512

5311

0.96

0.37

4.5

4.7

24.51

26.80

ug/l

0.05

420

4327

Open bite that required surgery (Lefort1 or BSSO)

169

0.76

0.37

2.2

4.6

5.98

5.27

ug/l

—

132

Contusion of toe(s) with damage to nail

309

1.18

0.37

5.4

4.8

3.48

44.64

ug/l

0.89

244

Contact with other specified venomous animals

226

1.22

0.37

4.2

23.82

27.82

ug/l

0.05

185

Temporomandibular joint disorders, including avohilmo

1813

17895

0.98

0.37

3.3

4.2

12.71

23.00

ug/l

0.82

1365

13788

Patellar tendinitis

386

0.85

0.37

2.6

5.4

2.06

35.72

ug/l

0.95

312

Viral conjunctivitis

592

1.12

0.37

3.0

4.5

280.11

27.23

ug/l

0.44

470

Polymyositis

320

0.83

0.37

2.6

4.3

3.23

21.02

ug/l

0.76

269

Mixed conductive and sensorineural hearing loss

613

5932

1.04

0.37

3.8

4.3

20.47

27.97

ug/l

0.39

493

4896

Hypoplasia of dental enamel , including avohilmo

359

1.16

0.37

3.0

4.2

2.00

6.68

ug/l

1.78

239

Hypertension, Pulmonary Arterial

310

1.18

0.37

2.4

4.5

36.04

35.91

ug/l

0.00

256

Renal agenesis and other reduction defects of kidney, including avohilmo

162

1.26

0.37

4.7

5.1

3.95

35.59

ug/l

0.61

128

Other disorders of pigmentation

199

1876

1.07

0.37

4.1

4.4

5.50

20.24

ug/l

2.36

164

1533

Other meningitis

488

1.14

0.37

3.8

4.4

4.17

15.50

ug/l

0.68

396

Degenerative and vascular disorders of ear

1.48

0.37

3.0

4.8

12.82

7.58

ug/l

—

Acute sinusitis

2420

21627

1.02

0.37

3.8

4.3

27.92

25.91

ug/l

0.09

1875

17122

Primary gonarthrosis, bilateral

3159

26811

0.98

0.37

3.5

4.4

20.27

25.34

ug/l

0.47

2540

22142

Macular cyst

159

1490

1.08

0.36

4.0

4.4

11.57

15.48

ug/l

0.18

130

1242

Gluteal tendinitis

199

1877

1.07

0.36

3.4

4.6

4.37

17.24

ug/l

2.48

163

1481

Polyhydramnios

108

994

1.09

0.36

4.0

3.8

49.32

49.64

ug/l

0.00

689

Other benign neoplasm of uterus: Other parts/unspecified

205

1938

1.07

0.36

3.2

3.7

8.97

12.56

ug/l

0.40

165

1583

Combined immunodeficiencies

367

1.16

0.36

4.9

4.0

3.61

38.03

ug/l

0.98

311

Other sleep disorders

493

4754

1.04

0.36

3.5

4.7

25.23

32.21

ug/l

0.15

409

3890

Recurrent and persistent haematuria

283

1.18

0.36

2.8

4.4

3.35

8.91

ug/l

2.03

233

Peripheral retinal degeneration

126

1171

1.08

0.36

3.1

4.3

34.80

17.42

ug/l

0.23

102

962

Other demyelinating diseases of the central nervous system

962

0.91

0.36

3.5

4.7

5.42

17.27

ug/l

1.03

737

Struck by thrown, projected or falling objec

173

1625

1.07

0.36

4.1

4.6

3.85

21.26

ug/l

2.55

141

1318

Other psoriatic arthropathies

389

4050

0.96

0.35

3.2

4.4

12.41

22.80

ug/l

0.93

316

3260

Lipomatosis, not elsewhere classified

109

1.33

0.35

1.2

5.0

2.31

7.75

ug/l

—

Rheumatoid arthritis

1776

15430

1.02

0.35

3.3

4.5

23.39

28.38

ug/l

0.26

1456

12606

Varus deformity, not elsewhere classified

396

1.15

0.35

4.2

4.7

8.14

27.05

ug/l

0.54

333

Schizophrenia or delusion, excluding more controls

1168

11800

0.98

0.35

3.2

4.5

20.27

26.87

ug/l

0.37

959

9335

Diabetic maculopathy, excluding more controls

435

4187

1.04

0.35

3.7

4.5

42.65

20.38

ug/l

0.43

371

3421

Pedestrian injured in collision with pedal cycle

115

1065

1.09

0.35

3.0

4.4

5.98

21.88

ug/l

1.27

878

Iridocyclitis in diseases classified elsewhere

672

1.11

0.35

4.0

4.6

3.89

28.78

ug/l

1.34

561

Valvular operations

696

6757

1.03

0.35

3.3

4.8

26.85

32.63

ug/l

0.17

565

5756

Tumor necrosis factor alpha inhibitors

541

5229

1.04

0.35

3.4

4.5

49.30

27.21

ug/l

0.31

398

4081

Congenital deformities of feet, including avohilmo

112

1036

1.09

0.35

3.3

4.6

4.50

15.38

ug/l

1.38

825

Post-traumatic wound infection, not elsewhere classified

104

960

1.09

0.35

3.1

4.5

3.64

24.38

ug/l

1.70

798

Other and unspecified mononeuropathies, also in other diseases

123

1144

1.08

0.35

3.8

4.5

8.01

24.60

ug/l

1.29

103

935

Deformity of finger(s)

242

0.81

0.34

2.8

4.9

4.13

21.60

ug/l

1.00

213

Neuromyelitis optica

0.67

0.34

7.0

4.1

6.83

5.36

ug/l

—

Muscle strain

121

1124

1.08

0.34

3.0

4.7

6.63

28.48

ug/l

1.78

905

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

165

1549

1.07

0.34

5.1

3.8

33.57

37.18

ug/l

0.03

116

1101

Postzoster neuralgia

683

1.11

0.34

2.6

4.4

4.32

30.69

ug/l

1.45

567

Ganglion

917

9405

0.97

0.34

3.6

4.6

9.22

27.12

ug/l

2.83

726

7418

Acute and transient psychotic disorders

387

4026

0.96

0.34

3.2

4.4

5.81

29.72

ug/l

2.04

315

3211

Other injuries of lower limb, level unspecified

303

1.17

0.34

2.6

4.6

3.93

21.40

ug/l

0.66

246

Foreign body in ear

593

0.89

0.34

4.8

4.7

5.35

14.97

ug/l

0.71

488

Optic neuritis

129

1202

1.08

0.34

3.4

4.4

5.43

25.22

ug/l

1.71

108

943

Aphakia

520

1.13

0.34

3.4

4.4

6.95

21.68

ug/l

0.87

439

Convergent concomitant strabismus

164

1541

1.07

0.34

3.4

4.4

107.18

17.02

ug/l

0.42

130

1199

Pedestrian injured in collision with car, pick-up truck or van

827

1.10

0.34

3.5

4.3

24.77

24.89

ug/l

0.00

691

Other strabismus

791

8094

0.97

0.34

3.6

4.2

27.80

27.96

ug/l

0.00

611

6417

Contact with and exposure to communicable diseases

828

8464

0.97

0.34

4.3

4.2

15.45

23.89

ug/l

0.45

629

6331

Androgenic alopecia

313

1.17

0.34

2.6

4.1

3.21

9.92

ug/l

2.25

248

Eccrine sweat disorders

1.37

0.34

4.9

4.5

2.77

57.82

ug/l

0.56

Other and unspecified localized connective tissue disorders

110

1.31

0.33

3.0

4.5

4.60

9.15

ug/l

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

181

1708

1.06

0.33

4.3

4.5

101.46

21.22

ug/l

0.43

149

1366

Respiratory tuberculosis, not confirmed, including avohilmo

174

1641

1.07

0.33

3.7

4.0

67.59

20.83

ug/l

0.49

150

1366

Other bursitis, not elsewhere classified

380

0.86

0.33

3.8

4.8

12.83

39.72

ug/l

0.62

314

276

1.18

0.33

2.7

4.1

5.05

47.18

ug/l

0.90

240

Amputation

490

4735

1.04

0.33

2.8

4.2

6.96

18.86

ug/l

3.30

424

3944

Sequelae of other and unspecified infectious and parasitic diseases

179

1689

1.06

0.33

4.1

4.5

102.79

21.40

ug/l

0.43

147

1352

Respiratory tuberculosis, not confirmed

173

1632

1.07

0.33

3.7

4.0

67.59

20.95

ug/l

0.48

150

1357

Other congenital malformations of circulatory system

915

1.09

0.33

4.1

4.7

11.12

23.91

ug/l

0.69

757

Psoriatic arthropathies, ICD10

402

4173

0.96

0.33

3.3

4.4

12.12

23.01

ug/l

1.04

328

3361

Contracture of muscle

165

1.24

0.33

1.9

4.9

2.44

65.06

ug/l

0.79

134

Testicular dysfunction

122

1137

1.08

0.32

5.0

5.3

14.95

22.00

ug/l

0.28

105

956

Pregnancy examination and test

332

2147

0.96

0.32

3.8

3.4

15.02

11.06

ug/l

0.24

214

1496

Amputation of ankle bones

861

0.91

0.32

2.4

4.5

8.24

29.32

ug/l

1.26

722

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

105

973

1.08

0.32

3.4

4.7

7.03

13.07

ug/l

0.50

751

Intentional self-harm by sharp object

436

1.13

0.32

2.7

4.5

7.88

16.93

ug/l

0.39

335

Cerebral aneurysm, nonruptured

367

3813

0.96

0.32

3.4

4.3

61.11

20.17

ug/l

0.47

315

3063

Unspecified nephritic syndrome

801

1.10

0.32

3.9

4.6

4.23

22.97

ug/l

1.18

664

Coronary atherosclerosis

3811

24307

0.99

0.32

3.5

4.6

20.74

29.49

ug/l

0.82

3128

20055

Sleep apnoea, including avohilmo

5517

33666

0.99

0.32

3.5

4.4

19.97

27.22

ug/l

0.82

4346

27267

Spasmodic torticollis

122

1139

1.08

0.32

4.4

7.13

21.83

ug/l

1.17

924

Contact with other and unspecified heat and hot substances

193

1.21

0.32

3.6

5.0

2.66

10.00

ug/l

2.67

161

Other operation for atrial fibrillation

203

1.21

0.32

4.1

4.8

8.82

71.87

ug/l

0.96

177

Other disorders of central nervous system

400

0.87

0.32

3.0

4.4

8.81

35.49

ug/l

0.70

328

Keratitis

1704

16746

1.02

0.32

3.9

4.3

17.15

22.97

ug/l

0.33

1364

13532

Tuberculosis of other organs, strict, including avohilmo

103

956

1.09

0.32

3.4

3.9

42.67

25.72

ug/l

0.20

798

Measles, including avohilmo

258

1.17

0.32

4.2

4.7

5.29

12.46

ug/l

0.55

199

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

258

2463

1.05

0.31

4.7

4.1

56.52

33.79

ug/l

0.24

191

1846

Family history of certain disabilities and chronic diseases leading to disablement

126

1177

1.07

0.31

3.6

4.4

43.44

17.94

ug/l

0.37

103

919

Severe visual impairment, monocular

399

0.87

0.31

2.4

4.3

3.34

17.81

ug/l

0.79

340

Mental and behavioural disorders due to cannabinoids

390

0.87

0.31

2.5

5.5

2.80

9.34

ug/l

0.93

297

Open bite

1017

0.92

0.31

2.8

4.3

5.05

19.18

ug/l

1.20

741

Multifocal fibrosclerosis

250

1.18

0.31

2.0

4.2

3.73

35.77

ug/l

0.63

209

Viral infections of the central nervous system, including avohilmo

275

2631

1.05

0.31

3.9

4.4

19.63

19.06

ug/l

0.02

216

2097

Chronic myeloproliferative disease

577

0.89

0.31

3.5

4.5

2.98

34.85

ug/l

1.53

485

Bullous pemphigoid

919

1.09

0.31

3.7

4.1

4.12

22.75

ug/l

1.47

779

Pedal cyclist injured in other and unspecified transport accidents

401

4156

0.96

0.31

4.2

4.3

40.56

21.73

ug/l

0.25

327

3329

Other retinal artery occlusion

106

987

1.08

0.31

3.9

4.3

10.63

17.94

ug/l

0.50

826

Benign neoplasm: Endocrine gland, other/unspecified

130

1.27

0.30

3.1

4.4

5.26

10.33

ug/l

—

104

Hypogonadotropic hypogonadism

776

0.91

0.30

3.0

5.3

38.68

20.38

ug/l

0.22

639

Migraine without aura and triptan purchases

474

4898

0.97

0.30

3.2

4.1

7.14

25.70

ug/l

1.60

330

3608

Atopic dermatitis, strict definition

921

8795

1.03

0.30

3.5

4.2

44.60

21.23

ug/l

0.51

723

6637

Artrosis, including avohilmo

4545

24609

1.01

0.30

3.8

4.6

15.52

29.93

ug/l

3.57

3627

19893

Short stature, not elsewhere classified

111

1.26

0.30

3.3

3.7

1.60

4.92

ug/l

—

FESS (DNB20)

470

4854

0.97

0.30

3.5

4.5

5.79

28.26

ug/l

2.45

379

3902

Pedal cyclist injured in collision with motor vehicle

982

0.92

0.30

3.7

4.4

11.69

23.44

ug/l

0.50

805

Other endophthalmitis

216

0.82

0.30

2.6

3.9

2.33

40.52

ug/l

0.62

174

Dislocation, sprain and strain of joints and ligaments at neck level

514

4984

1.03

0.30

3.9

4.3

5.42

29.14

ug/l

2.58

401

3901

Systemic sclerosis (FG)

102

950

1.08

0.30

2.4

4.8

4.10

25.98

ug/l

1.79

778

Contact with machinery

438

4238

1.04

0.29

4.5

4.8

27.79

27.80

ug/l

0.00

367

3565

Infliximab

411

1.13

0.29

2.7

4.6

2.17

23.98

ug/l

1.08

327

Mild or no visual impairment, binocular

149

1.23

0.29

1.8

4.3

4.67

10.45

ug/l

0.89

119

Other benign neoplasm of uterus: Corpus uteri

337

1.15

0.29

4.4

4.1

2.59

8.75

ug/l

2.58

275

Sequelae of tuberculosis

700

1.10

0.29

3.8

3.9

73.28

29.94

ug/l

0.41

600

Disorders of lacrimal system and orbit in diseases classified elsewhere

845

0.92

0.29

2.9

4.4

221.36

20.23

ug/l

0.46

678

Assault by unspecified means

450

1.12

0.29

3.8

5.1

4.77

17.29

ug/l

0.69

358

Necrosis of pulp, including avohilmo

2683

26840

0.99

0.29

4.0

4.4

16.30

25.24

ug/l

1.24

2105

21303

Drug-induced obesity

261

1.16

0.29

4.7

4.1

3.77

25.20

ug/l

0.72

215

Tuberculosis of other organs, strict

101

942

1.08

0.29

3.4

3.9

43.64

26.01

ug/l

0.21

785

Sequelae of tuberculosis, including avohilmo

710

1.09

0.28

3.8

3.9

72.29

29.72

ug/l

0.40

608

Left ventricular outflow tract obstruction, narrow definition

157

1485

1.06

0.28

3.5

4.5

55.51

19.88

ug/l

0.32

125

1218

Ankylosing hyperostosis [Forestier]

557

1.11

0.28

4.0

5.0

5.21

34.61

ug/l

1.28

465

Polycystic ovarian syndrome

902

1.08

0.28

2.8

3.7

5.46

55.86

ug/l

0.62

609

Statin medication

3290

18299

1.01

0.28

3.6

4.7

13.54

24.70

ug/l

2.97

2617

14475

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

153

1421

1.06

0.28

4.6

4.4

11.62

19.76

ug/l

0.46

116

1062

Inflammatory disorders of male genital organs, not elsewhere classified

423

1.12

0.28

3.7

5.1

25.44

41.29

ug/l

0.30

367

Other and unspecified bullous disorders

414

1.12

0.28

3.6

4.3

12.26

38.67

ug/l

0.66

345

Other lack of coordination

644

1.10

0.28

2.9

4.7

12.36

30.65

ug/l

0.62

540

Autism spe, excluding more controls

223

1.17

0.28

2.4

5.0

2.17

4.91

ug/l

0.83

161

Desensitization to allergens

1041

0.93

0.28

5.0

4.5

9.89

16.32

ug/l

0.36

770

Other infiltrative disorders of skin and subcutaneous tissue

178

1.20

0.28

4.1

4.8

3.05

12.56

ug/l

2.45

146

Amputation of foot

102

1090

0.93

0.27

2.8

4.4

4.73

24.82

ug/l

1.85

919

Complications of the puerperium, not elsewhere classified

885

0.92

0.27

3.5

4.1

8.30

55.38

ug/l

0.57

619

Fractures involving multiple body regions

0.68

0.27

6.6

4.5

4.20

11.77

ug/l

—

Glaucoma-related operations

262

2726

0.96

0.27

3.7

4.1

14.61

19.09

ug/l

0.25

221

2249

Guillain-Barre syndrome

572

0.90

0.27

3.0

4.7

644.45

26.48

ug/l

0.53

482

Disease of hard tissues of teeth, NOS

3027

16029

0.99

0.27

4.1

4.4

7.01

31.24

ug/l

10.68

2399

13122

Frostbite involving multiple body regions and unspecified frostbite

0.66

0.27

5.8

4.1

3.72

73.48

ug/l

—

Drug-induced tremor

244

1.17

0.27

1.4

4.4

3.31

23.78

ug/l

0.60

196

Other diseases caused by chlamydiae, including avohilmo

376

1.13

0.27

3.4

4.0

4.18

7.74

ug/l

0.96

291

Conductive hearing loss, unspecified

339

3274

1.04

0.27

4.1

4.3

7.95

27.79

ug/l

2.93

280

2645

Other congenital malformations of ear

150

1.21

0.26

1.7

4.4

47.15

4.70

ug/l

0.44

107

Toxic effect of contact with venomous animals

135

1428

0.94

0.26

4.4

12.28

22.26

ug/l

0.57

102

1160

Syndactyly, including avohilmo

0.65

0.26

1.2

4.3

1.92

10.35

ug/l

—

Thyrotropin deficiency

330

0.87

0.26

3.1

4.2

83.84

21.11

ug/l

0.34

265

Osteomalacia

254

1.16

0.26

4.2

4.6

67.97

25.16

ug/l

0.28

200

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

216

1.17

0.26

6.1

3.6

5.10

5.90

ug/l

0.09

158

Pyogenic granuloma

550

1.10

0.26

3.0

4.5

8.83

31.08

ug/l

0.86

459

Emotional disorders starting during childhood or adolecense, excluding more controls

351

0.88

0.26

3.7

4.1

2.88

4.49

ug/l

0.49

219

Benign neoplasm: Brain, supratentorial

483

1.11

0.26

3.3

4.5

46.93

31.64

ug/l

0.13

390

Distal bite

577

0.91

0.25

2.6

4.2

3.41

14.81

ug/l

0.77

425

Viral encephalitis, not elsewhere classified/unspecified

705

1.09

0.25

3.4

4.5

4.25

27.37

ug/l

1.30

592

Disorders in reading

160

1.19

0.25

3.8

4.3

2.46

6.91

ug/l

1.27

118

Hyperfunction of pituitary gland

148

1404

1.06

0.25

4.1

4.2

69.34

23.47

ug/l

0.38

117

1097

Unspecified maternal hypertension

213

0.84

0.25

2.9

4.1

1.71

30.57

ug/l

0.64

151

Contact with other hot fluids

850

0.92

0.25

5.3

4.6

4.15

23.18

ug/l

1.23

691

Isolated proteinuria with specified morphological lesion

398

1.12

0.25

3.1

4.4

4.50

35.60

ug/l

0.94

335

Helminthiases

561

1.10

0.25

5.1

4.2

5.08

29.71

ug/l

1.03

462

Other fall from one level to another

889

8708

1.02

0.25

3.8

4.5

20.99

25.58

ug/l

0.20

726

7084

Polycystic ovarian syndrome, broad definition

202

2111

0.96

0.25

3.2

3.7

6.98

30.19

ug/l

0.65

143

1409

Measles

255

1.15

0.25

4.1

4.7

5.29

12.57

ug/l

0.55

197

Congenital deformities of feet

609

1.09

0.25

3.3

4.4

3.44

14.30

ug/l

0.86

483

Other and unspecified pemphigoid

399

1.12

0.24

4.4

4.76

38.71

ug/l

1.09

346

Disorders of globe

1002

0.93

0.24

3.8

4.1

4.50

26.56

ug/l

1.80

826

Disorders of pituitary gland, other and/or unspecified

199

1.17

0.24

5.1

4.4

203.82

8.30

ug/l

0.46

163

Fourth [trochlear] nerve palsy

862

1.08

0.24

4.3

4.5

175.95

25.66

ug/l

0.42

732

Burn and corrosion of respiratory tract

1.39

0.24

1.4

5.8

1.98

12.40

ug/l

—

Primary open-angle glaucoma, strict

1505

15230

0.98

0.24

3.7

4.1

11.69

23.60

ug/l

2.84

1261

12658

Other abnormal auditory perceptions

370

1.12

0.24

3.7

4.5

9.07

19.78

ug/l

0.37

304

Amputation of thigh

117

1237

0.94

0.24

2.1

3.9

11.19

24.06

ug/l

0.65

105

1051

Other bullous disorders

109

1028

1.07

0.24

3.7

4.5

6.47

22.83

ug/l

1.14

842

Dissection of aorta

125

1319

0.94

0.24

3.8

4.3

5.66

22.49

ug/l

1.84

1102

Suppurative otitis media, unspecified

702

0.92

0.24

3.0

4.2

21.12

29.72

ug/l

0.16

574

Severe mental retardation

1.37

0.24

2.0

3.7

7.70

5.73

ug/l

—

Diabetes insipidus

327

0.88

0.24

3.5

4.5

3.50

41.15

ug/l

0.91

270

Acquired stenosis of external ear canal

400

0.89

0.24

5.6

5.0

3.13

40.83

ug/l

1.16

334

Periodontal disease, other/unspecified

103

970

1.07

0.24

3.6

4.5

8.89

20.58

ug/l

0.92

791

Contusion of ankle

120

1135

1.06

0.23

2.5

4.4

30.25

19.43

ug/l

0.23

102

909

Benign neoplasm: Bone and articular cartilage, unspecified

247

1.15

0.23

4.0

4.4

6.00

8.14

ug/l

0.30

200

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

284

0.87

0.23

3.3

4.7

2.49

51.13

ug/l

1.12

245

Pedal cyclist injured in noncollision transport accidents

417

4053

1.03

0.23

4.0

4.4

4.24

22.63

ug/l

4.45

333

3242

Tuberculosis of other organs

825

1.07

0.23

3.0

3.9

10.85

27.60

ug/l

0.71

692

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

718

1.08

0.23

3.4

4.4

4.21

26.86

ug/l

1.30

605

Universal erythroderma, KELA reimbursement

473

0.90

0.23

4.0

4.9

7.84

36.40

ug/l

0.95

396

Airway disease due to specific organic dust

0.72

0.23

7.9

4.9

2.64

83.71

ug/l

—

Paracoccidioidomycosis, including avohilmo

0.00

0.23

0.0

4.4

—

17.74

—

Paracoccidioidomycosis

0.00

0.23

0.0

4.4

—

17.74

—

Memory loss

435

4469

0.97

0.23

3.4

4.2

4.36

23.64

ug/l

6.66

340

3715

Dislocation, sprain and strain of joints and ligaments of head

122

1155

1.06

0.23

3.7

4.5

10.21

23.52

ug/l

0.79

901

!Aliquae complicationes praecoces traumatis

164

1566

1.05

0.23

3.2

4.4

3.92

19.76

ug/l

2.16

137

1287

Early complications of trauma

164

1566

1.05

0.23

3.2

4.4

3.92

19.76

ug/l

2.16

137

1287

Asymmetry of jaw

327

0.88

0.23

3.5

4.5

3.26

20.42

ug/l

0.69

260

Scissor bite

338

1.12

0.23

4.6

4.3

4.36

20.73

ug/l

0.62

252

Other and unspecified injuries of abdomen, lower back and pelvis

467

1.10

0.23

1.7

4.4

3.91

36.50

ug/l

1.14

383

Primary angle-closure glaucoma

207

1989

1.05

0.23

3.6

4.1

11.78

19.49

ug/l

0.54

168

1641

Biomechanical lesions, not elsewhere classified

215

2067

1.04

0.23

3.0

4.3

5.84

21.38

ug/l

2.48

178

1691

Atrioventricular septal defect

0.76

0.23

2.9

4.4

2.24

10.18

ug/l

—

Infections of genitourinary tract in pregnancy

323

3128

1.04

0.23

3.1

4.0

13.67

35.94

ug/l

0.83

249

2393

Unspecified abortion

170

1777

0.95

0.23

4.3

4.2

5.64

16.02

ug/l

0.85

119

1368

Third [oculomotor] nerve palsy

729

1.08

0.23

3.2

4.3

10.30

28.19

ug/l

0.83

608

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

258

2489

1.04

0.23

4.7

4.0

56.52

33.00

ug/l

0.25

191

1847

Disorders of psychological development

222

1978

1.04

0.23

3.4

4.3

44.81

19.93

ug/l

0.27

160

1468

Melanoma in situ of other and unspecified parts of face

575

1.09

0.22

4.1

4.4

4.36

27.66

ug/l

1.07

493

Postpartum haemorrhage due to anatomy

180

1880

0.96

0.22

3.4

3.7

38.50

32.03

ug/l

0.06

113

1263

Assault by drugs, medicaments and biological substances

1.24

0.22

6.2

5.2

2.84

4.16

ug/l

—

Transport accidents

2234

18801

0.99

0.22

3.9

4.5

16.27

30.63

ug/l

1.34

1767

15016

Glaucoma secondary to other eye disorders

172

1647

1.05

0.22

3.3

4.1

22.23

21.51

ug/l

0.02

138

1369

Exposure to other specified factors

4046

35004

0.99

0.22

3.9

4.3

12.44

26.91

ug/l

4.36

3194

28003

Mosquito-borne viral encephalitis

0.00

0.22

0.0

6.7

—

3.39

—

Carcinoma in situ of lip

1.22

0.22

2.2

4.0

15.58

112.66

ug/l

—

Idiopathic hypercalciuria

201

1.16

0.22

1.9

4.6

4.83

28.94

ug/l

0.60

168

Mosquito-borne viral encephalitis, including avohilmo

0.00

0.22

0.0

6.7

—

3.39

—

Bulimia nervosa (incl. atypical)

516

1.09

0.22

2.1

4.1

3.32

93.47

ug/l

0.63

344

Haemolytic disease of fetus and newborn

0.00

0.22

0.0

1.2

—

1.70

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

0.21

0.0

2.5

—

2.87

—

KRA_PSY_EATING, excluding more controls

142

1340

1.05

0.21

2.5

4.1

42.88

38.10

ug/l

0.04

100

908

Papulosquamous disorders

2028

20047

1.01

0.21

3.6

4.3

26.56

25.68

ug/l

0.04

1644

16255

Neovascular glaucoma

168

1610

1.05

0.21

3.3

4.2

22.48

21.04

ug/l

0.04

136

1344

Contraceptive management

1508

10683

0.99

0.21

4.0

4.3

24.62

25.41

ug/l

0.03

1148

8385

Abnormalities of forces of labour

317

3268

0.97

0.21

3.8

4.0

22.30

28.27

ug/l

0.12

229

2411

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1134

11518

0.98

0.21

3.7

4.4

9.60

26.57

ug/l

2.86

885

9074

Flat foot [pes planus] (acquired)

449

4602

0.97

0.21

3.8

4.6

6.20

28.28

ug/l

3.78

354

3757

Divergent concomitant strabismus

248

2566

0.96

0.21

3.1

4.4

7.92

18.18

ug/l

1.46

181

2042

Dystonia

218

2102

1.04

0.21

3.7

4.3

8.85

18.74

ug/l

1.10

172

1683

Mesial bite

192

1.15

0.21

2.7

4.6

3.81

31.61

ug/l

0.61

146

Diseases caused by chlamydiae, including avohilmo

335

1.11

0.21

3.3

3.9

4.36

6.87

ug/l

0.57

260

Congenital malformations of the musculoskeletal system, not elsewhere classified

335

1.11

0.21

3.0

4.3

2.62

8.64

ug/l

2.52

262

Obstructive hydrocephalus

511

0.91

0.21

4.5

4.3

7.63

28.58

ug/l

0.74

427

Non-allergic asthma

325

3343

0.97

0.21

3.4

4.2

86.02

21.18

ug/l

0.90

277

2717

Wegener granulomatosis

552

0.92

0.21

3.1

4.4

2.47

33.97

ug/l

1.42

464

Dacryoadenitis

288

1.12

0.21

2.8

4.6

10.52

25.98

ug/l

0.48

242

Deaf mutism, not elsewhere classified

176

0.84

0.21

1.9

4.8

2.82

45.85

ug/l

—

153

LSIL lesion of the vagina

490

1.09

0.20

3.6

4.2

7.88

8.67

ug/l

0.05

396

Valgus deformity, not elsewhere classified

250

1.13

0.20

3.6

4.8

2.58

35.36

ug/l

0.66

212

Lateral epicondylitis

566

5782

0.98

0.20

3.6

4.8

10.64

33.11

ug/l

2.27

471

4619

Corns and callosities

290

2814

1.03

0.20

3.0

4.4

7.48

20.24

ug/l

2.00

245

2303

Vaginal lichen planus

270

0.88

0.20

3.3

4.5

2.39

8.69

ug/l

2.33

223

Postprocedural disorders of ear and mastoid process, not elsewhere classified

312

0.89

0.20

2.7

4.5

10.24

47.29

ug/l

0.81

267

Other diseases of spinal cord

101

1065

0.94

0.20

2.6

4.6

3.65

23.51

ug/l

1.82

882

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

197

2045

0.96

0.20

3.2

4.0

5.39

30.84

ug/l

0.80

143

1477

Polyp of middle ear

1.20

0.20

4.2

16.07

11.47

ug/l

—

Benign neoplasm: Spinal cord

520

1.09

0.20

4.3

4.4

10.47

29.05

ug/l

0.61

437

Other specified and unspecified strabismus

346

1.11

0.20

3.6

4.5

480.03

7.00

ug/l

0.48

290

Juvenile arthritis (FINNGEN)

994

0.94

0.20

3.9

4.6

6.67

28.11

ug/l

1.30

749

Localized adiposity

184

1.16

0.20

4.9

4.5

6.06

7.02

ug/l

0.08

144

Other congenital malformations of peripheral vascular system

346

1.11

0.20

3.0

4.2

3.10

21.74

ug/l

0.85

279

Other disorders of optic disc

433

1.09

0.20

4.7

4.4

2.50

33.24

ug/l

1.01

356

Erythema in diseases classified elsewhere

1.27

0.20

1.3

4.3

2.36

7.85

ug/l

—

Kyphosis

511

1.09

0.19

4.1

4.5

10.43

31.30

ug/l

0.65

419

Exfoliative dermatitis

395

1.10

0.19

2.5

4.9

42.30

44.46

ug/l

0.02

331

Lichen planus

620

6322

0.98

0.19

3.6

4.3

29.00

22.06

ug/l

0.15

485

5169

Caught, crushed, jammed or pinched in or between objects

166

1595

1.04

0.19

4.1

4.6

3.56

22.89

ug/l

2.57

127

1296

Cleft lip, lip and palate or palate

291

0.89

0.19

2.7

4.7

109.08

22.14

ug/l

0.37

229

Retinal breaks without detachment

820

8064

1.02

0.19

3.9

4.5

57.03

24.16

ug/l

0.48

644

6636

Migraine without aura, drug-induced

301

0.89

0.19

2.8

3.9

3.43

7.72

ug/l

1.40

241

Other and unspecified intracranial injuries

110

1047

1.06

0.19

3.4

4.5

4.93

23.96

ug/l

1.68

876

Other disorders affecting eyelid function

363

0.90

0.19

4.9

4.7

2.90

37.18

ug/l

0.93

302

Benign neoplasm: Short bones of upper limb

492

1.08

0.19

4.4

4.5

17.99

17.53

ug/l

0.01

400

Visual field defects

361

3703

0.97

0.19

3.8

4.2

42.31

21.87

ug/l

0.36

300

3045

Angina pectoris

3397

22706

0.99

0.19

3.5

4.6

15.48

29.09

ug/l

2.70

2816

18836

Spinal enthesopathy

107

1016

1.06

0.19

3.4

3.8

21.28

20.21

ug/l

0.03

854

Other secondary gonarthrosis

237

2296

1.04

0.19

3.5

4.5

20.04

20.60

ug/l

0.02

197

1903

Chronic suppurative otitis media, including avohilmo

280

2719

1.03

0.19

4.0

4.3

28.65

18.14

ug/l

0.30

221

2204

Aortic valve malfunction, age under 60 years

342

3332

1.03

0.19

3.9

4.8

34.23

21.54

ug/l

0.22

266

2738

Glaucoma secondary to eye inflammation

300

0.89

0.18

2.6

4.7

8.77

8.93

ug/l

0.01

248

Effects of other external causes

687

1.07

0.18

3.8

4.8

41.58

29.84

ug/l

0.13

547

Toxoplasmosis

195

1.14

0.18

1.5

4.3

2.13

31.19

ug/l

0.75

163

Toxic effect of ethanol

110

1049

1.05

0.18

3.4

4.7

17.91

23.04

ug/l

0.20

846

Lesion of plantar nerve

268

2757

0.97

0.18

3.5

4.3

27.20

20.01

ug/l

0.13

226

2209

Benign neoplasm: Central nervous system, other parts/unspecified

131

0.83

0.18

2.4

4.1

2.15

44.76

ug/l

0.71

107

Acne varioliformis

1.25

0.18

2.7

5.5

3.12

64.38

ug/l

—

Pustulosis palmaris et plantaris

172

1659

1.04

0.18

2.6

4.5

51.16

19.65

ug/l

0.46

135

1341

Congenital malformations of aortic and mitral valves

125

1305

0.95

0.18

3.7

4.6

3.03

21.60

ug/l

2.14

101

1073

Urticaria due to cold and heat

226

0.88

0.17

5.0

4.7

5.25

26.95

ug/l

0.56

177

Benign neoplasm: Cranial nerves

120

1149

1.05

0.17

4.2

4.4

12.96

21.67

ug/l

0.38

957

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

397

1.09

0.17

2.8

4.1

2.52

19.45

ug/l

0.81

305

Sexual dysfunction

533

1.07

0.17

4.2

5.2

32.31

35.12

ug/l

0.03

434

Cervical root disorders

263

1.12

0.17

2.3

4.8

2.57

53.27

ug/l

0.96

208

Retinoschisis and retinal cysts

1007

0.95

0.17

4.6

4.3

17.39

19.36

ug/l

0.09

832

Other specified transport accidents

148

1.16

0.17

2.9

4.7

5.33

8.32

ug/l

0.61

119

Vascular syndromes of brain in cerebrovascular disorders

208

2016

1.04

0.17

3.3

4.2

11.98

24.74

ug/l

1.00

180

1694

Toxoplasmosis, including avohilmo

196

1.14

0.17

1.5

4.4

2.13

31.01

ug/l

0.75

164

Pustular psoriasis

190

1839

1.04

0.17

3.1

4.5

45.84

18.32

ug/l

0.45

152

1496

Other and unspecified injuries of ankle and foot

125

1199

1.05

0.17

4.1

4.5

23.71

22.24

ug/l

0.03

963

Pedal cyclist injured in transport accident

871

8837

0.98

0.16

4.0

4.4

21.84

28.96

ug/l

0.18

693

7084

Disorders of synovium and tendon in diseases classified elsewhere

808

1.06

0.16

3.3

5.0

7.82

29.32

ug/l

1.22

665

Other and unspecified mononeuropathies of lower limb

116

1112

1.05

0.16

3.1

4.5

7.38

22.30

ug/l

1.16

906

Burns and corrosions confined to eye and internal organs

749

1.06

0.16

3.4

4.8

2.65

20.78

ug/l

1.16

605

Disorders of glossopharyngeal nerve

0.77

0.16

2.3

4.5

2.77

8.21

ug/l

—

Cicatricial alopecia [scarring hair loss]

318

0.90

0.16

2.7

4.5

3.91

22.74

ug/l

0.80

265

Hyperprolactinaemia

886

1.05

0.16

4.1

4.5

4.28

28.96

ug/l

1.49

679

Lipoprotein deficiency

0.77

0.16

4.2

5.3

2.68

6.69

ug/l

—

Donors of organs and tissues

312

1.10

0.16

3.2

4.1

109.96

4.89

ug/l

0.48

243

Other obstructed labour

254

2609

0.97

0.16

3.6

4.1

49.00

31.88

ug/l

0.17

193

1997

Symptoms and signs involving the nervous and musculoskeletal systems

3065

30855

0.99

0.16

3.1

4.3

18.12

25.20

ug/l

0.36

2406

25057

Livedoid vasculitis

159

1.15

0.16

4.7

4.4

2.46

36.99

ug/l

0.72

133

Mental and behavioural disorders due to use of other stimulants, including caffeine

399

1.08

0.16

2.0

5.3

18.88

10.13

ug/l

0.25

305

Other/unspecified mastoiditis and related conditions

182

0.87

0.16

1.0

4.4

2.50

62.35

ug/l

—

146

Injury of muscle and tendon at ankle and foot level

819

1.05

0.16

2.8

4.7

17.72

23.79

ug/l

0.18

669

Use of rotigotine

441

0.92

0.16

2.8

4.4

2.21

37.34

ug/l

1.21

370

Crushing injury of wrist and hand

536

1.07

0.16

4.3

5.1

22.72

38.61

ug/l

0.35

450

Premature separation of placenta [abruptio placentae]

555

1.07

0.16

3.5

4.2

3.38

71.22

ug/l

0.54

409

Mental and behavioural disorders due to hallucinogens

0.76

0.16

3.0

6.0

2.73

57.53

ug/l

—

Acute otitis externa, noninfective

626

0.94

0.16

3.0

4.5

3.57

29.47

ug/l

1.29

523

Scleritis and episcleritis

227

2207

1.03

0.15

3.6

4.4

6.97

21.26

ug/l

1.89

172

1752

Other specified and unspecified disorders of eyelid

556

1.07

0.15

4.5

264.49

29.76

ug/l

0.43

464

Type 1 diabetes, strict (exclude DM2)

194

1995

0.97

0.15

4.4

4.6

16.26

33.19

ug/l

0.40

156

1498

Embolic stroke with flimmer

113

1084

1.05

0.15

2.6

4.3

16.75

36.73

ug/l

0.75

915

Contact with other sharp object(s)

177

1828

0.97

0.15

3.7

4.6

6.61

20.62

ug/l

1.54

139

1449

Somnolence

379

0.92

0.15

4.0

3.51

39.03

ug/l

0.99

305

Coxarthrosis, primary, with hip surgery

2863

26348

1.01

0.15

4.0

4.3

17.01

25.84

ug/l

1.13

2389

21851

Tularaemia, including avohilmo

656

0.94

0.15

2.9

4.6

5.29

29.25

ug/l

1.23

552

Peritonsillar abscess

744

7550

0.98

0.15

4.8

4.5

20.94

32.06

ug/l

0.42

617

5968

Use of glatiramer acetate

342

1.09

0.15

2.3

4.5

13.70

6.99

ug/l

0.33

260

Viral conjunctivitis, including avohilmo

111

1156

0.96

0.15

3.6

4.4

159.98

20.91

ug/l

0.42

918

Pedestrian injured in other and unspecified transport accidents

430

1.08

0.15

3.6

4.3

3.00

33.42

ug/l

1.00

358

Arthropathic psoriasis

449

4575

0.98

0.15

3.3

4.5

27.08

21.64

ug/l

0.13

367

3700

Ethmoidectomy

495

5039

0.98

0.15

3.5

4.5

5.94

27.91

ug/l

2.50

400

4050

Normotensive glaucoma

450

4583

0.98

0.15

3.8

4.1

6.45

22.65

ug/l

4.58

377

3771

Disorders of orbit

166

1608

1.04

0.15

3.4

4.5

180.56

22.88

ug/l

0.70

131

1309

Motorcycle rider injured in noncollision transport accidents

717

0.95

0.15

3.4

4.9

3.23

16.63

ug/l

1.18

566

Injury of nerves at hip and thigh level

139

0.85

0.15

4.4

5.1

3.91

7.36

ug/l

—

112

Allergic contact dermatitis due to drugs in contact with skin

792

1.05

0.15

3.6

4.3

5.29

14.13

ug/l

0.94

645

Oral lichen planus

118

1136

1.04

0.15

3.0

4.5

3.63

16.36

ug/l

2.19

929

Simple and mucopurulent chronic bronchitis

166

1608

1.04

0.14

3.7

4.1

6.46

22.91

ug/l

1.85

146

1346

Hereditary retinal dystrophy

460

0.93

0.14

2.5

4.3

62.19

16.63

ug/l

0.39

388

Acute bronchiolitis

767

1.05

0.14

3.5

3.9

4.05

22.42

ug/l

0.97

581

Acquired clawhand, clubhand, clawfoot and clubfoot

160

1.14

0.14

4.5

4.7

8.14

10.31

ug/l

0.14

136

Primary open-angle glaucoma

1866

18097

0.99

0.14

3.8

4.1

16.92

23.46

ug/l

0.50

1564

15104

Lesion of femoral nerve

305

1.09

0.14

2.7

4.6

3.89

7.30

ug/l

0.98

248

Lichen sclerosus et atrophicus

549

5578

0.98

0.14

3.5

4.2

5.50

23.42

ug/l

3.73

423

4513

Burns and corrosions

466

4743

0.98

0.14

4.3

4.5

15.63

22.21

ug/l

0.30

384

3824

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

117

1127

1.04

0.14

4.0

4.3

8.29

21.30

ug/l

0.77

912

Burns and corrosions of external body surface, specified by site

359

3663

0.98

0.14

4.3

4.4

17.43

19.41

ug/l

0.06

296

2944

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

261

2548

1.03

0.14

3.2

4.8

18.82

43.23

ug/l

0.82

207

2023

Status epilepticus

142

1374

1.04

0.14

3.2

4.6

9.43

25.56

ug/l

1.20

115

1146

Dermatophytosis, including avohilmo

3313

32644

0.99

0.14

3.7

4.4

31.13

25.77

ug/l

0.22

2612

26336

Congenital malformations of eyelid, lacrimal apparatus and orbit

149

0.87

0.14

3.0

4.4

2.20

40.06

ug/l

—

108

Anisometropia and aniseikonia

115

1108

1.04

0.14

3.8

4.4

81.53

21.72

ug/l

0.38

909

Injury of nerves at forearm level

383

1.08

0.14

4.1

5.3

7.99

25.18

ug/l

0.67

310

Cerebral atherosclerosis

549

0.94

0.13

2.7

4.2

10.10

29.92

ug/l

0.67

473

Haemorrhage in early pregnancy

1073

10307

1.01

0.13

3.5

4.0

14.97

20.06

ug/l

0.40

770

7738

Congenital malformations of great arteries

376

1.07

0.13

4.0

4.6

12.32

19.10

ug/l

0.18

294

Calcific tendinitis

384

1.08

0.13

2.3

5.4

5.92

44.19

ug/l

1.10

321

Arnold-Chiari syndrome

159

0.88

0.13

1.7

4.2

1.86

6.12

ug/l

—

119

Burn and corrosion confined to eye and adnexa

618

1.06

0.13

3.8

4.9

2.85

18.33

ug/l

1.22

500

Disorder of the sleep-wake schedule

442

1.07

0.13

2.4

4.9

3.53

17.91

ug/l

0.82

352

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

115

1191

0.96

0.13

3.9

4.1

96.98

25.55

ug/l

0.50

100

998

Other intracranial haemorrhages

137

1414

0.97

0.13

4.0

4.2

43.89

27.66

ug/l

0.24

120

1188

Contact with heat and hot substances

161

1658

0.97

0.13

4.4

3.79

20.26

ug/l

2.41

139

1341

Overjet

333

1.08

0.13

3.0

4.2

19.09

7.26

ug/l

0.32

243

Other disorders starting during childhood or adolescence

495

1.06

0.13

3.2

3.9

2.55

6.17

ug/l

2.14

321

Early lumbar disc prolapse operation

241

2467

0.98

0.13

3.7

4.6

14.53

27.99

ug/l

0.42

186

1841

Peripheral artery operations in Hilmo

620

6112

1.02

0.13

2.9

4.3

7.82

22.95

ug/l

2.73

540

5104

Anxious personality disorder

394

1.07

0.12

2.5

4.6

5.85

17.23

ug/l

0.49

308

Arthropod-borne viral fevers and viral haemorrhagic fevers

376

3694

1.02

0.12

4.1

4.5

11.27

22.42

ug/l

1.55

311

3023

Other congenital malformations of nervous system

179

0.89

0.12

1.7

4.3

2.24

6.78

ug/l

—

132

Anorexia (incl.atypical)

128

1321

0.97

0.12

2.9

4.2

124.42

47.36

ug/l

0.30

994

Rubella [German measles]

105

1014

1.04

0.12

5.8

5.2

26.30

13.77

ug/l

0.25

846

Other extrapyramidal and movement disorders in other diseases

1261

12721

0.99

0.12

3.5

4.3

24.69

26.50

ug/l

0.05

1021

10444

Toxic effects of substances chiefly nonmedicinal as to source

394

3876

1.02

0.11

3.8

4.3

10.56

20.35

ug/l

1.54

326

3103

Generalized epilepsy

108

1117

0.96

0.11

4.4

4.5

14.75

21.07

ug/l

0.27

889

Other disorders of iris and ciliary body

1025

0.96

0.11

3.3

4.4

4.77

22.81

ug/l

1.53

858

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

162

1663

0.97

0.11

3.8

4.4

56.68

17.75

ug/l

0.35

138

1349

Exposure to unspecified smoke, fire and flames

291

0.92

0.11

3.1

5.0

24.76

22.77

ug/l

0.03

243

Myopia

389

3953

0.98

0.11

3.8

4.4

39.45

28.26

ug/l

0.16

270

3059

Other diseases caused by chlamydiae

328

1.07

0.11

3.9

4.2

4.42

8.61

ug/l

1.02

250

Raynaud syndrome

332

3263

1.02

0.11

3.2

4.3

5.10

28.46

ug/l

1.52

266

2569

Injury of muscle and tendon at forearm level

563

1.05

0.11

3.3

5.0

32.77

20.05

ug/l

0.28

460

Rosacea

529

5361

0.99

0.11

3.2

4.2

10.38

31.67

ug/l

1.79

398

4263

Abnormal involuntary movements

584

5914

0.99

0.11

3.0

4.4

5.78

28.52

ug/l

3.31

468

4826

Benign neoplasm of male genital organs

770

0.96

0.11

4.2

4.5

4.19

31.63

ug/l

1.72

642

Macular pucker

900

8913

1.01

0.11

4.2

4.3

12.43

22.96

ug/l

1.80

741

7450

Beningn neoplasm: Meninges, unspecified

603

1.05

0.11

3.2

4.2

12.55

15.33

ug/l

0.11

510

Spontaneous rupture of synovium and tendon

389

3830

1.02

0.11

4.0

4.7

5.42

24.60

ug/l

5.01

311

3127

770

0.96

0.11

2.9

4.6

6.83

16.40

ug/l

0.68

612

Frostbite

311

0.93

0.11

2.8

4.5

3.06

23.71

ug/l

0.89

258

Thyrotoxicosis with toxic single thyroid nodule

319

1.07

0.11

2.5

4.2

2.76

43.24

ug/l

0.94

258

Behavioural disorders, excluding more controls

269

1.08

0.11

1.9

5.1

27.35

23.00

ug/l

0.06

200

Testicular hypofunction

103

997

1.04

0.10

5.3

16.90

21.85

ug/l

0.16

836

Spondylolisthesis/Spondylolysis

905

9137

0.99

0.10

3.2

4.6

34.50

27.95

ug/l

0.09

755

7404

Other deformities of toe(s)

159

1551

1.03

0.10

3.2

4.6

12.77

29.17

ug/l

1.00

124

1279

Rubella [German measles], including avohilmo

105

1017

1.04

0.10

5.8

5.2

26.30

13.73

ug/l

0.25

849

Dependent personality disorder

692

1.04

0.10

3.4

4.4

19.71

14.07

ug/l

0.18

555

Other acquired deformities of musculoskeletal system and connective tissue

167

1630

1.03

0.10

3.9

4.3

53.58

21.11

ug/l

0.29

133

1334

Benign neoplasm: Short bones of lower limb

329

1.07

0.10

3.8

4.3

6.63

40.79

ug/l

0.78

271

Hyphaema and other vascular disorders of iris and ciliary body

769

0.96

0.10

3.4

4.5

4.38

26.81

ug/l

1.42

651

Traumatic ischaemia of muscle

423

0.94

0.10

3.1

5.0

4.42

23.72

ug/l

0.96

343

Major anomalies of jaw size

759

0.96

0.10

4.4

4.6

3.51

16.53

ug/l

1.23

604

Other obstetric trauma

120

1165

1.03

0.10

4.2

4.0

14.14

41.78

ug/l

0.40

822

severe traumatic brain injury, does not include concussion

1100

11092

0.99

0.10

3.8

4.2

7.35

26.63

ug/l

7.22

901

9252

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

417

1.06

0.10

4.6

5.4

6.08

22.35

ug/l

0.72

337

Benign neoplasm: Bones of skull and face

341

0.93

0.10

3.9

4.4

160.62

38.43

ug/l

0.49

281

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

332

3374

0.98

0.10

3.3

4.1

15.21

35.02

ug/l

0.63

255

2630

Dysplastic lesion of unknown severity of the cervix uteri

251

1.08

0.10

3.4

4.3

17.66

7.48

ug/l

0.45

195

Osteolysis

1.15

0.10

5.4

4.3

3.78

13.66

ug/l

—

Open wound of wrist and hand

1989

19090

1.01

0.10

4.0

4.5

11.46

30.85

ug/l

5.21

1633

15379

Cerebral palsy

290

0.93

0.10

2.1

4.6

168.31

8.78

ug/l

0.47

230

Myocardial infarction, without ST-elevation

2333

20923

1.01

0.10

3.5

4.3

9.17

28.49

ug/l

10.35

1943

17578

Poor fetal growth

256

2609

0.98

0.10

4.0

3.7

7.22

25.52

ug/l

0.64

181

1766

Venous complications and haemorrhoids in pregnancy

329

1.07

0.10

3.8

4.1

2.53

115.23

ug/l

0.52

238

Generalized epilepsy, mode (most common among epilepsy diagnosis)

779

0.96

0.10

4.4

20.25

27.34

ug/l

0.20

629

Retained placenta and membranes, without haemorrhage

475

4688

1.01

0.10

4.7

4.0

16.50

27.88

ug/l

0.59

386

3623

Myocardial infarction

2900

20356

0.99

0.10

3.6

4.7

13.44

29.49

ug/l

4.30

2403

16972

Psoriasis (vulgaris), strict definition

116

1127

1.03

0.10

3.9

4.8

44.70

20.92

ug/l

0.25

916

Von Willebrand disease

359

1.06

0.10

2.6

4.3

3.50

20.56

ug/l

0.76

282

Congenital absence, occlusion, or narrowing of the ear canal

1.12

0.10

1.0

4.5

1.98

5.50

ug/l

—

Syndactyly

1.12

0.10

1.2

4.3

1.92

11.79

ug/l

—

Localized scleroderma [morphea]

534

0.95

0.10

2.8

4.2

62.44

17.20

ug/l

0.34

437

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

166

0.90

0.10

2.9

4.3

2.56

35.71

ug/l

—

122

Benign neoplasm: Female genital organ, unspecified

116

1.14

0.10

3.9

5.1

4.20

12.69

ug/l

—

Chronic sinusitis

2089

20979

0.99

0.10

3.6

4.4

34.68

26.92

ug/l

0.31

1613

16828

Other specified/unspecified necrotizing vasculopathies

507

1.05

0.09

2.7

4.4

77.78

32.13

ug/l

0.26

427

Other and unspecified corneal deformities and disorders

113

1162

0.97

0.09

5.0

4.5

5.99

23.46

ug/l

1.48

948

Felty syndrome

223

1.09

0.09

4.0

3.9

6.47

10.02

ug/l

0.47

191

Hydrocephalus in other diseases

227

0.92

0.09

5.1

4.4

85.76

8.62

ug/l

0.48

189

Peroneal tendinitis

574

0.95

0.09

2.9

4.9

2.77

14.16

ug/l

0.85

453

Traumatic amputation of wrist and hand

155

1586

0.98

0.09

4.6

4.7

11.43

31.50

ug/l

1.38

130

1315

Lower leg

223

1.08

0.09

3.6

4.3

5.03

7.85

ug/l

0.49

178

Excessive vomiting in pregnancy

238

2337

1.02

0.09

3.4

4.0

13.79

31.71

ug/l

0.48

156

1743

Other vitreous opacities

176

1723

1.02

0.09

3.3

4.4

7.83

20.45

ug/l

1.34

137

1410

Polypectomy (DHB20)

257

2614

0.98

0.09

3.9

4.6

42.74

22.94

ug/l

0.44

207

2162

Vascular dementia (mixed)

908

0.97

0.09

2.5

4.1

5.27

32.72

ug/l

1.93

781

Prepatellar bursitis

171

1747

0.98

0.09

3.3

5.0

58.06

34.90

ug/l

0.22

129

1460

Optic atrophy, wide definition

604

0.96

0.09

4.0

4.6

162.39

29.72

ug/l

0.40

501

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

332

2937

0.98

0.09

3.0

4.2

6.47

27.50

ug/l

0.91

223

2002

Enterobiasis, including avohilmo

360

1.06

0.09

3.2

4.5

3.68

21.04

ug/l

0.67

253

Other and unspecified trigeminal disorders

573

0.96

0.09

2.7

4.5

24.02

16.22

ug/l

0.14

466

Vertical strabismus

127

1239

1.03

0.09

3.4

4.3

135.72

24.16

ug/l

0.40

102

1013

Panhypopituitarism

593

0.96

0.09

4.1

4.7

83.80

32.82

ug/l

0.28

492

Other sexually transmitted chlamydial diseases

922

1.03

0.09

3.7

4.5

12.49

56.58

ug/l

0.53

636

Benign neoplasm: Cornea

0.80

0.09

4.4

4.8

12.76

7.48

ug/l

—

Carcinoma in situ of larynx

1.04

0.09

1.3

4.5

4.92

77.11

ug/l

—

Generalized pustular psoriasis

146

1.11

0.08

8.2

4.6

3.46

39.08

ug/l

0.63

117

Internal derangement of knee

1875

18660

0.99

0.08

4.1

4.7

19.70

31.20

ug/l

1.25

1498

15154

Cholera, including avohilmo

0.82

0.08

1.4

4.8

8.96

6.16

ug/l

—

Folliculitis decalvans

0.78

0.08

3.2

3.6

2.20

12.74

ug/l

—

Degeneration of nervous system due to alcohol

894

1.03

0.08

2.6

4.6

9.45

28.34

ug/l

1.03

747

Arteriovenous malformation of cerebral vessels

391

1.05

0.08

3.9

4.6

9.19

18.33

ug/l

0.36

320

Nezelof syndrome

156

1.10

0.08

7.3

4.3

3.54

54.67

ug/l

0.60

126

Manic episode

884

1.03

0.08

3.5

4.8

15.79

24.20

ug/l

0.23

715

Chronic suppurative otitis media

232

2281

1.02

0.08

4.1

4.3

15.73

17.25

ug/l

0.08

180

1866

Exposure to uncontrolled fire, not in building or structure

1.08

0.08

6.0

5.0

43.69

10.94

ug/l

—

Other acquired deformities of ankle and foot

297

0.94

0.08

3.1

4.9

4.00

34.08

ug/l

0.74

252

Type 1 diabetes, definitions combined

198

2010

0.98

0.08

4.4

4.6

15.92

34.72

ug/l

0.46

160

1508

Benign neoplasm: Uterine tubes and ligaments

254

1.07

0.08

3.8

4.1

6.46

8.92

ug/l

0.30

210

Carcinoma in situ of vagina

205

0.92

0.08

5.1

4.1

2.09

8.81

ug/l

2.12

159

Dermatographic urticaria

227

2233

1.02

0.08

3.8

4.3

72.63

33.06

ug/l

0.38

175

1734

Glucosamine medication

2879

22877

1.00

0.08

3.7

4.2

24.80

23.04

ug/l

0.12

2354

18950

Injury of muscle and tendon at lower leg level

621

6267

0.99

0.08

4.3

4.7

12.24

29.88

ug/l

1.69

488

5147

Pityriasis lichenoides chronica

137

1.11

0.08

2.1

4.6

549.52

55.46

ug/l

—

119

Migraine with aura, drug-induced

327

0.94

0.08

2.9

4.0

6.29

21.97

ug/l

0.61

263

Diffuse brain injury

122

1248

0.98

0.07

3.7

5.0

7.55

29.99

ug/l

2.03

1021

Torsion of testis

264

1.06

0.07

6.2

5.8

3.07

31.10

ug/l

0.56

219

Viral haemorrhagic fevers, not elsewhere classified/unspecified

300

2961

1.01

0.07

4.0

4.4

11.61

22.23

ug/l

1.27

247

2424

Contact with lifting and transmission devices, not elsewhere classified

560

1.04

0.07

4.6

4.9

15.33

38.95

ug/l

0.68

467

Juvenile Open Angle Glaucoma

153

0.91

0.07

1.9

4.7

2.04

34.72

ug/l

—

127

Optic atrophy

580

0.96

0.07

3.7

4.6

169.66

30.38

ug/l

0.40

484

Foreign body on external eye

509

5042

1.01

0.07

3.6

4.9

15.25

26.52

ug/l

0.68

411

4152

Other (seronegative) rheumatoid arthritis, wide

922

9282

0.99

0.07

3.4

4.2

32.32

27.21

ug/l

0.14

755

7554

Explosion of other materials

1.06

0.07

6.6

4.8

1.96

13.73

ug/l

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

1.04

0.07

3.0

4.5

2.97

58.56

ug/l

—

Other eating disorders

787

1.03

0.07

2.5

4.1

70.98

68.14

ug/l

0.01

549

Cardiomyopathy (excluding other)

572

5769

0.99

0.07

3.3

4.9

10.06

28.96

ug/l

2.89

477

4896

Lichen simplex chronicus

127

1296

0.98

0.07

3.2

4.3

4.28

23.40

ug/l

2.12

110

1069

Congenital malformations of ear causing impairment of hearing

0.87

0.07

1.4

4.4

2.40

11.76

ug/l

—

Disorders of tooth development and eruption

645

5289

0.99

0.07

3.8

4.5

17.00

22.09

ug/l

0.25

511

4173

Corneal scars and opacities

109

1066

1.02

0.07

4.2

4.4

126.88

25.17

ug/l

0.46

888

Mumps

842

0.97

0.07

4.1

4.5

22.56

26.45

ug/l

0.07

682

Intermittent heterotropia

144

1410

1.02

0.07

3.2

4.4

6.86

21.92

ug/l

1.38

106

1102

Embolic stroke

203

2059

0.98

0.07

3.2

4.2

17.89

26.54

ug/l

0.46

169

1727

Mandibular prognathia

336

0.95

0.07

2.8

4.2

2.73

28.92

ug/l

1.02

262

Impacted maxillary molar

818

1.03

0.07

3.0

4.2

3.06

21.66

ug/l

1.25

562

Migraine without aura

639

6439

0.99

0.06

3.0

4.3

6.10

25.59

ug/l

2.37

460

4815

Plantar fascial fibromatosis

447

4428

1.01

0.06

3.4

4.6

31.53

33.16

ug/l

0.02

340

3540

Blepharospasm

374

1.05

0.06

3.4

4.0

2.65

37.12

ug/l

0.98

312

Lichen planopilaris

148

1.09

0.06

3.3

4.6

5.57

9.66

ug/l

—

117

Abnormality of white blood cells, not elsewhere classified

315

1.05

0.06

3.9

4.7

55.22

21.96

ug/l

0.28

257

Hypertrophic cardiomyopathy

167

1643

1.02

0.06

3.0

4.4

13.71

20.86

ug/l

0.45

147

1365

Pre-eclampsia superimposed on chronic hypertension

104

0.86

0.06

1.3

4.0

2.62

9.29

ug/l

—

Sleep apnoea

5325

33461

1.00

0.06

3.6

4.4

20.46

27.01

ug/l

0.68

4198

27134

Anoxic brain damage

497

0.96

0.06

3.0

4.9

18.37

32.50

ug/l

0.35

417

Other keratitis

416

4199

0.99

0.06

3.6

4.4

10.92

25.41

ug/l

0.90

329

3374

Seronegative rheumatoid arthritis

565

5693

0.99

0.06

3.4

4.4

12.01

26.64

ug/l

2.24

467

4643

Wide developmental disorders, excluding more controls

298

1.05

0.06

2.4

4.9

2.04

30.95

ug/l

0.56

211

Intrahepatic Cholestasis of Pregnancy (ICP)

165

1624

1.02

0.06

5.1

3.9

33.57

35.86

ug/l

0.02

116

1152

Emotional disorders and disorders of social functioning with onset specific to childhood

417

0.96

0.06

2.6

4.0

13.84

6.15

ug/l

0.32

258

Childhood allergy (age < 16)

110

888

1.02

0.06

3.1

3.7

3.76

4.15

ug/l

0.08

495

Foreign body or object entering through skin

200

1973

1.01

0.06

4.0

4.7

56.96

20.71

ug/l

0.46

165

1611

Benign neoplasm: Pituitary gland, craniopharyngeal duct

180

1826

0.98

0.06

4.0

4.3

82.07

22.57

ug/l

0.57

136

1477

Myotonic disorders

247

1.06

0.06

3.2

4.7

7.03

54.21

ug/l

0.81

200

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

159

1566

1.02

0.05

4.1

4.4

55.96

20.90

ug/l

0.32

130

1289

Acute alcohol intoxication ICD-9

129

1268

1.02

0.05

3.9

4.6

22.76

21.76

ug/l

0.03

115

1042

Medial epicondylitis

140

1423

0.98

0.05

4.0

4.9

14.33

27.66

ug/l

0.48

115

1135

Irregular menses

1991

15001

1.00

0.05

3.4

4.1

19.64

21.38

ug/l

0.08

1483

11319

Mixed connective tissue disease

623

1.03

0.05

3.0

4.1

3.89

16.97

ug/l

1.20

510

Mumps, including avohilmo

859

0.98

0.05

4.2

4.5

22.29

26.09

ug/l

0.07

693

Renal tubulo-interstitial disorders in diseases classified elsewhere

354

0.96

0.05

2.3

4.7

3.19

37.08

ug/l

0.90

298

Episcleritis

181

1835

0.99

0.05

3.6

4.4

7.83

19.52

ug/l

1.12

136

1464

Unequal limb length (acquired)

141

0.92

0.05

4.0

4.8

2.14

7.63

ug/l

—

119

Other disorders of breast and lactation associated with childbirth

267

1.05

0.05

2.8

4.1

2.21

9.38

ug/l

2.15

188

Autism

257

1.05

0.05

2.3

4.6

2.17

6.27

ug/l

1.36

179

Stenosis and insufficiency of lacrimal passages

420

4234

0.99

0.05

3.6

4.1

11.52

22.04

ug/l

1.07

346

3448

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

208

1.06

0.05

2.9

4.6

2.55

6.86

ug/l

0.99

153

Other papulosquamous disorders

396

1.04

0.05

3.8

4.3

14.73

19.12

ug/l

0.13

329

Keratoconus

713

1.03

0.05

4.1

4.9

7.36

26.50

ug/l

0.94

585

Mental and behavioural disorders associated with the puerperium

232

0.95

0.05

2.9

4.3

2.55

6.82

ug/l

1.36

174

Pterygium

124

1260

0.98

0.05

3.3

4.3

28.88

24.92

ug/l

0.06

1053

Crowding of teeth, including avohilmo

138

1160

0.98

0.05

3.3

4.2

7.49

14.34

ug/l

0.43

829

Nonsuppurative otitis media

651

5679

0.99

0.05

3.7

4.2

8.78

27.82

ug/l

2.01

500

4405

Impacted teeth

346

2994

0.99

0.05

4.1

3.87

28.40

ug/l

1.24

246

2116

Atopic dermatitis, strict definition with reimbursement

988

9445

1.00

0.05

3.5

4.3

41.88

22.36

ug/l

0.44

777

7186

Trigger finger

698

7018

0.99

0.04

3.4

4.7

20.91

29.92

ug/l

0.29

574

5637

Melanoma in situ, other sites/unspecified

150

0.93

0.04

1.4

4.7

49.90

38.54

ug/l

—

120

Hereditary corneal dystrophies

153

1550

0.99

0.04

4.0

4.5

6.42

19.84

ug/l

1.46

114

1281

Toxic effect of alcohol

665

0.98

0.04

3.9

4.8

8.28

29.95

ug/l

0.96

547

Migraine, unspecified, drug-induced

231

0.95

0.04

2.8

4.1

3.34

8.87

ug/l

1.48

188

Melanoma in situ of upper limb, including shoulder

332

0.96

0.04

3.8

4.5

3.50

27.94

ug/l

1.03

282

Strabismus

1060

10612

1.00

0.04

3.6

4.3

21.90

26.88

ug/l

0.12

839

8476

Degeneration of the brain due to alcohol

904

1.02

0.04

2.6

4.7

9.45

28.17

ug/l

1.03

755

Villonodular synovitis (pigmented)

259

1.05

0.04

5.0

4.8

2.64

7.86

ug/l

1.82

220

Other disorders of choroid

527

1.03

0.04

3.9

4.2

30.19

15.16

ug/l

0.22

447

Other and unspecified atrophic disorders of skin

200

1.06

0.04

2.3

4.2

2.28

9.46

ug/l

2.36

164

Convergence insufficiency and excess

291

0.96

0.04

3.9

4.3

2.25

21.59

ug/l

0.68

226

Lesion of sciatic nerve

188

1899

0.99

0.04

4.1

4.2

33.06

23.72

ug/l

0.13

167

1578

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

159

1608

0.99

0.04

3.4

4.7

7.47

27.14

ug/l

1.90

127

1276

Dislocation, sprain and strain of joints and ligaments of elbow

200

1981

1.01

0.03

3.7

4.5

14.06

22.19

ug/l

0.55

150

1553

Eating disorders

220

2216

0.99

0.03

2.7

3.9

100.05

31.02

ug/l

0.49

160

1618

Conjunctivitis (acute, non atopic), including avohilmo

5476

33087

1.00

0.03

3.8

4.4

19.60

27.58

ug/l

0.93

4202

26905

Mouth breathing

1831

18324

1.00

0.03

3.8

4.5

17.64

29.68

ug/l

1.70

1439

14919

Fall on and from ladder

317

3149

1.01

0.03

4.3

4.5

10.98

23.86

ug/l

1.62

254

2616

Benign neoplasm: Connective and other soft tissue, unspecified

411

0.97

0.03

4.3

4.2

3.15

18.98

ug/l

0.90

341

Disorder of external ear, unspecified

124

1255

0.99

0.03

3.8

4.5

5.31

22.76

ug/l

1.70

1038

Myasthenia gravis

658

1.02

0.03

3.4

4.5

395.25

29.92

ug/l

0.48

554

Conduct disorder

300

0.97

0.03

1.9

4.6

27.35

21.41

ug/l

0.09

229

Adhesive middle ear disease

471

0.97

0.03

3.6

4.6

23.16

37.22

ug/l

0.30

393

Sequelae of injuries of head

177

1786

0.99

0.03

3.0

4.6

7.83

19.85

ug/l

1.38

135

1450

Atypical virus infections of central nervous system, including avohilmo

340

0.97

0.03

5.7

4.6

15.61

19.10

ug/l

0.08

285

Eating disorder

142

1432

0.99

0.03

2.5

3.9

42.88

39.95

ug/l

0.03

100

983

Other disorders of cornea

421

4189

1.01

0.03

4.4

4.3

5.92

17.79

ug/l

3.50

332

3391

Open wound of hip and thigh

983

0.99

0.03

3.5

4.8

3.77

26.77

ug/l

1.82

797

Clubfoot

221

1.04

0.03

2.6

5.1

51.42

6.72

ug/l

0.45

176

Increased muscle tone

229

0.96

0.03

1.9

4.5

2.48

35.46

ug/l

0.58

191

Motorcycle rider injured in other and unspecified transport accidents

136

1374

0.99

0.03

3.9

4.8

30.86

22.70

ug/l

0.13

113

1100

Other sexually transmitted chlamydial diseases, including avohilmo

134

1354

0.99

0.03

3.6

4.3

9.45

44.45

ug/l

0.63

909

Other melanin hyperpigmentation

938

1.01

0.02

3.3

4.2

4.05

23.60

ug/l

1.56

769

Burn and corrosion of hip and lower limb, except ankle and foot

681

0.98

0.02

3.1

4.6

3.53

28.66

ug/l

1.36

568

HSIL lesion of the vagina

480

1.02

0.02

4.6

4.1

2.39

10.12

ug/l

4.05

384

Heart failure and hypertrophic cardiomyopathy

759

1.02

0.02

2.3

4.4

16.73

26.95

ug/l

0.31

642

Corneal ulcer

751

7488

1.00

0.02

3.8

4.4

9.18

25.36

ug/l

2.24

611

6018

Pulmonary oedema

690

0.98

0.02

3.8

4.3

4.20

29.96

ug/l

1.49

588

Maternal care for known or suspected fetal abnormality and damage

385

3245

1.00

0.02

4.0

3.8

7.31

20.62

ug/l

0.57

233

2209

Pigmented purpuric dermatosis

401

1.02

0.02

4.5

6.31

9.41

ug/l

0.51

337

Trigeminal neuralgia

244

2426

1.01

0.02

3.3

4.3

16.23

19.59

ug/l

0.12

193

1933

Hypothermia

690

1.02

0.02

3.4

4.5

10.05

26.81

ug/l

0.73

578

Use of antiglaucoma preparations and miotics

379

3805

1.00

0.02

3.7

3.9

19.16

27.01

ug/l

0.36

314

3156

Wide developmental disorders

327

0.97

0.02

2.4

4.3

2.04

5.54

ug/l

1.52

227

Cardiomyopathies, Primary/intrinsic

558

5563

1.00

0.02

3.3

4.9

10.25

29.88

ug/l

2.91

463

4726

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

647

1.01

0.02

3.5

4.2

2.63

5.70

ug/l

2.58

443

Postprocedural disorders of nervous system

196

1972

0.99

0.02

3.3

4.5

4.47

33.80

ug/l

0.98

143

1500

Dermatitis herpetiformis

641

1.02

0.02

3.9

4.4

2.61

29.96

ug/l

1.45

543

Early lumbar disc prolapse, operated

239

2402

0.99

0.01

3.6

4.9

14.67

34.50

ug/l

0.66

184

1798

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

378

0.98

0.01

4.8

4.5

2.45

19.79

ug/l

0.90

310

Congenital malformations of spine and bony thorax, including avohilmo

143

1.05

0.01

3.0

4.2

3.73

40.17

ug/l

—

106

Noise effects on inner ear

150

1490

1.01

0.01

3.4

4.8

6.75

22.74

ug/l

1.82

113

1249

Diabetic nephropathy

748

7399

1.00

0.01

3.0

4.0

12.92

23.94

ug/l

1.58

646

6209

Disorders of acoustic nerve

111

1119

0.99

0.01

3.9

4.4

13.01

23.25

ug/l

0.43

930

207

0.96

0.01

2.5

4.6

6.72

30.59

ug/l

0.59

168

Mental and behavioural disorders of puerperium, not classified elsewhere

227

0.97

0.01

2.9

4.1

2.55

6.92

ug/l

1.37

170

Rhinophyma

253

1.03

0.01

3.1

5.1

3.07

66.83

ug/l

1.25

211

Subacute thyroiditis

137

1379

0.99

0.01

3.5

4.3

7.17

23.65

ug/l

1.51

111

1101

Autism spe

253

1.03

0.01

2.4

4.6

2.17

6.32

ug/l

1.37

178

Restless leg syndrome

652

6508

1.00

0.01

3.5

4.2

30.47

26.31

ug/l

0.06

529

5255

Fasciculation

347

0.98

0.01

3.2

4.9

2.76

8.01

ug/l

2.45

283

Multiple gestation

247

2479

1.00

0.01

3.3

3.8

21.02

25.98

ug/l

0.10

179

1755

Generalized epilepsy, strict definition

503

1.01

0.01

4.6

4.3

3.46

37.31

ug/l

1.32

413

Supervision of normal pregnancy

596

3394

1.00

0.01

3.8

3.7

29.83

15.68

ug/l

0.50

399

2452

Maternal care for cervical incompetence

133

1323

1.01

0.00

3.4

4.3

77.28

10.76

ug/l

0.48

105

1049

Congenital dislocation of hip, unilateral

146

0.96

0.00

4.4

4.9

2.49

7.71

ug/l

2.02

117

Benign neoplasm: Brain, unspecified

194

1.03

0.00

1.6

4.4

2.24

31.68

ug/l

0.76

162

Caries in Clefts patients

194

1.03

0.00

2.4

4.5

166.81

29.06

ug/l

0.37

148

Nystagmus and other irregular eye movements

396

0.98

0.00

4.6

4.4

3.94

18.27

ug/l

0.73

324

Cutis laxa senilis

326

0.98

0.00

2.4

4.0

22.28

6.64

ug/l

0.52

270

Cervicobrachial syndrome

1043

10438

1.00

0.00

3.5

4.5

5.15

28.20

ug/l

6.62

859

8308

Atypical virus infections of central nervous system

336

0.98

0.00

5.7

4.6

15.61

19.34

ug/l

0.09

281

Congenital malformations of the nervous system

426

0.99

0.00

2.7

4.3

2.91

18.70

ug/l

0.86

330

Contact with sharp object, undetermined intent

664

1.01

0.00

3.9

4.9

7.86

32.70

ug/l

1.11

540

Burn and corrosion of trunk

996

0.99

0.00

4.6

6.77

26.51

ug/l

1.41

824

Traumatic subdural haemorrhage

750

7006

1.00

0.00

3.7

4.8

7.29

28.45

ug/l

9.19

628

5935

Female genital prolapse

1403

7802

1.00

0.00

3.4

4.4

8.41

31.82

ug/l

3.61

1076

6265

Carpal tunnel syndrome

3415

29566

1.00

0.00

3.6

4.4

13.98

25.98

ug/l

2.83

2797

23727

Heterophoria

260

2597

1.00

0.00

3.9

4.4

5.26

31.94

ug/l

1.32

194

2040

Other juvenile arthritis

771

1.00

0.00

4.1

4.6

7.48

26.51

ug/l

0.90

590

Postpartum haemorrhage due to retained placenta

309

3092

1.00

0.00

3.8

12.32

32.59

ug/l

0.85

207

2207

Hyperkinetic disorders (excl. ADHD)

190

0.98

0.00

1.4

4.6

1.95

5.71

ug/l

1.52

132

Certolizumab pegol

415

1.01

0.00

3.3

4.1

3.00

7.54

ug/l

2.12

318

Adult respiratory distress syndrome

485

0.99

0.00

2.7

4.4

4.81

39.26

ug/l

1.30

402

Paranoid personality disorder

525

0.99

0.00

2.6

4.6

23.59

33.31

ug/l

0.15

427

CR(E)ST syndrome

605

0.99

0.00

2.4

4.1

4.62

8.95

ug/l

1.91

487

394

0.99

0.00

2.5

4.7

5.31

45.27

ug/l

1.21

330

Myocardial infarction, with ST-elevation

857

8566

1.00

0.00

3.5

4.3

13.80

26.11

ug/l

1.47

714

7216

Acute myringitis

212

0.99

0.00

2.7

4.7

2.81

8.96

ug/l

2.39

172

Hereditary ataxia

473

0.99

0.00

4.5

4.7

4.28

34.08

ug/l

1.13

403

Calcaneal spur

503

0.99

0.00

2.6

4.8

23.35

22.60

ug/l

0.01

405

Inflammation of lacrimal passages (acute and unspecified)

647

1.01

0.00

4.8

4.2

12.47

25.95

ug/l

0.45

533

Poisoning by medicine, drug-induced

378

1.01

0.00

4.4

2.70

17.82

ug/l

0.72

303

Abscess of external ear

402

0.99

0.00

3.0

4.6

5.26

38.10

ug/l

0.99

334

ILD medications: nintedanib

226

1.02

0.00

1.6

5.7

13.08

39.46

ug/l

0.58

189

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

139

1.01

0.00

5.7

4.4

7.61

3.27

ug/l

—

101

Hypersensitivity pneumonitis due to organic dust

608

1.00

0.00

3.0

4.6

18.86

31.54

ug/l

0.32

510

Cleft palate

171

0.99

0.00

2.6

4.7

184.15

9.37

ug/l

—

130

Atlantoaxial subluxation

251

1.00

0.00

3.0

4.8

2.54

25.08

ug/l

0.74

207

Other hammer toe(s) (acquired)

993

9028

1.00

0.00

3.5

4.5

11.40

26.97

ug/l

2.13

805

7465

Twin gestation

237

2374

1.00

0.00

3.3

3.8

21.78

26.57

ug/l

0.09

172

1686

Disorders of brain, other and unspecified

331

1.00

0.00

2.9

4.7

34.23

46.75

ug/l

0.12

275

Perioral dermatitis

661

1.00

0.00

2.0

4.1

34.61

7.41

ug/l

0.42

510

Behavioural disorders

285

1.02

0.00

1.9

4.7

27.35

22.41

ug/l

0.07

217

Ulcer of oesophagus, drug-induced

177

1.02

0.00

3.7

4.7

4.21

69.61

ug/l

0.87

151

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

108

1075

1.01

0.00

2.7

4.6

3.49

21.38

ug/l

1.58

873

Abscess of tendon sheath

227

1.01

0.00

3.8

4.8

2.13

8.92

ug/l

2.61

187

Dislocation, sprain and strain of joint and ligaments of hip

156

1555

1.00

0.00

3.6

4.3

6.36

21.00

ug/l

1.71

129

1288

Carcinoma in situ of uteri, other/unspecified

216

1.02

0.00

4.0

4.1

4.50

8.60

ug/l

0.92

168

Other congenital malformations, not elsewhere classified

174

0.98

0.00

3.6

4.3

2.81

9.92

ug/l

—

137

Mastocytosis

188

1.01

0.00

2.3

5.0

2.93

32.36

ug/l

0.67

149

Other intestinal obstruction of newborn

0.00

0.0

6.8

—

54.04

—

Arenaviral haemorrhagic fever

0.00

0.0

3.4

—

10.49

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.90

0.00

2.4

4.2

2.27

65.05

ug/l

—

Epileptic seizures related to drugs

0.93

-0.00

1.3

3.8

2.52

7.96

ug/l

—

Other drug-induced secondary parkinsonism

400

1.00

-0.00

2.4

4.7

4.15

24.05

ug/l

1.00

341

Defects in glycoprotein degradation

0.00

-0.00

0.0

1.8

—

5.64

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

1.02

-0.00

6.4

4.3

1.48

9.21

ug/l

—

Megavitamin-B6 syndrome

0.00

-0.00

0.0

6.3

—

3.72

—

Rickettsioses

1.02

-0.00

1.6

4.4

1.79

108.85

ug/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

560

1.00

-0.00

4.4

13.02

34.99

ug/l

0.75

464

Androgen resistance syndrome

0.00

-0.00

0.0

1.0

—

1.72

—

Maple-syrup-urine disease

0.00

-0.00

0.0

3.2

—

14.12

—

Personal history of risk-factors, not elsewhere classified

310

1.00

-0.00

2.2

4.8

9.15

20.04

ug/l

0.33

250

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.87

-0.00

2.0

5.0

36.27

11.83

ug/l

—

Congenital ectropion

0.00

-0.00

0.0

5.2

—

34.50

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

-0.00

0.0

6.9

—

9.35

—

Bullous disorders in diseases classified elsewhere

0.00

-0.00

0.0

3.6

—

25.10

—

Cramp and spasm

161

1610

1.00

-0.00

3.5

4.4

5.25

18.80

ug/l

1.65

124

1295

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

2.9

—

26.20

—

Arenaviral haemorrhagic fever, including avohilmo

0.00

-0.00

0.0

3.4

—

10.49

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS